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Abstract 
This thesis aimed to design novel sensor proteins that can identify and measure 
various metal ions in vivo and in situ.  Metal ions play key role in the metabolism of the 
cell, and monitoring of calcium has helped interrogate cellular processes such as 
fertilisation, contraction and apoptosis.  Real-time monitoring of more divalent metal 
ions like zinc and copper is required to gain much needed insight into brain function and 
associated disorders, such as Alzheimer’s and Parkinson’s disease.   
Aequorin is a calcium-regulated photoprotein originally isolated from the 
jellyfish Aequorea victoria.  Due to its high sensitivity to calcium and its non-invasive 
nature, aequorin has been used as a real-time indicator of calcium ions in biological 
systems for more than forty years.  The protein complex consists of the polypeptide 
chain apoaequorin and a tightly bound chromophore (coelenterazine).  Trace amounts of 
calcium ions trigger conformational changes in the protein, which in turn facilitate the 
intermolecular oxidation of coelenterazine and concomitant production of CO2 and a 
flash of blue light.   
Aequorin’s light emitting reaction can also be triggered by a range of other 
divalent and trivalent cations, leading however to significantly lower light yields.  
Based on aequorin’s promiscuity towards other ions, this project tested the hypothesis 
that aequorin’s preference for certain cations could be manipulated through mutations 
engineered in one or more of the three calcium-binding loops (EF-hands).   
In order to test the hypothesis, the following six stages were performed:  cloning 
of the apoaequorin gene for expression in E. coli; development of a high-throughput 
assay for expression and measurement of bioluminescent activity in microwells; design 
of a library containing forty eight mutant variants of aequorin; screening of the library 
against seven metal ions; protein purification of wild-type aequorin and one selected 
mutant; analysis of activity and kinetics of purified wild type and one chosen mutant 
against all seven ions.   
This work produced mutants with shifted selectivity towards new metal ions at 
the cost of luminescence yield.  The impact of mutations is analysed and it is suggested 
that one of the EF-hands (EF-I) is likely to serve as a gatekeeper to aequorin’s 
selectivity.  It was also shown that at least one mutant utilised zinc ions (that wild type 
failed to utilise) to achieve low levels of bioluminescent activity. 
- 5 - 
Acknowledgements 
I would like to thank my supervisor, Professor Paul Dalby for his valuable input 
throughout the duration of my project.  This work would not have been possible without 
his continued support.  I would also like to thank my advisor, Professor Gary Lye for 
his advice and encouragement.  
 
Special thanks go to Dr Rigini Papi, Lazaros Batsilas and Dr Jean Aucamp for 
providing their insights and feedback of my work.  I am also grateful to Dr Martina 
Micheletti for training on the robotic platform I used for all the screening work 
described in this thesis.  I would also like to thank the PhD students of Foster Court and 
UB18, who made the labs feel like a second home.  
 
Finally, I am most grateful to and for my parents, Sophia and Panagiotis and my 
dear friends Issy, Maria, Stephanos, Rigini, Lazaros, Spyros, Erato, Jean, Zehra, Rosie 
and Maria W. for genuine love and support.  Thank you for being patient with all my 
absenses and for waiting on the other side. 
- 6 - 
Contents  
Abstract..............................................................................................................4 
Acknowledgements ...........................................................................................5 
Contents .............................................................................................................6 
List of tables ....................................................................................................15 
List of figures...................................................................................................17 
Abbreviations ..................................................................................................21 
1 Introduction............................................................................................24 
1.1 Bioluminescence ..............................................................................24 
1.1.1 Definitions....................................................................................24 
1.1.2 Bioluminescence in nature ...........................................................26 
1.1.3 Aequorea victoria, the bioluminescent jellyfish ..........................27 
1.1.4 Flash- and glow-type luminescence .............................................28 
1.2 Bioreporters......................................................................................29 
1.2.1 Definitions....................................................................................29 
1.2.2 Need for ion bioreporters .............................................................30 
1.2.3 Desirable characteristics for bioreporters.....................................31 
1.2.4 Signal transduction methods ........................................................32 
1.2.5 Current methods for intracellular ion monitoring ........................34 
1.3 Aequorin:  a calcium-sensitive photoprotein ...................................36 
1.3.1 Introduction ..................................................................................36 
1.3.2 Uses of aequorin...........................................................................40 
1.3.3 Properties of aequorin ..................................................................41 
1.3.4 EF-hand motif:  general features..................................................44 
1.3.4.1 EF-hands and cooperativity ......................................................46 
1.3.5 Proposed mechanism for the bioluminescence reaction ..............47 
1.3.6 Regeneration of aequorin .............................................................47 
1.3.7 Ion selectivity of aequorin............................................................49 
1.3.8 Other photoproteins......................................................................50 
1.4 Coordination of metals in proteins...................................................51 
1.5 Protein engineering ..........................................................................56 
1.5.1 Rational design.............................................................................56 
- 7 - 
1.5.2 Directed evolution........................................................................57 
1.5.3 Integration of random and rational approaches............................58 
1.5.4 Metalloprotein engineering ..........................................................59 
1.6 Overview..........................................................................................60 
1.6.1 Aequorin mutants as potential bioreporters .................................60 
1.6.2 Potential activator ions for aequorin mutants...............................61 
1.7 Aims and organisation of thesis .......................................................62 
2 Materials and Methods ..........................................................................64 
2.1 Preparation of buffers and media .....................................................64 
2.1.1 LB medium ..................................................................................64 
2.1.2 LB agar.........................................................................................64 
2.1.3 YT agar.........................................................................................65 
2.1.4 SOC medium................................................................................65 
2.1.5 Kanamycin ...................................................................................65 
2.1.6 Ampicillin ....................................................................................65 
2.1.7 X-gal.............................................................................................66 
2.1.8 Tris-HCl buffer.............................................................................66 
2.1.9 EDTA ...........................................................................................66 
2.2 Cell culture .......................................................................................67 
2.2.1 E. coli strains................................................................................67 
2.2.1.1 TOP10 electrocompetent ..........................................................67 
2.2.1.2 BL21Star™(DE3) .....................................................................67 
2.2.2 Streaked plates .............................................................................67 
2.2.3 Overnight cultures........................................................................68 
2.2.4 Shake flask cultures......................................................................68 
2.2.5 Glycerol stocks.............................................................................68 
2.2.6 Sonication.....................................................................................68 
2.3 DNA .................................................................................................69 
2.3.1 Preparation of plasmid DNA........................................................69 
2.3.2 PCR amplification........................................................................69 
2.3.3 QuikChange® site-directed mutagenesis ......................................70 
2.3.4 Sequencing ...................................................................................73 
2.3.5 Oligonucleotides for amplification and sequencing.....................73 
2.3.6 Restriction digests ........................................................................73 
- 8 - 
2.3.7 Ligation ........................................................................................74 
2.3.7.1 Standard ligation .......................................................................74 
2.3.7.2 Ligation of TOPO® open vector ...............................................75 
2.3.8 Electrocompetent cell transformation ..........................................76 
2.3.9 DNA agarose gel electrophoresis.................................................76 
2.3.10 Absorbance measurement of DNA ..............................................77 
2.4 Protein ..............................................................................................78 
2.4.1 Determination of protein ..............................................................78 
2.4.1.1 Determination by UV absorbance.............................................78 
2.4.1.2 Determination by Bradford assay .............................................78 
2.4.2 Protein size – SDS-PAGE............................................................79 
2.4.2.1 Protein quantity by SDS-PAGE................................................80 
2.4.2.2 Protein sample purity by SDS-PAGE.......................................80 
2.5 Metal ion concentration....................................................................81 
2.5.1 Ion solution preparation ...............................................................81 
2.5.2 Atomic absorption........................................................................82 
2.6 Automation.......................................................................................82 
2.6.1 Automated colony picking ...........................................................82 
2.6.2 Automated liquid handling...........................................................82 
2.7 Luminescence measurements...........................................................83 
2.7.1 Platereader....................................................................................83 
2.7.1.1 Visualisation of results..............................................................84 
3 Cloning of apoaequorin gene.................................................................85 
3.1 Introduction ......................................................................................85 
3.1.1 Envisaged expression vector ........................................................85 
3.1.2 Cloning strategies.........................................................................86 
3.2 Apoaequorin in original capture vector............................................86 
3.2.1 Verification of apoaequorin gene in pHAQ vector ......................89 
3.3 pET cloning route.............................................................................90 
3.3.1 Vector pET26b .............................................................................91 
3.3.2 Schematic of pET cloning route...................................................92 
3.3.3 Methods for pET cloning .............................................................93 
3.3.4 Results and discussion for pET cloning .......................................95 
3.4 TOPO® cloning route .....................................................................100 
- 9 - 
3.4.1 Schematic of TOPO® cloning route ...........................................102 
3.4.2 Methods for TOPO® cloning......................................................103 
3.4.2.1 Design of primers....................................................................103 
3.4.2.2 PCR amplifications .................................................................103 
3.4.2.3 TOPO® ligation.......................................................................106 
3.4.3 Results and discussion for TOPO® cloning ...............................107 
3.5 Conclusions ....................................................................................113 
4 High-throughput expression and screening.......................................115 
4.1 Introduction ....................................................................................115 
4.1.1 Steps to developing a high-throughput process .........................115 
4.1.2 Requirements for a high-throughput assay ................................116 
4.2 Materials.........................................................................................118 
4.2.1 Chemicals...................................................................................118 
4.2.2 Consumables ..............................................................................118 
4.3 Method development strategy........................................................119 
4.3.1 Building the assay protocol........................................................119 
4.3.2 Experimental setup A.................................................................120 
4.3.3 Experimental setup B .................................................................122 
4.3.4 Experimental setup C .................................................................123 
4.4 Results and discussion ...................................................................124 
4.4.1 Measurement of cell density in microplates...............................124 
4.4.2 Process parameters .....................................................................126 
4.4.2.1 Choice of vector......................................................................126 
4.4.2.2 Part of culture as screening material.......................................127 
4.4.2.3 IPTG induction .......................................................................127 
4.4.2.4 Choice of bacterial strain ........................................................128 
4.4.2.5 Check for background signal ..................................................129 
4.4.2.6 Activity profile across the microplate.....................................129 
4.4.2.7 Cell growth and activity versus time ......................................132 
4.4.2.8 Optimum coelenterazine concentration ..................................132 
4.4.2.9 Injection, mixing.....................................................................133 
4.4.3 Check for cross-contamination between wells...........................134 
4.4.4 Yield of aequorin in microwells.................................................135 
4.5 Conclusions ....................................................................................137 
- 10 - 
4.5.1 Final process ..............................................................................137 
4.5.1.1 Cloning and microwell cultures..............................................138 
4.5.1.2 Charging of active protein ......................................................139 
4.5.1.3 96-well microplate library ......................................................139 
4.5.1.4 High-throughput screening assay............................................139 
4.5.2 Further improvements to the method .........................................140 
5 Aequorin structure and mutant library design .................................141 
5.1 Aequorin:  detailed structure..........................................................142 
5.1.1 Coelenterazine-binding cavity and calcium-binding EF-hands .142 
5.1.2 H-bond coupling of EF-hands....................................................146 
5.1.3 Theories on signal transduction following calcium binding ......149 
5.2 Previous mutagenesis on aequorin .................................................151 
5.2.1 Calcium sensitivity.....................................................................151 
5.2.2 Impaired EF-hands / central Gly→Arg mutations .....................152 
5.2.3 Spectral shift...............................................................................154 
5.2.4 Intensity......................................................................................154 
5.2.5 Thermostability ..........................................................................155 
5.3 Mutation of other calcium-binding structures................................158 
5.3.1 Short peptides with calcium-binding ability ..............................158 
5.3.2 EF-hand loops in model proteins ...............................................159 
5.4 Structural analysis methods ...........................................................161 
5.4.1 Crystallographic structure examination .....................................161 
5.4.2 Interatomic overlap calculations ................................................161 
5.5 Results and discussion ...................................................................163 
5.5.1 Calcium-free versus calcium-bound aequorin structure ............163 
5.5.2 Movement of residues to coordinate calcium ............................165 
5.5.3 Overlap of atomic radii in the ion-binding loop ........................169 
5.6 Conclusions ....................................................................................173 
5.6.1 Conclusions from structural analysis .........................................173 
5.6.2 Conclusions from previous mutational studies ..........................174 
5.6.3 Choice of mutant library ............................................................174 
6 Library screening and mutant selection ............................................180 
6.1 Introduction ....................................................................................180 
6.1.1 Creation of mutant library..........................................................180 
- 11 - 
6.1.2 Previous work in methods of aequorin mutagenesis..................180 
6.1.3 Screening of mutant library........................................................182 
6.2 Methods..........................................................................................184 
6.2.1 Mutant library construction........................................................184 
6.2.2 Mutant library layout and screening ..........................................186 
6.2.2.1 Metal ion concentrations for library injection ........................189 
6.2.2.2 Gain settings ...........................................................................189 
6.2.3 Data processing of high-throughput screening ..........................191 
6.3 Results ............................................................................................194 
6.3.1 Library creation results ..............................................................194 
6.3.2 Library screening results ............................................................196 
6.4 Discussion ......................................................................................210 
6.4.1 Overall effect on yield................................................................210 
6.4.2 Selectivity (D) versus retained activity (C)................................211 
6.4.3 EF-I versus EF-III ......................................................................211 
6.4.4 Ala-scan mutants and importance of side chains .......................212 
6.4.5 Importance of loop positions......................................................212 
6.4.6 Type of substitution ...................................................................213 
6.4.7 Impairment of EF-hands:  central Gly mutants..........................215 
6.4.8 Double mutations .......................................................................217 
6.4.9 Software for prediction of mutation effects ...............................217 
6.5 Conclusions ....................................................................................218 
6.5.1 Choice of mutant for further study.............................................220 
7 Protein purification..............................................................................221 
7.1 Introduction ....................................................................................221 
7.2 Materials.........................................................................................222 
7.3 Methods..........................................................................................223 
7.3.1 Culture........................................................................................223 
7.3.1.1 Host strain and plasmid...........................................................223 
7.3.1.2 Cell growth .............................................................................223 
7.3.2 Regeneration and extraction of aequorin ...................................223 
7.3.2.1 One-step extraction and charging of active aequorin .............223 
7.3.2.2 Periplasmic fraction ................................................................224 
7.3.3 Concentration of aequorin..........................................................225 
- 12 - 
7.3.3.1 Spin-filtration..........................................................................225 
7.3.4 Luminescence assay...................................................................226 
7.3.5 Size exclusion chromatography .................................................226 
7.3.5.1 Protein size by mass spectrometry..........................................227 
7.3.6 Protein handling considerations .................................................228 
7.4 Results and Discussion...................................................................229 
7.4.1 Bacterial cell culture ..................................................................229 
7.4.1.1 OD and activity versus incubation time..................................229 
7.4.2 Localisation of protein ...............................................................231 
7.4.2.1 Localisation of protein in the cell ...........................................231 
7.4.2.2 Localisation of protein after coelenterazine incubation..........232 
7.4.2.3 Periplasmic fraction ................................................................234 
7.4.3 Clarification of protein sample...................................................236 
7.4.4 Enrichment of aequorin prior to chromatography......................237 
7.4.4.1 Spin-filtration..........................................................................237 
7.4.4.2 Mass spectrometry of spin-concentrated sample ....................238 
7.4.5 Storage of purified fractions.......................................................238 
7.4.6 Size exclusion chromatography of aequorin:  wild-type, mutant and 
commercial aequorin..........................................................................................238 
7.4.7 SDS-PAGE of purified samples.................................................241 
7.4.8 Mass spectrometry of purified samples .....................................242 
7.5 Conclusions ....................................................................................244 
7.5.1 Improvements to the process......................................................246 
8 Response of wild-type aequorin and mutant Asn28Cys/Ser32His to 
seven metal ions ........................................................................................................247 
8.1 Introduction ....................................................................................248 
8.1.1 Binding studies...........................................................................248 
8.1.2 Affinity and apparent affinity.....................................................249 
8.1.3 Allostery and cooperativity ........................................................252 
8.1.4 Concentration-response curves ..................................................254 
8.1.5 The aequorin system ..................................................................256 
8.1.5.1 Fundamental work on the kinetics of aequorin.......................257 
8.1.5.2 A model of double exponential decay ....................................258 
8.2 Materials and methods ...................................................................260 
- 13 - 
8.2.1 Aequorin and coelenterazine......................................................260 
8.2.2 Protein concentration .................................................................260 
8.2.3 Concentration range of metal ions .............................................261 
8.2.4 Experimental setup and platereader settings ..............................261 
8.2.5 Method for double ion experiment.............................................263 
8.2.6 Data processing ..........................................................................263 
8.2.6.1 Luminescence curves and concentration-response curves......263 
8.2.6.2 Exponential model fitting .......................................................264 
8.2.6.3 Estimation of glow luminescence kinetics..............................264 
8.2.7 Artefacts from syringe injection.................................................265 
8.2.8 Assay objectives and limitations................................................266 
8.3 Results and discussion ...................................................................267 
8.3.1 Luminescence curves: flash and glow-type ...............................267 
8.3.2 Concentration-response curves ..................................................271 
8.3.3 Light yield comparison across all metals with wild-type and mutant 
aequorin ....................................................................................................277 
8.3.4 Analysis of bioluminescence kinetics ........................................280 
8.3.4.1 Flash-type luminescence:  Model of double exponential decay ...
 ................................................................................................280 
8.3.4.2 Glow-type luminescence kinetics ...........................................287 
8.3.5 Double ion experiments: wild type plus Zn2+ and Ca2+ .............289 
8.3.6 Correlation of ion size and shape of luminescence curve ..........294 
8.4 Conclusion .....................................................................................297 
9 Epilogue.................................................................................................301 
9.1 Overall summary of this project.....................................................301 
9.2 Overall conclusions........................................................................304 
9.2.1 Cloning of apoaequorin gene .....................................................304 
9.2.2 High-throughput screening process............................................304 
9.2.3 Mutant library screening ............................................................305 
9.2.4 Purification of aequorin..............................................................306 
9.2.5 Study of purified wild-type aequorin and mutant 
Asn28Cys/Ser32His ...........................................................................................306 
9.3 Future work ....................................................................................308 
9.3.1 Breaking down the problem.......................................................308 
- 14 - 
9.3.2 Mutational strategy.....................................................................309 
9.3.3 Repairing aequorin activity ........................................................310 
9.3.4 Alternative scaffold....................................................................310 
9.3.5 Alternative application ...............................................................311 
9.4 Analytics for future work ...............................................................311 
9.5 Value and risks of the project.........................................................313 
Appendix........................................................................................................315 
Appendix Chapter 1 ....................................................................................315 
Appendix Chapter 5 ....................................................................................323 
Appendix Chapter 6 ....................................................................................330 
Appendix Chapter 7 ....................................................................................332 
Appendix Chapter 8 ....................................................................................333 
References......................................................................................................334 
- 15 - 
List of tables 
Table 1-1  Aequorea victoria taxonomy .........................................................................27 
Table 1-2  Comparative sensitivity of detection methods...............................................32 
Table 1-3  Comparison of bioluminescent and fluorescent reporters .............................33 
Table 1-4  Amino acid sequence preference in the EF-hand loop ..................................45 
Table 1-5  Aequorin tested against ions for triggering light-emitting reaction...............49 
Table 1-6  Identity between aequorin and other Ca2+-binding proteins..........................51 
Table 1-7  Summary of preferred coordination geometries of metal ions derived from 
PDB and CSD .........................................................................................................52 
Table 1-8  Distances around metal ions from the PDB and CSD ...................................53 
Table 1-9  Metal-binding sites and experimental metal binding constants for ion-binding 
proteins....................................................................................................................55 
Table 2-1  PCR mix – general cloning............................................................................69 
Table 2-2  PCR cycles – general cloning ........................................................................70 
Table 2-3  PCR mix – QuikChange® ..............................................................................72 
Table 2-4  PCR cycles – QuikChange® ..........................................................................72 
Table 2-5  Double digestion reaction mixture.................................................................74 
Table 2-6  CloneSmart® ligation mixture .......................................................................75 
Table 2-7  TOPO® capture vector ligation mixture ........................................................75 
Table 2-8  Agarose gel concentrations............................................................................77 
Table 2-9  Metals in the form of hydrated salts ..............................................................81 
Table 3-1  Oligonucleotides for pET26b cloning route and sequencing ........................94 
Table 3-2  PCR amplification of apoaequorin from pHAQ............................................94 
Table 3-3  Oligonucleotides for TOPO® cloning route and sequencing.......................105 
Table 3-4  PCR conditions for TOPO® cloning............................................................105 
Table 3-5  PCR mix for TOPO® cloning reactions .......................................................106 
Table 4-1  Variation across the microplate with and without thermal insulation .........131 
Table 4-2  List of parameters chosen for the high-throughput assay............................138 
Table 5-1  Previous mutational work on aequorin.  Selected literature. .......................156 
Table 5-2  Properties of aequorin with coelenterazine and some of its analogues .......157 
Table 5-3  Shifts of residue positions between Ca2+-free and Ca2+-bound EF-hands...168 
Table 5-4  Mutants Nr 1-23...........................................................................................178 
- 16 - 
Table 5-5  Mutants Nr 24–48. .......................................................................................179 
Table 6-1  PCR conditions for creating mutants Nr 1–48.............................................185 
Table 6-2  Metal ion stock concentrations and platereader gain settings for library 
screening ...............................................................................................................190 
Table 7-1  Yield and purity of purified aequorin ..........................................................245 
Table 8-1  Aequorin kinetic constants in published literature ......................................257 
Table 8-2  Luminescence curve shapes.........................................................................268 
Table 8-3  Summary of characteristics of luminescence versus time and      
concentration-response curves ..............................................................................276 
Table 8-4  Metal ion concentrations used for overall yield comparisons .....................278 
Table 8-5  Fast time constant (τF) ranges for flash-type curves ....................................286 
Table 8-6  Slow time constant (τS) ranges for flash-type curves ..................................286 
Table 8-7  Ranges of P15/Max for glow-type curves .......................................................289 
Table 10-1  Intracellular metal ion sensors ...................................................................315 
Table 10-2  Multiple alignment of calcium-binding proteins .......................................317 
Table 10-3  Preferred coordination geometries of metal ions in CSD structures .........320 
Table 10-4  Metal-ligand distances in the CSD and PDB.............................................321 
Table 10-5  Average metal-ligand distances for metal ions as a function of metal charge, 
coordination number (CN), donor atom’s charge and coordination number of 
ligand.....................................................................................................................322 
Table 10-6  Primers for mutants Nr 1–8 .......................................................................323 
Table 10-7  Primers for mutants Nr 9–17 .....................................................................324 
Table 10-8  Primers for mutants Nr 18–23 ...................................................................325 
Table 10-9  Primers for mutants Nr 24–32 ...................................................................326 
Table 10-10  Primers for mutants Nr 33–40 .................................................................327 
Table 10-11  Primers for mutants Nr 41–48 .................................................................328 
Table 10-12  Ionic radii of metals according to their coordination and spin state........329 
Table 10-13  Library OD(600 nm) for aequorin wild-type and mutants ......................330 
Table 10-14  Gain settings used for luminescence curves ............................................333 
 
- 17 - 
List of figures 
Figure 1-1  Classification of light-emitting phenomena .................................................25 
Figure 1-2  View of Aequorea victoria (a)......................................................................28 
Figure 1-3  View of Aequorea victoria (b) .....................................................................28 
Figure 1-4  Typical schematics of flash- and glow-type luminescence ..........................29 
Figure 1-5  Schematic of the bioluminescent reaction of photoprotein aequorin ...........39 
Figure 1-6  Schematic of sigmoidal curve for light emission versus Ca2+ concentration39 
Figure 1-7  3-D model of aequorin with coelenterazine in the hydrophobic core ..........42 
Figure 1-8  Apoaequorin with calcium ions in the Ca2+-binding loops (EF-hands) .......42 
Figure 1-9  Conformation states of a photoprotein .........................................................43 
Figure 1-10  The EF-hand calcium-binding loop............................................................44 
Figure 1-11  Proposed reaction for the bioluminescence of aequorin ............................48 
Figure 1-12  Regeneration of aequorin ...........................................................................48 
Figure 2-1  Schematic of QuikChange® II Site-Directed mutagenesis method..............71 
Figure 2-2  Protein ladders used in SDS protein electrophoresis....................................80 
Figure 2-3  Platereader layout – luminescence mode .....................................................83 
Figure 3-1  Overview of worklow employed for cloning in this work ...........................87 
Figure 3-2  pHAQ vector ................................................................................................88 
Figure 3-3  pBluescript vector.........................................................................................88 
Figure 3-4  Plasmid vector pHAQ: agarose gel visualisation .........................................90 
Figure 3-5  pET26b vector and cloning expression region .............................................91 
Figure 3-6  pET26b cloning route schematic..................................................................92 
Figure 3-7  Agarose gel visualisation of pET26b cloning route .....................................96 
Figure 3-8  pETAQ DNA sequencing results (a)............................................................97 
Figure 3-9  pETAQ DNA sequencing results (b)............................................................98 
Figure 3-10  pETAQ open reading frame .......................................................................99 
Figure 3-11  TOPO® capture vector..............................................................................101 
Figure 3-12  TOPO® cloning route schematic ..............................................................102 
Figure 3-13  Agarose gel visualisation of TOPO® cloning route .................................108 
Figure 3-14  TOPAQ DNA sequencing results (a) .......................................................109 
Figure 3-15  TOPAQ DNA sequencing results (b).......................................................110 
Figure 3-16  TOPAQ DNA sequencing results (c) .......................................................111 
- 18 - 
Figure 3-17  TOPAQ open reading frame.....................................................................112 
Figure 4-1  Box diagram of the steps required for a complete HTS protocol...............116 
Figure 4-2  Experimental setup A for defining process parameters..............................120 
Figure 4-3  Experimental setup B for defining process parameters..............................122 
Figure 4-4  Experimental setup C for defining process parameters..............................123 
Figure 4-5  Correlation of cell culture optical densities in microplates and cuvettes ...125 
Figure 4-6  Linearity of OD (600 nm) versus dilution..................................................125 
Figure 4-7  Choice of expression vector .......................................................................126 
Figure 4-8  Part of culture to be used for the screening process ...................................127 
Figure 4-9  Time of induction .....................................................................................1288 
Figure 4-10  Choice of E. coli strain .............................................................................128 
Figure 4-11  Check for background signal....................................................................129 
Figure 4-12  Activity profile across the microplate with and without thermal insulation
...............................................................................................................................130 
Figure 4-13  Luminescence activity and cell density of 96-DSW cultures versus time132 
Figure 4-14  Optimum coelenterazine concentration....................................................133 
Figure 4-15  Check for cross contamination during incubation and injection..............134 
Figure 4-16  Yield of aequorin in luminescence plate microwells ...............................135 
Figure 4-17  Detailed schematic of the finalised high-throughput process ..................136 
Figure 5-1  Peroxidised coelenterazine in the hydrophobic core of aequorin...............144 
Figure 5-2  Coelenterazine binding site in the hydrophobic core of aequorin..............144 
Figure 5-3  Calcium binding in EF-I, EF-III and EF-IV hands of aequorin .................145 
Figure 5-4  Coupling of EF-I and EF-II of aequorin by means of hydrogen bonds .....147 
Figure 5-5  Coupling of EF-III and EF-IV of aequorin by means of hydrogen bonds .147 
Figure 5-6  EF-hand pair coupling residues, van der Waals distance range and cavity of 
aequorin.................................................................................................................148 
Figure 5-7  Aequorin and positions of interesting mutations........................................155 
Figure 5-8  Coelenterazine and nine analogues ............................................................157 
Figure 5-9 Atomic overlap ............................................................................................162 
Figure 5-10  Structurally aligned calcium-free aequorin (1EJ3, chain B) and       
calcium-bound apoaequorin (1SL8)......................................................................164 
Figure 5-11  Shifts in the EF-hands upon calcium binding ..........................................167 
Figure 5-12  Metal-ligand atomic overlap in EF-I of aequorin (a) ...............................170 
Figure 5-13  Metal-ligand atomic overlap in EF-I of aequorin (b) ...............................171 
- 19 - 
Figure 5-14  Metal-ligand atomic overlap in EF-I of aequorin (c) ...............................172 
Figure 6-1  Typical layout of each microplate of the mutant library............................186 
Figure 6-2  Layout of wild type and mutants in the four plates of the library..............188 
Figure 6-3  Illustration of measures of activity (C) and selectivity (D) in data  
processing..............................................................................................................193 
Figure 6-4  DNA agarose gel electrophoresis of mutant Asn28Cys.............................194 
Figure 6-5  DNA agarose gel electrophoresis of mutant Asn28Cys/Ser32His.............195 
Figure 6-6  Visualisation of raw screening data, plates 1 and 2 of library ...................198 
Figure 6-7  Visualisation of raw screening data, plates 3 and 4 of library ...................199 
Figure 6-8  % Activity (C) compared to wild type against all ions tested, for the entire 
library ....................................................................................................................200 
Figure 6-9  D as metric for ion selectivity shift of mutants ..........................................201 
Figure 6-10  D on logarithmic scale..............................................................................202 
Figure 6-11  C (activity compared to wt) of single mutations ......................................203 
Figure 6-12  Selectivity (D) of single mutations...........................................................204 
Figure 6-13  Matrix plot of D, arranged by number of EF-hand mutated ....................205 
Figure 6-14  Matrix plot of D, arranged by position mutated in the EF-hand loop......206 
Figure 6-15  Matrix plot of D, arranged by type of substitution in the EF-hand loop..207 
Figure 6-16  D versus C for all the mutants ..................................................................208 
Figure 6-17  Activity of central Gly mutants (impaired EF-hands)..............................209 
Figure 7-1  Luminescence activity and cell density of 500 mL cultures versus time...230 
Figure 7-2  Localisation of apoaequorin in the cell pellet – (a) ....................................231 
Figure 7-3  Localisation of apoaequorin in the cell pellet – (b)....................................232 
Figure 7-4  Localisation of apoaequorin after charging with coelenterazine................233 
Figure 7-5  Periplasmic extraction SDS gel – (a) of cultures carrying pETAQ and 
pET26b..................................................................................................................235 
Figure 7-6  Periplasmic extraction SDS gel – (b) .........................................................235 
Figure 7-7  Clarification of aequorin suspension after coelenterazine incubation........236 
Figure 7-8  Aequorin suspension concentated using Minisart® filters..........................237 
Figure 7-9  Mass spectrometry of aequorin sample prior to chromatographic purification
...............................................................................................................................238 
Figure 7-10  Elution profiles matched with activity of the elution fractions from size 
exclusion chromatography ....................................................................................240 
Figure 7-11  SDS-PAGE visualisation of purified aequorin samples...........................241 
- 20 - 
Figure 7-12  Mass spectrometry analysis of purified wild-type aequorin ....................243 
Figure 7-13  Mass spectrometry analysis of mutant Asn28Cys/Ser32His....................243 
Figure 7-14  Mass spectrometry analysis of commercial aequorin AquaLite® ............243 
Figure 7-15  Final protocol for the purification of aequorin.........................................245 
Figure 8-1 Bimolecular binding curves plotted on a linear x-axis and a logarithmic       
x-axis .....................................................................................................................251 
Figure 8-2 Bimolecular binding curves illustrating two experimental extremes..........252 
Figure 8-3  Sigmoidal concentration-response curve – stimulation..............................255 
Figure 8-4  Concentration-response curve – inhibition ................................................255 
Figure 8-5  Bell-shaped concentration-response curve.................................................255 
Figure 8-6  Light versus time – Wild-type aequorin.....................................................269 
Figure 8-7 Light versus time – Mutant Asn28Cys/Ser32His........................................270 
Figure 8-8  Concentration-response curves of wild-type aequorin...............................274 
Figure 8-9  Concentration-response curves of mutant Asn28Cys/Ser32His ................275 
Figure 8-10  Wild type against each metal ion .............................................................279 
Figure 8-11  Mutant Asn28Cys/Ser32His against each metal ion ................................279 
Figure 8-12  Decay kinetics of wild-type aequorin.......................................................284 
Figure 8-13 Decay kinetics of mutant Asn28Cys/Ser32His aequorin variant ..............285 
Figure 8-14  Decay kinetics of commercial aequorin AquaLite® .................................286 
Figure 8-15  Metric of reaction progress P15s/Max for glow-type curves........................288 
Figure 8-16  Wild type triggered by zinc and calcium .................................................292 
Figure 8-17  Mutant Asn28Cys/Ser32His aequorin triggered by zinc and calcium .....293 
Figure 8-18  Is radii overlap associated with sharpness of luminescence curves? .......296 
Figure 8-19  Type of luminescence, metal ion sensitivity and interatomic distance in the 
EF-I loop of wild-type aequorin............................................................................296 
Figure 10-1  Sequencing results for mutant Asn28Cys ................................................331 
Figure 10-2  Optimisation of reducing agent in charging of aequorin..........................332 
 
- 21 - 
Abbreviations 
 
AEX  Anion exchange (chromatography) 
BFP  Blue fluorescent protein 
BSA  Bovine serum albumin 
CaB  Calcium-binding 
CaBP  Calcium-binding Proteins 
CaM  Calmodulin 
CD  Circular dichroism 
CN  Coordination number 
CSD  Cambridge Structural Database 
Cys, C  Cysteine 
DMSO  Dimethyl sulfoxide 
DSW  Deep square well (microplate) 
dNTP  Deoxynucleoside triphosphates 
DTT  Dithiotreitol 
EC50  Half maximaleffective concentration 
EDTA  Ethylenediaminetetraacetic acid disodium salt 
EGTA  Ethyleneglycoltetraacetic acid 
ER  Endoplasmic reticulum 
FRET  Fluorescence resonance energy transfer 
GFP  Green fluorescent protein 
GPCRs  G-protein coupled receptors 
GP-HPLC Gel permeation high-performance liquid chromatography 
HIC  Hydrophobic interaction chromatography 
Kd  dissociation constant, µM 
MCS  Multiple cloning site 
MOPS  3-[N-Morpholino] propanesulfonic acid 
MW  Molecular weight 
 
 
 
- 22 - 
 
 
 
MWCO Molecular weight cut-off 
Ni-NTA Nickel-nitrilotriacetic acid 
ompA    outer membrane protein A 
ORF  Open reading frame 
OD  Optical density 
PCR  Polymerase chain reaction 
PDB  Protein data bank 
pET26b Expression vector from Novagen 
pETAQ pET26b with apoaequorin gene insert 
pHAQ  pBluescript vector carrying apoaequorin gene insert 
PMSF  Phenylmethanesulfonyl fluoride 
PP  Pyrophosphate 
PrP  Prion protein 
pTOPAQ TOPO® with T7, rbs, pelB (pET26b), and apoaequorin gene. 
RBP  Retinol binding protein (mammalian serum protein) 
RBS  Ribosome binding site 
RLU  Relative luminescence units 
RO  Reverse osmosis 
SDM  Site-directed mutagenesis 
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
STDEV Standard deviation 
TAE  Tris·acetate EDTA 
TBE  Tris·borate EDTA 
TCA  Trichloroacetic acid 
TnC  Troponin C 
TOPAQ TOPO® with T7, rbs, pelB (pET26b), and apoaequorin gene. 
TOPO® Open capture vector (Invitrogen Inc.) utilising the activity of 
DNA topoisomerase I 
 
 
 
- 23 - 
 
 
 
Tris  Tris(hydroxymethyl)aminomethane 
UV  Ultraviolet 
WELAC Western European Laboratory Accreditation Conference  
 
 
- 24 - 
1 Introduction 
Protein aequorin has been used as the preferred intracellular calcium sensor for 
more than three decades (Shimomura, 1995b).  This introduction aims to illustrate why 
it may be possible to expand the repertoire of aequorin to serve as a reporter for other 
ions such as zinc, cadmium, copper and lead, and thus help map brain disease states 
associated with such ions, like various forms of dementia (i.e.  Parkinson’s and 
Alzheimer’s disease), anxiety and psychosis. 
This chapter initially offers background information on what bioluminescence is and 
how it differs from other forms of light, e.g.  fluorescence, and then reviews 
intracellular biosensing methods based on light emission. The ion-binding properties, 
structure and bioluminescence reaction of aequorin are described, along with its use as a 
calcium probe in biomedical research.  An overview of geometries and distances of ion 
binding in metalloproteins is presented, in order to gain some insight of how metals are 
coordinated in various protein environments.  Protein engineering methods and their 
potential applications for altering aequorin’s ion selectivity are discussed along with 
examples of previous mutagenesis studies of calcium-binding sites. Finally, it is 
suggested that methods currently used for ion measurement in living cells are not 
sufficient to fully understand the role of divalent metals in cellular and tissue 
biochemistry and how mutants of aequorin could fill that gap. 
1.1 Bioluminescence  
1.1.1 Definitions  
Luminescence is the emission of light by a substance that has not been heated 
and in bioluminescence it is typically the result of an oxidation reaction in which 
chemical energy is converted to light energy within a living organism.  If  the 
compounds that generate light are synthetic chemicals, the phenomenon is called 
chemiluminescence (Van Dyke et al., 2002).  To distinguish bioluminescence from 
other light emitting phenomena used in chemistry and biology, it would be appropriate 
to highlight the differences between them (Figure 1-1).  
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Figure 1-1  Classification of light-emitting phenomena (Wong, 2006). 
 
Fluorescence is the emission of light that occurs where electromagnetic 
radiation, often ultraviolet light, is absorbed and “excites” an electron from a lower 
energy atomic orbital into a higher one.  The electron then releases energy in the form 
of light when it falls back to a lower energy state.  Light emission lasts only as long as 
the excitation energy is provided.  Unlike fluorescence, phosphorescence continues for a 
short while after the source of excitation energy is removed and produces light at longer 
wavelengths (lower energy) (Atkins, 2006).   
The two reactants in bioluminescence are often referred to as luciferins and 
luciferases.  Luciferins are the substrate molecules reacted upon to produce light and are 
a family of heterocyclic compounds with structures that vary between organisms (Tran, 
1993).  Luciferases are the enzymes that catalyse the oxidation of the substrate 
luciferins.  None of the major luciferases share sequence homology with each other, but 
Heating involved? 
Mechanical force? 
Excited by light? 
By a living organism? 
Fast? 
Incandescence 
Triboluminescence 
Fluorescence Phosphorescence 
Bioluminescence Chemiluminescence 
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are grouped together as a wide range of enzymes that catalyse the oxidation of substrate 
luciferins (Greer and Szalay, 2002). 
The bioluminescence reaction produces a chemical intermediate that can form at 
least one excited-state compound.  The excited compound relaxes to ground state 
producing non-reactive oxyluciferin and releasing photons (Greer and Szalay, 2002).  A 
simplified schematic of the bioluminescence reaction is provided below (Tran, 1993): 
 hvinOxyluciferinOxyluciferOHOLuciferin Luciferase +→ →++ *22
 
Only a handful of basic luciferin–luciferase systems account for the luciferase 
boluminescence found in many phyla and hundreds of taxa in nature.  This project 
concentrates on coelenterazine bioluminescence.  This phenomenon is found in sea 
animals known as coelenterates.  High-energy complexes that contain luciferin as a 
coelenterazine derived compound, luciferase as a protein chain, require molecular 
oxygen as a co-factor and calcium ions as a trigger of the enzymatic oxidation are 
known as photoproteins (Greer and Szalay, 2002).   
1.1.2 Bioluminescence in nature 
As a predominantly marine phenomenon, it was observed by man from times 
immemorial (Harvey, 1952).  The ability to produce light is a feature of many different 
groups of living organisms, but not shared by any of the higher vertebrates (Herring, 
1978).  Perhaps the most striking biological fact regarding the emission of light by 
animals and plants is the great numbers of totally unrelated and diverse organisms that 
have developed this ability.  Furthermore, one species in a genus may be luminous and 
another closely allied species may contain no trace of luminosity.  Behaviour based on 
natural bioluminescence is attributed to baiting, startle or camouflage and courtship 
(Greer and Szalay, 2002).    
Bioluminescent marine species include:  cnidaria (hydrozoa-hydroids, scyphozoa 
(medusae) and anthozoa (corals, sea pens, etc)), ctenophora (comb-jellies), mollusca 
(includes snails, squid, clams etc), arthropoda (includes sea spiders, millipedes, 
centipedes, insects), echinodermata (starfish).  On land it is most commonly seen as 
glowing fungus on wood (known as foxfire), in the railroad worm and in the few 
families of luminous insects such as fireflies (Haddock, 2004). 
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1.1.3 Aequorea victoria, the bioluminescent jellyfish 
The jellyfish Aequorea victoria (Figure 1-2) is shaped like a hemispherical 
umbrella or bell, (Figure 1-2 and Figure 1-3) with up to 5-10 cm in diameter.  The light 
emitting organs emit blue-green light and are located along the rim of the umbrella.  
This light captured the curiosity of scientists to extract and investigate the molecules 
responsible for light emission.  In the early 1960s (Shimomura, 2005, Shimomura et al., 
1962).  The work contributed two of the most widely used bioreporters to biological 
research:  aequorin and green fluorescent protein (GFP), used respectively as an 
intracellular calcium probe and as an imaging tool for gene expression and intracellular 
processes monitoring (Prendergast, 2000, Shimomura, 2005, Miyawaki, 2008). 
In the jellyfish, the function of aequorin and GFP are coupled:  blue light 
produced by aequorin is absorbed by GFP and emitted as light shifted towards the green 
(~505nm).  Why or how jellyfish use their bioluminescent capabilities is not well 
understood.  They do not glow continuously in the field; in fact, light emission is rarely 
seen in undisturbed animals (Mills, 2008). 
The evolutionary origins of bioluminescence remain obscure.  Rees and co-
workers (1998) have proposed that the anti-oxidative properties of the bioluminescence 
substrates (e.g. coelenterazine) were utilised in emergent bioluminescent systems for the 
detoxification of deleterious oxygen species.  Coelenterazine, which is received by 
jellyfish through their diet (Haddock et al., 2001), is highly reactive towards the 
superoxide anion or peroxides. 
Table 1-1  Aequorea victoria taxonomy (Myers, 2009) 
Kingdom:  Animalia (animals) 
Phylum:   Cnidaria (obsolete term:  Coelenterata) 
Class:      Hydrozoa (hydralike animals, hydroids and hydrozoans) 
Suborder:   Leptomedusae 
Family:   Aequoreidae 
Genus:   Aequorea 
Species:   Aequorea victoria  
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Figure 1-2  View of Aequorea victoria (a).  Picture reproduced from Shimomura (2005).   
Figure 1-3  View of Aequorea victoria (b).  Bottom view of the jellyfish taken in 
daylight and in the dark.  Left:  daylight view;  the overall glow reflects the flash of the 
camera.  Right:  taken in the dark.  The light organs of the jellyfish are located at the rim 
of the “umbrella”.  The bright formation in the centre of the jellyfish is its highly 
expandable mouth (Mills, 2008).  Picture reproduced from Shimomura (2005) and 
(2009).   
1.1.4 Flash- and glow-type luminescence 
The difference between flash- and glow-type luminescence is illustrated in 
Figure 1-4.  Glow-type luminescence involves sustained equilibrium and kinetic 
reactions.  Each type has distinct advantages and disadvantages.  In terms of their use in 
bioanalytical techniques, flash reactions are more useful when studying quick reactions 
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real-time, however they are more difficult to reproduce consistently and require 
equipment that ensures rapid and thorough mixing (Van Dyke et al., 2002).   
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Figure 1-4  Typical schematics of flash- and glow-type luminescence. 
 
1.2 Bioreporters 
1.2.1 Definitions 
A bioreporter is typically an enzyme or bacterium that produces a measurable 
signal in response to a specific chemical or physical agent in its environment.  
Biosensors usually refer to a device that incorporates a bioreporter molecule or 
organism with a transducer that is able to convert the recognition event into a 
measurable signal (Merriam-Webster, 2009, Van Dyke et al., 2002).  The terms 
biosensor and bioreporter are often used interchangeably in literature to refer to the 
molecules or organisms that produce the signal.   
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1.2.2 Need for ion bioreporters 
Metal ions perform a wide variety of specific functions associated with life 
processes.  In many cases, metal ions (e.g.  Zn2+, Mg2+, Ca2+) stabilise the structure of 
folded proteins, while in other cases they help to fix a particular physiologically active 
conformation of the protein.  Metal ions are integral part of many enzymes and are 
indispensable in several catalytic reactions, e.g.  hydrolytic, redox and isomerisation 
reactions.  Alkali and alkaline earth ions, especially Na+, K+ and Ca2+ also play a vital 
role in triggering cellular responses. 
The determination of metal concentration for extracellular components is 
performed by well established methods such as gas chromatography (GC), high 
pressure liquid chromatography (HPLC), and other analytical techniques.  Such 
methods require large equipment and/or highly trained personnel, which limits them to 
central facilities such as scientific institutes, hospitals and universities.  The need for in 
situ environmental monitoring led to the development of portable handheld devices 
which process samples quickly and efficiently.  Such devices are often “whole-cell 
biosensors” based on bacteria or fungi, that are genetically engineered to express 
bioluminescent or fluorescent proteins as a response to specific analytes in their 
environment, or to slow down their metabolic activity and stop emitting light in the 
presence of a deleterious analyte (Bachmann, 2003, Daunert et al., 2000, Keane et al., 
2002, Kohlmeier et al., 2007, Yagi, 2007, Belkin, 2003).   
To study the transients of metal ions from one part of the cell to the other is a 
problem that cannot be solved with devices of the aforementioned scale.  There have 
been extensive studies of intracellular Ca2+ (Allen and Blinks, 1978, Alvarez and 
Montero, 2002, Brini et al., 1997, Brini et al., 1995, Diarra et al., 1999, Shimomura, 
2005, Truong et al., 2001).  However, the study of biologically relevant trace metals 
such as zinc, and copper and contaminants such as cadmium and lead is far less 
advanced.  The increasing interest in brain degenerative diseases and other mental 
disorders and the recent association of metal ions with brain disease states (Faller and 
Hureau, 2009, Garzon-Rodriguez et al., 1999, Han et al., 2008, Karr et al., 2004, Miura 
et al., 2000, Streltsov et al., 2008, Talmard et al., 2007, Tougu et al., 2008), calls for 
new, in vivo and in situ, real-time intracellular metal ion sensors.   
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1.2.3 Desirable characteristics for bioreporters 
Scientists can choose the cellular interrogation system to suit the requirements of 
their experiments, but the available toolbox for intracellular monitoring is still limited 
and a long list of analytes is awaiting their bioreporters (Czarnik, 1995, Martin, 2008a).  
Reporters aimed at monitoring a target analyte have the following preferable 
characteristics.    
• Selectivity:  Reporters ideally respond to the presence of one analyte only.  In 
practice, complete selectivity is an unachievable ideal.  However, many 
potentially interfering species are either not present in biological samples or in 
the cellular compartment of interest in sufficient concentrations to cause a 
detectable interference.  The supply of competitive metals in cells is maintained 
in limited supply through the function of metal importers, exporters and metal 
stores, making proteins compete for metals rather than the other way around 
(Waldron et al., 2009). 
• High sensitivity:  A large change in signal in response to small changes in 
analyte concentrations would enable better quantitation of cellular signals. 
• Dynamic range:  The reporter must respond to physiologically relevant 
concentrations of the target ion in various compartments of the cell.  The 
concentration range may be very wide.  For example, in the cytoplasm of resting 
cells Ca2+ is maintained at ~100 nM, while in the endoplasmic reticulum (ER) it 
is stored at hundreds of micromolar (Palmer, 2009).   
• High signal-to-noise-ratio:  As a rule of thumb, it is desirable that light 
readings are higher than three standard deviations of the background noise. 
• Cellular localisation:  Localisation of probes to individual compartments of the 
cell enables the dissection of the origin and destination of ion signals. 
• Non-invasive:  Probes are preferred that do not interfere with cellular functions.   
• Safety:  Non-toxic and non-radioactive probes are preferred. 
• Fast-response kinetics:  Rapid measurement allows real-time monitoring of 
cellular functions. 
• Quantitative:  While qualitative (presence or absence of analyte) data is useful, 
more advanced studies require time-dependent quantitation of analyte 
concentrations. 
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• Signal wavelength:  Optical signals are often attenuated when monitored 
through certain thicknesses of tissue.  Red and infrared wavelengths are 
preferable as they penetrate through tissue more effectively than the other 
colours. 
1.2.4 Signal transduction methods 
Fluorescent, bioluminescent and radioactive labels are used in wide range of 
bioanalytical techniques (Van Dyke et al., 2002).  Radioactive labels are less preferred 
than fluorescent or bioluminescent ones due to safety handling considerations.  A 
comparison of sensitivity of methods is presented in Table 1-2.   
Table 1-2  Comparative sensitivity of detection methods (Van Dyke et al., 2002). 
Methods   Limit of detection 
Luminescence   10-19 M 
Radioisotope   10-18 M  
Fluorescence   10-12 M 
Absorbance   10 -9 M 
 
The main constraints are linked to the fact that fluorescence requires light 
excitation, which generates autofluorescence, photobleaching, and phototoxicity.  
Background fluorescence (or autofluorescence) is an inherent problem in biological 
samples, and as the scale of the samples decreases and lower level of detection is 
required, background fluorescence becomes more evident.  Bioluminescence is a 
relatively rare phenomenon in non-marine organisms and usually absent in the types of 
systems studied in biomedical sciences.  This allows for the detection of the proteins at 
extremely low levels, making these photoproteins attractive labels for analytical 
applications (Lewis and Daunert, 2000).   
Photobleaching and phototoxicity limit the duration of recording, while the 
autofluorescence prevents the recording of deep structures.  Fast phenomena can be 
monitored, with short time imaging, while the imaging of deep structures still remains 
difficult.  The real contribution of the phototoxicity to the signal itself is difficult to 
evaluate, since it is inherent to the technique (i.e. light excitation).  Additionally, the 
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excitation required is in some cases within the ultraviolet range.  UV exposure can be 
lethal to the cells in long running experiments.  Bioluminescence does not require light 
excitation and consequently, does not generate auto-fluorescence.  In terms of tissue 
depth, bioluminescence was used to monitor calcium ion activity in the ellipsoid body, 
which is located relatively deep within the brain (Martin, 2008b).   
Table 1-3  Comparison of bioluminescent and fluorescent reporters (Martin, 2008b). 
Bioluminescent reporter Fluorescent reporter 
Non-invasive (genetically encoded) Invasive (dye) or non-invasive 
(genetically encoded) 
Very good signal-to-noise ratio Generally brighter, but low signal-to-
noise ratio 
No excitation required Requires light excitation 
Bifunctional:  visualisation of localisation by 
fluorescence 
 
Autofluorescence 
Non-toxic Phototoxicity 
Long-term imaging (hours or few days of 
constant monitoring) 
 
Photobleaching 
Moderate spatial resolution Very good spatial resolution 
In vivo whole-animal imaging High temporal resolution when imaging  
for short durations 
 
A limitation of bioluminescence is that such reporters currently do not have the 
multiplexing capability that fluorescent labels do, where a wide variety of fluorescent 
markers can be utilised in a single assay and easily distinguished from one another.  
Attempts to change this are underway, and it is now possible to resolve signals from a 
dual bioluminescent assay based on the different kinetics of the bioluminescent reporter 
molecules (Rowe et al., 2008a).   
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1.2.5 Current methods for intracellular ion monitoring 
With non-destructive monitoring and accurate detection of weak optical signals, 
bioluminescent molecules have been used in a plethora of intracellular assays:  
monitoring important biological molecules (e.g. calcium, ATP);  whole cell biosensor 
assays and tracking the survival of implanted cells in stem-cell based therapies e.g. 
regeneration of injured cardiac tissue, among others (Roura et al., 2013, Scott et al., 
2011).  A compilation of intracellular metal ion sensors – with calcium being the most 
exhaustively studied metal ion – is provided in Table 10-1 of Appendix Chapter 1.  
1. Fluorescent dyes 
Small fluorophores which bind to metal ions and cause either a change in 
fluorescence intensity or a spectral shift are available.  This enables tracking if calcium 
ion dynamics in live cells using fluorescence microscopy.  The dyes are added to the 
medium of the cells or tissue under study and allowed to diffuse into the sample, but 
typically lack a highly defined cellular localisation.  To overcome this drawback 
reporter proteins were developed  (Palmer, 2009).   
2. Reporter proteins 
Reporter proteins (e.g. aequorin) respond to the presence of an ion via a binding 
event that causes a structural change leading to bioluminescence or fluorescence of the 
protein.  Transfection or transgenic technologies are used to express the protein in the 
cell, often fused to signal peptide sequences (e.g. ompA) to direct the protein to the 
desired intracellular location.  Aequorin is the most widely used reporter protein for 
calcium ion monitoring;.  it is not fully functional without its synthetic chromophore 
substrate (coelenterazine or chemical analogues thereof) that must be added to the cell 
medium. 
3. Reporter protein chimeras 
Fluorescent protein chimeras are practical alternatives to bioluminescent 
proteins.  GFP (Green fluorescent protein) or GFP variants are genetically fused to the 
functional domain of another protein (e.g. the calcium-binding region of calmodulin), or 
with a whole protein (e.g. aequorin).  The resulting chimera can be localised 
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subcellularly with the help of an appropriate signal peptide.  In this case, binding of an 
analyte (e.g. metal ion) alters the structure of the fused peptide which in turn affects the 
fluorescent properties of the GFP.   
In recent years considerable progress is being made in this field.  Genetically 
encoded FRET (Fluorescence resonance energy transfer) sensors are currently in 
development to monitor levels of magnesium, zinc and cadmium ions in transition metal 
homeostasis.  Improvements are still needed; the success of these sensors depends on 
the sensitivity of the sensors, on achieving significant ratiometric changes of 
fluorescence signal upon ion binding and on successful intracellular calibration of the 
sensors, as in vitro calibration is not useful.  Future scope is to achieve simultaneous 
imaging of multiple metals and in different locations of the cell (Vinkenborg, 2010, 
Vinkenborg et al., 2009). 
4. In situ fluorescent tagging of proteins 
Another option employed recently has been to express and localise proteins that 
incorporate a peptide “linker”.  The linker can bind covalently to an appropriate 
fluorophore that is added to the cell medium (Brun et al., 2009).  The fusion peptide is 
expressed in the cell and after a short incubation period the fluorophore labels the 
expressed localised peptide.  This method can be used to tag and quantify the amount 
and location of the expressed protein, or act as a reporter that tracks changes of the 
fluophore when an analyte, such as Ca2+, binds to the protein or to the fluophore.  A 
wide range of fluorophores are available that emit light at different wavelengths 
(Covalys Biosciences, 2009). 
5. Microinjection 
Microinjection of ion dyes or reporter proteins into cells was used for the 
delivery of reporters.  It is a laborious and limited method, now becoming obsolete due 
to the development of the systems described above (Creton et al., 1999, Blinks, 1990). 
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1.3 Aequorin:  a calcium-sensitive photoprotein 
1.3.1 Introduction 
Aequorin is calcium-sensitive photoprotein originating from the jellyfish 
Aequorea victoria (Shimomura, 2005, Shimomura et al., 1962).  The active protein is 
formed from apoaequorin, the luminophore coelenterazine and molecular oxygen (Tsuji 
et al., 1986, Dikici et al., 2009).  The apoaequorin DNA encodes for 196 amino acids.  
Coelenterazine (MW 423) is an imidazolopyrazine that forms a hydroperoxy derivative 
with molecular oxygen, and is tightly but non-covalently bound within the photoprotein 
as an oxidation reaction intermediate (Ohmiya and Hirano, 1996, Vysotski and Lee, 
2004).   
Bioluminescent reaction in aequorin 
Upon binding traces of Ca2+ aequorin undergoes a conformational change which 
triggers the oxidative decarboxylation of coelenterazine into coelenteramide (Figure 
1-5).  Products of this reaction are a flash of blue light (λmax ≈ 469 nm), CO2 and Blue 
Fluorescent Protein (BFP), which consists of the apoprotein loosely bound to 
coelenteramide (Shimomura and Inouye, 1999).  The emission of light is caused by the 
decay of the bound coelenteramide from an excited state to the ground state (Ohmiya 
and Hirano, 1996).  A schematic of the aequorin bioluminescent reaction is presented in 
Figure 1-5.   
The reaction was found to follow first order kinetics (Shimomura et al., 1962), 
with reaction rate constants of luminescence ranging from:  0.95−1.33 s-1 for eight 
different purified isoforms of native aequorin (isoaequorins).  Luminescence activities 
for the same isoaequorins were found to range from 4.35−5.16×1015 photons/mg 
aequorin (Shimomura, 1986), which correspond to approximately 0.16−0.2 photons per 
molecule of aequorin. 
Crystallographic structures  
Aequorin has a compact globular shape with a hydrophobic cavity in the centre 
of the molecule.  Two different conformations of aequorin have been crystallised, 
shown in Figure 1-7):  PDB ID:1EJ3 is fully active aequorin, prior to any addition of 
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calcium, at 2.3 Å resolution (Head et al., 2000) and PDB ID:  1SL8 is calcium-loaded 
apoaequorin, without coelenterazine at 1.7 Å resolution (Deng et al., 2005).  The latter 
is as of yet and to the best knowledge of the author, the closest structure to the “post-
calcium-binding” conformation.   
Calcium in the EF-hands and Coelenterazine in the hydrophobic core 
The protein scaffold is formed by sets of four helices comprising helix-turn-helix 
(HTH) motifs called EF-hands.  The EF-hands are arranged in pairs:  EF-I and EF-II in 
the N-terminal region and EF-III and EF-IV in the C-terminal region (Figure 1-7, Figure 
1-8).  The anatomy of a typical EF-hand motif is presented in Section 1.3.4.  In 
aequorin, three out of four EF-hand structures (EF-I, EF-III and EF-IV) are “canonical” 
EF-hands and serve as Ca2+-binding sites.  Their presence was already known from 
analysis of the protein primary sequence (Inouye et al., 1985, Charbonneau et al., 1985) 
even before the crystallographic structure was resolved.  Each loop contains twelve 
sequentially arranged amino acids, with residues in loop positions 1, 3, 5, 7 and 9 
coordinating to each calcium ion (Head et al., 2000).  In the crystal structure of calcium-
bound apoaequorin (Figure 1-8), each of the canonical EF-hand loops is occupied by 
one calcium ion, coordinated in the characteristic pentagonal bipyramidal configuration 
(Deng et al., 2004).  EF-II lacks the necessary amino acids to facilitate binding of 
calcium.  Since it is apparently unable to bind calcium in aequorin, this domain might 
instead have a role in the enzymatic function, such as forming a stable scaffold against 
which the rest of the molecule moves upon the binding of calcium ions (Head et al., 
2000). 
Hydroperoxy-coelenterazine (an “activated” coelenterazine) is accommodated in 
the hydrophobic core of the aequorin.  The coelenterazine binding pocket is highly 
hydrophobic and is formed by residues originating from each of the helices (Vysotski 
and Lee, 2004).  
Stoichiometry of calcium ions 
Previous studies have suggested that occupancy of two of the three calcium-
binding sites in aequorin is sufficient to trigger activation (Shimomura, 1995a, 
Shimomura and Inouye, 1996).   
A log-log plot of light intensity as a function of calcium concentration over a 
range of 10-9 to 10-2 M produced a sigmoidal curve with a lag phase, logarithmic phase 
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and saturated phase (Figure 1-6).  The lag phase of the sigmoidal curve was attributed to 
binding of calcium by the EDTA in solution.  Only when EDTA is saturated with 
calcium is any additional calcium available to aequorin which utilises it for the 
triggering of luminescence.  The logarithmic phase occurred at physiologically relevant 
concentrations of calcium (10-7−10-5 M) and had a slope of 2.0−2.5 (Allen et al., 1977).  
Based on the slope of the logarithmic curve the authors suggested that a molecule of 
aequorin must bind at least two calcium ions.  The exponential part of the sigmoidal 
curve corresponds to the utilisation of the available calcium while the plateau of the 
sigmoidal curve shows that metal binding sites of aequorin are saturated and additional 
calcium does not contribute to increased activity. 
Studies determining the stoichiometry of Ca2+ by luminometric titration proved 
that the light emission from aequorin is proportional to the amount of Ca2+ added and 
that two Ca2+ per protein molecule are needed to exhaust the luminescence capability of 
an aequorin sample (Shimomura, 1995a).  The requirement for two calcium ions in the 
luminescence reaction justifies a slope of approximately 2.0−2.5 log-log plot of the 
relationship  between calcium concentration and light intensity reported by Allen and 
co-workers (1977). 
Further work by Shimomura and Inouye (1996) used titration of recombinant 
aequorin with calcium solution and measured concentration of free calcium by the use 
of a calcium-sensitive electrode.  Three calcium ions were bound by aequorin, which is 
also consistent with the crystal structures of calcium-bound apoaequorin and other 
photoproteins (Deng et al., 2005) and the two out of three binding sites were found to 
have 20-fold higher affinity for calcium ions compared to the third site, although it 
would not be possible to identify which site this was.  Coupled with the fact that 
approximately two ions are needed to exhaust the luminescent reaction, the third 
binding site could be unrelated or simply not required for the luminescent reaction. 
Slopes greater than 2 could be artifacts (Shimomura, 1995a); main cause for 
artifacts would be the presence of EDTA in the calcium buffer solutions when studying 
the relationship between light intensity and calcium concentration;  the authors 
suggested that EDTA may inhibit light emission by binding to aequorin, the effect 
becoming more pronounced in buffers of low calcium concentration and higher EDTA 
concentration.  Higher calcium concentrations may lead to recycling of calcium and 
slight increase of light emission occurring in the plateau. 
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Calcium-independent luminescence 
Aequorin emits light even in the absence of calcium ions; at very low levels of 
calcium (<10-8 M) the protein gives off a very low and calcium-independent 
concentration level of light termed as “calcium-independent luminescence”; however, 
the light intensity is increased up to one million-fold or more on the addition of calcium 
(Allen et al., 1977).  Detailed structural information on aequorin and theories on how 
binding of calcium ions may result in the de-stabilisation of the hydroperoxy-
coelenterazine are presented in Chapter 5. 
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Figure 1-5  Schematic of the bioluminescent reaction of photoprotein aequorin (Ohmiya 
and Hirano, 1996).  “Apo” refers to the apoaequorin polypeptide chain. 
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1.3.2 Uses of aequorin 
Calcium concentration levels regulate a wide range of biological processes in 
eukaryotic cells, including gene expression, muscle contraction, glycolysis, cell division 
and growth (Dudev and Lim, 2003).  Due to its high sensitivity to calcium, instant 
response to calcium concentration changes, its non-invasive nature and the lack of 
background interference signals, aequorin has been well suited in its use as a calcium 
indicator for more than three decades.  The bioluminescent reaction proceeds within the 
physiological pH range and its rate varies steeply with calcium concentration between 
the biologically relevant range between 10-7 and 10-5 M (Hastings et al., 1969). 
Initial applications of aequorin required microinjection of protein purified from 
jellyfish, into cells (Allen and Blinks, 1978, Blinks et al., 2000).  Subsequent cloning of 
its gene (Inouye et al., 1985, Prasher et al., 1985, Charbonneau et al., 1985) allowed for 
the recombinant expression of apoaequorin and the genetic transformation of bacteria, 
yeasts, plants, and animal cells.  Fusion of apoaequorin with signal peptide sequences 
allowed its targeting to specific cellular compartments (Sala-Newby et al., 2000).  A 
few select examples are:  the monitoring of gene expression in hamster ovary eggs 
(Inouye et al., 1992), analysis of calcium ion homoeostasis at the subcellular level using 
aequorin targeted to specific organelles (Chiesa et al., 2001), use as a reporter enzyme 
in studying gene expression in mammalian cells (Tanahashi et al., 1990) and analysis of 
Ca2+ homeostasis in primary cultures of skeletal muscle myotubes (Brini, 2008, Brini et 
al., 1997). 
Small peptides were fused at both the C- and N-terminal of aequorin, resulting in 
functional new proteins.  It was shown that aequorin can tolerate fusions at both termini 
so long as the C-terminal proline is intact (Deo and Daunert, 2001, Lewis and Daunert, 
2000).  Thus it is possible to incorporate an affinity or fluorescent tag on one terminus 
and a peptide of interest at the other (Deo et al., 2001).  Using this capability, aequorin 
and its variants have been used as bioluminescent labels in immunoassays (Deo and 
Daunert, 2001, Deo et al., 2001, Dikici et al., 2009, Shrestha et al., 2002) and as a tool 
for the search of GPCR (G-protein coupled receptors) ligands in the drug discovery 
(Dupriez VJ, 2002).  The addition of an N-terminus hexahistidine tag allowed metal 
affinity purification resulting in highy pure and functional aequorin (Glynou et al., 
2003).   
- 41 - 
1.3.3 Properties of aequorin 
Rapid loss of aequorin luminescence activity occurs at elevated temperatures 
(Shimomura et al., 1962).  The total light emitted is independent of pH over a wide 
range of 5.1−8.3.  The reaction rate constants, however, are pH dependent.  It increases 
with alkalinity from a near plateau between 6.5 and 7.5 and decreases in the same 
manner as enzyme activity when pH is lower than 6.5 (Shimomura et al., 1962).  The 
protein is unstable at pH lower than 4.0.  When calcium and EDTA are equimolar, the 
velocity is about half of maximum, whereas only a slight excess of Ca2+ results in nearly 
maximum velocity.   
Due to high sensitivity of the protein to Ca2+, certain precautions need to be 
taken when handling aequorin or apoaequorin:  use of only high purity chemicals is 
recommended, avoidance of any contact of solutions with soft (soda-lime) glass or 
metal parts where that is possible.  EDTA and EGTA have been used to preserve the 
luminescent activity of aequorin until its use and to prepare calcium-buffer solutions for 
calibrating the light emission of aequorin (Shimomura, 1991).  When the concentration 
of EDTA exceeds that of Ca2+ no luminescence is emitted.   
As oxygen is incorporated in the holoprotein structure, Ca2+-triggered light 
emission can occur in a vessel completely evacuated by air (Shimomura et al., 1962), 
but an active aequorin complex cannot be regenerated in the absence of molecular 
oxygen (Shimomura and Johnson, 1975b).  Coelenterazine is also retained by aequorin 
during purification by gel filtration, whereas coelenteramide is easily diffusible from the 
spent Blue Fluorescent Protein complex.   
(NH4)2SO4 is useful during long term storage due to the stabilising effect it has 
on the protein (Shimomura and Inouye, 1999).  Aequorin solution aliquots can be stored 
at 4º C and −20º C for a few months without any loss of luminescent activity, but 
−80º C is required for long-term storage (Shimomura et al., 1962). 
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Figure 1-7  3-D model of aequorin with coelenterazine in the hydrophobic core.  The 
EF-hand Ca2+-binding loops are coloured green and bound coelenterazine hyperoxide is 
coloured orange.  PDB ID:  1EJ3 (Head et al., 2000), 3-D model rendered with Pymol 
(DeLano, 2002). 
Figure 1-8  Apoaequorin with calcium ions in the Ca2+-binding loops (EF-hands).  PDB 
ID:  1SL8 (Deng et al., 2005), 3-D model rendered with Pymol (DeLano, 2002). 
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Figure 1-9  Conformation states of a photoprotein.  Apoprotein (state I), photoprotein 
(with 2-hydroperoxycoelenterazine, without Ca2+) (state II), Ca2+-discharged 
photoprotein (protein with the reaction product, coelenteramide, and bound Ca2+) (state 
III), Ca2+-discharged photoprotein without Ca2+ (protein with coelenteramide without 
Ca2+) (state IV), Ca2+-loaded apoprotein (state V).  The photoprotein conformational 
states were revealed by HSQC-NMR spectroscopy study of obelin (Deng et al., 2005, 
Lee, 2001).  Figure was reproduced from Deng and co-workers (2005). 
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1.3.4 EF-hand motif:  general features 
The EF-hand motif consists of two perpendicular alpha helices (each 10 to 12 
residues long) with a 10 to 15 residue loop region between, forming a single calcium-
binding site (helix-loop-helix).  One calcium ion interacts with residues contained 
within the loop region.  It is found in a broad range of functionally diverse calcium-
binding proteins, known as the EF-hand protein superfamily.  The EF-hand has been 
fine-tuned to selectively bind Ca2+ against the background of up to 105-fold higher 
concentrations of Na+, K+, and Mg2+.  Depending on length and the amino acid content 
of their loops, EF-hands are categorised as “canonical” and “non-canonical”. 
Figure 1-10  The EF-hand calcium-binding loop.  On the left:  A schematic of the 
calcium coordination sphere with the entering and exiting helices in red, the 
coordinating protein ligands in blue and coordinating water molecule (W) in blue.  
Purple highlights the conserved hydrophobic residue that forms the short β-sheet in the 
paired EF-hand.  Also indicated are the most common amino acids found at the critical 
positions.  On the right:  calcium coordination by the canonical EF-hand (EF-I of CaM 
(PDB ID:  1EXR) illustrating the pentagonal bipyramidal coordination of the calcium 
ion.  The calcium ion is in yellow, the side-chain oxygen atoms in red, and the 
coordinating water in blue.  Backbone NH groups are indicated in black.  Figure 
reproduced from Gifford et al (2007). 
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“Canonical” EF-hands represent the vast majority of the EF-hand motifs.  Their 
loop contains twelve amino acids, each one being important for calcium coordination.  
Residues in positions 1, 3, 5, 9, and 12 of the loop region are highly conserved and 
provide oxygen ligands necessary for binding of calcium, while position 7 of the loop 
ligates the calcium ion with a main-chain carbonyl oxygen.  The most common residues 
coordinating calcium and their respective positions in the canonical loop are listed in 
Table 1-4.  In most EF-hand proteins the residue at position 12 is a glutamate, which 
contributes both its side-chain oxygens for calcium coordination.  The calcium ion is 
coordinated in a pentagonal bipyramidal array with an average 2.4 Å separation to 
oxygen atoms (Figure 1-10).  Frequently one or two water molecules are also involved 
in ligating calcium (Strynadka and James, 1989).   
Table 1-4  Amino acid sequence preference in the EF-hand loop.  Table recreated from 
Gifford et al (2007). 
EF-loop 
position 1 2 3 4 5 6 7 8 9 10 11 12 
Coordinating 
ligand 
X 
sc 
 
Y 
sc 
 
Z 
sc 
 
-Y 
bb  
-X 
sc* 
  
-Z 
sc2 
Most  
common 
Asp 
100% 
Lys 
29% 
Asp 
76% 
Gly 
56% 
Asp 
52% 
Gly 
92% 
Thr 
23% 
Ile 
68% 
Asp 
32% 
Phe 
23% 
Glu 
29% 
Glu 
92% 
Frequently 
observed 
 Ala 
Gln 
Thr 
Val 
Ile 
Ser 
Glu 
Arg 
Asn Lys 
Arg 
Asn 
Ser 
Asn 
 Phe 
Lys 
Gln 
Tyr 
Glu 
Arg 
Val 
Leu 
Ser 
Thr 
Glu 
Asn 
Gly 
Gln 
Tyr 
Ala 
Thr 
Leu 
Glu 
Lys 
Asp 
Lys 
Ala 
Pro 
Asn 
Asp 
The Ca2+ ligands are indicated by both their position in the EF-loop and in the coordinating 
array.  (sc) indicates side chain coordination and (bb) indicates coordination via the backbone.  
The asterisk (*) indicates that the oxygen ligand is typically provided by a water molecule that 
is hydrogen-bonded to the side chain of the amino acid at position 9.  The most common amino 
acids at each position are noted with their corresponding percentages of occurrence, followed by 
those that occur with a frequency greater than 5% in known EF-loops.   
 
“Non-canonical” EF-loops can also bind Ca2+ in a pentagonal bipyramidal or 
octahedral coordination.  The length of the loops ranges from eleven amino acids (rarest 
cases) to fourteen and sometimes fifteen amino acids.  They may carry substitutions that 
disable Ca2+-binding or insertions that bring the coordinating residues too far apart to 
bind calcium in the canonical manner.  However, they compensate for these adversities 
by offering oxygen from their main-chain carbonyl groups for ligating calcium, in some 
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cases even turning inside-out to accommodate this coordination and in some cases 
exhibit high affinity for calcium (Strynadka and James, 1989).   
The role of EF-hands in proteins can be regulatory or structural.  In regulatory 
EF-hand proteins binding of calcium induces a conformational change that is 
transmitted to their target proteins, and (often) ultimately results in catalysing enzymatic 
reactions.  In structural EF-hand proteins, EF-hand domains do not undergo significant 
conformational changes but seem to play a role in buffering leverls of intracellular 
calcium ions (Gifford et al., 2007). 
EF-hands tend to occur in pairs, which form a discrete domain so that most 
family members have two, four or six EF-hands.  This pairing also enables 
communication, and many EF-hands display positive cooperativity.  The ability of an 
EF-hand to bind Ca2+ depends on its selectivity over Mg2+ (a cation with similar 
chemical properties to Ca2+ and with a cytoplasmic concentration several orders of 
magnitude higher).  Variation in calcium binding affinity for different EF-hand proteins 
is due to the amino-acid composition of the residues at the coordinating positions  
(dissociation constants for Ca2+ range from 0.5×10-3 to 0.3×10-9 M) (Dudev and Lim, 
2003).   
 
1.3.4.1  EF-hands and cooperativity 
EF-hands tend to occur in pairs, which form a discrete domain so that most 
family members have two, four or six EF-hands.  This pairing also enables 
communication, and many EF-hands display positive cooperativity.  The 
conformational effects of Ca2+ binding are varied, function-dependent and in some 
cases, minimal.  EF-hand proteins exhibit various sensitivities to Ca2+, reflecting the 
intrinsic binding ability of the EF-hand as well as the degree of cooperativity in Ca2+ 
binding to paired EF-hands. Relatively little is known about the mechanisms of 
cooperativity or dynamic conformational effects of Ca2+ binding of the other EF-hand 
proteins as most research in this field to date has focused on the model members CaM, 
TnC and calbindin D9K (Gifford et al., 2007). 
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1.3.5 Proposed mechanism for the bioluminescence reaction 
Despite the availability of the tertiary structure, the precise catalytic mechanism 
of the photoprotein remains unsolved (Prendergast, 2000).  The bioluminescence 
reaction mechanism has been partially deciphered on the basis of detailed structure-
activity studies of both the apoprotein and coelenterazine (Ohmiya and Hirano, 1996) as 
well as on the resolved crystal structure of aequorin (Head et al., 2000), and is assumed 
to follow the same mechanistic pathway as the proposed mechanism of a 
chemiluminescence reaction pathway proposed by Ohmiya and Hirano (1996).  Figure 
1-11 shows the mechanism proposed by Prendergast (2000):  a) a reactive carbanion is 
formed as result of distortion of the ground state of coelenterazine  b) the carbanion 
attacks molecular oxygen bound by the protein, forming coelenterazine hydroperoxide  
c) coelenterazine hydroperoxide is stabilised by Tyr184 of the protein chain  d) a 
conformational change in the protein (caused by binding of calcium ions) allows the 
attack of hydroperoxy anion on the reactive carbonyl  e) leading to the formation of an 
unstable, intermediate dioxetanone  f) the dioxetanone undergoes scission to produce 
CO2 and enolate ion in an excited state, which emits light when relaxing to ground state. 
1.3.6 Regeneration of aequorin 
The enzymatic function of aequorin was proven when it was shown that it could 
be recharged repeatedly and reversibly (Shimomura and Johnson, 1975b).  BFP (Blue 
Fluorescent Protein) is a complex consisting of apoaequorin non-covalently bound to 
coelenteramide and calcium ions, which can be dissociated into its components.  The 
regeneration procedure requires removal of Ca2+ with a chelating agent such as EGTA 
or EDTA, separation of the protein from coelenteramide and incubation with molecular 
oxygen and coelenterazine (Figure 1-12).  BFP can be dissociated into apoprotein and 
coelenteramide by gel filtration or treatment by ether (Ohmiya and Hirano, 1996).  A 
reducing (thiol) agent such as DTT or β-mercaptoethanol is added to facilitate the 
harbouring of coelenterazine into the hydrophobic cavity of the apoaequorin.   
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Figure 1-11  Proposed reaction for the bioluminescence of aequorin.  Picture reproduced 
from Prendergast, 2000.  Description in Section 1.3.5. 
 
 
 
 
 
 
 
 
 
Figure 1-12  Regeneration of aequorin.   
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1.3.7 Ion selectivity of aequorin 
The selectivity of aequorin bioluminescence against various cations has been the 
object of some debate (Shimomura et al., 1962, Izutsu et al., 1972, Shimomura and 
Johnson, 1973, Izutsu et al., 1974).  Originally believed to be triggered by calcium and 
rare earth metal ions only, it was shown that aequorin may also respond to a number of 
other cations, yielding lesser light outputs and depending on conditions such as pH and 
presence of various metal chelators.  Table 1–5 is a synopsis of aequorin metal 
selectivity studies:  fifteen cations in the form of salts of chloride, sulfate or acetate 
were tested for possible activation of the bioluminescence reaction.   
             Table 1-5  Aequorin tested against ions for triggering light-emitting reaction 
Ion Charge Ionic radius (Å) Atomic Number Activity? 
Sodium +1 0.095 11 Inhibition 
Potassium +1 0.133 19 Inhibition 
Ammonium +1 0.143 7 Inhibition 
Magnesium +2 0.065 12 No 
Copper +2 0.069 29 Low 
Cobalt +2 0.075 27 Low 
Iron +2 0.076 26 No 
Manganese +2 0.08 25 No 
Cadmium +2 0.095 48 Yes 
Calcium +2 0.106 20 Yes 
Europium +2 0.112 63 Yes 
Strontium +2 0.113 38 Low 
Barium +2 0.135 56 Low 
Lead +2 1.19 82 Yes 
Iron +3 0.064 26 No 
All ions were tested by Shimomura and co-workers (1962) and verified by Shimomura and 
Johnson (1973), unless stated otherwise.  Inhibition caused by monovalent cations was reported 
by Moisescu and co-workers (1975).  Strontium-triggered luminescence was used in monitoring 
changes of free Ca2+ concentration in the endoplasmic reticulum (ER) (Montero et al., 1995). 
 
Most divalent cations failed to initiate a light-emitting reaction, while the rare 
earth metals (here represented by Eu2) and Sr2+ were found to successfully substitute for 
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Ca2+ (relative potencies of the different cations have been estimated as Eu2+>Ca2+>Sr2+).  
The fact that Mg2+, K+ and Na+ ions do not initiate luminescence, but inhibit the Ca2+-
triggered reaction suggests that they compete with Ca2+ for the binding sites without 
triggering luminescence (Ohmiya and Hirano, 1996).  Previously contradicting results 
(Shimomura et al., 1962, Izutsu et al., 1972) were put down to the presence of 
contaminating calcium during protein handling and metal ion preparations and to pH 
buffering or lack thereof (Shimomura and Johnson, 1973).   
As a conclusion, the luminescence reaction of aequorin is highly specific for 
Ca2+ at pH 7.5-8.0 and in the absence of rare earth metals or strontium (the latter 
condition is typically met when performing intracellular studies) (Shimomura and 
Johnson, 1973).  Since then the usefulness of aequorin as an intracellular calcium 
indicator has been widely established (see Section 1.3.2).  It may be possible that given 
the appropriate coordination environment, ions other than Ca2+ could potentially induce 
the required structural changes for evoking the luminescence yielding reaction. 
1.3.8 Other photoproteins 
Since the discovery of aequorin, more jellyfish photoproteins have been isolated, 
which use the same, or a very similar, chromophore (Tsuji et al., 1995).  Photoproteins 
mitrocomin, clytin and obelin showed very strong amino acid sequence identities with 
aequorin.  The amino acid sequences of apo-photoproteins of aequorin, clytin (or 
phialidin), mitrocomin and obelin have been aligned with the amino acid sequences of 
non-luminescent Ca2+-binding proteins:  human and bovine calmodulin (a typical Ca2+-
binding protein), parvalbumin, troponin C, intestinal Ca2+-binding protein and 
sarcoplasmin Ca2+-binding protein (Table 1-6 and Table 10-2).  The Ca2+-binding sites 
of all these proteins share conserved positions (Table 10-2).  The distance between the 
second and third EF-hand in aequorin and the third and fourth EF-hand structures in 
bovine calmodulin is conserved, suggesting that both have a common evolutionary 
origin (Tsuji et al., 1986).  The photoprotein group differed from other Ca2+-binding 
proteins in that they contained a relatively large number of cysteine, tryptophan, 
histidine, proline and tyrosine residues, suggesting that these residues may have evolved 
as part of the light-emitting mechanism (Tsuji et al., 1995). 
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Table 1-6  Identity between aequorin and other Ca2+-binding proteins.  Mitrocomin, 
obelin and clytin are also photoproteins.  The remaining proteins bind calcium but have 
no light emitting capabilities.  Pairwise alignment and identity calculation was 
performed with BioEdit (Hall, 2007). 
Pairwise alignment of aequorin with:  Reference Identity 
Mitrocomin  GenBank:  AAA29298.1 69% 
Obelin PDB:  1SL7 63% 
Clytin GenBank:  BAG49091.1 58% 
Human calmodulin GenBank:  CAA36839.1 19 % 
Bovine calmodulin PDB:  1PRWA 19% 
Human parvalbumin GenBank:  CAA44792.1 12% 
Intestinal Ca2+-binding protein PDB ID 1B1G 5% 
Sarcoplasmic Ca2+-binding protein PBD ID 2SAS 10% 
Troponin C GenBank:  AAA30011.1 3% 
1.4 Coordination of metals in proteins 
Proteins that chelate metal ions specifically are called metalloproteins.  One third 
of all proteins belong in this category (Palmer, 2002).  Properties of the protein-metal 
interactions, such as coordination geometry, side chain interactions, overall charge and 
size of cavity, all play a role in ion binding and selectivity (Dudev and Lim, 2003).  
There are currently no generic rules on the binding and selectivity of metal ions in 
proteins.  However, the factors required for metal binding are relatively well understood 
and metal-ion binding sites have been attractive targets in protein engineering (Lu and 
Valentine, 1997). 
Metal-ligand (M–L) distances play a central role in metal discrimination in 
proteins.  They reflect the properties of the metal complex, namely the electronic 
distributions of the metal and the ligands, their polarising abilities and interactions, as 
well as the metal coordination number (CN) and coordination geometry, which are key 
factors governing the structure and reactivity of a metal complex (Cotton and 
Wilkinson, 1988).  It has been proposed that it is the protein matrix that dictates the 
specific role of a metal ion and M–L distances have been used to distinguish between 
catalytic versus structural role for Zn2+ in proteins (Kuppuraj et al., 2009).   
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Native metal ions fulfil the best “fit” conditions in metalloproteins, and when 
substituted with an alien ion, their structures adopt different arrangements.  For 
example, Cd2+ can replace the native Zn2+ in Zn-finger motifs in the same tetrahedral 
coordination as the native ion, but it cannot maintain the requisite conformation for the 
DNA-binding function of Zn-finger proteins due to increased metal-protein ligand 
distances (Kuppuraj et al., 2009).  
The preferred coordination geometry for some selected metal ions derived from 
statistical analysis (Harding, 2006) and data collection/observation (Dudev and Lim, 
2003, Rulisek and Vondrasek, 1998), are summarised in Table 1-7 and more analytical 
information is given in the Appendix Chapter 1(Table 10-3).  
Analysis of the preferred coordination geometries and distances in the 
Cambridge Structural Database (CSD) for organic molecules and metal-organic 
compounds (Allen, 2002) shows that small metal ions exhibit a strong preference for a 
particular coordination but the larger metal ions are found in two or more geometries 
with comparable frequencies.  In Table 1-9 some of the existing metal binding sites are 
listed and experimental dissociation constants are provided.  Table 1-8  summarises 
distances of O, N and S around metal ions, taken from PDB and CSD structures.  For 
Asn and Gln, M—O distances are expected to be similar or very slightly longer to 
monodentate carboxylates.  For Ser and Thr, expected M—O distances are between 
those for water and for monodentate carboxylate.  For Tyr, expected M—O distances 
are shorter by ~0.1 Å than for monodentate carboxylate (Kuppuraj et al., 2009).   
Table 1-7  Summary of preferred coordination geometries of metal ions derived from 
PDB and CSD.  The results of the original analysis are presented in Table 10-3.   
Metal ion Preferred coordination geometries 
Co2+ Octahedral 
Cu2+ Square pyramidal or square planar 
Zn2+ Tetrahedral 
Cd2+ Tetrahedral, often octahedral 
Ca2+ Octahedral 
Pb2+ Tetrahedral 
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Table 1-8  Distances around metal ions from the PDB and CSD.  Resolution of PDB 
and CSD structures was less than 1.25 Å and 0.065 Å respectively.  Table reproduced 
from Harding (2006). 
 
*** most reliable values (standard deviation is ≤0.05 Å);  ** standard deviation is ~0.10 Å;       
* standard deviation is 0.15–0.20 Å;  No asterisk:  least reliable 
 
 
For some types of complexes, mainly those of Co2+, Cu2+ and Zn2+, several 
different coordination numbers are found.  The complexes involving water and 
carboxylate donors have metal-ion coordination number six; some Zn2+ and Cu2+ 
complexes are four or five-coordinate and Ca2+ may also be seven- or eight-coordinate.  
Where imidazole is present, most Zn2+ complexes are four-coordinate. Cu2+ is found in 
four-, five- and six-coordinate examples.  In thiolate complexes the common 
coordination numbers are 4 and 6 for Co2+ and mostly 4 for Zn2+, while all the Cu2+ 
complexes are three-coordinate. 
Generally, M–L distances increase with cationic radius but also with metal 
coordination number due to increased electronic and steric repulsion among the 
coordinating ligands.  Donor atoms that can transfer more negative charge to the metal 
centre also result in shorter M–L distances.  It was noted however that the size and 
charge donating ability of the coordinating atom is affected by the size, charge and 
volume of the other constituent atoms of the same ligand.  Exceptional M–L distances 
can also occur.  For example, zinc can make one or more abnormally long (2.3–2.5 Å) 
bonds in addition to the existing four or more typical bond lengths (Harding, 2006).  
Copper ions with coordination numbers 5 or 6 have also resulted in distances in the 
range 2.10–2.91 Å, depending on the ligand (Harding, 2006). 
In order of decreasing prevalence, Ca2+ is typically coordinated to carboxylates, 
carbonyls, water and hydroxyl oxygen atoms, with a coordination number in proteins 
ranging from six to eight.  The ionic radius of a calcium ion is always higher than that 
of Mg2+ for a given coordination number.  In the EF-hands of aequorin calcium binds to 
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six ligands from amino-acid residues and one water molecule, with a coordination 
number of 7 in a pentagonal bipyramidal geometry. 
Zn2+ is most commonly found in the zinc-finger family of proteins which are 
DNA-binding domains that contain zinc-binding motifs including Cys2His2, Cys3His 
and Cys4 metal-binding sites.  Zinc prefers soft ligands such as the sulfide from Cys 
and imidazole nitrogen atom from His, but is also found coordinated to Asp and Glu 
side chains.  In Zn-finger proteins the zinc usually prefers a tetrahedral coordination, but 
it can also adopt five- or six-coordinate geometries.   
Mg2+ binds to ligands of low polarisability, with oxygen being the most preferred 
coordinating atom, followed by nitrogen.  All Mg2+-binding sites in proteins contain at 
least one carboxyl ligand.  Non-charged protein ligands include the side chains of 
Asn/Gln and the backbone carbonyl groups, followed by the Ser/Thr, His, and Tyr side 
chains.  Mg2+ nearly always prefers an octahedral ligand coordination geometry, which 
is complemented by water ligands.  The few Mg2+-binding sequence motifs that have 
been identified include -NADFDGD-, -YXDD- or -LXDD- Table 1-9 (Lu and 
Valentine, 1997). 
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Table 1-9  Metal-binding sites and experimental metal binding constants for ion-binding proteins.   
1:  Psoriasin is the only member of the S100 EF-hand CaB family that doesn’t bind calcium.  Instead, it exhibits affinity for zinc  2:  Pseudo or variant-EF-
hand is the N-terminal, 14-amino acid EF-hand loop found in members of the S100 protein family.  The N-terminal EF-hand amino acid sequence in protein 
S100b is QYSGREGDKHKLKK (Brodersen et al., 1999).  3:  Canonical EF-hand is the C-terminal, 12-amino acid EF-hand loop normally found in all CaB 
proteins.  The same formation serves as calcium binding site in aequorin (Charbonneau et al., 1985).  NA:  Not available in the particular reference. 
molecule Ca site Zn site Mg site Cu site Kd (M ) Reference 
pseudo EF-hand2    2.8×10-7 
  pseudo EF-hand  3.7×10-4  
canonical EF-hand3    5×10-8 
calmodulin 
  canonical EF-hand  1.7×10-3 
Dudev and Lim, 2003 
pseudo EF-hand    1.8×10-5 
calmodulin 
canonical EF-hand    2.4×10-6 Porumb et al, 1977 
NA    3.7×1010 parvalbumin  
  NA  1×10-5  Dudev and Lim, 2003 
S100A7 (psoriasin) 1  His-X4-His within pseudo EF-hand   1×10
-4
 
Brodersen, 1999 
S100B  His-X4-His   NA Brodersen, 1999 
S100B    NA 4.6×10-7 Nishikawa et al, 1997 
PrP (priorin protein)     -HGGGW - <5×10-6 Burns et al, 2002 
Different RNA polymerases   -NADFDGD-  NA  Dudev, 2003 
DNA polymerase I    -NADFDGD-  NA Dudev, 2003 
HIV reverse transcriptase   -NADFDGD-  NA  Dudev, 2003 
Reverse transcriptase and 
telomerase   
-YXDD- 
-LXDD-  NA  Dudev, 2003 
Zinc finger family protein  Cys2His2   NA  Baudier et al, 1986 
Zinc finger family proteins  Cys3His, Cys4   NA  Baudier et al, 1986 
De novo RBP A  His-X-His and His 3   3.6×10-8 Muller and Skerra, 1994 
De novo RBP B  His-X-His and His 3   4.4×10-7 Regan, 1995 
Metallotheionins  NA    1.4×10-13 Heizmann and Cox, 1998 
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1.5 Protein engineering 
Protein engineering is the process of creating new proteins with desirable traits 
and has evolved since the mid 1980s when the first protein mutants were created 
(Ulmer, 1983), into two main branches:  rational design and directed evolution. 
1.5.1 Rational design 
Rational design is specific, deliberate design of a protein, based on knowledge of 
the protein’s structure and function and/or use of structural homology in order to 
achieve new or improved properties.  Rational design relies on well-developed 
mutagenesis techniques and typically involves a limited number of mutations.   
Site-directed mutagenesis (SDM) is a PCR-based method that allows single point 
mutations in the amino acid sequence (replacement, deletion or insertion of a residue) 
(Old, 1994).  Variations of the methods allow alterations in multiple adjacent amino 
acids (Stratagene, 2005)or mutations at up to five different selected sites of the amino 
acid sequence (Hogrefe et al., 2002).   
Seebeck and Hilvert (2003) reported the conversion of a pyridoxal phosphate 
(PLP)-dependent alanine racemase into an aldolase via a single active-site mutation 
Tyr265Ala.  Lawson and co-workers (2009) increased solubility and decreased 
aggregation of 11 beta-hydroxysteroid dehydrogenase type 1 by replacing key 
hydrophobic surface residues with charged glutamic acid. 
The prediction of specific mutations that elicit the desired effect is still very 
difficult in many cases (Dalby, 2003).  Computational protein design algorithms, 
potential functions such as CharmM (Brooks et al., 1983, MacKerel Jr et al., 1998), and 
molecular dynamics simulations (Karplus and Kuriyan, 2005) are available to assist 
rational design, but their low accuracy often results in a need for repeated cycles of 
engineering and experimental testing.  
A branch of protein engineering is the de novo protein design of new 
polypeptides from scratch (DeGrado, 1997).  The number of possible amino acid 
sequence variations is enormous, but only a subset of these variations will fold reliably 
and quickly to a single native state.  De novo protein design involves identifying such 
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sequences, and preferably those with a physiologically active native state.  The holy 
grail of protein engineering is the “true” design of a protein to any specification; that is 
writing down a single sequence that will perform a desired function. 
Successful results in rational protein design depend upon the availability of 
reliable structural information, an understanding of the mechanism of the protein 
function, and either a good predictive method for identifying the structure adopted by 
the newly mutated residues, or otherwise blind faith and intuition.  In computation, the 
limitation is often in the experimental testing; the rate at which hypotheses, 
improvements or new approaches can be verified or rejected is low (Plückthun and 
Mayo, 2007).  Much research currently is taking place into the understanding of protein 
folding and protein recognition for protein design principles, but the details that dictate 
function are still elusive.  An alternative protein engineering approach requiring little or 
no understanding of the tertiary structure and function of the protein of interest is 
directed evolution.   
1.5.2 Directed evolution 
The detailed structural knowledge of a protein is often unavailable, and even 
when it is available, it can be extremely difficult to predict the effects of various 
mutations.  Directed evolution borrows from nature's toolbox of mutational mechanisms 
to alter proteins without requiring any prior knowledge of their structure (Stemmer, 
1994, Arnold, 2001, Arnold et al., 2001, Arnold, 1993, Arnold, 1998).  One directed 
evolution technique applies random point mutagenesis to a protein by for example, 
error-prone PCR (Zhou et al., 1991, Zhao et al., 1998, You and Arnold, 1996) followed 
by a screening regime to identify variants with the desired qualities.  Further rounds of 
mutation and selection are then applied.  This process mimics natural evolution and can 
produce results superior to rational protein design (Dalby, 2003, Dalby, 2011).  DNA 
shuffling is a mix and match of DNA fragments from successful variants to produce 
improved variants (Stemmer, 1994).  This method mimics recombination occuring 
naturally in sexual reproduction.  More recent DNA shuffling techniques such as 
SHIPREC (Sieber et al., 2001), ITCHY (Chopra and Ranganathan, 2003) and 
SCRATCHY (Lutz et al., 2001) swap fragments between completely different non-
homologous proteins.  Using the latter approaches it is possible to explore and combine 
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distant regions of sequence space in combinations that would not have been attempted 
through rational design;  new chimeric proteins with functionality and native folds can 
be created using this approach (Carbone and Arnold, 2007).   
Directed evolution can produce variants with desired properties often through 
mutations that would not have been predicted from knowledge of the original protein’s 
structure.  To success probability of directed evolution depends on having large mutant 
libraries, high-throughput protocols for screening of desired qualities and expensive 
automation to support these functions.  A challenge pertaining to any mutational 
approach – but more so to directed evolution – is that not all desired activities can be 
easily screened for (Goddard and Reymond, 2004).   
1.5.3 Integration of random and rational approaches 
Rational design and directed evolution techniques are not mutually exclusive; 
most researchers use various combinations of rational desing and directed evolution 
strategies to improve or alter proteins.  The best approach is a matter of personal 
preference and decided judged on a case by case basis.  Typically, the protein 
engineering strategy comprises of the following stages:  (1) choice of locations for 
changes based on structural knowledge, homology modelling, sequence comparisons 
and/or computational modelling;  (2) applying random or rational mutagenesis methods 
(using single or multiple substitutions, recombination, permutation, insertions and 
deletions) in the selected regions;  (3) screening or selection for desired properties. 
(Bornscheuer and Kazlauskas, 2009). 
Beneficial mutations for altering specificity and enhancing enantioselectivity are 
most often occurring in enzyme binding sites (Dalby, 2011, Morley and Kazlauskas, 
2005, Kazlauskas, 2005) random mutagenesis within specific regions of binding sites 
can offer an efficient mutational strategy.  Substitutions that increase the catalytic 
activity have been identified within binding/catalytic sites but also are scattered widely 
throughout the protein (Kazlauskas and Bornscheuer, 2009), suggesting that wider areas 
should also be targeted.  
The knowledge of a protein’s structure and computational methods are still not 
solely sufficient to predict and design the most effective mutations.  DeSantis and co-
workers used site saturation mutagenesis (SSM) to find a nitrilase variant with increased 
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enantioselectivity toward an intermediate for the synthesis of atorvastatin.  Dumon and 
co-workers (Dumon et al., 2008) achieved a 25 °C increase in thermostability of 
xylanase by using a combination of random and rational approaches (Gene site 
saturation mutagenesis, GSSM) followed by rounds of GeneReassembly Library 
construction, whereby combinatorial segments were blended;  subtle but beneficial 
changes were created.  The molecular basis for the increased thermostability was 
extraordinarily subtle and these changes would not have been predicted through 
knowledge of protein structure or confirmed computationally.    
The capabilities of protein engineering are constantly expanding through 
advances in computation, mutational/evolutionary technologies, structural biology and 
screening/selection capabilities.  Combination of all the relevant available options will 
be the winning strategy for protein design in the foreseeable future (Plückthun and 
Mayo, 2007).   
1.5.4 Metalloprotein engineering 
The area of design and redesign of metal binding sites is one with an increasing 
publication rate over the past two decades.  The approach consists of starting with a 
naturally occurring, folded, and stable protein scaffold.  By modifying local portions of 
the protein without causing significant perturbation to its folded structure and stability, a 
functional protein with altered or enhanced activity can be created.  Nature has used the 
same approach successfully.  Thousands of protein 3D structures can be classified into a 
limited number of basic scaffolds, while the active-site diversity (such as metal binding 
sites in metalloproteins) has been achieved by evolutionary fine-tuning (Lu and 
Valentine, 1997). 
Metal-binding sites in proteins are attractive targets in protein engineering due to 
their importance in biological functions and relative simplicity compared to other 
protein ligands (Regan, 1995).   
Metal-binding sites have been engineered into proteins for use in immobilised 
metal affinity chromatography.  One example of this approach is a high-affinity zinc site 
engineered into recombinant serum retinol-binding protein (Schmidt et al., 1996).  
Redesign of metal sites in order to change their specificity has also been achieved.  
Restriction endonuclease EcoRV metal-binding specificity was switched from Mg2+ to 
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Mn2+ by a single Ile→Leu mutation (Vipond et al., 1996, Lu and Valentine, 1997).  
Another example was the redesign of the classical blue copper proteins azurin into 
purple CuA protein containing a mixed-valence binuclear copper site, through the use of 
loop-directed mutagenesis (Hay et al., 1996) (Lu and Valentine, 1997).  Cavity 
complementation is a method also used to redesign metal-binding sites.  It involves 
changing one of the ligands to a smaller, non-coordinating ligand such as glycine or 
alanine, thus creating a 'cavity' within the metal-binding site.  Adding different 
exogenous ligands can complement the cavity sterically.  This can either restore the 
activity or result in a new structure and activity (Lu and Valentine, 1997). 
Computational design approaches have also been used to design metal binding 
sites in protein scaffolds (DeGrado, 1997, Kaplan and DeGrado, 2004, Nanda et al., 
2005).  However, this approach is still somewhat embryonic as the ability of the current 
generation of molecular dynamics force fields to properly describe metal pockets is 
severely lacking due to the intrinsic difficulty of handling polarisation and charge 
transfer contributions (Dal Peraro et al., 2007). 
1.6 Overview 
1.6.1 Aequorin mutants as potential bioreporters 
Aequorin has been the preferred intracellular calcium sensor, used for 
interrogating a wide range of biological processes in eukaryotic cells, including gene 
expression, muscle contraction, glycolysis, cell division and growth (Dudev and Lim, 
2003).  Many metal ions play a key role in the metabolism of the cell, and particularly 
zinc and copper have been found to participate in brain function and have been 
associated with degenerative brain diseases.  Currently, the scientific toolbox lacks 
established intracellular reporters with a set of advantages similar to that of aequorin.   
The wealth of knowledge available in the literature that explores the preferred 
coordination and parameters affecting ion binding in proteins could be very useful in 
altering the specificity of the protein for other ions.  Previous mutational studies on 
aequorin and the EF-hand domains of other proteins suggest that it is possible to 
modulate the affinity of the calcium-binding loop, shift the spectral emission, and alter 
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the kinetics of the light-emitting reaction mechanism through mutagenesis of aequorin 
(Section 5.2). 
1.6.2 Potential activator ions for aequorin mutants 
The metal ions tested in the scope of this work as potential activators for 
aequorin and mutant variants thereof are:  calcium, zinc, copper, cadmium, lanthanum, 
cobalt and lead.  Since considerable time, effort and resources would be invested in 
creating both the library and the screening assay, it made sense to include as many ions 
as possible in order to allow space for serendipity.  As it is not possible to predict the 
effects of the mutations, it may be that by serendipity, the preference of aequorin could 
be tweaked towards an ion that is not at the top of the list in terms of biological 
relevance, but still of great value for environmental studies.   
Monovalent ions were excluded on the basis of their low charge and reported 
inhibition (Section 1.3.7, Table 1–5).  Divalent ions would be more likely to bind tightly 
to the EF-hand loop and at least one member of the lanthanides (trivalent) would be 
used as these metals are known aequorin activators (Le Clainche et al., 2003).  Calcium, 
as the natural activator and lanthanum (as representative of the lanthanide group) were 
obvious choices.  Zinc and copper became primary choices for study as they are 
associated with brain diseases which have become of ever increasing interest in the 
recent years (Barkalifa et al., 2009, Faller, 2009, Gu et al., 2009, Marino et al., 2010).  
Cadmium prefers coordination geometry similar to that of calcium and has been used as 
a substitute for calcium in crystallographic studies, thus it would be interesting to 
observe its effect on aequorin mutants.  Cobalt and lead were chosen on the basis that 
aequorin potentially showed some positive response to these ions.  Iron (valence II and 
III) was excluded based on Table 1–5 and magnesium was excluded as it is known to 
stabilise aequorin and prevent calcium-independent luminescence (Ohashi et al., 2005) 
which means it is bound in the EF-hands without triggering the light emitting reaction.   
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1.7 Aims and organisation of thesis 
The main aim of this project was to create a novel metal ion sensor through 
protein engineering, using wild-type aequorin as template.  The envisaged molecule 
would have new specificity for a divalent ion other than calcium but otherwise retain its 
ion-triggered light-emitting reaction.  Hence, it would have the potential to offer as 
much insight into the role of different metal ions as aequorin has for intracellular 
calcium.  In order to pursue the main aim, the work in this project was broken down into 
several stages, addressed in Chapters 3 to 8. 
Subcloning of the apoaequorin gene into a suitable expression vector is described 
in Chapter 3.  Chapter 4 discusses the development of a high-throughput screen capable 
of identifying the desired activity in mutant microwell cultures.  Protein engineering can 
lead to dramatic changes (positive or deleterious in the majority of cases) or small, 
gradual steps towards a desired protein function.  The sensitivity of such a screen must 
be maximised in order to identify slight changes within the mutant library.  Steps taken 
for this purpose included:  (1) selecting between expression vectors for the best 
candidate;  (2) selecting the E. coli strain for the highest expression of the mutant 
library;  (3) developing an effective procedure for reconstitution of the holoprotein 
mutants;  (4) producing the highest possible activity levels from the functional protein 
variants;  (5) extracting the maximum value from the screen.   
The structure of aequorin in relation to calcium binding and light emission is 
discussed in Chapter 1 and additional insight gained from analytical structural analysis 
of aequorin (published and author’s own) and published mutational studies of aequorin 
and other calcium-binding formations are presented in Chapter 5.   
The mutational strategy is discussed in Chapter 5.  Even though both rational and 
directed evolution methods, and various combinations of both are promising, an EF-
loop targeted mutational strategy was chosen as it was considered more likely to 
drastically change the ion selectivity within the time constraints of the project.  The 
focus is on the individual residues in the calcium coordinating positions of each EF-
hand; they were substituted with cysteine and histidine, which are the prevalent residues 
in copper and zinc-binding sites.  More mutations (alanine substitutions and impairment 
of EF-hand flexibility) were introduced to study the importance of specific amino acids 
or individual EF-hands.  A total of forty eight mutants were designed. 
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Implementation of the high-throughput screening assay on the aequorin library is 
described in Chapter 6, where the complete library of mutants was tested against seven 
different metal ions.  The screening results were analysed in detail and a few selected 
mutants were chosen as candidates for further analysis.  Chapter 7 describes the 
preparation of high purity wild-type aequorin and one of the selected mutants 
(Asn28Cys/Ser32His) for testing against the set of the seven ions and Chapter 8 studies 
the response of the purified molecules to the same set of ions without the potential 
interferences from bacterial culture components of the crude screen.  Conclusions drawn 
and future work arising from this research are presented in Chapter 9. 
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2 Materials and Methods 
This chapter is organised as follows:  Standard buffers and media, standard 
materials and methods in cell culture, DNA, protein and metal ion solution preparations.  
Where modifications of any of the procedures were necessary for method development 
or sample preparation, those will be described in the respective sections of Chapters 3-8.  
Automation-based methods (liquid handling and colony picking) are described in 
Chapter 4. 
2.1 Preparation of buffers and media 
All chemicals used were of Molecular Biology grade and purchased from Sigma-
Aldrich Company Ltd, unless stated otherwise.  Buffers and media for molecular 
biology were prepared according to (Sambrook et al., 1989).  Standard molecular 
biology protocols for glycerol stocks, overnight cultures, and streaked plates were from 
the same reference, unless otherwise stated.  All solutions and buffers were prepared 
with R.O. water from an Elix Millipore purification system. 
2.1.1 LB medium 
LB (Luria Bertani) medium was prepared by dissolving 10 g tryptone, 5 g yeast 
extract and 10 g NaCl in 1 L of deionized water. The pH of LB medium was adjusted to 
7.0 with concentrated NaOH solution and the medium was autoclaved at 121 °C and 
1.2 atm for 20 min.   
2.1.2 LB agar 
LB agar was prepared by adding 2% w/v bacteriological agar in LB medium.  It 
was used to fill Petri dishes (agar plates) for growth of solid cultures.  The mix was 
sterilised by autoclaving as above.  Petri dishes were partially filled with warm liquid 
LB agar containing added antibiotics.  
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2.1.3 YT agar 
YT (yeast extract and tryptone) agar is a nutrient-rich medium designed for 
growth of recombinant strains of E. coli on agar plates.  YT was prepared by dissolving 
8 g tryptone, 5 g yeast extract and 5 g NaCl and 15 g of bacteriological agar in 1 L of 
deionised water, with adjustment to pH 7.0 and autoclaving as above. 
2.1.4 SOC medium 
SOC (Super Optimal broth with catabolite suppression) medium is a nutrient-
rich bacterial growth medium which results in higher transformation efficiencies of 
plasmids.  SOC medium was prepared by dissolving 20 g tryptone, 5 g yeast extract,  
0.58 g NaCl and 0.19 g KCl in 1 L of deionized water and pH was adjusted to 7.0 with 
concentrated NaOH solution.  After autoclaving, the following filter-sterilised solutions 
were added:  20 mM glucose and 10mM MgCl2. 
2.1.5 Kanamycin 
Kanamycin stock solutions were prepared at 10 mg/mL in RO water, sterilised 
by filtration through a 0.2 µM Minisart® filter (Sartorius Stedim Biotech), aliquoted into 
1.5 mL eppendorfs and stored at −20 °C.  Working concentration of kanamycin in liquid 
cultures and agar plates was 50 µg/mL.  Preparations containing 50 µg/mL of 
kanamycin are denoted Kan+ in the text. 
2.1.6 Ampicillin 
Ampicillin stock solutions were prepared at 10 mg/mL in RO water, sterilised by 
filtration through a 0.2 micron Minisart® filter and aliquoted into 1.5 mL eppendorfs 
and stored at −20°C.  Working concentration of ampicillin in liquid cultures and agar 
plates was 150 µg/mL.  Preparations containing 150 µg/mL of ampicillin are denoted 
Amp+ in the text. 
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2.1.7 X-gal 
X-gal (5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside) is used to indicate 
whether a cell expresses the β-galactosidase enzyme, which is encoded by the lacZ 
gene, in a technique called blue/white screening. If X-gal and an inducer of β-
galactosidase (usually IPTG) are added in a bacterial culture, colonies carrying a 
plasmid which encodes for the lacZ gene are able to produce the enzyme β-
galactosidase which can then cleave the X-gal present within the nutrient agar, resulting 
in a blue colony.  Bacteria which are not transformed with a plasmid encoding for the 
lacZ gene or where the lacZ gene has been interrupted by a cloned DNA sequence 
remain white.  Blue/white screening was not applicable in the case of E. coli strain 
BL21(DE3)1SHOT which encodes for lacZ in its genomic DNA. 
X-gal stock solution was prepared at 20 mg/ml by dissolving into DMSO 
(dimethyl sulfoxide).  Tubes containing the stock solution were wrapped in foil for 
protection against light and stored at −20 °C.  X-gal solutions do not require sterilisation 
(Sambrook et al., 1989).  X-gal was either spread on top of pre-made agar plates (40 µL 
of stock solution) or poured into melted agar at ~55 °C (final concentration 40 µL/mL).  
IPTG was added to 0.1 mM final concentration in the media.   
2.1.8 Tris-HCl buffer 
1 M stock solutions of Tris-HCl (tris(hydroxymethyl)aminomethane 
hydrochloride) of pH 7.2, 7.5 and 7.8, molecular biology grade, were purchased from 
Sigma-Aldrich.  This ensured the lowest possible (and measured) contamination from 
various metal ions which may activate aequorin or aequorin variants. 
2.1.9 EDTA 
0.5 M EDTA (ethylenediamine tetraacetic acid) stock solution at pH 8.0 was 
purchased from Sigma-Aldrich at molecular biology grade. EDTA solution is prepared 
by dissolving the appropriate mass of EDTA disodium salt in deionized water and 
adjusting the pH to 8.0 with NaOH concentrated solution. 
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2.2 Cell culture 
2.2.1 E. coli strains 
2.2.1.1 TOP10 electrocompetent 
E. coli TOP10 electrocompetent cells (Invitrogen) were used for routine cloning:  
transformation and storage of plasmids, production of plasmid DNA.  Their genotype is:  
F– mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 ∆lacX74 recA1 araD139 ∆(ara leu) 
7697 galU galK rpsL (StrR) endA1 nupG.   
2.2.1.2 BL21Star™(DE3) 
BL21Star™(DE3) electrocompetent cells from Invitrogen and Lucigen were 
used in this work.  E. coli BL21Star™ (DE3) electrocompetent cells (Invitrogen) were 
used in protein expression applications.  This strain is suitable for production from 
target genes cloned into T7 driven expression vectors and deficient in RNAseE 
(me131).  The Invitrogen BL21Star™ (DE3) genotype is:  F– ompT hsdSB(rB–, mB–) 
gal dcm rne131 (DE3).    
BL21(DE3) E. cloni™ electrocompetent cells from Lucigen were also used in 
protein expression applications.  This strain exhibits high transformation efficiency and 
is suitable for production from target genes cloned into T7 driven expression vectors 
and deficient in the lon and ompT proteases.  The Lucigen BL21(DE3) E. cloni™ 
genotype is:  F- mcrA ∆(mrr-hsdRMS-mcrBC) Φ80dlacZ∆M15∆lacX74 endA1 
recA1araD139 ∆(ara, leu)7697 galU galK rpsL nupG λ- tonA. 
2.2.2 Streaked plates 
Streaking a plate allows the bacteria to be spread out so that a colony from a 
single bacterium can be isolated from a culture sample.  Cultures were streaked out on 
Petri dishes containing Kan+ (or Amp+ where appropriate) LB agar.  Each plate was 
incubated at 37 °C overnight and stored at 4-6 °C for approximately one week. 
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2.2.3 Overnight cultures 
A single colony was picked from a Petri dish using a sterile loop or sterile 
toothpick into 5 mL of LB medium in a 50-mL Falcon tube.  The tube was incubated 
overnight at 37 °C with 225 rpm agitation. 
2.2.4 Shake flask cultures 
Appropriate volume of the overnight culture was added to sterile LB medium in 
250-, 500-mL or 2-L Erlenmeyer flask and incubated for 8 h at 37°C with 225 rpm 
agitation.  For a 5% inoculation 5 mL of overnight culture was added to 95 mL fresh 
medium in a 500-mL flask. 
2.2.5 Glycerol stocks 
Glycerol stocks at 20% (v/v) were used for long term storage of DNA constructs.  
To create a glycerol stock, a single colony of each clone was picked from an agar plate 
and grown overnight as described in Section 2.2.3.  Samples from the overnight culture 
and 40% v/v sterile glycerol solution were mixed in a one to one volume ratio and 
aliquots were stored stored at –80°C, in sterile eppendorf tubes or microplates. 
2.2.6 Sonication 
Sonication was performed in an MSE Soniprep 150 (Sanyo Europe Ltd.).  One 
milliliter of culture was transferred into a 1.5-mL eppendorf tube which in turn was 
packed into a small beaker containing ice.  The sonicator probe was placed in the 
culture and the cells were lysed on ice using a protocol of 10 s on/off for 10 cycles at 
8 µm amplitude. Cell debris was removed by centrifugation at 1,600 rpm for 20 min. 
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2.3 DNA  
2.3.1 Preparation of plasmid DNA 
Isolation of plasmid DNA from E. coli cultures was performed using Qiaprep 
mini- and midi-preparation kits, purchased from Qiagen Ltd. and the procedure 
followed was according to the manual. 
Purification of DNA products from polymerase chain reaction mixtures was 
performed using Qiaquick PCR purification kit and according to Qiagen’s manual. 
DNA gel extraction from low melt agarose electrophoresis gels was performed using 
Qiaex II Gel Extraction kit from Qiagen Ltd. 
2.3.2 PCR amplification 
PCR reactions were performed on a Techgene Thermo Cycler or a Techne 
thermal cycler, when gradient PCR was required.  Samples were loaded and prepared 
with DNAse and RNAse-free, low-retention tips and eppendorfs from Molecular 
Bioproducts Inc.  PfuTurbo® DNA polymerase was from Stratagene Inc. and ProofStart 
DNA polymerase was purchased from Qiagen.  The template method used is presented 
in Table 2-2; where any deviations where applicable, those will be presented in the 
relevant sections. 
Table 2-1  PCR mix – general cloning 
Component Volume 
10× Reaction Buffer 5 µl 
5–50 ng of dsDNA template X µl 
125 ng of oligonucleotide primer #1 1.25 µl (stock 100ng/µl) 
125 ng of oligonucleotide primer #2 1.25 µl (stock 100 g/µl) 
dNTP mix 1 µl 
ddH20 up to 50 µl 
PfuTurbo DNA polymerase (2.5 U/µl) 1 µl 
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Table 2-2  PCR cycles – general cloning 
PCR Step Duration (min) Temperature (°C) 
Initial activation  
(required with HotStart enzymes, e.g. ProofStart) 
 
5 
 
95 
3-step cycling, 35 cycles:   
Denaturation 1 94 
Annealing 1 69* 
Extension 1 72 
Final extension 7 72 
End of PCR cycling: Indefinite 4 
* a range of annealing temperatures was tested (50-72 ºC).  69 °C were found to be the optimum 
for all amplifications of the apoaequorin gene (Section 3.3.3 and 3.4.2.2), while 60 °C were 
sufficient for the amplification of pET components (Section 3.4.2.2). 
 
 
2.3.3 QuikChange® site-directed mutagenesis 
QuikChange® II SDM (Stratagene Ltd.) is a rapid four-step procedure 
(Stratagene, 2004b).  The basic procedure is shown in Figure 2-1.  It utilises supercoiled 
dsDNA vector as template and two oligonucleotide primers containing the desired 
mutation.  PfuTurbo® DNA polymerase is used to extend the primers and generate a 
mutated plasmid containing staggered nicks.  The product is then treated with 
endonuclease Dpn I to digest the methylated parental DNA template and to select for 
mutation-containing synthesised DNA (non-methylated).  The nicked vector DNA 
containing the desired mutations is transformed into electrocompetent cells.  After 
transformation the nicks in the mutated plasmid are repaired by the host cell. 
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Figure 2-1  Schematic of QuikChange® II Site-Directed mutagenesis method.  Image 
reproduced from Stratagene (2004b). 
 
In this work QuikChange® Site-Directed Mutagenesis (SDM) protocol was used 
with only minor variations.  PfuUltra High Fidelity DNA polymerase (used instead of 
PfuTurbo for its higher fidelity) was used to extend the primers and generate a mutated 
plasmid containing staggered nicks.  Primers were approximately 45 bases in length, 
with a melting temperature of ≥78°C.  A 25 µl QuikChange® reaction mix (Table 2–3) 
was submitted to a program of temperature cycling (Table 2–4) in a PCR thermal cycler 
(Techne Ltd.).  Typically, a master mix would be created for the number of reactions 
carried out on the day and aliquoted out; DMSO, MgSO4, Qsolution or water would be 
added, where applicable, for a final volume of 25 µl.  The QuikChange® reaction was 
digested with 0.6 µL (or 1.53 U) of Dpn I (Stratagene Ltd.) for one hour at 37 °C, 
followed by a second addition of 0.6 µL Dpn I in the mix and incubation for an 
additional hour at 37 °C.  One microliter of the digestion was transformed into 
competent E. coli TOP10 electrocompetent cells (Invitrogen) by electroporation 
(Section 2.2.1.1 and 2.3.8).  The transformed cells were spread on LB Kan+ agar.  
Plasmid DNA was prepared (Section 2.3.1) from overnight cultures (Section 2.2.3) of 
one colony per PCR reaction, checked for correct size on DNA agarose gels (Section 
2.3.9) and mutations were verified through sequencing (Section 2.3.4). 
 
- 72 - 
             Table 2-3  PCR mix – QuikChange® 
Component Volume (µL) 
10x reaction buffer * 2.5 
dNTP mix (10 mM of each) 1 
Sense Primer (62.5 ng per 25 µl reaction) Variable 
Antisense Primer (62.5 ng per 25 µl reaction) Variable 
Pfu UltraHigh Fidelity (2.5 U/µL) 0.25 
Template DNA (5 ng in 25 µl) 0.25 
25 mM MgSO4 Optional 
DMSO Optional 
Qsolution Optional 
RNAse-free H2O Top up to final volume 
Total Volume (µL)  25 
* 10× Reaction Buffer contains: 100 mM KCl, 100 mM(NH4)2SO4, 200 mM Tris-HCl (pH 8.8), 
20 mM MgSO4, 1% Triton® X-100, 1 mg/ml nuclease-free bovine serum albumin (BSA).  
Qsolution: PCR additive (proprietory content) by Qiagen, for amplification of templates that are 
GC-rich or have extensive secondary structure.  Additional concentrations in the final mix of the 
optional chemicals for each reaction are presented in Table 6 1.  
 
        Table 2-4  PCR cycles – QuikChange® 
PCR Step Duration (min) Temperature (°C) 
Initial activation  
(applies only to ProofStart) 
 
30 s 
 
95 
3-step cycling, 35 cycles: 12–18  
Denaturation 30 s 94 
Annealing 1 min * 
Extension 1 min/kb of plasmid length 68 or 72 
Final extension 5 min 72 
End of PCR cycling: Indefinite 4 
*  a range of annealing temperatures was tested (50–69 ºC).  Final temperatures per individual 
reaction for all QuikChange® mutants in Table 6-1. 
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2.3.4 Sequencing 
All DNA samples were sequenced at the Scientific Support Services of the 
Wolfson Institute for Biomedical Research, UCL.  For the sequencing reactions the 
following amount of DNA was prepared:  100 ng/µL for plasmids, 1 ng/µL per 100 bp 
for PCR product, at 10 µL of template per reaction.  Primers were prepared at 
2-5 pmoles/µL at 6 µL per reaction.  
2.3.5 Oligonucleotides for amplification and sequencing 
Primer sequences were designed using Bioedit software.  Calculation of 
annealing temperatures and testing of oligos for dimers and hairpin loops was 
performed on AnnHyb (Friard, 2004).  All primers were from Operon Biotecnologies 
GmbH, with the exception of primers M13-20, M13-40 (supplied by Wolfson Institute) 
and primers T7 promoter, T7 terminator purchased from Novagen.  Sequences of the 
primers used for PCR and sequencing reactions are shown in Table 3-1 and Table 3-3.  
Primers M13-For and M13-Rev were supplied in the TOPO® ligation kit (Invitrogen).  
Where restriction sites were to be introduced (refer to TOPO® cloning Section 3.4.2) the 
design of primers met the following criteria:  (1) restriction sequences should be unique 
both in the template and in the destination plasmid;  (2)  corresponding restriction 
enzymes would leave cohesive ends,  (3)  restriction sites subject to Dcm, Dam and 
EcoR methylation were excluded and (4)  all selected restriction enzymes are active in 
Universal Buffer by NEB, so that double digests can be performed. 
2.3.6 Restriction digests 
Restriction digests were performed to unravel circular, supercoiled and plasmid 
DNA dimer forms of pHAQ, pET26b and pETAQ and to shave off bases from PCR 
constructs described in Chapter 3.  A typical mixture of restriction digest is shown in 
Table 2-5.  All other digestion reactions performed were adapted to this protocol.  
Diagnostic digests were usually performed in 25 µL of final volume, while preparative 
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digests were performed in a total volume of 50 µL.  Xho I, Msc I, BamH I, Sand I and 
Nhe I restriction enzymes were purchased from New England Biolabs Inc. 
                                  Table 2-5  Double digestion reaction mixture 
Diagnostic Preparative Component 
         Volume (µL) 
H2O x 2 × x 
NEB Buffer 4 2.5 5 
BSA solution 2.5 5 
DNA template y 2 × y 
R.E.1 (1 U/µL) 1 2 
R.E.2 (2 U/µL) 0.5 1 
Final volume 25 50 
                                    x:  added water to a final volume of 25 µL  
                                    y:  appropriate volume containing 1000 ng of PCR2 or 500 ng of pET26b 
                                    R.E.1: Restriction enzyme 1 (e.g. Msc I) 
                                    R.E.2:  Restriction enzyme 2 (e.g. XhO I) 
2.3.7 Ligation 
2.3.7.1 Standard ligation 
UltraClone DNA ligation and transformation kit, containing E. cloni™ 
electrocompetent cells was purchased from Lucigen, USA, were used for the pET 
cloning approach (see Chapter 3).   
The cut vector and insert were quantified by measurement of UV Absorbance. 
The appropriate amount of insert and vector was determined in order to satisfy the 3:1 
molar ratio of insert to vector.  The ligation reaction was prepared as seen in Table 2-6 
and the components mixed by gentle pipetting. The reaction mixture was incubated at 
room temperature for 10 min and immediately after the ligation the mixture was 
incubated at 70 °C for 15 min to terminate the reaction. 
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                       Table 2-6  CloneSmart® ligation mixture 
Component Volume (µL)  
Vector x 
Insert y 
CloneDirect 10xLigation Buffer 1 
CloneSmart DNA ligase 1 
H2O z 
Final volume 10 
                        x:  appropriate volume containing 0.03 pmol vector 
                        y:  appropriate volume containing 0.1 pmol insert  
                        z:  added water for final volume of 10 µL 
 
2.3.7.2 Ligation of TOPO® open vector 
Zero Blunt® TOPO® vector kit with One Shot electrocompetent cells was 
purchased from Invitrogen and used for the TOPO® cloning approach (Chapter 3, 
Section 3.4.2). 
                           Table 2-7  TOPO® capture vector ligation mixture 
Component Volume (µL) 
Fresh PCR product (PCR4) 3 
Dilute salt solution (provided in kit) 1* 
H2O 2 
pCR® II-Blunt-TOPO® 1 
Open TOPO® capture vector 1 
Final volume 6 
                             * recommended:  0.5–4 µL 
 
The ligation mix consisted of 3 µL of blunt ended PCR product, dilute salt 
(provided in Kit), water and TOPO® open vector as shown in Table 2–7.  The mix was 
incubated for 5 min at RT.  The transformation procedure was:  2 µL of the ligation 
mixture were transferred into 50 µL of Top10 One Shot® electrocompetent E. coli that 
had been completely thawed on ice.  
Falcon tubes with 5-10 mL Luria-Bertani media containing 100 mg/L of 
ampicillin were inoculated with transformants and placed in a shaking incubator at 
37°C, 200 rpm agitation for 12 h.  Cells that contain non-recombinant vector (no insert) 
- 76 - 
are killed upon plating as successful ligation would cause disruption of the lethal E. coli 
gene ccdB (Bernard et al., 1994) (Invitrogen, 2004).  
2.3.8 Electrocompetent cell transformation 
Electroporation was performed on a Micro-Pulser Electroporator from Bio-Rad 
Laboratories, according to the manufacturer’s instructions for the electroporation of 
bacterial cells.  0.1 cm electroporation cuvettes were from Bio-Rad Laboratories. 
E. cloni™ electrocompetent cells (Lucigen) were left to thaw on wet ice and 
aliquoted in pre-chilled eppendorf tubes (25 µL of cells per tube).  1 µL of the heat 
denatured reaction mixture was added to the cells and stirred briefly using a sterile 
pipette tip.  The cell/DNA mixture was pipetted into pre-chilled electroporation 
cuvettes.  The cuvette was flicked downward so as to deposit the cells across the bottom 
of the well, followed by electroporation.  Within 10 s of the pulse, 980 µL of SOC 
medium were added to the cuvette and cells were resuspended by gentle pipetting.  The 
mixture was transferred to a 15 mL centrifuge tube and incubated at 250 rpm and 37 °C 
for 1 hour to allow expression of the antibiotic resistance genes.  The transformed cells 
were spread on agar plates containing 50 µg/mL kanamycin and plates were incubated 
at 37°C overnight.  This culture was used for further growth of the transformed clones 
for preparation of glycerol stocks and plasmid extraction with Qiagen miniprep kit. 
In a similar manner, One Shot TOP10® Electrocomp™ electrocompetent cells 
were transformed according to the Invitrogen Instruction Manual (Invitrogen, 2004). 
2.3.9 DNA agarose gel electrophoresis 
Agarose gel preparation and casting was according to (Sambrook et al., 1989).  
The most commonly used buffers for electrophoresis of DNA are TAE (Tris-acetate-
EDTA) and TBE (Tris-borate-EDTA).  A concentrated (10x) stock solution of TBE was 
supplied by Bio-Rad Laboratories.  Higher concentrations of agarose allow separation 
of lower molecular weight DNA molecules, while low agarose concentrations allow 
resolution of higher molecular weight DNA molecules.  Table 2–8 presents the agarose 
gel concentration used for various DNA fragment sizes. 
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                                     Table 2-8  Agarose gel concentrations 
Agarose and low-melt agarose were purchased from Sigma-Aldrich.  Agarose 
was used for visualisation and low-melt agarose for preparatory electroporation 
(followed by gel extraction). 
Typically 0.8% or 1% were used for visualisation of plasmids and 1.2% gels 
were used for visualisation of PCR constructs.  The wells of the gel lanes were loaded 
with 3 µL or 6 µL of DNA samples mixed with 6x DNA loading buffer (Novagen).  The 
wells of the lanes containing DNA ladders were loaded with 5 µL Perfect 1kb DNA 
ladder (0.5–12 Kb) or PCR markers (50 bp–2 Kb), as required, both purchased from 
Novagen.  Visualisation of DNA electrophoresis gels was performed on a Gel Doc 2000 
from Bio-Rad Laboratories. 
2.3.10 Absorbance measurement of DNA  
Measurement of DNA absorbance was performed on a UV2 spectrophotometer 
by Unicam Ltd, in quartz cuvettes by Sigma-Aldrich Company Ltd. Absorbance of 
DNA was measured at 260 nm and 280 nm after appropriate dilutions to absorbance 
values <1.0 AU (Absorbance Unit). 
DNA fragment size (Kb) % agarose gel 
1–30 0.5 
0.8–12 0.75 
0.5–10 1.0 
0.4–7 1.25 
0.2–3 1.5 
0.01–0.5 2–5 
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2.4 Protein 
2.4.1 Determination of protein 
2.4.1.1 Determination by UV absorbance 
Protein concentration of purified protein samples (used in Chapter 8) was 
determined by measuring the absorbance (A) at 280 nm and converting to concentration 
through the Beer-Lambert law:  
                 ClA E cm ⋅⋅= %1.01       Equation 2.1 
where %1.01cmE  is the mass extinction coefficient for a 0.1% or 1 mg/mL protein 
solution, l is the pathlength (cm) and C is the protein concentration (mg/mL).  This is an 
excellent method for measuring protein concentrations provided that an accurate value 
of %1.01cmE  is available and that the sample is of high purity.  A280 absorbance 
measurements of purified protein were performed on a Nanodrop (Thermo Scientific).  
The value for molar extinction coefficient of aequorin was derived from previously 
published literature %1.01cmE  at 280 nm =3.0 (Shimomura et al, 1990) and verified from 
280 nm absorbance measurements of pure, commercially available aequorin (Aqualite® 
Molecular probes). 
An established and well-trusted method for estimating molar extinction 
coefficient ε for proteins is the Edelhoch method (Pace et al., 1995), based on the 
protein’s content of tryptophan, tyrosine and cystine (disulfide bonds).  An extinction 
coefficient of aequorin could not be calculated using the Edelhoch method as it that 
designed for polypeptide chains; aequorin is comprised of a polypeptide chain and a 
prosthetic chromophore and the extinction coefficient of aequorin is not the product of a 
simple addition of the extinction coefficients of the participating molecules. 
2.4.1.2 Determination by Bradford assay 
For the determination of total protein concentration the Bradford assay was used 
(Bradford, 1976). Bradford is a colorimetric protein assay based on an absorbance shift 
of the dye Coomassie Brilliant Blue G-250 under acid conditions when a redder form of 
the dye is converted into a bluer form on binding to protein.  Binding of the protein 
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stabilises the blue form of Coomassie dye, thus the amount of complex present in 
solution is a measure for the protein concentration by use of an absorbance reading at 
595 nm.  Protein standard solutions must be prepared in the same buffer as the samples 
to be assayed.   
Coomassie Brilliant Blue G-250 stock solution was purchased from Bio-Rad and 
used in an appropriate dilution.  A standard curve was made using bovine serum 
albumin (BSA) from Sigma-Aldrich.  When the standard procedure was used, 1 mL of 
each sample or BSA standard solution was mixed with 1 mL of Bradford reagent 
diluted 1:2, and absorbance at 595 nm was recorded.  BSA standard solutions ranged 
from 0.015 to 0.125 mg/ml.  When performing the assay in microtiter plates, 10 µL of 
sample or BSA standard solution were mixed with 200 µL of Bradford reagent diluted 
1:5 and protein standards were ranged from 0.05 mg/ml to 0.5 mg/ml. In the Nanodrop 
determination 10 µL of sample or standard solution were mixed with 10 µL of 1:2 
diluted Bradford reagent and protein standards were 0.015–0.125 mg/ml. 
2.4.2 Protein size – SDS-PAGE 
Electrophoresis of protein samples was carried out using 12% and 15% w/v 
polyacrylamide gels.  Gels were purchased from Bio-Rad while SDS running buffer was 
prepared as in (Sambrook et al., 1989).  Each sample was diluted 1:1 (or at other 
appropriate ratio) with SDS loading buffer, purchased from Bio-Rad.  Samples were 
heated at 95 °C for 5 min prior to electrophoresis.  To determine the size of a sample 
protein, a series of standards (proteins of known molecular weight) were loaded in 
adjacent lanes of the gel.   
Precision Plus Protein™ Standards, containing ten recombinant protein bands 
(10 kDa–250 kDa) pre-stained with Coomasie Blue were purchased from Bio-Rad 
Laboratories, Inc.  These standards contain three bands (25 kDa, 50 kDa and 75 kDa) 
which are three times as intense as the other bands and pre-quantified protein 
bandswhich can be used for a rough approximation of a protein of interest. 
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Figure 2-2  Protein ladders used in SDS protein electrophoresis. 
 
2.4.2.1 Protein quantity by SDS-PAGE 
The Precision Plus Protein™ Standards contain three bands (25 kDa, 50 kDa and 
75 kDa) which are three times as intense as the other bands and pre-quantified protein 
bands which can be used for a rough approximation of a protein of interest by 
densitometry.  This method was used only as a rough guide and not relied upon for 
accurate quantification of protein.  
2.4.2.2 Protein sample purity by SDS-PAGE 
Pre-cast Ready Gel® Tris-HCl, 12% and 15% polyacrylamide gels for protein 
electrophoresis were purchased from Bio-Rad Laboratories.  The SDS running buffer 
was 50 mM Tris-HCl, 0.38 M glycine, 0.1% (w/v) SDS in RO water, adjusted to pH 
8.8.  The staining solution was 0.05% (w/v) Coomassie Brilliant Blue, 50% (v/v) 
methanol, and 10% (v/v) acetic acid in RO water.  Protein ladders used were Presision 
Plus Standards (Bio-Rad Laboratories) and Benchmark Protein Ladder (Invitrogen) 
(Section 2.4.2.1, Figure 2-2). 
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2.5 Metal ion concentration 
2.5.1 Ion solution preparation 
All metal ion salts and Tris-HCl stocks were purchased from Sigma Aldrich.  
Stock solutions were created by weighing chloride ion salts (nitrate salt in the case of 
lead) into polypropylene volumetric flasks, suitable for atomic absorption assays.  All 
metal salts were diluted in 50 mM Tris-HCl pH 7.5 buffer with the exception of lead 
nitrate, which precipitates in Tris-HCl and R.O. water was used instead.  Serial dilutions 
were performed to obtain solutions in a wide range of nominal concentrations down to a 
few micromolar (µM).  To correct for possible dilution errors and salt precipitation of 
the stock solutions, the solutions were tested for ion concentration with atomic 
absorption (Section 2.5.2) and the nominal metal ion concentrations were corrected 
where necessary.  The corrected ion concentration values were used in Chapters 7 and 8.  
Blank buffers containing 50 mM Tris-HCl 10 µM EDTA pH 7.5 were also tested for 
total calcium contamination which was found to be 2.1×10-7 M. 
 
                   Table 2-9  Metals in the form of hydrated salts.   
Salt  Purity  
Calcium chloride hexahydrate CaCl2·6H2O 99+% 
Cobalt chloride hexahydrate CoCl2·6H2O 99-102% 
Cadmium chloride  CdCl2   99.99+% 
Copper sulfate pentahydrate CuSO4·5H2O 99.99+% 
Lanthanum chloride heptahydrate LaCl3·7H2O 99.99+% 
Zinc chloride  ZnCl2 99.999+% 
Lead nitrate  Pb(NO3)2 99.99+% 
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2.5.2 Atomic absorption 
Atomic absorption measurements were conducted by ICP-AES (Inductively 
Coupled Plasma Atomic Emission Spectrometry) on a Varian VISTA PRO by the 
Natural History Museum Analytical imaging facilities department.  This method enables 
the detection of major, minor and trace elements in sample solutions.  Samples are 
dispersed into a stream of argon gas through a nebuliser and carried to an ICP.  As the 
sample atoms are excited in the ICP they lose electrons.  As they regain their lost 
electrons the sample atoms emit photons of light, with wavelengths characteristic of the 
elements present.  A spectrometer is used to separate the light emitted into the various 
wavelengths and these are detected and recorded simultaneously using a solid-state 
detector. 
2.6 Automation 
2.6.1 Automated colony picking 
A Qpix2 robot (Genetix Ltd.) was used to pick colonies of E. coli.  The robot 
was programmed to inoculate every well of a 96-DSW (deep square well) plate with 
colonies of E. coli from petri dishes.  Each plate was sealed by adjusting firmly an 
inverted shallow 96-well plate (Sarstedt Inc) and taping it over the top of the DSW 
plate.  The sealed plates were incubated for 16 hours at various agitation speeds on a 
Variomag Teleshake unit (Camlab Ltd.) at 37 °C.   
2.6.2 Automated liquid handling 
Automated liquid dispensing into microplates was carried out using a TECAN 
Genesis (TECAN Ltd, Reading, UK) robotic platform fitted with an 8-channel 
multipipette, sterile disposable filtered tips within a clean cabinet pre-sterilised using 
one in-built and one floor-mounted UV lamp.  
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2.7 Luminescence measurements 
2.7.1 Platereader 
The light measurements were performed using the FluoStar Optima microplate 
reader (BMG Lab technologies Ltd, Bucks, UK), a luminescence, fluorescence and 
absorbance reader equipped with two syringe pumps for reagent injection.  The 
luminescence mode was used (no excitation as it is not required in bioluminescence).  
Emission of light was obtained through the emission lens (no filters were used) in order 
to collect light from the all the visible spectrum.  This option offers the advantage of not 
missing light emitted in a shifted wavelength, in case this may occur with certain 
protein variants.  The BMG Fluostar Optima has a limit of detection lower than 
50 amol/well ATP, spectral range between 240 and 740 nm and a dynamic range of nine 
decades.  The instrument was checked annually for recalibration using radioactive 
luminescence standards by BMG Lab Technologies.  
 
 
Figure 2-3  Platereader layout – luminescence mode. 
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2.7.1.1 Visualisation of results 
The typical flash luminescence activity of aequorin vs time is shown in Figure 
1.4.  The activity is usually assessed by measuring the peak (and less often by 
measuring the total amount) of light derived from the flash luminescence curve.  The 
platereader software enables simultaneous visualisation of the luminescence curves of 
all of the wells of the microplate, thus allowing direct comparison between them.  In 
most cases this visual output option was adequate to inform on decisions such as which 
operating parameter was optimal or whether an operating condition met the purposes of 
the assay.   
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3 Cloning of apoaequorin gene 
This chapter describes the efforts to create an expression vector which facilitates 
production of apoaequorin in a way that allows for easy reconstitution with the 
heterocyclic compound coelenterazine in high-throughput assays and also for the 
purification of the protein (apo- or holo-form of aequorin).  Two separate cloning routes 
are described.  For clarity, this chapter in particular is divided in four main sections:  In 
Introduction (Section 3.1) the envisaged expression vector and possible cloning routes 
are identified.  Following this, Section 3.2 describes the verification and sequence of the 
apoaequorin gene in its original plasmid vector.  Each of the two subcloning routes is 
presented separately (Section 3.3 and Section 3.4) with methods, results and discussion.  
The outcome and expectations for the competing approaches will be discussed in 
Conclusions (Section 3.5).  
3.1 Introduction 
3.1.1 Envisaged expression vector 
A suitable expression vector would contain the following features: 
(1) gene encoding for apoaequorin 
(2) promoter site and ribosome-binding site (RBS) for transcription and 
translation 
(3) signal peptide sequence, e.g. pelB leader sequence:  for localisation of 
the expressed apoaequorin in the periplasmic space of the cell, where it can be easily 
reconstituted into fully charged holoprotein complex by incubation with coelenterazine 
(4) 6xHis-tag encoding sequence for potential metal affinity purification in 
Ni-NTA columns and/or Ni-NTA coated microwell plates 
5) unique restriction sites flanking the apoaequorin gene, for the future 
option of “lifting” the construct from the vector with restriction digest, in order to ligate 
into another vector. 
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3.1.2 Cloning strategies 
In order to ensure successful cloning of the apoaequorin gene in the construct 
described, two subcloning routes were pursued: 
The first route (pET cloning route) aimed to transfer the apoaequorin gene into 
the pET26b commercial expression vector by double digestion and ligation. 
The second route (TOPO® cloning route) aimed to create the desired construct 
by using a consecutive series of PCR amplifications, resulting in a blunt ended construct 
that could be ligated into an open TOPO® vector. 
The first route (pET cloning route) not immediately successful; the second route 
(TOPO® cloning) was pursued in parallel, as an alternative.  In the end both routes 
yielded successful results at the same time. 
3.2 Apoaequorin in original capture vector 
This section describes studies conducted to verify the integrity of the 
apoaequorin gene which would be used as a template for further cloning.  All general 
materials and methods used in this Section and the two Sections thereafter are described 
in Chapter 2, Section 2.1.  Cell culture methods and E. coli strains are described in 
Section 2.2 and DNA handling methods are described in Section 2.3.  Modifications and 
optimisations to the methods described in Chapter 2 are presented in the relevant 
sections.  The overall implementation of methods and verification of outcomes of both 
cloning routes was based on a general framework which is described in Figure 3–1. 
The gene encoding for apoaequorin was a kind gift from Professor Trewavas of 
the Institute of Cell and Molecular Biology, University of Edinburgh.  The gene came 
inserted in plasmid pHAQ (Figure 3–2).  pHAQ is a pBluescript vector (Figure 3–3), 
with the apoaequorin gene ligated between Sal I and Pst I restriction sites.  In the maps 
of all vectors shown, the orientation of each gene is represented by the direction of its 
arrow.  pBluescript is a high copy number plasmid vector which was designed for DNA 
cloning, DNA sequencing, in vitro mutagenesis and in vitro transcription (Stratagene, 
2004a) as shown on the relevant plasmid maps it lacks features encoding for 
periplasmic localisation and metal affinity. 
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Figure 3-1  Overview of workflow employed for cloning in this work. 
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Figure 3-2  pHAQ vector:  pBluescript backbone with apoaequorin gene inserted in the 
polylinker region between Sal I and Pst I recognition sites. 
 
 
Figure 3-3  pBluescript vector.  Image reproduced from Stratagene.com (Stratagene, 
2004a).  Apoaequorin gene was cloned into the MCS, between Sal I and Pst I restriction 
sites.           
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3.2.1 Verification of apoaequorin gene in pHAQ vector 
Electrocompetent E. coli TOP10 were transformed with pHAQ vector and the 
transformed cells were plated on LB agar-kanamycin plates.  Colony selection, 
cultivation in LB media, centrifugation of the culture and plasmid DNA purification 
were performed as described in Sections 2.2 and 2.3.  A double digest with restriction 
enzymes BamH I and Xho I was performed on the purified plasmid, followed by gel 
electrophoresis separation (1.2 % agarose gel). This was done to verify that the insert of 
the expected size was indeed within the specific restriction sites. The Xho I site is 6 bp 
upstream of the Sal I site and the BamH I site is 15 bp downstream of the Pst I site 
(Figure 3-2, Figure 3-3).  Visualisation of the gel showed two fragments of the expected 
sizes in Figure 3-4.  
The unrestricted plasmid was sequenced with standard T3 and T7 promoter 
primers which flanked the apoaequorin gene.  Using Bioedit (Hall, 2004), the resulting 
sequence was aligned with the sequence of apoaequorin retrieved from Genbank, 
Accession Number M16104 (Benson et al., 2005).  The alignment is presented in Figure 
3-8 amongst the sequencing results from pET system cloning. 
Figure 3-8 shows the sequence of the apoaequorin gene as provided in pHAQ 
(sequence name: denoted: apoaequorin_gene) aligned with the M16103 apoaequorin 
gene sequence in Genbank, Accession Number M16104 (Benson et al., 2005).  One 
base difference is observed between the two sequences:  position 424 TCTGAT in 
M16103 versus TCTGCT in the pHAQ sequence translates to a D (Asp) in M16103 
instead of an Ala in the sequence used in this work.  In Chapter 5 the translated protein 
sequence of the apoaequorin gene (used this work) is aligned for comparison with the 
translated M16103 and the published crystallographic PDB structures of the 
apoaequorin chains 1EJ3 (Head J.F., 2000) and 1SL8 (Deng et al., 2005). 
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Figure 3-4  Plasmid vector pHAQ:  agarose gel visualisation. 1.2% agarose (left) and 
2.5% low melt agarose (right) gel visualisation of:  (1) 0.5-12 Kb DNA ladder, (2) open 
circular, linear and supercoiled forms of pHAQ uncut plasmid 3,506 bp, (3) pHAQ 
double digest with BamH I and Xho I restriction enzymes.  The faint lower band at 
609 bp corresponds to apoaequorin gene plus a few flanking base pairs and upper band 
at ~2,900 bp corresponds to the remaining vector.  
3.3 pET cloning route 
The first cloning approach towards obtaining the apoaequorin gene within a 
desired expression vector (Section 3.1.1) was a “traditional” approach:  the gene of 
interest would be cut from its carrier plasmid using the appropriate restriction enzymes 
(if the carrier did not incorporate the expression features required and in the correct 
orientation).  The destination vector, one which includes the desired features and in the 
correct orientation would also be cut using the same restriction enzymes so that its 
multiple cloning site (MCS) has flanking restricted ends complementary to the ones of 
the restricted DNA fragment of interest.  The cut vector and the cut gene of interest 
(insert) are ligated in order to form a complete expression vector and the ligated product 
is transformed into competent cells.  The schematic of the pET cloning concept and its 
details is described in Figure 3-6.   
 (1)                   (3) 
- 91 - 
3.3.1 Vector pET26b 
The pET vector is a powerful system for the cloning and expression of 
recombinant proteins in E. coli.  Target genes are cloned in pET plasmids under control 
of strong bacteriophage T7 transcription.  It incorporates fusion tags which can facilitate 
detection and purification of the target protein, affect recombinant protein solubility in 
the cytoplasm or facilitate export to the periplasm.   
Due to its availability in the lab, pET26b (Novagen) was the vector of choice.  
Figure 3-5 shows the plasmid map and expression region details.  For the purposes of 
this project, key features of interest include the T7 promoter region, N-terminal pelB 
signal sequence for potential periplasmic localization, C-terminal 6xHis-tag sequence 
and the kanamycin resistance cassette (Figure 3-5). 
 
 
 
 
 
 
 
 
 
 
  
Figure 3-5  pET26b vector and cloning expression region.  Image reproduced from 
www.novagen.com.   
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3.3.2 Schematic of pET cloning route 
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3.3.3 Methods for pET cloning 
Primer sequences used in this Section and their melting temperatures are shown 
in Table 3–1.  Primers AEQMSCI and AEQXHOI were designed to introduce the 
restriction endonuclease site for Msc I and Xho I upstream and downstream of the 
apoaequorin sequence, respectively.  The two primers were used for the amplification of 
apoaequorin gene from pHAQ while obtaining overhangs for Msc I upstream and Xho I 
downstream of the gene.  Primers For10+26, For252+20, Rev450-20 were designed for 
sequencing purposes. Their names indicate their position and direction in the 
apoaequorin gene, for example For10+26 is a forward (sense) primer which starts at 
position 10 of the apoaequorin gene and is 26 bases long. 
Amplification PCR2 was carried out in 50 µL final volume and according to the 
general methods described in Table 2-2 and 3-1, Section 2.3.2. 
Vector pET26b and the product of reaction PCR2 were digested with restriction 
enzymes Msc I and Xho I.  The digested DNA was electrophorised on low-melt agarose 
gels and the bands of desired size were extracted and purified using Qiaex II DNA 
extraction kit by Qiagen.  Vector (Figure 3-7, lane 3) and insert (Figure 3-7, lane 5) 
were ligated at 3:1 molar ratio using CloneSmart Ligase (Lucigen, USA) as described in 
Section 2.3.7.1.  Successful ligation using the Lucigen kit followed a series of 
unsuccessful ligations using T4 DNA ligase at 3:1 and 5:1 insert to vector ratio.  The 
product of ligation was used to transform electrocompetent E.cloni™ cells (Table 2–5).  
Plasmid DNA was isolated from overnight cultures and sequenced using the following 
primers:  T7 Promoter and T7 Terminator (Novagen), For10+26, For252+20 and 
Rev450-20 (Operon). 
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Table 3-1  Oligonucleotides for pET26b cloning route and sequencing 
Primer  Sequence  Tm 
(ºC) 
AEQMSCI sense 5'CGGCGATGGCCATGACCAGCGAACAATACTCAGTCA3 82.0 
AEQXHOI antisense 5'GTGGTGCTCGAGGGGGACAGCTCCACCGTAGAGC3' 84.8 
T7 promoter sense 5'TAATACGACTCACTATAGGG3' 46.8 
T7 terminator antisense 5'GCTAGTTATTGCTCAGCGG3' 52.9 
For10+26 sense 5'GAACAATACTCAGTCAAGCTTACACC3' 63.0 
For252+20 sense 5'TGAATGGCCTGAATACATCG3' 58.6 
 
 
Table 3-2  PCR amplification of apoaequorin from pHAQ 
PCR  
 Nr 
Enzyme Template (mg) Primers DMSO 
(v/v) 
 Mg2+  
(mM) 
Qsol Cycles  Ta  
(°C) 
PCR2 Pfu pHAQ 20 AEQMSCI 
AEQXHOI 
- - - 30 60 
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3.3.4 Results and discussion for pET cloning 
The incorporation of the apoaequorin gene in pET26b vector resulted in the 
plasmid named pETAQ.  Figure 3-7 shows the DNA agarose gel electrophoresis of the 
pET cloning route.  Figure 3-8 and Figure 3-9 show the sequencing results obtained for 
pETAQ, aligned with the apoaequorin sequence as was expected from the lab of 
Professor Trewawas and with the apoaequorin gene sequence obtained from Genbank 
database.  The expected one base pair difference with the Genbank entry is highlighted 
in red.  The sequencing results indicate that apoaequorin gene was successfully ligated 
between Msc I and Xho I recognition sites in pET26b, between pelB leader sequence 
and 6xHis-tag sequence.  The end codon TGA follows immediately after the 6xHis-tag 
sequence. Six base pairs between the apoaequorin gene and the 6xHis-tag came as part 
of the pET26b vector; they add two amino acids (Leu, Glu) to the C-terminal of the 
translated protein sequence before the 6xHis-tag.   
The ORF of pETAQ was explored using the ExPASy Translate tool (Gasteiger et 
al., 2003) and the translated protein sequence was aligned with the M16103 translated 
apoaequorin in Figure 3-10.  The translated protein sequence of the pETAQ ORF was 
compared to the translated M16103 gene.  The pelB peptide leader is indeed expressed 
upstream of the apoaequorin gene (black font, amino acid numbering 1-23).  The 
alignment shows that the one base pair difference leads to one amino acid difference at 
position 143, counting from the beginning of the apoaequorin gene (or position 165 
counting from the beginning of the pelB peptide) and that 2 extra amino acids are added 
at the C-terminus upstream of the six histidines. 
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Figure 3-7  Agarose gel visualisation of pET26b cloning route. (1) open circular, linear 
and supercoiled forms of pET26b uncut plasmid (5,360bp), (2) pET26b single digest 
with Msc I restriction enzyme (5,360bp) (3) vector for ligation (5,293 bp):  pET26b 
plasmid following double digest reaction with Msc I and Xho I restriction enzymes, (4) 
gel:  blunt ended PCR2 construct (611bp), (5) insert for ligation (605 bp) PCR2 
following double digest reaction with Msc I and Xho I restriction enzymes, (6) pETAQ 
plasmid: open circular, linear and supercoiled forms.  Lanes (1) to (5) were of 1.2% 
agarose gels and (6) was of 1.4% agarose gel.  (7) pETAQ single digest with Xho I, 
band at ~5.9 Kb(8) pETAQ double digest with Xho I and Msc I restriction enzymes.  
The faint lower band at ~588 bp corresponds to apoaequorin gene plus a few flanking 
base pairs and upper band at ~5.3 Kb corresponds to the remaining vector. 
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Figure 3-8  pETAQ DNA sequencing results (a).  Multiple alignment of pETAQ plasmid sequence with the apoaequorin gene sequence received 
from Professor Trewawas lab, apoaequorin gene sequence described in Genbank M16103 and the desired features of T7 promoter region, pelB 
leader sequence and 6xHis-tag.  Multi-alignment was performed using software Bioedit (Hall, 2004) and MultAlin (Corpet, 1988). 
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Figure 3-9  pETAQ DNA sequencing results (b).  Figure 3-8 continued.  Multiple alignment of pETAQ plasmid sequence with the apoaequorin 
gene sequence received from Professor Trewawas lab, the apoaequorin gene sequence described in Genbank M16103 and the desired features of 
T7 promoter region, pelB leader sequence and 6xHis-tag.  Multi-alignment was performed using software Bioedit (Hall, 2004) and MultAlin 
(Corpet, 1988).  
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Figure 3-10  pETAQ open reading frame.  M16103_translate is the translated protein sequence of M16103, used as reference sequence. 
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3.4 TOPO® cloning route 
The second cloning approach towards obtaining the apoaequorin gene within a 
desired expression vector (Section 3.1.1) was decided as backup to the pET cloning 
route and as a result of initially unsuccessful pET vector and apoaequorin insert ligation 
attempts (Section 3.3.3). 
This approach would avoid restriction digests and sticky (cohesive) end ligation 
methods.  The envisaged DNA construct (Section 3.1.1) incorporating the apoaequorin 
gene behind a strong promoter, pelB leader sequence for periplasmic localisation and 
6xHis-tag for metal affinity purification would be constructed through a series of PCR 
amplifications.  The DNA construct produced this way would be inserted into a suitable 
capture vector using blunt ended ligation.  The pCR®-Blunt TOPO® vector had 
successfully been used for blunt ended cloning in the lab and hence was the capture 
vector of choice.  The TOPO® cloning route is illustrated in Figure 3-12. 
The pCR®-Blunt II-TOPO® open capture vector incorporating genes for 
replication, transcription and antibiotic resistance was from Invitrogen Ltd. shown in 
Figure 3-11.  TOPO® already contains a T7 promoter for eukaryotic RNA; the T7 
promoter region from pET system would be utilised for E. coli expression.   
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Figure 3-11  TOPO® capture vector.  Image adapted from www.invitrogen.com.  
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3.4.1 Schematic of TOPO® cloning route 
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3.4.2 Methods for TOPO® cloning 
3.4.2.1 Design of primers 
Primer sequences and melting temperatures are shown in Table 3-3.  Primers 
PET26bFOR and PET26bREV are specific to the T7 promoter region and pelB 
sequence of plasmid pET26b respectively.  Primer PET26bFOR contains an overhang 
with Nhe I restriction site and T7 promoter at the end of the gene encoding for the N-
terminus of the protein.  Primer PET26bREV (antisense) contains an overhang with the 
first 29 bases of the apoaequorin gene.  
Primers AEQMSCI, AEQXHOI, AEQfor and AEQrev are specific to the 
apoaequorin gene.  AEQMSCI and AEQXHOI had been previously designed to 
introduce the restriction endonuclease site for Msc I and Xho I upstream and 
downstream of the apoaequorin sequence, respectively and had been used for pET 
cloning route. AEQfor was designed to add the last 25bp of pelB leader of pET26b to 
the upstream of the apoaequorin gene.  AEQrev was designed in order to add 6xHis-tag, 
end codon TAA and restriction site SanD I to the C-terminus of the protein.  Restriction 
sites SanD I and Nhe I were chosen as unique restriction sites at the N- and C-terminus 
end of the construct respectively, according to the criteria set in Section 2.3.5. 
3.4.2.2 PCR amplifications  
PCR amplifications were carried out in mixtures of 25 or 50 µL final volumes, 
using the general methods described in Table 2-2 and 3-1, Section 2.3.2.  The reactions 
required several optimisation attempts and the final optimum conditions for each 
reaction are shown in Table 3-4.  The success of each step of the series of PCR reactions 
was initially verified by DNA agarose gel electrophoresis.  When more than one size of 
products was generated despite optimisation attempts, the band of the desired size was 
excised and extracted from low melting-point agarose gel and purified (Section 2.3.1) 
for use in subsequent PCR steps. 
PCR1:  The T7 promoter and pelB signal encoding region of template plasmid 
pET26b were amplified using primers PET26bFOR and PET26bREV. In the resulting 
blunt-ended construct, this region is flanked by restriction site Nhe I at the 5’ end and by 
the first 25 bp encoding for the apoaequorin gene at the 3’ end. 
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PCR0:  Attempt to amplify the apoaequorin gene, flanked by the last 25 bp of the 
pelB signal sequence at the 5’ end and a sequence encoding for 6 His-tags, end codon 
and recognition site for restriction enzyme SanD I using pHAQ as template and primers 
AEQFOR and AEQREV.  Despite numerous optimisation attempts this reaction was 
unsuccessful, which led to PCR3.  For the reaction PCR3 the template used was the 
product of PCR2 (previously used in pET cloning route), instead of the full plasmid 
pHAQ. 
PCR2:  The apoaequorin gene was amplified from template pHAQ, flanked by 
Msc I and Xho I restriction enzyme recognition sites at the 5’ and 3’ end respectively, 
using primers AEQMSCI and AEQXHOI. This construct served as an intermediate 
template for reaction PCR3. 
PCR3:  This reaction resulted in the amplification of the apoaequorin gene, 
flanked by the last 25bp of the pelB signal sequence at the 5’ end and a sequence 
encoding for 6 His-tags, end codon and recognition site for restriction enzyme SanD I.  
It was not possible to acquire a product of the desired length by using pHAQ as a 
template with primers AEQFOR and AEQREV, despite numerous optimisation 
attempts. For reaction PCR3 the template used was the product of PCR2, instead of 
plasmid pHAQ.  
PCR4:  Creation of the final construct using primers PET26bFOR and 
AEQREV.  This has been the most successful of a series of several attempts to optimise 
this reaction.  Gel visualisation suggests possible formation of more constructs than the 
one of the desired size (721 bp).  Band of the desired size was extracted from low melt 
agarose gel for further ligation step with TOPO® open vector.  
PCR4 product and TOPO® were ligated and the resulting plasmid was used to 
transform electrocompetent E. coli Top10 (Table 2–7).  Plasmid DNA was isolated 
from overnight cultures of the transformed cells and sequenced using standard primers 
M13 For and M13 Rev. The sequencing results indicated that the desired construct was 
successfully ligated into TOPO® vector. The resulting plasmid was named TOPAQ. 
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Table 3-3  Oligonucleotides for TOPO® cloning route and sequencing 
Name   Sequence Tm (ºC) 
PET26bFOR sense 5'GCTAGCATGCGTCCGGCGTAGAGGATCGAGATCTCGATCCCGCGAAATTAATACGACTCACTATA3' 78.2 
PET26bREV antisense 5'TGACTGAGTATTGTTCGCTGGTCATGGCCATCGCCGGCTGGGCAGCG3' 79.6 
AEQMSCI  sense 5'CGGCGATGGCCATGACCAGCGAACAATACTCAGTCA3' 82.0 
AEQXHOI  antisense 5'GTGGTGCTCGAGGGGGACAGCTCCACCGTAGAGC3' 84.8 
AEQFOR  sense 5'CCTCGCTGCCCAGCCGGCGATGGCCATGACCAGCGAAC AATACTCAGTCA3' 80.3 
AEQREV antisense 5'GGGTCCCTTAGTGGTGGTGGTGGTGGTGGGGGACAGCTCCACCGTAGAGCTTTT3' 80.7 
M13-for sense 5'GTAAAACGACGGCCAG3' 49.6 
M13-rev antisense 5'CAGGAAACAGCTATGAC3' 46.1 
For10+26 sense 5'GAACAATACTCAGTCAAGCTTACACC3' 63.0 
Table 3-4  PCR conditions for TOPO® cloning 
Reaction Sense primer Antisense primer Templates Enzyme DMSO (v/v) Qsol (v/v) Mg2+ (mM)  Nr cycles Ta (ºC) 
PCR1 PET26bFOR PET26bREV pET26b Pfu 2%  1.5 30 60 
PCR2 AEQMSCI  AEQXHOI  pHAQ Pfu   1.5 30 60 
PCR3 AEQFOR AEQREV PCR2 ProofStart 4% 20% 1.5 30 68 
PCR4 PET26bFOR AEQREV PCR1 and PCR3 ProofStart   2.5 30 68 
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3.4.2.3 TOPO® ligation 
TOPO® ligation was performed according to the manufacturer’s instructions and 
as described in Section 2.3.7.2. 
Table 3-5  PCR mix for TOPO® cloning reactions 
Component Volume 
(µL) 
PCR1  PCR2 PCR3 PCR4 
10x optimal buffer 5 5 5 10 5 
25mM MgSO4 Variable - - - 3 
dNTP mix (10 mM of each) 1.5 1 1 3 1.5 
Sense Primer Variable 1 1 2 1 
Antisense Primer Variable 1 1 2 1 
ProofStart/Pfu polymerase (2.5U/ µL) 1 1 
(Pfu) 
 
1 
(Pfu) 
2 
(Proof) 
1 
(Proof) 
RNAse-free H2O Variable 39.4 40.6 55.4 25.7 
Template DNA (20ng final) Variable 0.6 0.4 1.6 1 
Template DNA 2 (applies only to 
creation of construct PCR4) 
Variable - - - 0.8 
DMSO Variable 1 - 4 - 
Qsolution Variable - - 20 10 
Total Volume 50 50 50 100 50 
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3.4.3 Results and discussion for TOPO® cloning 
The incorporation of the apoaequorin gene in TOPO® open vector resulted in the 
plasmid named TOPAQ.  Figure 3-13 shows the DNA agarose gel electrophoresis of the 
TOPO® cloning route.  Figure 3-14 to Figure 3-16 show the sequencing results obtained 
for TOPAQ, aligned with the apoaequorin sequence as was expected from the lab of 
Professor Trewawas and with the apoaequorin gene sequence obtained from Genbank 
database.  As with pETAQ results, the expected one base pair difference with the 
Genbank entry is highlighted in red.  The sequencing results indicate that apoaequorin 
gene was PCR amplified downstream of T7 promoter region and pelB leader sequence 
and 6xHis-tag sequence.  The end codon TGA follows immediately after the 6xHis-tag 
sequence.  The construct is flanked by SanD I and Nhe I restriction sites.  The ORF of 
the expressed sequence in TOPAQ is aligned with the theoretical expected apoaequorin 
sequence in Figure 3-17.  TOPO® vector already contains a T7 promoter priming site 
downstream of the blunt ended cloning site.  The apoaequorin DNA construct created in 
Section 3.4.2.2 contains its own T7 region and lac operator as those were amplified by 
PCR from pET26b template.  The direction of the insert in TOPO® was reverse-oriented 
to the vector numbering shown in Figure 3-11.   
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Figure 3-13  Agarose gel visualisation of TOPO® cloning route.  PCR0:  Attempts to 
amplify apoaequorin gene using primers AEQFOR and AEQREV, using pHAQ as 
template.  There is no product of the desired size (642 bp).  Contamination seen on gel 
picture is suspected to be primer-dimer formations, possibly due to a specificity 
problem of the primers and template.  This problem was circumvented by consecutive 
reactions PCR2 and PCR3.  PCR1:  Amplification of T7 promoter and pelB leader using 
primers PET26bFOR and PET26bREV. PCR product was of expected size (209 bp).  
PCR2:  Amplification of apoaequorin gene using primers AEQMSCI and AEQXHOI. 
Product of the desired size (611 bp) seems to have been produced. This fragment was 
used as template for PCR3.  PCR3:  Amplification of apoaequorin gene using primers 
AEQFOR and AEQREV. Product of the desired size (634 bp) seems to have been 
produced.  This product was used in combination with PCR1 product, as template for 
PCR4.  PCR 4:  Production of the final construct using primers PET for and AEQREV.  
This has been the most successful of a series of several attempts to optimise this 
reaction.  Faint bands near the product of the desired size (721 bp) indicate presence of 
some contamination.  The band of desired size was extracted from the gel in order to be 
used for ligation into the open capture vector.  Lane (1):  TOPAQ uncut plasmid open 
circular, linear and supercoiled forms, Lane (2):  TOPAQ digested with Msc I, fragment 
~4.22 Kb.  
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Figure 3-14  TOPAQ DNA sequencing results (a).  Multiple alignment of TOPAQ plasmid sequence with the apoaequorin gene sequence 
received from Professor Trewawas lab, the apoaequorin gene sequence described in Genbank M16103 and the desired features of T7 promoter 
region, pelB leader sequence and 6xHis-tag.  Multi-alignment was performed using software Bioedit (Hall, 2004) and MultAlin (Corpet, 1988). 
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Figure 3-15  TOPAQ DNA sequencing results (b).  Figure 3-14 continued.  Multiple alignment of TOPAQ plasmid sequence with the 
apoaequorin gene sequence received from Professor Trewawas lab, the apoaequorin gene sequence described in Genbank M16103 and the 
desired features of T7 promoter region, pelB leader sequence and 6xHis-tag.  Multi-alignment was performed using software Bioedit (Hall, 
2004) and MultAlin (Corpet, 1988). 
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Figure 3-16  TOPAQ DNA sequencing results (c).  Figure 3-15 continued.  Multiple alignment of TOPAQ plasmid sequence with the 
apoaequorin gene sequence received from Professor Trewawas lab, the apoaequorin gene sequence described in Genbank M16103 and the 
desired features of T7 promoter region, pelB leader sequence and 6xHis-tag.  Multi-alignment was performed using software Bioedit (Hall, 
2004) and MultAlin (Corpet, 1988). 
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Figure 3-17  TOPAQ open reading frame.  M16103_translate is the translated protein sequence of M16103, used as reference sequence. 
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3.5 Conclusions 
The gene encoding for apoaequorin was successfully subcloned into two 
different plasmid vectors:  pETAQ is a pET26b derivative and TOPAQ is a pCR-Blunt 
II-TOPO® derivative, both containing the apoaequorin cDNA (one base pair difference 
from GenBank Accession No. M16103), the pelB signal peptide sequence and 6xHis-
tag fusion downstream of the T7 promoter.  Both are inducible expression systems. 
T7 was chosen in both cloning approaches as it is a very strong promoter and T7 
RNA polymerase transcribes the ORF very quickly.  However there are problems 
associated with overproduction of recombinant proteins and not efficient 
expression/release at the periplasmic space.  Translocation across the cell membrane of 
E. coli is still not well understood; a leader (e.g. pelB, ompT, CBD or DsbA/C) is 
necessary, but not sufficient for export into the periplasm.  Translocation also can 
depend on the mature domain of the target protein, which is recognised by SecB, the 
major chaperone of export (Wickner et al., 1991). 
Based on the features of the two vectors, their expression performance could 
differ; for example, the pET vectors are optimised for high expression levels.  TOPO®, 
as well as pBluescript vectors containing T3 and T7 bacteriophage promoters allow 
efficient in vitro synthesis of strand-specific RNA.   
Even with the T7 promoter present in both vectors, the pET system is 
specifically designed for protein expression having some specific features that allow 
and maximize the performances in the host cell strain.  pET vectors ensure high level of 
activity of the polymerase and high translation efficiency mediated by the T7 gene 10 
translation initiation signals, which is not present in TOPO® vector.  In pET the gene 
encoding the protein of interest may be cloned directly after the gene 10 initiation codon 
using cloning sites engineered for optimal expression of the cloned protein-coding 
sequence; the gene 10 transcription terminator is also included downstream of the 
cloning sites to allow efficient termination of transcription, preventing transcriptional 
read-through of unwanted plasmid sequences and increasing the RNA polymerase 
density on the sequence of interest—allowing high level accumulation of the specific 
protein-coding RNA transcripts.  TOPO® also lacks the ribosome binding site (RBS). 
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As both approaches were successful, the resulting vectors were both tested for 
expression of luminescent activity in microplate studies (Chapter 4) and a high 
throughput expression assay was developed with the vector providing the highest levels 
of expression (Chapter 4) and subsequently used in library creation (Chapter 5), 
screening (Chapter 6) and protein kinetics (Chapter 7 as preparation for Chapter 8).   
An alternative cloning approach would be to engineer the pelB leader sequence 
and 6xHis-tag sequence into pHAQ (pBluescript derivative).  As pBluescript lacks a 
strong STOP sequence and RBS, protein expression would likely be lower compared to 
the pET system. 
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4 High-throughput expression and screening 
This chapter describes the development of a high-throughput method which 
facilitates the production of aequorin wild type and mutants by E. coli in 96-well plates, 
followed by an activity assay against several potential activators (metal ions).  The 
envisaged assay was required to serve as a preliminary screen in order to identify 
promising mutants for purification and further in-depth analysis.  It builds upon the 
work described in Chapter 3, which yielded two plasmid vectors (pETAQ and TOPAQ) 
encoding for the apoaequorin gene.  Hierarchical optimisation was employed for the 
development of the final high-throughput protocol. 
4.1 Introduction 
4.1.1 Steps to developing a high-throughput process 
The high-throughput process should include cell growth, expression of 
apoprotein, incubation with coelenterazine for the reconstitution of functional aequorin 
in the cell medium and testing of aequorin mutant libraries for activation by seven 
different ions (as chosen in Chapter 5):  calcium, zinc, copper, lead, cobalt, cadmium 
and lanthanum.  The protocol should describe all the steps between handling of bacterial 
colonies in agar plates and measuring activity of the produced aequorin variants.  Figure 
4-1 presents the required stages of such a method and contains some main 
considerations pertaining to each stage.  As the assay is meant to be a preliminary/crude 
screen for the assessment of aequorin mutant libraries, the design of the individual steps 
must satisfy a set of general high-throughput screen requirements adapted to the 
properties and behaviour of the aequorin system (see Section 4.1.2). 
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Figure 4-1  Box diagram of the steps required for a complete HTS protocol.  Some main 
considerations pertaining to each step are included. 
 
4.1.2 Requirements for a high-throughput assay 
Several factors contribute to a suitable high-throughput assay for aequorin 
activity as expressed from E. coli in a microplate format: 
(1)  High expression of native apoaequorin 
(2)  Ease of activation to holo-aequorin with simple addition of coelenterazine to 
the medium.  This requires either cell lysis or secretion of the apo-aequorin into the 
periplasm.  
(3)  Practicality/ease of use.  Assays with the fewest processing steps are 
generally more robust, accurate, cheaper to use and easier to automate. 
(4)  Low limits of detection (high signal-to-noise ratio).  Some emergent 
activities from new ions may be very low at first.  Sensitivity will allow these to be 
detected. 
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(5)  Reproducibility and low standard deviation.  Few repeats are carried out for 
high-throughput assays initially as “hits” can be re-evaluated later.  High reproducibility 
and low error makes it less likely that “hits” will be missed. 
(6)  Size of library and automation.  The microplate format and use of 
automation enables the processing of large library sizes.  Flexibility of this protocol to 
adapt to different mutational strategies in this and future work will allow the processing 
of large libraries (directed evolution) as well as selected individual mutants (rational 
approach). 
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4.2  Materials 
4.2.1 Chemicals  
Standard buffers and media and reagents used in this chapter are described in 
Chapter 2.  Coelenterazine (1 mg) in lyophilised form was purchased from Sigma 
Aldrich and stored in -20 °C.  When ready to use, 1 mL of ice cold ethanol was used to 
resuspend and mix the coelenterazine by pippeting and transferred into a pre-chilled 
eppendorf tube and kept on ice.  The tubes were covered with foil and dim light 
conditions were used in order to protect the chromophore from light.  Polypropylene 
volumetric flasks suitable for atomic absorption were used in order to minimise metal 
ion contamination of the protein samples.  For the preparation of coelenterazine 
solutions the flasks and eppendorf tubes used were pre-chilled and covered in foil for 
protection against light and heat and kept on ice.  
4.2.2 Consumables  
All microplates used were of the 96-well format.  Deep square well (DSW) 
microplates used for bacterial cultures and mixing of apoprotein with coelenterazine 
were from Sarsted.  Clear Shallow clear round-well flat bottom ( F type) microplates 
used for optical density (OD) measurements of bacterial cultures and as lids for the 
DSW plates were also from Sarsted.  Luminescence measurements were performed in 
Lumitrac™ white polystyrene, F-type (flat-bottom) 96 well microtiter plates (Greiner 
Bio One Ltd., Gloucestershire, UK).   
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4.3 Method development strategy 
4.3.1 Building the assay protocol 
The assay design was based on published work by Shimomura and Inouye 
(1999) who described a simple method for the production of aequorin at bench scale.  
The method exploits the fact that apoaequorin is genetically fused with a signal peptide, 
is transferred to the periplasm and can be extracted into the medium and reconstituted 
with coelenterazine into fully functional aequorin in one step.  In summary, E. coli cells 
with a plasmid expression vector that included the apoaequorin cDNA downstream of 
the ompA signal peptide sequence were cultivated in LB medium using standard cell 
growth conditions.  Luminescent activity was measured using one of two ways, 
depending on the requirements:  
(1)  0.1 mL of bacterial suspension was incubated with 1 mL of 20 mM Tris 
buffer (pH 7.5) containing 10 mM EDTA, 5 mM 2-mercaptoethanol, and 1 mM 
coelenterazine at 0 °C for 3 h to regenerate aequorin, while allowing oxygen diffusion 
to occur.   
(2)  The bacterial suspension was centrifuged and the cell pellets are cooled and 
dispersed in a buffer containing EDTA, dithiothreitol and coelenterazine, then left to 
incubate for 1 h, while allowing diffusion of oxygen to occur.   
In both (1) and (2) options, after overnight storage at 0 °C and centrifugation, a 
clear supernatant was produced that contains aequorin (Shimomura and Inouye, 1999).  
The method was adapted to the 96-well microplate scale, based on the expression 
levels of the bacterial system, the operating capabilities of equipment and other 
considerations (i.e. sensitivity, robustness, cost, time restrains and availability).  A range 
of other methods have been described for obtaining purified aequorin and these are 
considered in Chapter 7 (Protein Purification, Section 7.1).   
Some of the principal questions concerning the application of microwell format 
for aequorin production were:  (1) could adequate luminescent activities be achieved in 
the microwells?  (2) could microwell cultures produce consistent activities across the 
microplate with reproducibility across microplates?  (3) what were the optimal 
conditions in order to achieve maximum activity?  (4) was there external or well-to-well 
cross-contamination? 
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The following sections explore what is possible and practical in achieving a HTS 
protocol for aequorin activity which satisfies the criteria mentioned in Section 4.1.2.  A 
number of experimental setups were used to test different conditions and to gradually 
optimise the process for sensitivity, signal-to-noise and assay variability.  Each 
experimental setup is described in the relevant section.   
4.3.2 Experimental setup A 
 
Figure 4-2  Experimental setup A for defining process parameters. 
 
E. coli BL21(DE3) Star (F– ompT hsdSB(rB–, mB–) gal dcm rne131 (DE3)) 
(Invitrogen) electrocompetent cells were transformed with plasmid expression vectors 
pETAQ or TOPAQ, brought forward from Chapter 3.  Single colonies were used to 
inoculate 10 mL of LB medium in Falcon tubes containing 50 µg/ml of kanamycin and 
left to incubate overnight at 37 °C in an orbital shaker at 250 rpm.  One milliliter of 
each overnight seed culture was used for a 10% inoculation into fresh medium (10 mL 
final volume, 50 µg/ml of kanamycin) in falcon tubes and grown at 37 °C and 250 rpm 
for up to 7 h.   
One culture was induced by addition of IPTG at the start of incubation 
(time = 0 h), one culture was induced at 2.5 h and one culture was not induced.  During 
the incubation 1 mL samples were collected at times 2.5, 5 and 7 h.  The samples were 
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measured for cell optical density (OD), 100 µL of neat culture was saved for further 
processing, and 500 µL of culture were centrifuged at 12,000 rpm for 10 min and the 
resulting supernatant and cell pellets were stored separately for further processing.  The 
neat culture, cell pellets and supernatant were stored on ice in order to hinder further 
growth and protein production.   
When samples from all time points were collected, a cold (0–4°C) solution was 
prepared that contained 2 µM coelenterazine, 20 mM Tris-HCl, 10 mM EDTA and 
5 mM 2-mercaptoethanol, pH 7.7.  The wells of a pre-chilled 96-DSW plate were filled 
with 950 µL of the coelenterazine solution.  One hundred microliters of each of the cell 
culture samples and of the culture supernatant were transferred into wells of the DSW 
plate according to their category (type of vector, time of harvest, time of induction).  
The cell pellets were dissolved by pipetting in 1 mL of coelenterazine solution and 
transferred into wells of the DSW plate as described previously.  The position of each 
sample in the 96-well plate is highlighted in Figures Figure 4-7 to  
Figure 4-9).  The DSW microplate was covered with an inverted shallow 96-well 
plate (Sarstedt Inc) and placed on a table top thermomixer (Eppendorf Inc) with 
intermittent shaking at 1000 rpm for 3 h, temperature control at 1 °C and the whole set 
up placed in a cold cabinet (4–8 °C).   
After the end of the cold incubation with coelenterazine solution, 100 µL of each 
well were transferred into the respective wells of a Lumitrac™ shallow well plate using 
an 8-channel multipipette.  The activity of the regenerated aequorin in the 100 µL 
mixtures was assayed in the FluoStar platereader, by measuring the light emission of the 
sample when an equal volume of 10 mM CaCl2 solution was injected.  
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4.3.3 Experimental setup B  
Figure 4-3  Experimental setup B for defining process parameters 
 
 
Two E. coli BL21(DE3) electrocompetent high expression strains available in 
the lab were transformed with plasmid expression vector pETAQ.  The transformed 
cells were spread on agar plates (Sections 2.2.2 and 2.3.8).  Single colonies were picked 
from the agar plates manually and were used to inoculate 10 mL of Kan+ LB medium in 
falcon tubes.  These seed cultures were left to incubate overnight at 37 °C and 250 rpm.   
The wells of a 96-DSW plate were filled with LB Kan+ medium (450 µL).  this 
plate would serve as the “day culture plate”.  The overnight seed cultures in the falcon 
tubes were used for a ~10% inoculation into a new DSW plate containing 450 µL of 
Kan+ LB medium (500 µL final volume), making sure that the starting OD of the two 
different strain microcultures was equal.  The LB medium of the microwells was topped 
up to the final volume of 500 µL.  This plate was incubated at 37 °C and 1000 rpm for 
up to 7 h.  Induction with IPTG was performed at 1 h after inoculation (corresponding 
to OD 0.6–0.8).  Samples of the culture were collected at various time points and kept 
on ice for further processing.   
At the end of incubation, 100 µL of each of the collected samples were 
transferred into the corresponding wells of a new DSW plate, each containing 950 µL of 
cold coelenterazine solution 4 µM, 20 mM Tris-HCl, 10 mM EDTA and 5 mM 2-
mercaptoethanol, pH 7.7.  The DSW was covered with an inverted shallow 96-well 
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plate (Sarstedt Inc), placed on a table top thermomixer (Eppendorf Inc) with intermittent 
stirring at 1000 rpm and 1 °C overnight and placed in a cold cabinet (4–8 °C).  After the 
end of the cold incubation with coelenterazine solution, 100 µL of each well was 
transferred into the corresponding wells of a Lumitrac™ shallow well plate using a the 
liquid handling robotics of Tecan.  The activity of the regenerated aequorin in the 
100 µL mixtures was assayed in the FluoStar platereader, by measuring the light 
emission of the sample when an equal volume of 100 mM CaCl2 solution in 20 mM 
Tris-HCl, pH 7.5 was injected. 
 
4.3.4 Experimental setup C 
Figure 4-4  Experimental setup C for defining process parameters 
 
E. coli BL21(DE3) electrocompetent cells (Lucigen) were transformed with 
plasmid expression vector pETAQ (expressing wild type apoaequorin).  The 
transformed cells were spread on agar plates (Sections 2.2.2 and 2.3.8).  The wells of a 
96-DSW plate were filled with LB Kan+ medium (950 µL).  Qpix2 robot was used to 
inoculate each well of this “seed culture plate” with colonies from the agar plate.  The 
plate was left to incubate overnight at 37 °C and 1000 rpm.  The overnight seed culture 
was used for a 10% inoculation into a new DSW plate containing 450 µL of Kan+ LB 
medium (500 µL final volume).  This “day culture plate” was incubated at 37 °C and 
1,000 rpm for up to 10 h.  Induction with IPTG was performed at OD 0.6–0.8 or 1 h 
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after inoculation.  Samples of the culture could be collected at various time points or at 
the end of the day culture (depending on the type of question being answered) and saved 
on ice for further processing.   
At the end of incubation, 100 µL of each of the collected samples were 
transferred in the wells of the same corresponding position in a new DSW plate, 
containing 950 µL of cold coelenterazine solution 4 µM, 20 mM Tris-HCl, 10 mM 
EDTA and 5 mM 2-mercaptoethanol, pH 7.7.  The DSW was covered with an inverted 
shallow 96-well plate (Sarstedt Inc) and placed on a table top thermomixer (Eppendorf 
Inc) with intermittent stirring at 1000 rpm and 1 °C overnight and placed in a cold 
cabinet (4–8 °C).  After the end of the cold incubation with coelenterazine solution, 
100 µL of each well was transferred into the respective wells of a Lumitrac™ shallow 
well plate using the Tecan liquid handling robot.  The activity of the regenerated 
aequorin in the 100 µL mixtures was assayed in the FluoStar platereader, by measuring 
the light emission of the sample when an equal volume of 100 mM CaCl2 solution was 
injected.  
4.4 Results and discussion 
4.4.1 Measurement of cell density in microplates 
Measurement of optical density in microplate format is necessary in order to 
monitor and validate a high-throughput expression method.  Optical density 
measurements for a serial dilution of bacterial culture were made in microplates (using 
the Tecan Magellan absorbance reader) and in standard cuvettes in benchtop 
spectrophotometer.  The association between the measurements is presented in Figure 
4-5 and was found to correlate linearly with an R2 value of 0.998.  The slope of 
approximately 1.5 reflects the different pathlengths used in the two formats.  These data 
show that the platereader selected for plate-based measurements was sufficiently 
accurate to reproduce values obtained in a cuvette based spectrophotometer. 
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Figure 4-5  Correlation of cell culture optical densities in microplates and cuvettes.  
OD(600 nm) values of cell culture were measured in 96-well microplates using 
Magellan platereader and the corresponding OD (600 nm) were measured in a benchtop 
spectrophotometer. 
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Figure 4-6  Linearity of OD (600 nm) versus dilution.  The original culture was of 
OD(600 nm)=2.0 in Magellan platereader, pathlength corresponding to 200 µL total 
volume in a 96-microplate well.  The dashed line includes the neat culture, whereas the 
continuous line excludes the neat sample. 
Figure 4-6 further explores the linearity of readings obtained in the Tecan 
Magellan platereader as the bacterial samples were diluted.  These data show that the 
dynamic range of the platereader was sufficiently accurate for cell density 
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measurements in the range if OD(600nm) of 0–1.0.  Having determined this, the 
platereader was adopted for all further optimisations of strain and vector development, 
cell culture and bioluminescent assays. 
4.4.2 Process parameters 
4.4.2.1 Choice of vector 
This initial experiment to compare different plasmid vectors for the aequorin 
bioluminescence assay was based on experimental setup A (Section 4.3.2).  The two 
expression vectors were assessed in conjunction with two different E. coli high 
expression strains in order to determine the expression system with the highest 
luminescence activity for testing mutant variants of aequorin in microwell assays.  The 
variation in luminescence profiles obtained as a function of time are shown in Figure 
4-7 using the different strains.  It can be seen that BL21(DE3)Star cells produce higher 
luminescence when carrying pETAQ vector than TOPAQ vector.  The results of the 
comparison are consistent using cell suspension, cell culture supernatant or resuspended 
cell paste obtained from cell culture centrifugation. 
Figure 4-7  Choice of expression vector.  Graphical output of luminescence traces 
versus time. Each well represents a different experimental condition. In each trace 
depicted, y-axis represents Relative Luminescence Units and the x-axis represents time 
(8 s total measurement time, readings taken at 0.1 s intervals).  The highest producers 
(highlighted in blue) are cultures expressing the pETAQ vector.  Platereader gain set at 
2,000.  Experiment carried out as described in Section 4.3.2 (Experimental setup A) and 
generic Section 2.7 (Luminescence measurements).   
 
Harvested at 
time (h): 
- 127 - 
4.4.2.2 Part of culture as screening material 
Figure 4-8  Part of culture to be used for the screening process. Experimental settings as 
in Figure 4–7. Comparing luminescence curves from cell suspension, supernatant and 
(resuspeded) cell paste, sufficient amount of luminescence is produced from cell 
suspension (highlighted in pink) to use as high-thoughput screening platform.    
This experiment was based on experimental setup A.  It answers the question:  
which part of the culture produces adequate luminescence in the most practical, easily 
automatable method?  As seen in Figure 4-8, the cell suspension of the microwells 
produces enough signal for screening.  Cell paste produces the maximum signal, but 
requires the extra steps of microplate centrifugation, supernatant removal and 
resuspension of pellets, which would prolong and complicate the assay.  Therefore the 
cell suspension is an adequate and practical choice as HTS material.  
4.4.2.3 IPTG induction 
This experiment was based on experimental setup A.  It answers the question:  
“when to induce with IPTG?”  Nine hundred microliters of 100 mM IPTG stock were 
diluted with 2.1 mL LB and 10 µL of the mix were transferred into each well using a 
multipipette.  As seen in Figure 4–9, microwell cultures were induced at time 0, 2.5 h 
and one set was not induced at all.  The relatively high activity at early induction is 
most likely attributable to the high inoculation (10%) from overnight culture, whereas 
“leaky” T7 expression is likely to be responsible for activity in non-induced cultures.  
Highest activity was observed at IPTG induction at 2.5 h, at OD~1.0, although earlier 
induction times would be preferable and were assessed in the later steps of assay 
development.  The maximum harvest time out of those tested in this set (7 h) was 
Harvested at 
time (h): 
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optimum, although longer times would be possible to achieve higher protein yields and 
luminescence activity. 
Figure 4-9  Time of induction.  Experimental settings as in Figure 4–7 and 
Section 4.3.2.  Comparison of luminescence curves from cell cultures induced with 
IPTG at time 0, 2,5 h after inoculation and not induced.  Maximal luminescence activity 
from the cell suspension was observed when inducing at 2.5 h.  
4.4.2.4 Choice of bacterial strain 
This experiment was based on experimental setup B.  E. coli BL21(DE3) Star 
(F– ompT hsdSB(rB–, mB–) gal dcm rne131 (DE3)) (Invitrogen) and E. coli (E. 
BL21(DE3) (F- mcrA ∆(mrr-hsdRMS-mcrBC) Φ80dlacZ∆M15∆lacX74 endA1 
recA1araD139 ∆(ara, leu)7697 galU galK rpsL nupG λ- tonA) (E.cloni™, Lucigen)  
electrocompetent cells were compared for expression levels of apoaequorin.  E.cloni™ 
cells exhibited slightly higher activity than the Invitrogen strain, possibly due to more 
rapid growth (ODs not shown).  
  
Figure 4-10  Choice of E. coli strain.  Graphical output of luminescence traces versus 
time.  In each trace depicted, the y-axis represents Relative Luminescence Units and the 
x-axis represents time (8 s total measurement time, readings taken at 0.1 s intervals).  
This figure compares luminescence activity produced in the cell suspension of E. coli 
BL21(DE3) cells from Lucigen and Invitrogen, both carrying expression vector 
Harvested at 
time (h): 
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pETAQ. The highest producers were cultures of BL21(DE3) from Lucigen.  Experiment 
carried out as described in Section 4.3.3 (Experimental setup B) and generic Section 2.7 
(Luminescence measurements).  Platereader gain set at 2,000.   
4.4.2.5 Check for background signal 
 
Figure 4-11  Check for background signal.  Same experimental setup as Figure 4-10;  
Comparison of luminescence curves from Lucigen BL21(DE3) cell cultures carrying  
pETAQ versus those of the same cells that incorporate pET26b vector without the 
apoaequorin gene insert.  Luminescence traces in purple show that luminescence 
activity is only observed in cells that encode for apoaequorin.  Residual coelenterazine 
that is present in all experimental preparations does not cause detectable background 
luminescence.  
This experiment was based on experimental setup B.  The test was performed in 
order to verify that no background signal is produced by any component encoded in the 
host strain or expression vector pET26b (pET26b is pETAQ without the apoaequorin 
gene).  As expected, there is no background signal; bioluminescence is not naturally 
observed in E. coli.  
4.4.2.6 Activity profile across the microplate 
This experiment was based on experimental setup C.  Significant variation of 
activity across the geometry of the microwells was observed.  As seen in Figure 4-12, 
the outer wells of the microplate exhibit significantly lower activity than the central 
wells of the microplate.  A preliminary test (not shown here) proved that the step 
responsible for the variation of activity across the microplate was the overnight cold 
incubation step with coelenterazine and not the microwell culture.  In light of the 
temperature-sensitive nature of coelenterazine, there was need for better temperature 
control during the cold incubation step. 
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Originally, during this step the microplate was adjusted on a table top 
thermomixer where temperature control is delivered through the base of the microplate 
holder, with cooling capabilities of up to 15 °C lower than ambient temperature, the 
lower attainable setting being 1 °C.  In order to achieve the lowest possible ambient 
temperature, the thermomixer carrying the microplate is placed in a cold cabinet         
(4–8 °C).  These settings were clearly not sufficient for achieving uniform temperature 
across the plate. 
In order to achieve (more) uniformity of temperature (and therefore activity) 
across the microplate, thermal insulation was applied to the plate, so that the wells 
proximal to the microplate edges may retain the lowest possible temperature.  Slices of 
polystyrene foam (thickness of approximately 0.5 cm) were carved out of polystyrene 
ice boxes and taped around the 96-DSW (deep square well) plate and on top of the 
shallow well plate that served as its lid.    
As seen in Figure 4-12 and Table 4–1, uniformity of activity improved 
significantly with insulation of the microplate during O/N reconstitution.  Excluding the 
outer lines and columns further reduces variation across the remaining microplate area.  
Improved uniformity across the plate allows maximal usage of the plate area, hence 
testing more mutant variants per plate and easier direct comparison between wells of the 
same microplate. 
 
   
Figure 4-12  Activity profile across the microplate with and without thermal insulation.  
Graphical output of luminescence traces versus time from E. coli BL21(DE3) (Lucigen) 
carrying expression vector pETAQ.  In each trace depicted, y-axis represents Relative 
Luminescence Units and the x-axis represents time.  Profile across plate (left) and with 
insulation (right).  Shown here are columns 1–6 of each microplate, symmetrical to 
columns 7–12 (not shown).  Experiment carried out as described in Section 4.3.4 
(Experimental setup C) and generic Section 2.7 (Luminescence measurements).  
Platereader gain set at 2,000.   
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 Table 4-1  Variation across the microplate with and without thermal insulation 
Microplate area  Variation of activity 
without insulation 
Variation of activity 
with insulation 
  Relative STDEV Relative STDEV 
all wells 
 Peak 54% 15% 
 Total light 52% 12% 
 
all wells excluding  1 outer line and 2 outer columns 
 Peak 29% 12% 
 Total light 27% 10% 
    
all wells excluding 2 outer lines, 2 outer columns 
 Peak 24% 10% 
 Total light 22%   9% 
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4.4.2.7 Cell growth and activity versus time 
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Figure 4-13  Luminescence activity and cell density of 96-DSW cultures versus time.  
At time zero a 10% inoculation from O/N culture was performed and IPTG induction 
was at time 0.9 h at OD=0.7.   
This experiment was based on experimental setup C.  It correlates cell growth 
with activity levels in the microwell cultures.  Samples from various positions of the 
“day culture plate” were collected at time intervals and stored on ice in order to delay 
cell growth.  At the end of a nine-hour incubation the samples were mixed with 
coelenterazine solution in the central wells of a “cold incubation” plate and left 
overnight to reconstitute active aequorin.  Maximum activity was reached at 8–9 h of 
incubation and after OD had reached a plateau. 
4.4.2.8 Optimum coelenterazine concentration 
To ensure that the highest possible activities were achieved in the screening 
reactions, the concentration of coelenterazine needed to be optimised.  Apoaequorin and 
coelenterazine bind at 1:1 molar ratio, but published literature has suggested an excess 
of coelenterazine during the cold incubation step (coelenterazine being 4–6 times or 
1.2–1.3 times the calculated amount) (Shimomura and Inouye, 1999).  Bacterial 
suspension was collected from the “day culture plate” after nine hour incubation.  
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Coelenterazine solutions were prepared at a range of concentrations (1–100 µM) in 
20 mM Tris-HCl, 10 mM EDTA and 5 mM 2-mercaptoethanol buffer, pH 7.7.  One 
hundred microliters of the bacterial suspension were added to 950 µL of the prepared 
coelenterazine solutions in central wells of a pre-chilled 96-DSW plate and left for a 
cold overnight incubation, as previously described.  The optimum concentration of 
coelenterazine for the apoaequorin produced in the “day culture plate” is ~10 µM. 
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Figure 4-14  Optimum coelenterazine concentration.  Shown here are average activity 
values of duplicates. 
 
4.4.2.9 Injection, mixing 
Flash reactions require rapid and thorough mixing, which depends upon 
variables such as the force, angle, and volume of injection; the geometrical relationship 
of the injector to the container; and the speed and completeness of mixing relative to the 
kinetics of reaction (Van Dyke et al., 2002).  The highest injection speed of the FluoStar 
Platereader was used (420 µL/s) for 1:1 volume ratios of mixing in order to achieve 
most efficient and rapid mixing. 
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4.4.3 Check for cross-contamination between wells 
           
Figure 4-15  Check for cross contamination during incubation and injection.  Concept of 
layout (left) and picture of microwell injected with loading buffer containing dye.  The 
neighbouring wells were not affected.  The same concept of testing applied to bacterial 
cultures in microwells.    
This section checks for cross-contamination between wells in all of the stages 
where it might occur:  automated colony picking, microwell culture, liquid handling and 
injection during the luminescence assay in BMG.   
Figure 4-15 features a Lumitrac™ well plate for luminescence assays. The wells 
of the microplate were filled with 100 µL of RO water.  Marked wells were injected 
with blue loading buffer (1 volume of SDS loading buffer to 8 volumes of water) at 
maximum injection speed 420 µL/s.  The absorbance of the wells adjacent to the wells 
injected with blue dye was compared to the absorbance of RO water at 595 nm.  There 
was no observed difference in absorbance between the measured samples, which 
indicates there was no spillage/tranfer to neighbouring wells due to platereader 
injection.   
In a similar manner, tests using blue dye were performed in 96 DSW plates in 
order to check that 1,000 rpm shaking, liquid transfer/pippetting would not cause cross-
contamination.  Microwells of O/N culture plates were tested for bacterial 
contamination by testing OD at 600 nm:  Wells containing LB nutrient and adjacent to 
wells inoculated with E. coli did not exhibit any bacterial growth.  
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4.4.4 Yield of aequorin in microwells 
Concentration of soluble protein in the microwells was calculated using the 
Bradford method (Section 2.4.1.2) by adding 50 µL of 1:2 diluted Bradford reagent to 
50 µL of protein sample.  The total soluble protein present in the microwells of the 
“cold incubation step” was ~26.3 µg/mL, while the supernatant of a microwell at the 
end of the “cold incubation step” was 12.3 µg/mL.  Densitometry analysis of SDS-
PAGE protein gels showed that the protein sample present in the cold supernatant 
contains approximately 78% apoaequorin, hence ~9.6 µg/mL are present in the 
supernatant.  Each microwell of the cold incubation step contains ~0.4 µM aequorin.  
Taking into account the dilution of protein suspension in the cold incubation step by 
10.5 times, 4.3 µM of functional wild-type aequorin is present in each “day culure” 
well.   In terms of total soluble protein and taking into account the dilution of protein 
suspension in the cold incubation step by 10.5 times, the total soluble protein in each 
microwell of the “day culture” microplates was ~276.2 µg/mL, ~36% of which is 
apoaequorin with cleaved pelB signal peptide (therefore potentially available for release 
into the medium) and ~24% has retained the peptide leader sequence and will remain in 
the intracellular environment.  Analysis of the localisation of the protein in cell 
suspension, cell pellets and cold incubation is available in Chapter 7, Section 7.4.2. 
 
Figure 4-16  Yield of aequorin in luminescence plate microwells.  L: Benchmark™ 
Protein Ladder (Invitrogen, Figure 2-2); Lanes 1 and 4:  neat protein sample in the 
luminescence screening plate microwells, represents total protein in the well;  Lane 2:  
supernatant of centrifuged sample of Lane 1, represents extracellular protein;  Lane 3:  
supernatant after sonication and centrifugation of sample of Lane 1.  This represents the 
total soluble protein in the well.   Lane 5:  same as Lane 2, concentrated 35× (aequorin 
purity: 78%);  Lane 6:  same as Lane 3, concentrated 26× (aequorin purity: 66%). 15% 
polyacrylamide gel. All lanes were loaded with 10 µL.  Samples were prepared as in 
Section 2.4.2.  Sample concentration was performed with a 10MWCO spin filter. 
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Figure 4-17  Detailed schematic of the finalised high-throughput process  
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4.5 Conclusions 
This chapter describes the building of a high-throughput system for expression of 
apoaequorin in 96-microwell plates, the incubation of the apoprotein with the 
chromophore coelenterazine for charging of the active protein aequorin and activity 
screening against up to nine different potential activators (metal ion solutions).  The 
assay described here is a practical, automated and scalable assay which allows for the 
screening of small to large number of mutants and displays high activity signals with 
zero background noise.   
 
4.5.1 Final process 
Based on the results of this experiment, the high-throughput production and 
activity screening of aequorin libraries is presented in the schematic of Figure 4–17 and 
the detailed parameters and conditions are presented in Table 4–2.  The process is 
divided in five major steps:  
(1)  cloning 
(2)  microwell cultures 
(3)  charging of active protein 
(4)  96-well microplate library 
(5)  high-throughput screening (HTS) assay 
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                       Table 4-2  List of parameters chosen for the high-throughput assay. 
Parameters Results Section 
Vector pETAQ 4.4.2.1 
E. coli strain BL21(DE3) Lucigen 4.4.2.4 
Part of culture used Bacterial suspension 4.4.2.2 
Incubation time 8 h 4.4.2.7 
Induction time ~1 h 4.4.2.3 
Coelenterazine 10 µM 4.4.2.8 
Background signal None at Gain 2,000 4.4.2.5 
Variation across plate Apply insulation 4.4.2.6 
Injection Max speed 420 µL/min 4.4.2.9 
Cross-contamination none 4.4.3 
 
4.5.1.1 Cloning and microwell cultures 
Colonies of E. coli BL21(DE3) cells (Lucigen) carrying plasmid pETAQ (for 
wild-type apoaequorin) or variants thereof (for mutant apoaequorin) are picked from 
(50 µg/mL) Kan+ agar plates into conical bottom 96-DSW (deep square well) plates 
(“seed culture plates”).  Each well contains LB Kan+ medium (950 µL, 50 µg/mL 
kanamycin).  Colony picking can be manual, using sterile inoculation loops, or 
automatic, using the QPix2 robotic colony picker, depending on whether the library 
consists of selected mutants or a large number of random mutants.  Each individual 
microplate is inoculated with at least three wild-type colonies in assigned wells and 
these positions are kept constant throughout the entire library.  These wells containing 
wild type will serve as internal controls and the proposed library layout is explained 
analytically in Section 6.2.1.   
All liquid handling of microplates is automated using the Tecan Genesis robot. 
The top of each 96-DSW plate is covered by an inverted shallow 96-well plate (Sarstedt 
Inc), sealed onto the DSW plate using autoclave tape.  The 96-DSW plate is then 
secured on a table top thermomixer (Eppendorf Inc) with shaking at 1,000 rpm, which 
in turn is placed in a 37 °C incubator/cabinet for the duration of the fermentation.  This 
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method of sealing prevents evaporation, but sufficient air is trapped above each culture 
to permit aerobic growth. 
The “seed culture plate” is incubated overnight at 37 °C and 1,000 rpm.  
Following the overnight incubation, the seed culture is used for a 10% inoculation into a 
new DSW plate containing 450 µL of Kan+ LB medium (500 µL final volume).  This 
“day culture plate” is incubated at 37°C and 1000 rpm for 8 h.  Induction with IPTG is 
performed at 1 h after inoculation, which corresponds to OD ~0.8.   
If a library of random mutants were to be assessed, the seed culture plate would 
be copied into a glycerol stock plate for the later identification of interesting mutant 
variants by sequencing.   
4.5.1.2 Charging of active protein 
At the end of the 8 h fermentation, the plate is left to cool to room temperature 
and 100 µL of cell suspension are transferred into a pre-chilled 96-DSW plate, 
containing 950 µL of cold coelenterazine solution 10 µM, 20 mM Tris-HCl, 10 mM 
EDTA and 5 mM 2-mercaptoethanol, pH 7.7.  This “cold incubation plate” is covered 
with an inverted shallow 96-well plate (Sarstedt Inc), insulated thermally using 
polystyrene foam and secured on a table top thermomixer (Eppendorf Inc) with 
overnight intermittent stirring at 1,000 rpm and 1 °C, which in turn is placed in a cold 
cabinet (4-8 °C). 
4.5.1.3 96-well microplate library 
After the end of the cold incubation with coelenterazine solution, Tecan robotics 
are used to make nine identical library copies in white shallow Lumitrac™ 96-well 
plates.  More analytically, 100 µL from the wells of the “cold incubation plate” are 
transferred into the respective wells of each of the Lumitrac™ microplates.  This allows 
for the same library to be tested against up to a maximum of nine potential activators.  
In practice seven potential activators were tested while the two out of the nine replicate 
plates were kept as backup in case a screening run required repetition (e.g. if 
luminescence readings were too high or too low and gain required adjustment). 
4.5.1.4 High-throughput screening assay   
The activity of the libraries against the potential activators is assayed using the 
FluoStar Platereader (BMG Lab technologies Ltd, Bucks, UK).  Light emission from 
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each well is measured when an equal volume (100 µL) of an activator ion solution is 
injected at maximum speed (420 µL/s).  Light measurements started before injection (in 
order for any background signal to be detected) and the duration of reading was 15 s.  
At the Gain setting equal to 2,000, wild-type aequorin in microplates produced light 
counts in the scale of 106 against zero background signal. 
Data deriving from luminescent assays performed in microplate format were 
exported in .xls format and copied onto template Microsoft Excel worksheets for data 
processing. 
4.5.2 Further improvements to the method 
A seamlessly automated process could be achieved with further adjustments to 
the setup, such as temperature control within the enclosure of the Tecan robot (for both 
heating to 37 °C and cooling to 1 °C).  The ionic strength and pH conditions of the 
luminescence assay were not explored in this chapter, but they were revisited in 
Chapter 7 which deals with purification of the proteins.  A potentially useful further 
development would be to explore or establish an association between the kinetics of 
aequorin luminescence in the crude library conditions with the kinetics of purified 
protein. 
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5 Aequorin structure and mutant library design 
Aim of this chapter is to enhance the understanding of the structure of aequorin 
and its response to calcium ions.  This knowledge will be useful in: 
a) selecting an appropriate strategy for mutant library design.  The envisaged 
variants would exhibit altered ion-binding properties.  This library will be screened 
against new potential activator ions in Chapter 6.  
b) discussion and interpretation of the library screening results presented in 
Chapter 6 and of further studies on purified fractions in Chapter 8. 
Section 5.1 is a literature review of the detailed structural analysis published on 
aequorin.  It builds on the general information given in Chapter 1, Section 1.3 and 
highlights important positions and amino acids in the protein structure and their 
interdependent relationship/nature.  The published crystallographic structures of 
aequorin without calcium and apoaequorin with calcium are examined in detail in terms 
of the repositioning of the residues as a result of population of the EF-loops by calcium 
ions.   
Sections 5.2 and 5.3 are a compilation of previous mutagenesis studies 
performed on aequorin or other calcium-binding proteins and peptides in order to study 
or enhance properties such as metal affinity, intensity, sensitivity and thermostability.  
As function of the protein is attributed to changes in its structure this compilation is a 
library of what has already been tried by researchers and a possible basis on how to 
proceed with further mutagenic studies. 
In Section 5.4 the aequorin crystallographic structures are further analysed by the 
author, particularly relating to the metal-ligand distances within each of the EF-hands 
and the extent of structural rearrangement undergone by the protein in order to 
accommodate calcium ions.   
Assuming the “native” octahedral coordination is required for optimal triggering 
of the bioluminescent reaction; seven metal ions were modelled by simple replacement 
into the coordinate position of calcium in the ion binding loops of EF-I to examine their 
potential for coordination in this specific protein conformation.  Finally, the library of 
mutants is chosen in Section 5.6.3. 
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5.1 Aequorin:  detailed structure 
This section zooms into the crystallographic structures of the fully functional 
protein containing coelenterazine (PDB ID:  1EJ3, Figure 1-7) and the apoaequorin 
molecule with three calcium ions bound (PDB ID:  1SL8, Figure 1-8) shown in Section 
1.3.1.  The coelenterazine binding cavity is illustrated in Figure 5-1 and Figure 5-2 and 
the calcium ions bound within the EF-hands are shown in Figure 5-3.  Coupling of the 
EF-hands is illustrated in Figure 5-6 and Figure 5-7.  Some images were reproduced 
from published work and some were created in Pymol (DeLano, 2002) in order to aid in 
visualisation and analysis.   
Numbering of amino acids in aequorin structure is according to the 1EJ3 
structure numbering throughout the text, unless stated otherwise.  From alignment of the 
amino acid sequences of 1EJ3, 1SL8 and the translated sequence of wild-type aequorin 
used in this thesis, the numbering of amino acids across the three sequences is: 
31_7__
31_281_
EJNumberingaequorintypewildNumbering
EJNumberingSLNumbering
+=−
+=
 
For example, Glu35 in 1EJ3 is Glu37 in 1SL8 and Glu42 in wild-type 
apoaequorin expressed in this work. 
5.1.1 Coelenterazine-binding cavity and calcium-binding EF-hands 
The hydrophobic cavity has a volume of approximately 600 Å3 and binds 
coelenterazine in the form of coelenterazine-2-hydroperoxide.  The hydroperoxide 
group is attached at the C2 position of the ligand, as shown in Figure 5-1 and Figure 5-2 
(Head et al., 2000).  It appears to be stabilised by hydrogen bonding to the phenolic 
oxygen of Tyr184 which is itself hydrogen bonded to the Nϵ2 of His169.  The imidazole 
of His169 is situated close to the carbonyl oxygen of C3 on the ligand and to the indole 
of Trp173 (Head et al., 2000). 
The following side-chain interactions in the binding cavity may position 
coelenterazine in the binding site and contribute to the mechanism of aequorin action:  
(1) the phenolic OH of Tyr132 hydrogen bonds to N1. It is also linked through 
hydrogen bonds by a water molecule to His58.  This histidine imidazole is adjacent to 
the indole ring of Trp108 which partly overlays the imidazopyrazinone ring system, 
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coming as close as 3.6 Å;  (2) The p-OH of the phenol attached at C6 of coelenterazine 
is positioned at the centre of a triangle made by the third set of Tyr–His–Trp, consisting 
of the phenolic oxygen of Tyr82, the Nϵ1 of His16 and the Nδ1 of Trp86; (3) The p-OH 
group on the benzyl substituent at C2 of the ligand is hydrogen bonded to a water 
molecule which itself interacts with the carbonyl oxygen of Ile105 and the side-chain 
oxygen of Thr166 (Figure 5-1 and Figure 5-2). 
Tyr184 is part of an extended loop structure at the C-terminal of aequorin 
(residues 177-189, numbering according to 1EJ3) which lies in a space between the first 
helix of EF hand I and the first helix of EF hand IV and closes the coelenterazine-
binding cavity.  Numerous hydrogen bonds are formed in this region anchoring the C-
terminal chain in its conformation and positioning the side chain of Tyr184 adjacent to 
both His169 and the ligand. Some of these hydrogen bonds also couple the C-terminal 
chain with both of the flanking helices (Head et al., 2000).  
The calcium-loaded apoproteins retain the same compact scaffold and overall 
fold as the unreacted photoproteins containing the bound substrate, 2-hydroperoxy-
coelenterazine (see Section 5.5).  Binding of Ca2+ into the loops of the EF-hands leads 
to subtle structural shifts in the photoprotein that destabilise hydroperoxy-coelenterazine 
and lead to decarboxylation of the hydroperoxide and rapid emission of 
bioluminescence (Liu et al., 2006).  
Figure 5-3 shows a close up of each of the calcium binding EF-hands 
coordinating a calcium ion.  Metal-ligand distances were measured using  Pymol 
(DeLano, 2002).  NMR and X-ray data by Ohashi and co-workers showed that the loop 
conformation of EF-IV exhibits more structural flexibility than EF-I and EF-III  (Ohashi 
et al., 2005).  
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Figure 5-1  Peroxidised coelenterazine in the hydrophobic core of aequorin, showing all 
distances to protein atoms within 3.6 Å and some other local interactions.  Distances are 
mean of the distances measured A and B chain of the crystallised dimer.  Hydrogen 
bonds are indicated by dotted lines, other distances are indicated with dashed lines.  
Atom numbering is shown for the imidazopyrazinone ring system.  Figure reproduced 
from Head and co-workers (2000).   
 
Figure 5-2  Coelenterazine binding site in the hydrophobic core of aequorin.  
Coelenterazine is shown as yellow sticks.  The residues believed to stabilise 
coelenterazine through hydrogen bonds are shown as red sticks and the residues within 
close proximity (up to 3.6 Å) are shown as orange sticks.  Water molecules participating 
in the hydrogen bonding network are depicted as red spheres.  The water molecule 
hydrogen bonding to His58 and Tyr132 is visible from this angle.  Distances and 
interactions are shown analytically in Figure 5-21.  PDB ID: 1EJ3.  Picture rendered 
using Pymol (DeLano, 2002). 
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Figure 5-3  Calcium binding in EF-I, EF-III and EF-IV hands of aequorin.  One calcium 
ion (cyan coloured sphere) is bound in pentagonal bipyramidal configuration.             
Coordinating oxygens from residues at positions 3,5,7 and 12 form a planar pentagon 
and position 1 and one oxygen from a water molecule (hydrogen bonded to position 9) 
are axial coordinating residues.  Picture rendered and interatomic distances between 
calcium ions and each coordinating oxygen atom were calculated using Pymol (DeLano, 
2002).  
EF-I EF-III 
EF-IV 
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5.1.2 H-bond coupling of EF-hands 
Deng and co-workers (2005) described the extensive hydrophobic interactions 
between the two sets of EF-hand pairs EF-I with EF-II and EF-III with EF-IV and the 
effect of calcium binding to the coupling (Deng et al., 2005).  
The loops of EF-I and EF-II are bound by means of hydrogen bonds between 
main-chain nitrogen and carbonyl oxygen atoms of Ile31 and Thr77, the side-chain Oδ1 
of Asp34, and the main-chain nitrogen atom of Gly74, and between Nζ of Lys30 and the 
side-chain oxygen atom of Glu76 (Figure 5-4) (Deng et al, 2005).   
The binding of calcium ion in loop I of aequorin abolishes the hydrogen bond 
between Lys30 and Glu76.  The accommodation of calcium in the loop makes the 
hydrogen bond distances between the main-chain nitrogen atom of Ile31 and the main-
chain carbonyl oxygen atom of Thr77, and the main-chain carbonyl oxygen atom of 
Ile31 and the main-chain nitrogen atom of Thr77 shorter. The hydrogen bond distances 
between Oδ1 of Asp34 and the main-chain nitrogen atom of Gly74 that bind helices B 
and C of aequorin increase in distance upon calcium binding.   
The interaction between the loops of EF-III and EF-IV occurs mainly through 
hydrogen bonds between main-chain atoms of Ile124 and Leu160 and between the 
main-chain carbonyl oxygen atom of Gly122 and the main-chain nitrogen atom of 
Val162 (Figure 5-5).  In the calcium-loaded state of aequorin, the hydrogen bond 
distances between the main-chain nitrogen atom of Ile124 and the main-chain carbonyl 
oxygen atom of Leu160, and the main-chain carbonyl oxygen atom of Ile124 and the 
main-chain nitrogen atom of Leu160 become shorter than in the calcium-free state. The 
hydrogen bonding between Gly122 and Val162 is abolished after calcium binding 
(Figure 5-5).  Gly122, Ile124 occupy positions 6 and 8 of loop EF-III and Leu160 and 
Val162 occupy positions 8 and 10 of the loop, respectively.  
Within van der Waals interaction range (3.6–4.5 Å) from the residues 
participating in H-bond coupling between the EF-hand loops lie residues which directly 
coordinate coelenterazine or are within close proximity (Figure 5-6).  Tyr82 (directly 
coordinates coelenterazine) and Met19 (close proximity) are within the range in the N-
terminus EF-hand pair and Thr166 (directly coordinates coelenterazine and is in close 
proximity to His169 and Trp129, Phe113, Met165 and Trp108). 
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Figure 5-4  Coupling of EF-I and EF-II of aequorin by means of hydrogen bonds.  The 
left hand side shows the calcium-free conformation and the right hand side the Ca2+-
bound conformation.  Image reproduced from Deng et al (2005). 
 
 
Figure 5-5  Coupling of EF-III and EF-IV of aequorin by means of hydrogen bonds.  
The left hand side shows the calcium-free conformation and the right hand side the 
Ca2+-bound conformation.  Image reproduced from Deng et al (2005). 
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Figure 5-6  EF-hand pair coupling residues, van der Waals distance range and cavity of 
aequorin.  The EF-I-EF-II hydrogen bonding residues are shown as green sticks, the EF-
III-EF-IV hydrogen bonding residues are shown as dark blue sticks.  In the protein core 
coelenterazine is shown as yellow sticks.  As in Figure 5-2, red sticks are amino acids 
that directly bind to coelenterazine and orange sticks are in close proximity of the 
chromophore.  The grey transparent surfaces indicate regions of van der Waals 
interactions with the amino acids involved in EF-hand coupling hydrogen bonds.  Some 
of the amino acids which stabilise coelenterazine (Tyr82, Met19, Thr166, Trp129, 
Phe113, Met165, Trp108) lie within these regions.  Image created using Pymol 
(DeLano, 2002). 
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5.1.3 Theories on signal transduction following calcium binding 
The mechanism of signal transduction upon calcium binding is still under 
discussion and the exact number of Ca2+ ions required for bioluminescence is discussed 
in Section 1.3.1.  The holo-aequorin and apoaequorin structures provide some insights.  
The sequence of molecular events occurring in a photoprotein molecule has been 
hypothesised based on structural data and the assumed mechanism for triggering the 
bioluminescence.   
When calcium binds at either or both EF-I and EF-IV the helices of these ‘hands’ 
change their relative orientations.  Displacement of the helices flanking the C-terminal 
tail disrupts the local hydrogen-bonding network, resulting in a relocation of the side 
chain of Tyr184 (see Figure 5-10).  This in turn disrupts the hydrogen bonds to His169 
and the peroxide.  No longer stabilised, the peroxide would be free to attack the adjacent 
carbon C3 (Figure 5-2) to initiate the light-emitting reaction (Figure 1-11).  Depending 
on the extent of the shift in the flanking helices during calcium activation, the C-
terminal ‘tail’ could become partly or completely uncoupled from the helices (see 
Figure 5-10), thus affecting the rate of bioluminescence (Head et al., 2000).  
A concurring hypothesis by Deng and co-workers (2005) suggests that 
displacement of His169 that lies in helix H is a crucial step for triggering the 
bioluminescence (Figure 5-11).  Binding of one Ca2+ to the loop of EF-IV preceding 
helix H, and needing a significant repositioning of the coordinating residues to properly 
accommodate the Ca2+, would propagate to a repositioning of His169.  Due to the 
existence of hydrogen-bonding networks and other types of interaction between the EF-
hand motifs (Section 5.1.2), particularly between loops III and IV, binding of Ca2+ to 
each of the loops will not be independent (Deng et al., 2005).  A possible sequence of 
molecular events has been proposed to connect binding of calcium to the triggering of 
bioluminescence in photoprotein obelin and a similar cascade of events is expected for 
aequorin.   
The events proposed are as follows, with residues numbered according to the 
aequorin sequence PDB ID 1EJ3: 
(1) One calcium ion is preferentially bound to loop I as observed in the soaked 
obelin structure (Liu et al., 2003) and expected from the “preformed” nature of this loop 
itself (Deng et al., 2005).  
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(2) The binding of calcium ion to the EF-I loop and optimisation of the 
pentagonal, bipyramidal geometry (Figure 5-3) produces a “twist” of the EF-I around a 
pivot point by means of changes in hydrogen bond distances between the main-chain 
atoms of Ile31 and Ile77. The accommodation of the calcium ion also changes slightly 
the inter-helical angle between helices A and B.  
(3) All these changes produce a pulling of helix A in the direction of the N-
terminus of the protein.  
(4) Since helix A is tightly bound with helix H and the C-terminus through 
numerous hydrogen bonds, the changes in helix A will result in a displacement of helix 
H and the C-terminus.  For this reason, the binding of only one calcium ion into the 
Ca2+-binding loop of the EF-I could be sufficient to trigger bioluminescence.  
(5) The binding of a calcium ion to loop of EF-IV and the optimisation of the 
pentagonal, bipyramidal geometry produces a “twist” of the EF-IV around a pivot point 
by means of changes in hydrogen bond distances between the main-chain atoms of 
Ile124 and Leu160.  A small change of inter-helical angle is induced between helices H 
and G.  
(6) The displacement of helix G produces a rearrangement of helix F, which is 
hydrogen-bonded with helix G. The displacement of helix F can therefore adjust the 
Ca2+-binding loop of EF-III, increasing its affinity for calcium and facilitating its 
binding.  The accommodation of calcium into this Ca2+-binding loop completes the 
rearrangements of helices F and E of EF-III and again leads to an additional stimulation 
of the bioluminescence.  The accommodation of the third calcium ion and the 
rearrangements in EF-III complete all the structural rearrangements in the photoprotein 
molecule, producing a final conformation that is optimal for effective bioluminescence 
(Deng et al., 2005). 
Based on this sequence of events, Deng and co-workers (2004) and Vysotski and 
Lee (2004) have suggested that binding of even one calcium ion in EF-I will be enough 
to set off bioluminescence and that binding of the other two calcium ions is a co-
operative event leading to greater stimulation of bioluminescence.  In terms of binding 
preference, Liu and co-workers (2003) found that after exposing obelin crystals to a 
trace of calcium, one calcium ion was bound in the loop of EF-I and according to Deng 
and co-workers (2004) and Vysotski and Lee (2004) the second calcium ion binds to the 
loop of EF-IV. 
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The likelihood that each binding event will trigger a bioluminescence response 
depends on three factors:  (1) the on-rate for Ca2+ binding, which is probably 
proportional to the binding affinity;  (2) the degree of residue shift for Ca2+ ligation and 
the rate of propagation of this change to helix H and 3) the amount of any position shift 
that His169 undergoes as a result (Deng et al., 2005). 
5.2 Previous mutagenesis on aequorin 
After an in-depth study of the protein structure, this section is dedicated in 
compilation of some interesting mutational studies conducted on aequorin.  Selected 
mutations are also presented in Table 5-1.   
5.2.1 Calcium sensitivity  
It is possible to alter the sensitivity of aequorin’s response to trace amounts of 
calcium by changing the chromophore attached to the protein chain, rather than by 
altering the protein itself.  Analogues of coelenterazine were previously synthesised to 
produce semi-synthetic aequorins, namely cp-, i-, br- and n-aequorin (Table 5–2 and 
Figure 5-8) taken after the names of the chromophore moieties.  Crystal structures of 
their complexes with aequorin at resolutions of 1.6–1.8 Å show that their overall 
structures were almost identical to native aequorin, though some significant differences 
were found in the interactions between the substituents of the coelenterazine moiety and 
the amino acid residues in the binding pocket.  The differences of various semi-
synthetic aequorins in Ca2+-sensitivity and reaction rate are explained by the capability 
of the involved groups and structures to undergo conformational changes in response to 
the Ca2+-binding (Toma et al., 2005).  Depending on the bulk of their C2-substitutions, 
the coelenterazine analogues can interfere with or increase the conformational freedom 
of the protein to promote the light-emitting reaction, with implications on the light yield 
and rate of light production (Toma et al., 2005).  These results add to previous work by 
Shimomura and co-workers, (1993) who created semi-synthetic aequorins using 15 
different chromophore analogues, which also displayed a wide range of Ca2+-sensitivity. 
Shifts of aequorin sensitivity were also achieved through mutations in the protein 
chain.  This work is presented in the next section (Section 5.2.2). 
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5.2.2 Impaired EF-hands / central Gly→Arg mutations 
From mutational studies in each of the three binding sites of aequorin, it has been 
elucidated that not all of the EF-hands share the same importance in calcium-triggered 
luminescence.  To determine the importance of each of the Ca2+-binding sites, amino 
acid substitutions were made at the three EF-hand loops. 
Tsuji and co-workers (1986) targeted the highly conserved central glycine at 
position 6 of the EF-hand loop (see Section 1.3.4 and Figure 1-10).  This site was 
independently mutated to arginine at each of the three functional EF-hands in aequorin. 
Mutation of the third calcium binding site (EF–IV) gave no significant loss of activity 
relative to the wild type, suggesting that the binding of Ca2+ to this site may be 
unnecessary for light emission.  By contrast, the same mutations directed to EF-I and 
EF-III, significantly reduced luminescence activity by 100% and 50% respectively 
(Tsuji et al., 1986).  Therefore, the authors concluded that two calcium ions may be 
sufficient for initiating the bioluminescence reaction. 
In a similar study, Tricoire and co-workers (2006) created aequorin mutants with 
the first or last residue of the Ca2+-binding loops (an Asp or Glu) replaced by Gly; these 
substitutions removed oxygen ligands essential for calcium coordination (Tricoire et al., 
2006).  Interestingly, the sensitivity of aequorin towards calcium increased for mutants 
with impaired EF-I and decreased for mutants with impaired EF-III and EF-IV.  Among 
the mutants with only one EF-hand intact, sensitivity for calcium decreased for EF-I+ 
EF-III¯  EF-IV¯  and increased for EF-I¯  EF-III+ EF-IV¯  and with EF-I¯  EF-III¯  EF-IV+ 
suggesting that EF-I has lower affinity for calcium (Tricoire et al, 2006).   
The two studies appear at odds with each other, which may be a result of indirect 
effects due to the different mutational strategies as well as different types of reported 
outputs; Tsuji and co-workers measured intensity but not sensitivity whereas Tricoire 
and co-workers (2006) presented sensitivity but no intensity results.  However, the latter 
did publish half-times of light decay curves for each mutant.  Coupled with the premise 
that the total light remained constant, the half-life of the decay curves could provide an 
indication of relative intensity amongst the mutants:  higher values of half-life would 
suggest lower initial light intensity.  Based on this premise, mutations which removed 
essential oxygen ligands in EF-I resulted in greater loss of initial intensity than similar 
mutations in EF-III and EF-IV.  It is also worth noting that mutations at different sites 
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within the loop yielded varied half-life times, e.g. Asp117Gly at position 1 of the EF-III 
loop yielded a longer half-life decay (28.6 ± 1.3 s) than Glu128Gly at position 12. 
Even though both mutational strategies aim to impair EF-hands it is worth 
considering the nature of the substitutions and their potential effect on protein function.  
The central glycine of the loop at position 6 is highly conserved in most calcium-
binding proteins and in all known photoproteins (see Section 1.3.4).  A survey on the 
architecture of metal coordination groups showed that glycine has a particular 
significance in calcium coordination groups, especially in the position adjacent to a 
donor residue (Harding, 2004).  It is found adjacent to donor residues more frequently 
(20% probability) than random statistics would predict (6.9% probability); sometimes it 
provides a `turn' in the protein-chain direction and at high coordination numbers (e.g. 
calcium binding) or small chelate loops its small size may be helpful in allowing the 
protein chain to make the required coordinate links to a metal atom (Harding, 2004).   
It is reasonable to assume that mutation of central glycine to a longer and more 
bulky arginine introduces rigidity in a position which is flexible throughout the family, 
thus affecting ion binding, signal transduction or both.  Replacing calcium-coordinating 
Glu or Asp with Gly replaces conserved binding residues, with a small and flexible 
glycine which is unlikely to be sterically perturbing, so the protein can possibly “work 
around it” using its remaining oxygen ligands.  However it does remove one 
(Asp→Gly) or two coordinating oxygen atoms (Glu→Gly) from the loop, a loss 
expected to decrease the loop’s affinity to calcium ion.  Lack of binding at the entrance 
and exit of the loop (positions 1 and 12) would limit the response of the loop upon 
calcium binding and its effect on the entering and exiting helices, which in turn serve to 
transduce the signal (or binding effect) to the rest of the molecule (Section 5.1.3). 
As the EF-hands are coupled in pairs and “communicate” with the coelenterazine 
binding site through a hydrogen bond network (Sections 5.1.2 and 5.1.3), both strategies 
can cause structural disruption beyond the loop and hence disrupt the signal 
transduction to the protein core.   
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5.2.3 Spectral shift 
Rowe and co-workers (2008a) developed a method for discriminating two semi-
synthetic aequorin variants (each incorporating a different coelenterazine analogue) 
from one another using time resolution.  Two aequorin variants were paired with 
different coelenterazine analogues and their signals were resolved from one another 
using the difference in decay kinetics and half-life times.  The resulting aequorins were 
used to develop simultaneous, dual-analyte, single-well immunoassays.   
Taking this approach one step further, Dikici and co-workers (2009) changed the 
emission characteristics of aequorin by mutating the aequorin protein chain as well as 
by pairing the mutants with ten different coelenterazine analogues to yield semi-
synthetic aequorins.  The mutations targeted residues of aequorin known to play a role 
in the light emitting reaction (residues His16, Met19, Tyr82, Trp86, Trp108, Phe113 
and Tyr132).  The result was a set of semi-synthetic photoprotein mutants with 
significantly altered bioluminescent properties:  emission wavelengths, decay kinetics, 
and stability (Dikici et al., 2009).   
5.2.4 Intensity 
In vitro evolution experiments by Tsuzuki and co-workers (2005) obtained high 
intensity yielding aequorin mutants.  Mutations neighboured the His16 or His169 
coelenterazine-binding residues or were located in the first EF-hand (amino acid 
numbering according to PDB ID:  1EJ3).  In particular, high intensity mutants were 
Lys17Arg Val25Ala, Asn26Asp, Gln168Arg and Leu170Ile.  Other mutations located in 
the EF-hand loops or their vicinity resulted in lower peak intensities and slow decay 
times.  A prevailing characteristic of these mutants was removal of at least one oxygen 
donor, e.g. Glu35Gly, Asp117Gly, Glu128Gly, and Asp135Gly.   
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5.2.5 Thermostability 
The screen described in Section 5.2.4 produced two aequorin mutants with 
increased thermostability (Gln168Arg and Leu170Ile) and one mutant (Phe149Ser) with 
decreased thermostability (Figure 5-7).  Two random libraries were created based on 
Gln168 and Leu170 respectively and screened for the impact of these positions on 
thermostability.  The experimental results in conjunction with crystal structures of 
aequorin in published literature suggested that both Phe149 and Gln168 fulfill a dual 
purpose:  they stabilise the coelenterazine peroxide and contribute to triggering of light 
by linking EF-III to the coelenterazine-binding residues Trp129 and His169 (Tsuzuki et 
al., 2005).   
 
Figure 5-7  Aequorin and positions of interesting mutations.  Three-dimensional 
representation of aequorin with bound coelenterazine (yellow sticks).  The Ca2+-binding 
loops are transparent blue and the rest of the protein is transparent green.  Amino acids 
that were found to contribute to the bioluminescent activity and/or stabilisation of 
bound coelenterazine are highlighted as red sticks (His16, His58, His169, Trp108, 
Trp173).  Amino acids that have been linked to thermostability are highlighted as 
magenta sticks (Gln168, Leu170).  PDB 1EJ3, 3D model rendered with Pymol 
(DeLano, 2002).   
EF-I 
EF-III 
EF-IV 
HIS-58 
TYR-132 
TYR-184 
PRO-189 
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Table 5-1  Previous mutational work on aequorin.  Selected literature. 
Type of alterations  Location  
in aequorin 
Property altered Effect on 
activity 
References 
Q168R, L170I Hydrophobic core Thermostability ↑ (Tsuzuki et al., 2005) 
F149S Hydrophobic core Thermostability ↓ (Tsuzuki et al., 2005) 
Coelenterazine 
analogues 
Hydrophobic core Calcium sensitivity ↑ , ↓ (Shimomura et al., 1993, Toma et al., 2005) 
Central Gly→Arg Centre of EF-I loop Flexibility  ↓ (Tsuji et al., 1986) 
Central Gly→Arg Centre of EF-III 
loop 
Flexibility  ↓ (Tsuji et al., 1986) 
Central Gly→Arg Centre of EF-IV 
loop 
Flexibility ↓ (Tsuji et al., 1986) 
Fusion with 6xHis N-terminal Metal affinity tag − (Glynou et al., 2003) 
Fusion N- and/or  
C-terminal 
Metal affinity tag 
− 
(Deo et al., 2001, Lewis and Daunert, 2000) 
Deletion of Pro C-terminal Light emission, 
stability 
↓ (Nomura et al., 1991, Watkins and Campbell, 
1993) 
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Figure 5-8  Coelenterazine and nine analogues.  Different coelenterazine analogues were incorporated in mutant variants of photoproteins 
aequorin and obelin to create photoproteins with altered light emission characteristics.  Figure reproduced from Rowe et al (2008b).   
        Table 5-2  Properties of aequorin with coelenterazine and some of its analogues.  Data taken from Shimomura and co-workers (1993). 
Coelenterazine Analogue  Emission maxima  (nm)  Relative Luminescence Capacity1  Relative Intensity
2
 Half-Rise Time3 (ms)  
native  466 1 1 6–30 
cp  442 0.63 28 2–5 
f  472 0.8 20 6–30 
h  466 0.75 16 6–30 
hcp  445 0.65 500 2–5 
n  468 0.25 0.15 6–30 
1:  Relative luminescence capacity = total time-integrated emission of aequorin in saturating Ca2+ relative to native aequorin = 1.0  2:  Relative intensity at 
100 nM Ca2+.  3:  Half-rise time = time for the luminescence signal to reach 50% of the maximum after addition of 1 mM Ca2+ to a standard of aequorin 
reconstituted with the coelenterazine analogue of interest.   
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5.3 Mutation of other calcium-binding structures 
Valuable information on the metal-binding requirements of EF-hands has come 
from studies with synthetic peptides, de novo proteins and even non-EF-hand proteins 
that have calcium coordination similar to that of the EF-hands.  Such systems come with 
benefits such as lack of the complexities associated with cooperativity, engineered 
tyrosines within or near the loop for fluorescence monitoring and use of terbium instead 
of calcium for its phosphorescence properties.   
5.3.1 Short peptides with calcium-binding ability 
Researchers have attempted to study the ion binding affinities of the EF-hands 
isolated from the complex protein scaffold.  Le Clainche and co-workers (2003) created 
33-34 amino acid peptides corresponding to the helix-turn-helix EF-hand motif of the 
calcium binding site I from Paramecium tetraurelia calmodulin.  Isolated from the rest 
of the protein these peptides were able to acquire native-like conformations due to the 
incorporation of a disulfide bond to bridge the two helical regions.  The disulfide-
stabilised peptides acquired a calcium-dependent helical conformation and native-like 
affinity for calcium and lanthanide ions (Le Clainche et al., 2006, Le Clainche et al., 
2003).  Their work showed that metal selectivity of the calcium binding loop can be 
modulated by specific mutations in metal coordinating and non-coordinating positions.   
Replacement of Glu by Asp at position 12 in the calcium binding loop resulted in 
loss of calcium affinity but preserved lanthanide affinity.  The mutation is presumed to 
leave more space in the binding loop for larger ions.  The presence of carboxylate 
oxygens at positions 1, 3, 5 and 12 of the loop allowed for high affinities for terbium 
and particularly the presence of Asp at position 5 of the loop was decisive in 
maintaining high affinity for terbium. 
Interestingly, while at position 3 Asp→Asn abolished calcium affinity of the 
peptide system, the equivalent sites in aequorin are normally Asn.  However this may 
indicate the effects of the neighbouring sequence, including the different structural 
constraints on the loop for the small peptide such as the impact of the engineered 
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disulfide bond and also the introduction of a tyrosine residue at position 7 (used as a 
fluorescent probe of metal binding in the peptides). 
Alanine substitutions at non-coordinating residues did not abolish calcium 
binding to the peptide, but significantly reduced the affinity, as did alanine substitutions 
in the helix preceding the loop. 
Finally, Oishi and co-workers (1992) investigated the affinities of EF-hands I, III 
and IV for Ca2+ by using 20-22 amino acid synthetic peptide fragments.  The 
dissociation constants for Ca2+ showed the binding affinity order of III, I and IV (Oishi 
et al., 1992).   
5.3.2 EF-hand loops in model proteins 
A study by Drake and co-workers (1996) examines the contribution of the ninth 
position of the Ca2+-coordinating EF-loop of the E. coli galactose binding protein to the 
tuning of calcium affinity and selectivity.  It was proposed that position 9 (see Section 
1.3.4 Figure 1-10) serves in:  (1) charge selectivity, which may stem from the 
electrostatic repulsion between the coordinating oxygens and (2) size selectivity, which 
may involve complex interactions between multiple coordinating side chains. 
Position 9 of the EF-hand was substituted with residues commonly found in 
other EF-hand loop sequences.  The Ca2+ affinities and ionic selectivities of the new 
loop variants were compared with those for ions of groups Ia, IIa, and IIIa of the 
Periodic Table and for the lanthanides.  Variants with neutral side chains of different 
sizes (Gly, Ala, Ser, Thr, Asn, Gln) exhibited similar affinities for calcium ions and 
excluded Na+, K+, and Mg2+.  Acidic residues (Glu, Asp) reduced affinity for calcium 
and significantly enhanced affinity toward trivalent cations.  All mutants exhibited a 
partial loss of ion size selectivity and favoured lanthanide binding.  In a relevant study, 
Drake and Falke (1996) used the same EF-hand model to propose that position 9 of the 
EF-hand loop serves as a “gateway” to modulate the kinetics of Tb3+ binding. 
A similar study was carried out for the E. coli receptor for D-galactose and D-
glucose (GGR), which contains one single Ca2+-binding site.  The effects of metal ion 
size and charge on the affinity (Kd) of metal binding was studied for spherical ions from 
groups IA, IIA, IIIA of the periodic table and some of the lanthanides (Snyder et al., 
1990).  GGR was at the time of publication structurally the closest known relative of the 
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EF-hand class. It has the significant experimental advantage that only one Ca2+-site is 
present in the molecule, hence was considered ideal for a systematic study of Ca2+-site 
affinity.   
Monovalent ions exhibited very low affinities.  Divalent group IIA exhibited 
affinities related to their size with optimal binding at an effective ionic radius between 
those of Mg2+ (0.81 Å) and Ca2+ (1.06 Å) (Snyder et al., 1990).  Comparison of the 
dissociation constants for the binding of spherical ions from groups IA, IIA and IIA and 
the lanthanides indicated that both charge and size were important parameters in 
determining the specificity of the GGR Ca2+-binding site, with monovalent ions being 
excluded on the basis of charge. 
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5.4 Structural analysis methods 
5.4.1 Crystallographic structure examination 
The structures of calcium-free aequorin (PDB ID:  1EJ3) and calcium-bound 
apoaequorin (PDB ID:  1SL8) were visualised in Pymol (DeLano, 2002) and used to 
calculate distances between the centres of the metal ion and coordinating oxygen atoms.  
The upper limit for hydrogen bond distances between donor and acceptor atom was set 
to 3.2 Å and the range for accepted van der Waals distances was set to 3.6−4.5 Å.  
Structural alignment between 1SL8 and 1EJ3 was also performed in Pymol.  
5.4.2 Interatomic overlap calculations 
Interatomic overlap (D-r-R) was defined as the interatomic distance between 
calcium and each of the oxygen ligands in the pentagonal bipyramidal coordination 
(PDB ID: 1SL8) subtracted by the sum of their atomic radii (Figure 5-9).  When          
D-r-R<0 there is overlap of the atoms which suggests tight binding.  In Pymol this 
would be indicated as steric clash between the metal ion and the coordinating rotamer of 
the residue (image not shown).  The ionic radii of metal ions tested were taken from 
Shannon (1976) (Appendix Chapter 5, Table 10-12).  Some metal ions were assigned 
more than one ionic radii in line with the metal-ligand distances found in different 
coordination geometries in protein metal-binding sites.  When more than one ionic 
radius was used for the atomic overlap calculations, the highest ionic radius of the metal 
was included in the range. 
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Figure 5-9 Atomic overlap.  Distances and overlap between neighbouring atoms.  The 
distance is calculated from the crystal structures and the ionic radii are from Shannon 
(1976).  
Distance – (r + R) > 0 
r R r R 
Distance – (r + R) < 0 
             overlap 
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5.5 Results and discussion 
This section designs the mutations to be made and screened in Chapter 6.  
Observations arising from structural analysis of Sections 5.5.1-5.6 combined with the 
literature review conducted in Sections 5.1-5.3 could help elucidate properties of the 
EF-hand and response towards calcium and potentially new ions and subsequently help 
identify targets for mutational studies.  Where information is retrieved from published 
bibliography, this is clearly stated in the text.   
5.5.1 Calcium-free versus calcium-bound aequorin structure 
Figure 5-10 shows the structural alignment of the two crystallographic structures 
1EJ3 and 1SL8 and Figure 5-11 presents detailed views of the EF-hands with and 
without calcium bound. 
There is very little gross structural difference among Ca2+-bound apoaequorin 
(1SL8) and Ca2+-free aequorin (1EJ3), but closer examination reveals that there are 
local changes (Deng et al., 2005).  The overall conformation of the molecules remains 
intact with one notable difference in the C-terminus where the C-terminus “tail” is 
released into the solvent leaving the hydrophobic core exposed and the bond between 
Tyr184 and hydroperoxy-coelenterazine disrupted.  
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Figure 5-10  Structurally aligned calcium-free aequorin (1EJ3, chain B) and calcium-
bound apoaequorin (1SL8).  1EJ3 is coloured green and 1SL8 is coloured blue.  The 
calcium ions of 1SL8 are represented as red spheres.  Stabilised coelenterazine in the 
centre of 1EJ3 is coloured yellow.  Tyr184 of the C-terminus is shown as sticks; in 1EJ3 
(green) it is hydrogen bonded to hydroperoxy-coelenterazine.  The hydrogen bond is 
shown as red dashes.   
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5.5.2 Movement of residues to coordinate calcium 
This section compares the three functional EF-hands of the two crystallographic 
structures 1SL8 and 1EJ3.  Figure 5-11 shows that some of the coordinating residues 
move further than others in order to achieve coordination of calcium.  The distances 
travelled before and after calcium binding by the coordinating oxygen (O) and the α-
carbon of the respective residue are presented in Table 5-3. 
Observations on the changes in conformation of the EF-hands due to binding of calcium 
ions 
Upon binding of calcium ion by the loop of EF-I, both helices are “pulled” 
upwards towards the loop.  Asp24 is pulled closer to calcium to coordinate it.  The 
distance between the entry and exit of the loop, assigned as the exit of helix A and 
entrance of helix B in the Pymol representation of the molecule, was 11.81 Å and 
9.75 Å in 1EJ3 and 1SL8 respectively, showing a contraction of the loop.  The most 
structural rearrangement occurs in the first half (the N-terminus) of the loop (positions 
1-5) with Asn26 (position 3 in the loop) changing orientation to face inwards and Asn28 
(position 5 in the loop) rotating to coordinate the calcium ion. 
In EF-III the entrance and exit of the loop are identified as Asp117 and Thr125.  
The distances between them are 7.68 Å and 8 Å in 1EJ3 and 1SL8 respectively, 
indicating little or no contraction at the entry and exit points of the loop.  Residues at 
positions 3 and 5 rotate to bind calcium ion, but overall there is minimal backbone 
distortion.  As in EF-I, the most obvious rearrangements occur in the N-terminal half of 
the loop. 
EF-IV is overall more disordered prior to calcium binding than are EF-I or EF-
III.  As in EF-III, the maximum structural re-adjustment occurs in the N-terminal half of 
the loop.  The entering helix (helix G) is pulled upwards towards calcium.  Interestingly, 
the entrance and exit of the loop are identified at different positions in 1EJ3 and 1SL8.  
In 1EJ3, the entrance and exit of the loop are Cys152 and Val162 (distance 10.7 Å) 
whereas in 1SL8 they are Asp155 and Asp163 (distance 8 Å), exhibiting considerable 
contraction.  This observation however is made with caution, as the limits between helix 
and loop in the Pymol representation of the molecule are indicative and depend on the 
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definitions of secondary structure used by the software.  Aspartate at position 9 changes 
orientation with the side chain oxygens facing towards the loop.   
As seen in Figure 5-11 and summarised in Table 5-3, in EF-I and EF-III:  
residues at positions 3 and 5 rotate or change orientation upon calcium binding.  In EF-
IV residue at position 1 rotates but residues at positions 3 and 5 are displaced in parallel 
orientation compared to their calcium-free state.  Interestingly, position 9 in EF-IV is 
occupied by aspartate which changes orientation upon calcium binding, which is not 
observed in serine at position 9 of EF-I and EF-III.  Potentially position 9 is of special 
significance in EF-IV than in the other EF-hands.  In EF-IV residues at position 1 and 
12 respond by rotation/change in orientation, while residues at positions 3 and 5 move 
in parallel compared to their calcium-free state.  Overall, residues at positions 1 and 12 
are likely to be critical in achieving loop contraction upon binding and thus “pulling” 
the entering and exiting helices of each loop. 
The local differences in response to calcium binding by the EF-hand loops are 
likely to be associated with their intrinsic affinities and their ability to transduce the 
conformational shifts towards destabilisation of hydroperoxy-coelenterazine. 
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Figure 5-11  Shifts in the EF-hands upon calcium binding.  Isolated fragments from 
Figure 5-10.  1EJ3 (calcium-free) is coloured green and 1SL8 (calcium-bound) is 
coloured blue.  The entering (N-terminus) helix of each EF-hand is shown on the left 
hand aide and the exiting helix (C-terminus) is shown on the right hand side.  Calcium 
ions are shown as transparent yellow spheres.  The coordinating residues are shown as 
sticks, both in the Ca2+-bound and Ca2+-free conformation. All oxygen atoms are 
coloured red.  Coordinating water molecules were omitted from this picture.  Picture 
was rendered in Pymol (DeLano, 2002).  
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Table 5-3  Shifts of residue positions between Ca2+-free and Ca2+-bound EF-hands.  
Distances were calculated between the α-carbon atoms of the superimposed 1EJ3 
(calcium-free) and 1SL8 (calcium bound) structures for each residue in the loop.  For 
the coordinating residues (marked in bold letters), distances between oxygen 
coordinating atoms were calculated.  Amino acid numbering shown for both structures. 
EF-hand a.a. in1EJ3 a.a. in SL8 Position O-O, Å Cα- Cα comments 
EF-I N24 N26 1 1.8 2.5  
 V25 V27 2  4.41 Same orientation 
 N26 N28 3 4.9 3.3 Orientation out→in 
 H27 H29 4  2.3 Some twist 
 N28 N30 5 3.8 0.5 Rotates 
 G29 G31 6  0.59 Same orientation 
 K30 R32 7 1.0 1.0  
       
 S32 S34 9 0.9 1.1  
       
       
 E35 E37 12 1.6 (O1) 
1.3 (O2) 
1.51  
EF-III D117 D119 1 0.9 0.9  
 K118 K120 2  2.3 Change orientation 
 D119 D121 3 2.9 3.2 Rotates 
 Q120 Q122 4  2.6 Slight rotation 
 N121 N123 5 6.6 3.9 Rotates 
 G122 G124 6  3.1  
 A123 A125 7 0.7 1.3  
 I124 I126 8  1  
 T125 S127 9 1.1 1.1  
 L126 L128 10  1.4 parallel 
 D127 D129 11  1.3  
 E128 E130 12 1.0 (O1) 
1.1 (O2) 
1.1  
EF-IV D153 D155 1 6.4 2.4 Rotates 
 I154 I156 2  5.2 Change orientation 
 D155 D157 3 5.8 5.6 Move parallel 
 E156 E158 4  6.0 Same orientation 
 S157 S159 5 5.4 5.4 Move parallel 
 G158 G160 6  1.8  
 E159 E161 7 1.0 1.1 Move parallel 
       
 D161 D163 9 3.3 1.3 Orientation out→in 
 V162 V164 10  1.9  
 D163 D165 11  0.65 Change orientation 
 E164 E166 12 5.5 (O1) 
4.1 (O2) 
0.8 Orientation out→in 
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5.5.3 Overlap of atomic radii in the ion-binding loop 
It is reasonable to assume that the octahedral bipyramidal coordination of 
calcium as seen in structure 1SL8 is the optimal for exerting the maximum effect upon 
ion binding.  This section replaces the calcium ion in the loop of EF-I (PDB ID:  1SL8) 
with each of the additional six metal ions chosen in Section 1.6.2 and calculates the 
distance D and D-r-R (see Section 5.4.2).  For all ions other than calcium this is a 
hypothetical calculation and illustrates the effect of the cavity size in potential for tight 
binding, or lack thereof.  Two basic assumptions are made:  (1) the metal ions are 
spherical and (2) the local protein environment would “choose” the coordination and 
place the ions in the native calcium-binding geometry, despite of the fact that the 
preferred coordinating geometries of these metals in existing metalloproteins are 
different (Section 1.4).  In Figure 5-12 to Figure 5-14 D-r-R is calculated between the 
ion and every coordinating oxygen atom at positions 1, 3, 5, 7, 9 and 12 in the loop.  At 
position 9 the distance is calculated from the oxygen of a water molecule (Section 1.3.4 
and Figure 5-3) and position 12 offers two oxygen atoms from glutamate, assigned in 
the graphs as pos 12-1 and pos 12-2.   
Negative values of D-r-R show potential for overlap between the oxygen ligands 
and the metal ion, hence tight binding.   
As shown in Figure 5-12, calcium, lanthanum and cadmium can overlap with the 
coordinating oxygens of the loop.  Lead also shows potential for atomic overlap (Figure 
5-13) which varies depending on the coordination number the ionic radius corresponds 
to.  Smaller ions cobalt, zinc and copper cannot be reached by all the oxygen ligands 
(Figure 5-14).  It is worth noting that oxygen is not the preferred ligand for these metals 
(Section 1.4).  It is possible that in reality these ions would bind in different 
coordination geometries engaging fewer ligands from the ion EF-hand loop.  This in 
turn would affect the signal transduction to the protein core where luminescence is 
produced. 
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Figure 5-12  Metal-ligand atomic overlap in EF-I of aequorin (a).  Interatomic distances 
taken from 1SL8 crystallographic structure of calcium-bound EF-I and applied to 
calcium, lanthanum and cadmium ions.  Ionic radii for each ion correspond to the 
coordination numbers shown in each graph.  
Calcium(II) 
(VII coordination) 
Cadmium(II)  
(VII coordination) 
Lanthanum(III)  
(VII coordination)) 
- 171 - 
 
pos 1
pos 3
pos 5
pos 7
pos 9
pos 12-1
pos 12-2
-0.8
-0.7
-0.6
-0.5
-0.4
-0.3
-0.2
-0.1
0
D-
R-
r 
(A
)
 
pos 1
pos 3
pos 5
pos 7
pos 9
pos 12-1
pos 12-2
-0.7
-0.6
-0.5
-0.4
-0.3
-0.2
-0.1
0
D
-
R
-
r 
(A
)
 
 
pos 1
pos 3
pos 5
pos 7
pos 9
pos 12-1
pos 12-2
-0.5
-0.4
-0.3
-0.2
-0.1
0
D
-
R
-
r 
(A
)
 
Figure 5-13  Metal-ligand atomic overlap in EF-I of aequorin (b).  Interatomic distances 
taken from 1SL8 crystallographic structure of calcium-bound EF-I and applied to lead 
ions for ionic radii corresponding to three different coordination numbers/geometries. 
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Figure 5-14  Metal-ligand atomic overlap in EF-I of aequorin (c).  Interatomic distances 
taken from 1SL8 crystallographic structure of calcium-bound EF-I and applied to 
cobalt, copper and two different coordination geometries of zinc ions.   
Cobalt(II) 
(VI coordination) 
Zinc(II) 
(VI coordination) 
Zinc(II) 
(IV coordination) 
Copper(II) 
(VI coordination) 
- 173 - 
5.6 Conclusions 
5.6.1 Conclusions from structural analysis 
The decisive conformational shift for the light emitting reaction is associated 
with the release of the C-terminus “tail” of the protein, which carries Tyr184, a residue 
that stabilises the hydroperoxy of coelenterazine and interacts with His169.  This C-
terminus displacement of aequorin is the only major conformational change obvious at 
first glance.  It is also clear that the more subtle local conformational shifts upon 
binding of calcium ultimately propagate into the major shift and bioluminescence 
reaction (Section 5.5).   
The binding of calcium ion by the EF-hands requires different levels of re-
adjustments of the loops.  EF-IV seems to undergo the most extensive local 
rearrangements to accommodate calcium amongst the three calcium binding EF-hands.  
Residues of EF-III seems to be already pre-positioned for calcium binding judging from 
the extent of loop contraction and residue rearrangement while EF-I and EF-IV may be 
carrying the most weight in the transduction of the conformational shifts upon binding 
of calcium (Section 5.5.2).   
In each of the loops the N-terminal side (positions 1-5) undergoes more 
extensive rearrangements upon calcium binding than does the C-terminal side (positions 
6-12).  In terms of EF-hand coupling, it occurs between the C-terminal part of the 
participating loops (EF-I with EF-II and EF-III with EF-IV).  The residues participating 
in hydrogen bonding between the pairs or EF-hands are within van der Waals range 
from residues which directly stabilise coelenterazine or are within close proximity of it 
(Section 5.1.2 and Figure 5-6).  The coordinating residues may rotate, change 
orientation or move in parallel compared to their calcium-free state to achieve calcium 
binding, and there is some variability in the type of response among the three EF-hands.  
This variability could be associated with their metal binding affinity and their role in 
transduction of the conformational shift.  Overall, positions 1, 3 and 5 are important in 
binding of a new ion while positions 1 and 12 mark the entry and exit of the loop. 
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The size of the EF-loop cavity favours metals of similar ionic size as calcium.  A 
theoretical substitution of calcium by six other metal ions in the loop of EF-I (PDB ID:  
1SL8) shows that metal ions with ionic size similar to that of calcium (lead, lanthanum, 
cadmium) are more likely to assume tighter binding in the native coordination geometry 
than smaller ions which will not be reached by all required ligands for this geometry 
(Section 5.5.3).  Instead the smaller ions could attract fewer ligands from the protein 
environment and hence trigger reduced signal transduction. 
5.6.2 Conclusions from previous mutational studies 
The central glycine of each EF-hand is highly conserved and its replacement 
with the more rigid and bulky arginine can result in loss of luminescence, possibly by 
impeding adequate structural response to calcium (Section 5.2.2).  This strategy can be 
used to potentially “knockout” EF-hands one by one and hence elucidate their 
contribution to overall activity.  Removal of coordinating side chain oxygens from 
positions 1, 3, 5 and 12 of the loops also results in reduction of aequorin’s activity by 
reducing affinity for calcium (Sections 5.2.2, 5.2.4, 5.3.1).  Position 9, which 
coordinates indirectly to calcium through a water molecule, could serve for size and 
charge selectivity as well as a “gateway” to modulate binding kinetics (Section 5.3.2).  
Alanine substitutions at non-coordinating positions in the EF-hand loop or its preceding 
helix reduced affinity for calcium (Section 5.3.1).  Spectral tuning is possible by 
mutating residues within the coelenterazine binding site or in close proximity to it as 
well as by using coelenterazine analogues, however this topic is outside the scope of 
this work.  
Finally, the effect of mutations is highly dependent on the surrounding protein 
environment; one type of substitution in a certain position of the EF-hand would not 
necessarily have the same effect in two different EF-hand proteins. 
5.6.3 Choice of mutant library 
The goal was to create an aequorin library with a high likelihood of including 
desirable mutations in key positions of the molecule.  Ideally these mutations should 
lead to altered metal ion selectivity while preserving luminescence activity.   
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While directed evolution (Section 1.5.2) and random-rational approaches 
(Section 1.5.3) present possible routes to altering the ion selectivity of aequorin, the 
availability of the crystallographic structures 1SL8 and 1EJ3 enables the direction of 
mutations to the ion binding sites.  The examination of crystallographic structure and 
literature review presented in the previous sections were combined with common sense 
and curiosity.  The priority was to introduce specific mutations in specific positions of 
the EF-hand loops.  The mutations designed can be divided in the following categories:  
(1) histidine and cysteine substitutions, (2) alanine substitutions, (3) central Gly→Arg 
mutations, (4) double mutations.  The forty eight mutants that were designed are 
presented in Table 5-4 and Table 5-5 and annotated in regards to their position in the 
protein and the nature of their substitution.  The reasoning behind the choices is outlined 
below.   
Preference amongst EF-hands 
EF-I and EF-III were targeted first as they are more optimally pre-positioned to 
bind calcium than EF-IV, which suggests they may carry more weight in ion selectivity.  
Amongst the two, EF-I was studied more extensively because in published literature its 
impairment was reported to be the most detrimental to aequorin activity amongst the 
other EF-hands.   
Mutations of coordinating and non-coordinating residues 
Coordinating residues were prime targets for mutations as they are directly 
responsible for binding of calcium; however, non-coordinating residues were also 
targeted to a lesser extent.  The logic behind this was that mutations at non-coordinating 
positions could potentially introduce a new rearrangement for metal binding.  These 
positions could also be more “forgiving” to radical mutations as their amino acids are 
not highly conserved (Table 1-4).  This statement excludes glycine at position 6 of the 
EF-hand loop which was targeted for different reasons, as explained in this section. 
Histidine and cysteine substitutions 
In aequorin there are three calcium-binding EF-hands (EF-I, EF-III and EF-IV), 
with six calcium-coordinating residues in each, four out of which are highly conserved 
and two not as highly conserved (Section 1.3.3 and Table 1-4).  All published 
mutational work has highlighted substitutions of these residues by glycine (e.g. 
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Asp→Gly, Glu→Gly) or by other conserved coordinating residues (e.g. Asp→Asn, 
Glu→Asp).   
To the best of the author’s knowledge, the selectivity of the EF-hands has never 
been engineered towards binding of smaller (e.g. zinc, copper and cobalt) or softer ions, 
(cadmium, lead).  Cysteine and histidine would normally be found in metal-binding 
sites of zinc and copper but are “exotic” to the EF-hand.  For this reason these amino 
acids were deemed as highly likely to alter the ion selectivity of the EF-hand loops.  
Each of the coordinating residues of EF-I and EF-III were individually 
substituted by histidine and cysteine. Some non-coordinating residues were also 
targeted in both EF-hands.  Histidine and cysteine have never been purposely 
introduced in the EF-hand loop before, nor have such mutants been isolated from 
previous high-throughput mutagenesis screens.   
Alanine substitutions (or alanine scan) 
In this group of mutants each of the coordinating, conserved residues at positions 
1, 3, 5, 9 and 12 (position 9 is less conserved) of EF-I were replaced by alanine.  These 
substitutions can help appreciate the significance of each of the essential side chains by 
removing them.   
Central Gly →Arg mutations 
Impairing the EF-hands by introducing rigidity in the loops (Gly→Arg at 
position 6) has been used to assess the importance of each EF-hand in the luminescence 
reaction, however these mutants were only tested against calcium (Section 5.2.2).  
These mutants were re-created in order to be screened against each of the seven metal 
ions of interest.  This set consists of mutants with one or both impaired EF-hands.  In 
the initial (mutant design and screening) stages of this work, the set of Gly→Arg 
mutants were referred to as “knockout mutants” due to the expectation from published 
literature that this type of mutation would abolish activity.  This choice of nomenclature 
however was revisited upon examination of the screening results and comparison with 
the effect of other mutations with similar or more dramatic effect. 
Double mutations 
Variants of this set carried two mutations each:  two substitutions within EF-I or 
one substitution in EF-I and one in EF-III.  These combinations always target the 
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coordinating residue at position 5 of EF-I (Asn30) which was found to significantly 
rearrange itself in space in order to bind calcium (Section 5.5.2).  The use of combined 
mutations was deemed as a more drastic measure to alter the protein’s ion selectivity.  
Options not pursued – ideas for future work 
Due to time constraints the library did not include more mutants in EF-IV, which 
was a prospect for future studies.  Further rounds of either localised random 
mutagenesis or random mutagenesis – both achievable with alterations of the 
MEGAWHOP (megaprimer PCR of whole plasmid) method (Miyazaki and 
Takenouchi, 2002) – could possibly serve for restoration of activity and/or further fine-
tuning of selectivity of the molecule.  Such a strategy would potentially address aspects 
such as cooperativity between the EF-hands and intricate hydrogen bonding network 
interactions, which are notoriously hard to predict and engineer with rational 
mutagenesis at our current level of insight on aequorin function. 
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Table 5-4  Mutants Nr 1–23.  Amino acid numbering according to PDB IDs 1SL8 and 
1EJ3 and numbering of mutated positions within each EF-hand. 
Nr#  Amino acid Nr 
according to 1EJ3 
Amino acid Nr 
according to 1SL8 
position 
in EF-I 
position 
in EF-III 
position 
in EF-IV 
Alanine scan:  replaces coordinating and conserved positions 1,3,5,9 and 12 with 
alanine 
1 Asp24Ala Asp26Ala 1   
2 Asn26Ala Asn28Ala 3   
3 Asn28Ala Asn30Ala 5   
4 Ser32Ala Ser34Ala 9   
5 Glu35Ala Glu37Ala 12   
Central Gly→Arg mutations in EF-I, EF-III and EF-IV 
6 Gly29Arg Gly31Arg 6   
7 Gly122Arg Gly124Arg  6  
8 Gly158Arg Gly160Arg   6 
9 Gly29Arg/Gly122Arg Gly31Arg/Gly124Arg 6 6  
10 Gly29Arg/Gly158Arg Gly31Arg/Gly160Arg 6  6 
11 Gly122Arg/Gly158Arg Gly124Arg/Gly160Arg  6 6 
Histidine substitutions in EF-I 
12 Asp24His Asp26His 1   
13 Val25His Val27His 2   
14 Asn26His Asn28His 3   
15 Asn28His Asn30His 5   
16 Ser32His Ser34His 9   
17 Glu35His Glu37His 12   
Cysteine substitutions in EF-I 
18 Asp24Cys Asp26Cys 1   
19 Val25Cys Val27Cys 2   
20 Asn26Cys Asn28Cys 3   
21 Asn28Cys Asn30Cys 5   
22 Ser32Cys Ser34Cys 9   
23 Glu35Cys Glu37Cys 12   
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Table 5-5  Mutants Nr 24–48.  Amino acid numbering as in Table 5-4. 
Nr#  Amino acid Nr 
according to 1EJ3 
Amino acid Nr 
according to 1SL8 
position 
in EF-I 
position 
in EF-III 
position 
in EF-IV 
Histidine substitutions in EF-III    
24 Asp117His Asp119His  1  
25 Asp119His Asp121His  3  
26 Asp121His Asp123His  5  
27 Ala123His Ala125His  7  
28 Ser125His Ser127His  9  
29 Asp127His Asp129His  11  
30 Glu128His Glu130His  12  
Cysteine substitutions in EF-III 
31 Asp117Cys Asp119Cys  1  
32 Asp119Cys Asp121Cys  3  
33 Asp121Cys Asp123Cys  5  
34 Ala123Cys Ala125Cys  7  
35 Ser125Cys Ser127Cys  9  
36 Asp127Cys Asp129Cys  11  
37 Glu128Cys Glu130Cys  12  
Double mutations in EF-I 
38 Asn28Cys/Glu35His Asn30Cys/Glu37His 5, 12   
39 Asn28His/Glu35Cys Asn30His/Glu37Cys 5, 12   
40 Asn28Cys/Ser32His Asn30Cys/Ser34His 5, 9   
Double mutations in EF-I and EF-III 
41 Asn28Cys/Asp119His Asn30Cys/Asp121His 5 3  
47 Asn28Cys/Asp121His Asn30Cys/Asp121His 5 5  
42 Asn28Cys/Ser125His Asn30Cys/Ser127His 5 9  
43 Asn28Cys/Asp127His Asn30Cys/Asp129His 5 11  
44 Asn28Cys/Asp119Cys Asn30Cys/Asp121Cys 5 3  
45 Asn28Cys/Asp121Cys Asn30Cys/Asp123Cys 5 5  
46 Asn28Cys/Asp127Cys Asn30Cys/Asp129Cys 5 11  
48 Asn28Cys/Ser125Cys Asn30Cys/Ser127Cys 5 9  
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6 Library screening and mutant selection 
This chapter describes the creation of the mutant DNA library brought forward 
from Chapter 5 (see Table 5–4 and 5–5) using PCR mutagenesis methods, followed by 
high-throughput screening of the library against seven potential activator ions:  Co2+, 
Cu2+, Zn2+, Cd2+, Ca2+, La3+ and Pb2+ using the methods developed in Chapter 4.  The 
mutants will be assessed in terms of retained activity and relative selectivity compared 
to wild-type aequorin and a select number of mutants will be proposed as potential 
candidates for further study.  One mutant plus wild-type aequorin will be carried 
forward for purification (Chapter 7) and study of their response towards the same set of 
metal ions (Chapter 8) without background interferences present in the crude lysate used 
in this chapter.   
6.1 Introduction 
6.1.1 Creation of mutant library 
The available mutational approaches are described in Sections 1.5.1–1.5.3.  
Site-directed mutagenesis (SDM) was the sensible mutagenic method for the creation of 
the library specified in Chapter 5 (Table 5-4 and Table 5–5).  The most practical SDM 
protocol available was QuikChange® (Stratagene, 2004) (Section 1.5.1, Section 2.3.3).  
The manufacturer’s protocol for QuikChange® is supplied in general Materials and 
Methods Chapter 2, Section 2.3.3 and its implementation (including variations from the 
basic protocol) is described in Section 6.2.1.  Wild-type apoaequorin gene in plasmid 
pETAQ (Chapter 4, Table 4.2) was used as template for mutagenesis and E. coli TOP10 
cells were used for DNA preparations. 
6.1.2 Previous work in methods of aequorin mutagenesis 
Due to its advantages, QuikChange® has been employed in the most recent work 
involving rational mutagenesis;  Row and co-workers (2008b) and Dikici and co-
- 181 - 
workers (2009) used it to target aequorin residues involved in the stabilisation of 
hydroperoxy-coelenterazine.   
Before this method was available, Tsuji and co-workers (1986) employed site-
specific mutagenesis in order to introduce single mutations in aequorin (Section 5.2.2) 
based on a method by Morinaga and co-workers (1984);  the desired mutations were 
incorporated in a synthesised oligonucleotide strand (mutagen).  The apoaequorin gene 
was encoded in a plasmid vector also encoding for β-lactamase (allowing ampicillin 
resistance).  One sample of this plasmid was digested in order to remove a portion of the 
gene for β-lactamase and the cleaved fragment treated with the Klenow fragment of 
DNA polymerase I and dNTPs for creating blunt ends.  Another sample was digested in 
order to remove a portion of the aequorin gene to be mutagenised.  Both fragments 
(plasmid with portion of β-lactamase gene cleaved off and plasmid with portion of 
apoaequorin cleaved off) were mixed with the synthetic oligonucleotide and the mixture 
was denatured at 100 °C for 3 min, followed by gradual cooling for the complementary 
fragments to re-anneal.  The mixture of re-natured DNA was treated with the Klenow 
fragment and dNTPs (for creating blunt ends), T4 ligase for blunt ended ligation and 
transformed into E. coli and the ampicillin-resistant transformants were isolated.  This 
method yielded 13% yield for a single base substitution and was simpler than previous 
methods requiring an M13 phage vector for gene expression (Morinaga et al., 1984).   
Tsuzuki and co-workers (2005) used random mutagenesis approach in order to 
find aequorin mutants with improved thermostability and random-rational approach in 
order to further explore specific sites highlighted from the random approach (Section 
5.2.2 and 5.2.5).  In vitro evolution by DNA shuffling was the method used for random 
mutagenesis.  The cDNA sequence encoding for apoaequorin was cleaved with DNAse I 
and fragments 50-300bp isolated through extraction from a DNA electrophoresis gel.  
The isolated fragments were used in a primerless PCR for DNA shuffling to occur.  The 
product of this PCR was used as template for a second round of PCR with primers 
designed to flank the start and finish of the entire apoaequorin gene while adding 
appropriate restriction sites (Kpn I and EcoR I) at each end.  Digestion with Kpn I and 
EcoR I followed and the digested fragment was inserted into a plasmid vector under 
control of Plac promoter (for β-galactosidase production) and further transformed into 
E. coli.  The transformants were plated on agar plates containing ampicillin and their 
colonies picked into wells of 96-well microplates.  The colonies were grown into the 
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microplates and aequorin was reconstituted by addition and of coelenterazine into each 
well and screening for luminescence after injection with calcium solution.   
The forty brightest mutants were selected and grown into new cultures for the 
isolation of plasmid DNA.  These plasmids were mixed in equal proportions and co-
amplified using primers that flanked the start and finish of the entire apoaequorin gene 
(used also in the second round of PCR).  The product of this amplification was entered 
in a new round of DNA shuffling for in vitro evolution.   
The same authors (Tsuzuki et al., 2005, Tricoire et al., 2006) employed rational-
random approach by creating randomised mutants in two specific positions in the 
apoaequorin sequence (Gln168 and Leu170) appearing to be crucial in bioluminescence 
yield.   
As a first step, mutagenesis of the Gln168 and Leu170 was performed by a PCR 
step with a mutagenic sense primer containing NNS codons at the two positions of 
interest.  The same primer introduced a silent mutation one codon upstream of codon 
Gln168 encoding for a unique restriction site (Mlu I).  The antisense primer did not 
introduce any mutations but included one unique restriction site (EcoR I) which was 
part of wild-type apoaequorin sequence.   
The products of the first PCR step were used as template for a second round, in 
which the population of all mutagenised fragments was amplified using a new sense 
primer that included the unique restriction site (Mlu I) upstream of the mutated codons 
but did not include the mutated codons and the same antisense primer as the first round 
PCR.  A unique Mlu I site was also created upstream of the Gln168 codon by 
introducing silent mutations in the wild-type apoaequorin cDNA within the plasmid 
vector.  The product of the second round of PCR was digested using Mlu I and EcoR I 
as was the plasmid carrying wild type apoaequorin and the silent mutation allowing Mlu 
I digestion and the digested mutagenised fragments of aequorin were ligated into the 
vector.  The resulting population of plasmids was transformed into E. coli and protein 
expression and screening was similar as in the DNA shuffling mutants. 
6.1.3 Screening of mutant library 
This is a library of 48 mutants and wild type in a total of four 96-well 
microplates.  Each plate was injected with each of the seven test ions:  calcium, 
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cadmium, cobalt, copper, lanthanum, lead and zinc.  The screening process was 
developed in Chapter 4 (Section 4.5.1, Figure 4.17) and implemented as described in 
Section 6.2.2.  Raw data from each microwell of the library will consist of relative 
luminescence units (RLUs) versus time (milliseconds). 
Before processing the raw data arising from the high-throughput screen, it is 
important to set the metrics for meaningful comparison and clarifying the relevant 
terminology.  Selectivity is key in assessing the response of the mutants towards 
calcium and new ions.  The terms selectivity or specificity are in many cases used 
interchangeably in analytical chemistry, biochemistry and enzymology.  Selectivity 
describes “whether the analyte can be measured without interferences from other 
components in the mixture” (Persson and Vessman, 2001).  According to IUPAC 
(2001) “specificity is the ultimate of selectivity” and only a method which is perfectly 
selective for an analyte is said to be specific (den Boef and Hulanicki, 1983).  
In previous work on aequorin mutagenesis the performance of aequorin variants 
has been presented as relative to that of wild type (Tsuji et al., 1986, Tsuzuki et al., 
2005) or in terms of the half-life of the luminescence decay curves compared to that of 
wild type in the context of kinetics studies (Tricoire et al., 2006).  Relative activity of 
mutants compared to that of wild type has also been considered in this chapter but 
additional metrics stem from the expectations arising from the mutations.  Aequorin has 
three calcium binding EF-hands containing six calcium-coordinating amino acids each.  
In this work, only one or two amino acids were mutated at a time.  Realistically, single 
point or double mutations are unlikely to turn around the ion selectivity of a molecule 
that relies on up to three sites and eighteen amino acids for this function.   
Each mutant of the library will be assessed in terms of (1)  yield of mutant versus 
wild type for every metal ion tested and (2)  shift of a mutant’s response from calcium 
towards a new ion compared to the equivalent shift of wild type.  Details on the 
calculation of the metrics used are presented in Section 6.2.3.  Ranking of the mutants 
according to these metrics is aided by the use of matrix plots and bar plots (Figure 6-8 
to Figure 6-17).  Bar plots allow visual assessment of the performance of the mutants 
and identification of salient traits.  Matrix plots were constructed to visualise possible 
correlations between traits and to identify determinants of selectivity between different 
metal ions. 
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6.2 Methods 
6.2.1 Mutant library construction 
Mutagenic primers were designed to flank the residues to be replaced and as 
described in Section 2.3.5.  Due to the large number of primers created, these are 
presented in Appendix Chapter 6, Tables Table 10-6 to Table 10-11.  Their length was 
50–60 bp, which exceeds the usual requirement of 18–25 bp;  this was found to reduce 
the occurrence of by-products due to multiple insertions of primer sequence in the final 
construct.  
The QuikChange® Site-Directed Mutagenesis (Stratagene Ltd.) protocol and 
PCR reaction mix were as described in in Section 2.3.2 and Tables 2-2 to 2-4.  The was 
made up as described.  PCR cycles are presented in Table 2-4.  Any variations or 
deviations applicable to individual PCR reactions (e.g. additional Mg2+ and DMSO or 
changes in annealing temperature) are captured in Table 6-1.  The QuikChange® 
reaction was initially performed in a TechGene thermal cycler (Techne Ltd.).  Due to an 
initial low success rate and in order to speed up the process of attaining successful PCR 
reactions, multiple reactions were run per mutant, including variations in the PCR mix 
and annealing temperatures.  A temperature gradient PCR thermal cycler was used 
(Techne Ltd.) for this purpose.  
After the PCR reaction, the stages of digestion with Dpn I, transformation in 
E. coli and selection of transformants were performed as described in section 2.3.2.  
Growth of bacterial cultures and preparation of plasmid DNA was performed as 
described in Section 2.2.1 to 2.2.4 and Section 2.3.1.  Existence of the desired mutations 
was verified by sequencing (Section 2.3.4).  Where the QuikChange® reaction yielded 
more than one product (visualised through DNA gel electrophoresis) the entire miniprep 
of the transformed cells would then be run on a low-melt agarose gel and only the band 
of the desired size would be extracted and sent for sequencing.  An example of such a 
case is presented in Figure 6-4.  Sequencing results for the reactions are supplied in 
their original Bioedit file format as Supplementary Material.   
Expression of apoaequorin mutant in E. coli cultures and cold incubation with 
coelenterazine for production of aequorin variants were conducted in microplate format 
as dictated in Chapter 4, Section 4.5.1 and Figure 4-17.   
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Table 6-1  PCR conditions for creating mutants Nr 1–48.  Annealing temperatures are 
deviations from the template protocol of Table 2–4.  Concentrations of magnesium 
sulfate, DMSO and Qsolution in the final reaction mix are additional to the 
concentration shown in Table 2-3.  Numbering of mutants as in Table 5-4 and Table 
5-5.   
Nr   Ta 
(°C) 
Mg2+ 
(mM) 
DMSO 
  (v/v) 
Qsol 
(v/v) 
   Nr   Ta 
(°C) 
Mg2+ 
(mM) 
DMSO 
  (v/v) 
Qsol 
(v/v) 
1 69 0.5 2%     25 68 0.5 2%  
2 69 0.5 2%     26 68 0.5 2%  
3 69 0.5 2%     27 67.5 0.5 2%  
4 69 0.5 2%     28 68 0.5 2%  
5 69 0.5 2%     29 68 0.5 2%  
6 67.5 0.5 2%     30 68 0.5 2%  
7 67.5 0.5 2%     31 68 0.5 2%  
8 51       32 68 0.5 2%  
9 67.5 0.5 2%     33 68 0.5 2%  
10 53  0.8%     34 67.5 0.5 2%  
11 53  0.8%     35 68 0.5 2%  
12 61.5 0.5      36 68 0.5 2%  
13 62 0.5 2%     37 68 0.5 2%  
14 64  2% 10%    38 62 0.4 2.2%  
15 56.3 0.75      39 62 0.4 2.2%  
16 69 0.5 2%     40 62 0.4 2.2%  
17 63   4%    41 67 0.5 2%  
18 63       42 67 0.5 2%  
19 62 0.5 2%     43 67 0.5 2%  
20 57 0.5 2%     44 67 0.5 2%  
21 65 1 2%     45 67 0.5 2%  
22 62 0.5 2%     46 67 0.5 2%  
23 64  2%     47 67 0.5 2%  
24 68 0.5 2%     48 67 0.5 2%  
       Mutant Nr 21:  DNA polymerase KOD (Novagen) was used for a successful reaction  
       instead of PfuUltra High Fidelity polymerase.   
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6.2.2 Mutant library layout and screening 
The forty eight mutants of the library were arranged in a total of four sub-
libraries in 96-well microplate format.  A typical layout of each microplate is presented 
in Figure 6-1.  In each microplate, the wells marked with X1,X2,…,X48 were 
inoculated with a single colony of E. coli cells expressing either wild-type or a mutant 
of apoaequorin.  Each mutant and wild type was arranged in triplicates as shown in 
Figure 6-1.  In order to avoid position-related bias within the plate (e.g. effects of 
temperature and humidity gradient which can ultimately affect protein yield and 
activity), bacteria expressing wild-type apoaequorin were always grown in wells 
X4,X5,X6 (positions B4,C4,D4 in microplate coordinates) and in wells X28,X29,X30 
(positions E4,F4,G4 in microplate coordinates), while the rest were used for mutant 
variants.  The outer wells of each plate were not inoculated, as they are associated with 
high errors, as illustrated in Chapter 4.  They were however filled with the same liquid 
media as the inoculated wells at all stages of microwell aequorin production in order to 
help maintain constant temperature throughout the microplate.  Based on this layout, 
each microplate can hold a maximum of 14 triplicate sets of aequorin variants and two 
triplicate sets of the wild type.  Wild type produced in wells B4,C4,D4 was used as 
internal reference for each plate. 
Figure 6-1  Typical layout of each microplate of the mutant library.  Wells highlighted 
in blue contain wild-type protein throughout the library.  The remaining wells contain 
mutant variants of aequorin.  The black line grid between the wells marks the positions 
of triplicates.   
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Wild type produced in E4,F4,G4 of each plate was harvested and pooled.  This 
sample was used for the determination of optimal luminescence reading parameters (e.g. 
gain settings, optimal concentration of each metal ion to be injected) on the BMG 
microplate reader.  In some plates (Figure 6-2) additional wild type was produced in 
wells X22,X23,X24 (microplate coordinates B10,C10,D10) or X46,X47,X48 
(microplate coordinates E10,F10,G10) in case additional wild type would be required.  
It was important to set the luminescence screening settings based on the properties of 
aequorin produced under the same conditions as the microplate library under study.  
These wild type samples were stored at –20º C separately from the microplates so that 
optimisation experiments for screening parameters could be carried out without need to 
thaw the library.   
Figure 6-2 shows the exact position of the mutants in the each of the four plates 
of the library during the entire process form inoculation into microwells through to 
high-throughput screening against metal ions.  The numbering of the forty eight mutants 
is according to Table 5-4 and Table 5-5 and they are arranged in triplicates.  
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Figure 6-2  Layout of wild type and mutants in the four plates of the library.  
Numbering of mutants as in Table 5-4 and 5-5.  In Plate-3: In mutant denoted 6* the 
codon for arginine was CGA and in mutant 6 the codon was CGT.  Both were used for 
construction of the mutant library but only readings for mutant Nr 6 were used in data 
processing.  Mutants Nr 28 and 35 were repeated in Plate-4. 
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6.2.2.1 Metal ion concentrations for library injection 
For practical reasons only one concentration per metal ion could be used to 
screen the entire library.  It was suspected that high concentrations of certain metals 
could prove deleterious for aequorin activity but there was no published work on the 
subject.  It was also understood that the optimal concentration of each ion for each of 
the forty eight mutant variants may differ.  Determination of optimal conditions (metal 
ion concentration and photomultiplier gain) would be based on performance of wild 
type only.   
The experiments were performed using wild type in the presence of a range of 
concentrations of each metal.  The wild type was from wells E4,F4,G4 of the microplate 
library (Section 6.2.2). 
Metal ion preparations were according to Section 2.5.1.  Solutions of calcium 
chloride, zinc chloride, cadmium chloride, copper sulfate, lanthanum chloride and 
cobalt chloride were prepared at nominal concentrations of 1, 5, 10, 12.5, 20 and 
30 mM in 50 mM Tris-HCl pH 7.5.  Lead nitrate was prepared in RO water.  
Concentrations of metals were at the millimolar range as the protein suspension was in 
~10 mM EDTA (Section 4.5, Figure 4.17). 
100 µL of protein solution was injected with metal ion solution at 1:1 volume 
ratio and the light output measured in the FluoStar Platereader (Section 2.7).  At 
constant gain settings, protein solutions were injected with the range of metal salt 
concentrations in order to find the optimum.  The light readings from all the wells tested 
were plotted against the nominal concentrations of the metal ion solutions.  The 
resulting curves are provided in Supplementary Material.   
The titration curves showed that there was indeed an optimum concentration for 
each metal; low concentrations would trigger low response whereas for certain metals 
higher concentrations seemed to cause aequorin inhibition.  The optimal concentration 
of each metal was used for the screening of the mutant library and is shown in Table 
6-2.   
6.2.2.2 Gain settings 
Initial tests of Section 6.2.2.1 demonstrated that one uniform gain setting for all 
metals might result in missing low activity levels from poor performers (if the gain is 
set relatively low) or in over the linear range readings from high performers.   
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The point mutations introduced in aequorin were likely to bring about minor 
shifts to protein response towards various metals accompanied by major loss in light 
production.  The desired output of the screening process was to capture even minor 
improvements occurring at low light levels.  This required using high gain settings for 
ions that cause low level aequorin response.  Conversely, the combination of wild type 
with calcium was expected to yield high levels of activity and would need to be read at 
low gains. 
Gain settings for each ion were determined by trial and error at photomultiplier 
gains within the range of 1,650 to 2,200 in order to ensure that readings would not 
exceed the instrument’s range.  The settings chosen for the screening of the library are 
shown in Table 6-2.   
Table 6-2  Metal ion stock concentrations and platereader gain settings for library 
screening. 
Metal Ion salt Concentration for library injection (mM) Platereader Gain 
CaCl2 25 1,650 
CdCl2 20 1,900 
CoCl2   12.5 2,200 
CuSO4   12.5 2,150 
ZnCl2 25 2,000 
LaCl3   2.5 1,850 
Pb(NO3)2   12.5 2,150 
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6.2.3 Data processing of high-throughput screening 
A schematic of the concept behind data processing is shown in Figure 6-3.  
Every microplate contains an internal reference of wild-type aequorin in triplicate (wells 
B4,C4,D4).  The average mean of the luminescence peak (or in lack of a clear peak, the 
highest luminescence reading) is calculated and divided by the respective mean of the 
internal control wild type.  This ratio is called C and is a measure of the performance of 
the mutant compared to wild type, for each ion.  Using an internal control takes into 
account factors that may influence the production of aequorin variants in each 
microplate (Figure 4-17).  Hence, measure of activity C is comparable between different 
plates and across the library (Equation 2): 
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The next measure is selectivity.  The envisaged mutants would detect a new ion 
and discriminate the other ions present in the test sample.  The abolishment of calcium 
affinity would be an ideal result.  Measure of selectivity (D) was introduced to assess 
the extent to which a mutant responds favourably to a new ion versus calcium and to 
simultaneously compare this response to the extent to which wild type responds to a 
new ion versus calcium.  Measure of selectivity D is also comparable across the library 
as shown by Equation 3: 
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D=1 means no change in selectivity compared to calcium. 
D<1 means selectivity towards Ca2+ was enhanced as affinity for other ions was 
even further diminished comparatively to calcium. 
D>1 is preferential selectivity of mutant for X2+ (or La3+) versus Ca2+. 
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True selectivity is defined when the competing substances are present in the test 
sample, which is not the case in this initial screen.  Derivation of measures C and D are 
described schematically in Figure 6-3.  The calculations were carried out using Excel 
(Microsoft Ltd) and the results were arranged in Excel and Minitab (Minitab Ltd).  In 
Figure 6-2 it is shown that all mutants were arranged in triplicates.  If the % deviation 
amongst the measured triplicate values was ≥20% the raw data was examined and 
outliers amongst the triplicates were excluded.  In such a case the final values of C and 
D would represent the average C and D for a duplicate set.   
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Figure 6-3  Illustration of measures of activity (C) and selectivity (D) in data 
processing.  As an example, Plate-1 injected with calcium and Plate-1 injected with zinc 
are compared.  In blue oval shape are the triplicate sets of wild type and in red ovals are 
the triplicate sets of one mutant variant.  For each mutant, the ratio of the mean average 
peak luminescence of the mutant (red) over the wild type (blue) gives value C 
corresponding to the ion tested in each plate (symbol in red square boxes).  The ratio of 
the C value for any given ion over C value for calcium is value D corresponding to that 
particular ion (symbol in square green box).  Metrics C and D can be used for 
comparisons across the entire library due to the internal references in each plate.  
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6.3 Results 
6.3.1 Library creation results 
The size of the plasmids carrying mutated apoaequorin sequence was verified by 
agarose DNA gel electrophoresis and successful mutations were verified with 
sequencing.  Figure 6-4 and Figure 6-5 present a typical set of DNA gel visualisations 
of mutants Asn28Cys and Asn28Cys/Ser32His respectively.   
 
 
Figure 6-4  DNA agarose gel electrophoresis of mutant Asn28Cys.  0.8% agarose gel.  
Lanes 1, 3, 5 and 7: 0.5–12 Kb DNA marker;  Lane 2:  primerless PCR (control) 
containing  template pETAQ (wild type) in very faint band;  Lane 4:  product of PCR 
with primers “Asn28Cys for” and “Asn28Cys rev” (primer sequences in Appendix 
Chapter 6, Table 10-7 and Table 10-11).  The product of QuikChange® amplification is 
an open circular plasmid, hence the dominant band of ~6 Kb;  Lane 6:  5 µL of plasmid 
miniprep of transformed E. coli with PCR product of Lane 4.  Remaining amount of 
plasmid was run on low-melt agarose gel and the lowest band (supercoiled form) 
extracted using QIAquick® gel extraction kit.  Lane 8:  product of gel extraction low-
melt agarose gel.  This sample was sequenced and upon verification of desired results 
stored as part of the mutant DNA library.  
- 195 - 
 
 
Figure 6-5  DNA agarose gel electrophoresis of mutant Asn28Cys/Ser32His.  0.8% 
agarose gel.  Lanes 2 and 3: 0.5–12 Kb DNA ladder;  Lane 1:  product of PCR with 
template plasmid containing mutation Asn28Cys and primers “Ser32His for” and 
“Ser32His rev” (primer sequences in Appendix Chapter 6, Table 10-8 and 10-11).  The 
product of the QuikChange® PCR amplification is an open circular plasmid, hence the 
dominant band of ~6 Kb;  Lane 4:  plasmid miniprep from E. coli cells transformed with 
material of Lane 1.   
 
Figure 10-1 (Appendix Chapter 6) shows a typical set of sequencing results for 
Asn28Cys mutant aligned with the sequence of wild-type apoaequorin.  The sequencing 
results for the library of mutants are presented in Supplementary Material in Bioedit file 
format.   
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6.3.2 Library screening results 
The schematic output of screening results (four plates, seven ions per plate) as 
displayed by the platereader software after the completion of each test run is shown in 
Figure 6-6 and Figure 6-7.  In this style of representation each well contains the trace of 
luminescence counts versus time.  The raw screening data is presented in 
Supplementary Material.   
Processing of the raw data show metrics of activity C and selectivity D 
(definitions in Section 6.2.3) for all mutants and the results are shown in Figure 6–8 to 
Figure 6–10, which will be discussed in Section 6.4.  Figure 6–8 shows the activity of 
the mutants compared to that of wild type for each of the seven ions tested.  The 
mutants are grouped according to type of mutation and location in the molecule (also 
refer to Table 5-4 and Table 5-5):  cysteine and histidine mutants in EF-I or EF-III;  
single and double Gly→Arg mutants;  alanine replacements in EF-I;  double mutations 
in EF-I and double mutations in EF-I and EF-III combined.  Their position in the 
molecule and substitution type is shown on the x-axis.   
Figure 6-9 plots D in the y-axis.  D takes into account not only the activity of 
mutants in response to each new ion, but also their response towards calcium, in that 
way serving as a measure of selectivity.  As high D values do not necessarily guarantee 
high protein activity, the x-axis is also highlighted to mark mutants with C values >10% 
and >50% so it would be possible to select mutants with high D and reasonable C.  
Figure 6-10 is an alternative presentation of D for each mutant.  Logarithmic scale is 
used for values of D in order to visually aid assessment of the entire library:  D=1 
corresponds to wild type and the higher the D value the greater the shift of selectivity 
towards new ions and further away from calcium.   
Figure 6-11 and Figure 6-12 are alternative representations of values C and D 
respectively.  The same data as in Figure 6-9 and Figure 6-10 is presented in individual 
value plots and arranged according to the EF-hand targeted (EF-I or EF-III), the final 
substitution (His or Cys) and the exact position in the EF-hand loop targeted (positions 
1, 2, 3, 5, 7, 9, 11, 12).  This type of representation can reveal potential trends 
associated with these groupings.  Central Gly→Arg mutants were excluded from these 
graphs.  
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Figure 6-13 to Figure 6-15 are matrix plots of the metric of selectivity D for all 
the metal ions tested.  In each of the three graphs the data points are coloured according 
to EF-hand mutated (Figure 6-13), position in the EF-hand loop (Figure 6-14) and type 
of mutation (Figure 6-15).  Matrix plots can help identify pairwise associations between 
parameters, clustering of groups or presence of outliers. 
Figure 6-16 plots the metrics of selectivity D against retained activity C for the 
entire library and against all of the metals tested.  An ideal outcome would be a mutant 
that rates highly in both metrics.  
Figure 6-17 plots the retained activity for the single and double Gly→Arg 
mutants in order to assess the importance of each of the EF-hands I, III and IV in the 
activity of aequorin with each of the seven metal ions tested. 
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            plate-1                                                     plate-2 
Figure 6-6  Visualisation of raw screening data, plates 1 and 2 of aequorin library.  Each 
well represents a luminescence versus time curve.  The wells of plates 1 to 4 contain 
protein injected with each of the seven metal ion solutions as candidates for triggering 
luminescence.  The experimental design is described in Section 6.2.2 and discussed in 
6.3.2.  The position of wild type and mutants in each plate was according to the layout 
in Figure 6-1 and 6-2.  Gain settings for luminescence measurements and concentrations 
for each metal ion injected are presented in Table 6-2.  Data analysis was according to 
Figure 6-3.  
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             plate-3                                                    plate-4 
Figure 6-7  Visualisation of raw screening data, plates 3 and 4 of aequorin library.  
Continued from Figure 6-6. 
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Figure 6-8  % Activity (C) compared to wild type against all ions tested, for the entire library.   
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Figure 6-9  D as metric for ion selectivity shift of mutants.  Highlighted labels:  light blue for mutants exhibiting C≥50% and yellow for 
10%≤C≤50%.   
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Figure 6-10  D on logarithmic scale.  An alternative representation of Figure 6-9, clearly sets apart the cases where D>1.  D for wild type=1.  
D>1 indicates a stronger preference than wild type toward ions other than calcium. light blue for mutants exhibiting C≥50% and yellow for 
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Figure 6-11  C (activity compared to wt) of single mutations.  Arranged by site (EF-hand and position in the loop) and type (Ala, Cys, His) of 
mutation.   
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Figure 6-12  Selectivity (D) of single mutations.  Arranged by site of mutation (EF-hand and position in the loop) and type. 
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Figure 6-13  Matrix plot of D, arranged by number of EF-hand mutated.  Metric D is a dimentionless number. 
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Figure 6-14  Matrix plot of D, arranged by position mutated in the EF-hand loop. 
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Figure 6-15  Matrix plot of D, arranged by type of substitution in the EF-hand loop. 
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Figure 6-16  D versus C for all the mutants.  Any shift of ion selectivity is associated 
with loss of activity for the entire mutant library. 
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Figure 6-17  Activity of central Gly mutants (impaired EF-hands).  Top:  All ions.  
Bottom:  Calcium only.  Figure 6-17 zooms into the central Gly→Arg set of mutants 
from Figure 6-8 in order to aid visualisation. 
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6.4 Discussion 
In Chapters 1 and 5 aequorin was shown to be a complicated allosteric and 
cooperative system.  Calcium ions bind in the solvent-exposed EF-hands and the effect 
of this binding is transduced to the hydrophobic core of the protein where organic 
compound coelenterazine is bound as an oxidation intermediate.  Destabilisation of the 
oxidation intermediate leads to its decarboxylation and emission of blue light.  Upon ion 
binding the EF-hands undergo only a slight conformational change but an intricate 
network of hydrogen bonds connects the sites of ion binding with the sites of 
coelenterazine binding.   
The effect of mutations placed in the EF-hand loops will be discussed in terms of 
aequorin’s response to its natural activator (calcium and substitute lanthanum) and 
candidate activators (zinc, copper, cadmium, cobalt and lead). 
The discussion of the library screening results will focus on salient points 
followed by some more detailed observations on the effect of position and type of 
mutation on the metrics of protein’s yield (C) and ion selectivity (D). 
6.4.1 Overall effect on yield 
The first striking observation is that the vast majority of mutations lead to 
significant loss of yield compared to wild type.  This applies to all ions tested.  The only 
exception includes one mutant’s response to lanthanum and will be discussed.  Loss of 
protein function is not surprising for two reasons:  (1)  canonical EF-hands are finely-
tuned to be highly selective for calcium and (2)  the mutants of this library contain only 
single or double mutations out of a total of eighteen ion coordinating positions in the 
entire protein.  These mutations are not expected to completely transform the ion 
binding sites in favour of new ions whilst fully retaining the intricate network of 
allosteric activation of aequorin. 
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6.4.2 Selectivity (D) versus retained activity (C) 
The second major observation is that there is trade off between yield (C) and 
shift of selectivity (D).  This effect is best illustrated in Figure 6-17.  Increase of D 
comes at the cost of C and vice versa, highly retained activity C is associated with low 
or no change in selectivity.  This again is not a surprising outcome in protein 
engineering, especially as a result of an initial round of mutation. 
6.4.3 EF-I versus EF-III 
Retained activity 
At first glance of Figures 6-8 and 6-11 it would appear that EF-III is overall 
more tolerant to mutations than EF-I.  Upon careful examination it can be seen that 
substitutions at all coordinating positions lead to 50–100% loss of luminescence in both 
EF-I and EF-III, for all ions tested.  Mutants in EF-III exhibiting higher yields carry 
substitutions at positions not mutated in EF-I:  position 7 (coordinating through 
backbone oxygen and non-conserved) and position 11 (non-coordinating and non-
conserved).  
Selectivity 
Shift of selectivity (D) is markedly different in the two studied EF-hands (Figure 
6-9, 6-10 and 6-12), in contrast to the comparable loss of retained activity (C) which is 
more uniform across the library.  Some mutants in EF-I exhibited significant increase of 
D, whilst D remained very low in all EF-III mutants.  This leads to the conclusion that 
EF-I is responsible for the selectivity of aequorin against various metal ions, whereas 
EF-III does not appear to be as suitable for modulating ion selectivity.   
The contribution of EF-I and EF-IV is discussed in Section 5.1.3:  the exiting 
helix of EF-I contains residues that directly hydrogen-bond to coelenterazine or are 
within close proximity (Figures 5-1 to 5-6).  Aequorin’s C-terminal tail is flanked by the 
entering helices of both EF-I and EF-IV.  Movement of EF-I or EF-IV helices can 
disrupt the hydrogen bond network around the C-terminal tail which would cause 
relocation of Tyr184 side chain and disrupt hydrogen bonds to His169 and the peroxide.  
A possible sequence of events following binding of calcium was proposed by Head and 
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co-workers (2000), Deng and co-workers (2004) and Vysotski and Lee (2004) and 
summarised in Section 5.1.3. 
6.4.4 Ala-scan mutants and importance of side chains 
The alanine mutants (designed in Section 5.6.3) illustrate the effect of removal of 
the side-chain oxygens from the calcium-coordinating positions 1, 3, 5, 9 and 12 of EF-
I.  These results serve as references for the effect of the side-chain substitutions of 
histidine and cysteine at the respective positions of EF-I.  Whereas the alanine 
substitutions completely remove the ability to coordinate ions through a side chain 
oxygen, the histidine and cysteine substitutions introduce the possibility to coordinate 
ions using an imidazole nitrogen or a sulfur of a sulfhydryl group, respectively.   
Salient observations 
All alanine mutants result in sharp loss of activity (C) compared to wild type 
(Figure 6.9) and increase of the selectivity measure D.  Every single one of the 
conserved coordinating amino acids is very important to activity.  Increase of D can 
occur from either reduction of affinity for calcium or increase of affinity for other ions, 
or both.  As activity triggered by calcium is reflected in the denominator of the fraction 
defining D (Equation 6.2), a reduced response to calcium is sufficient to increase the 
value of D.  
Increase of D occurs in positions 5 and 12 of the EF-I loop.  Values of D among 
alanine, histidine and cysteine substitutions of EF-I are comparable, which suggests that 
the elimination of the coordinating side chains of aspartate, asparagine or glutamate is in 
fact the highest contributor to the shift of selectivity away from calcium.  However, 
there is some differentiation in D values for different ions depending on the type of 
substitution, suggesting that histidine and cysteine do indeed fulfil some requirement for 
triggering luminescence.  These subtle differences will be presented in Section 6.4.6. 
6.4.5 Importance of loop positions 
Out of the coordinating positions, the entry (position 1) and exit (position 12) of 
the loops are least tolerant to mutations in both EF-hands.  The other coordinating 
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positions of the loop exhibit different levels of tolerance to mutation depending on the 
EF-hand they belong to.  For example, position 5 in EF-I does not tolerate mutations 
whereas in EF-III it appears to be more tolerant.  Position 3 is more tolerant to 
mutations in EF-I whereas position 9 is more tolerant in EF-III.  All mutants that stand 
out in terms of selectivity contain substitutions at positions 5 and 12.  As a conclusion, 
positions 1 and 12 must be essential for activity, followed by positions 3, 5 and 9 which 
may also be endowed with modulator roles in ion binding.   
6.4.6 Type of substitution 
The type of substitution (histidine or cysteine) contributes to the selectivity 
towards various ions.  Whereas the alanine mutants served as reference in the 
coordinating positions of EF-I, the matrix plot of Figure 6-15 presents a general 
overview of the selectivity of mutants according to the type of substitution for all of the 
ions and positions tested.  Some preferences can be extracted.  For example, copper 
prefers histidine over cysteine while zinc prefers cysteine as well as histidine ligands.  
There is a preference between lead and alanine and between lanthanum and cysteine.  
However any interpretations of preference must take into account the context of the 
protein environment.  Figures 6-12 to 6-14 capture the positioning and type of mutation 
but not the effect of steric, electrostatic effects, van der Waals and hydrogen bonds in 
the extended environment.   
Mutants’ increase of D for lead can partly be explained with the help of 
Figure  5-13: lead may require only four (IV coordinate binding) or six (VI coordinate 
binding) out of the eight oxygens that coordinate calcium in the native EF-hand of 
aequorin, whereas the loss of one coordinating oxygen is detrimental to correct calcium 
coordination.   
Substitution of glutamate at position 12 removes two Ca2+-coordinating oxygens 
and introduces nitrogen or sulfur instead.  Substitution of asparagine at position 5 
removes one side chain oxygen.  Asn→His at position 5 of EF-I loop favours zinc and 
lead, Asn→Ala favours copper and lead and Asn→Cys exhibits the least discrimination 
among metals.  At position 12 of EF-I Glu→His favours zinc, copper and lead while 
Glu→Cys favours zinc and lanthanum and Glu→Ala favours copper and lead. At 
position 9 Ser→His favours zinc, which does not occur for Ser→Cys or Ser→Ala.   
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The matrix plots of Figures 6-13 to 6-15 can aid in identifying correlations in the 
shift of selectivity for groups of ions.  Ideally the envisaged mutant would exhibit high 
D values for one ion and very low values for all the remaining ions.  Clusters of points 
or points falling onto a y=x line would suggest that increase in selectivity is not 
evolving separately for different ions.  For example, preference for zinc and copper is 
linked which suggests certain mutants would not make good biosensors for one in the 
presence of the other.  However this study cannot determine dissociation constants 
which would be the required indicator as to whether one ion would be selected from a 
background of potential competitors.  In conclusion, it can be seen that selectivity can 
potentially be tweaked through combined mutations in the metal binding loop of EF-I. 
The exception: one high performer towards lanthanum 
The mutation of position 7 of EF-III from alanine to cysteine (Ala123Cys) 
resulted in the only aequorin variant that responds to another ion (lanthanum) more 
efficiently than it does to calcium (Figure 6–9).  The nucleophilic sulfur of cysteine 
attracts the increased (trivalent) positive charge of lanthanum and its small size 
increases the cavity size of the EF-hand loop to accommodate the slightly larger 
lanthanum ion.  Cysteine is not a ligand normally found in calcium-binding sites and its 
shorter side chain could make it more difficult to coordinate to calcium ion, although 
calcium is coordinated to the backbone oxygen of position 7. 
Lanthanum is large enough to reach the cysteine and can still use the remaining 
intact coordinating amino acids for successful coordination.  The high tolerance of 
mutations in this position, as well as in position 11, suggests that these could be used as 
a means to alter the ion binding properties of the EF-hand without destroying the 
mechanism of allosteric activation. 
The principle of ion discrimination through modulation of cavity size was shown 
in Section 5.3.1.  In particular, Le Clainche and co-workers (2003) abolished calcium 
affinity and enhanced terbium affinity by replacing Glu with Asp in position 12 of EF-
hand-like peptides.   
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6.4.7 Impairment of EF-hands:  central Gly mutants 
The central Gly mutants (Gly→Arg at position 6 of each loop) were created in 
order to compare the significance of the three EF-hands in the bioluminescent reaction.  
Two previously published strategies towards impairment of the EF-hands are discussed 
in Section 5.2.2.  The mutational strategy by Tsuji and co-workers (1986) (Gly→Arg 
substitution of the highly conserved central glycine of each loop) was chosen to 
“disable” each of the EF-hands of aequorin (Section 5.2.2).  Arginine is meant to 
introduce rigidity in the ion binding loop and prevent the mutated EF-hand from 
assuming the required conformation upon ion binding (section 5.2.2).  It is possible 
however that an EF-hand may already be in the right order before being populated by 
the ion, requiring minimal adjustment upon ion binding (Section 5.2.2). 
An alternative strategy for impairing EF-hands by Tricoire and co-workers 
(2006) consisted of replacing the position 12 glutamate with glycine, thus removing one 
essential amino acid that carries two coordinating side chain oxygens.  These mutants 
were still able to carry out cooperative ion binding, as indicated by the sigmoidal shape 
of activity versus Ca2+ concentration curves (Tricoire et al, 2006).  Although the 
strategy by Tricoire and co-workers was not applied for EF-hand impairment, positions 
1 and 12 of the loop were targeted with His, Cys and Ala substitutions.  Tricoire and co-
workers (2006) showed that impairment of EF-I resulted in higher calcium sensitivity 
whereas impairment of EF-III or EF-IV resulted to lower calcium sensitivity.  As a 
result, low calcium affinity was assigned to EF-I and high affinity to the C-terminal EF-
hand pair, EF-III and EF-IV. 
The results obtained in this work show that the substitution central Gly→Arg is 
less damaging than removal of a single coordinating side chain, as shown by the 
groupings of mutants in Figure 6-8.  Amongst the single central Gly mutations (Figure 
6-17A,B), impairement of EF-I results in greater loss of activity towards calcium, 
followed by impairment of EF-IV and EF-III.  Amongst the double central Gly mutants, 
the one with only EF-I intact exhibits the highest activity, followed by the mutant with 
intact EF-IV.  Both these findings suggest that EF-I is more important to activity than 
EF-III and EF-IV and hence more likely to dictate selectivity.   
The results agree qualitatively with the findings by Tsuji and co-workers (1986) 
in terms of the importance of EF-I, but not regarding EF-III and EF-IV.  In their work, 
Gly→Arg in EF-I resulted in the loss of almost 100% activity, in EF-III ~50% loss and 
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in EF-IV almost no loss of activity.  Based on this results, the authors suggested that 
EF-IV is not necessary for activation of aequorin by calcium.  The differences may be 
attributed to using a different experimental system (conditions and aequorin wild type). 
EF-III is more tolerant to central Gly→Arg substitution than EF-I and EF-IV, 
probably due to being already preformed for the binding of calcium (Sections 5.5.2 and 
5.6.1) and flexibility is not critical.  Population of calcium in the loop may already have 
been in the right order, despite the particular mutation.   
Interestingly, impairing EF-IV reduces C and D for zinc, more so than it does for 
the other ions, an observation made on both single and double central Gly mutants 
(Figure 6-17A).  This suggests that EF-IV is more actively implicated in the response to 
zinc than the other EF-hands and that the flexibility offered by the central glycine in the 
loop is comparatively more important for zinc binding.  Considering the low ionic 
radius of zinc in its preferred geometries (refer to Section 1.4 and Table 9-4 to Table 9-
6), the dependency on loop flexibility is also consistent with the fact that ligands of the 
EF-hand would have to reach further towards the metal in order to coordinate it. 
Mutants with impaired EF-I exhibit the lowest activity.  Impairment of EF-III 
results in the least loss of activity amongst the single central Gly mutants.  Out of the 
single intact EF-hands (double central Gly mutants) the variant carrying only EF-III 
intact exhibits the maximum loss of activity.  EF-I is more susceptible to change of 
selectivity towards most of the metal ions tested (Figure 6-9), which agrees with the 
proposition in published work that EF-I is endowed with lower affinity towards calcium 
compared to the other EF-hands (Tricoire et al., 2006). 
Positions 1 and 12 of the loop are important in its rearrangement and position 12 
is believed to be important for cooperativity (Gifford et al., 2007).  In wild-type 
aequorin an ion as small as zinc or copper cannot be coordinated by both residues as it 
is not possible to be within required distance from both.   
The EF-I calcium-binding loop’s preference for ions other than calcium can be 
further manipulated.  In order for a smaller ion – e.g. zinc – to be tightly bound in the 
EF-hand and exert the required transduction of the binding effect to the protein core, the 
metal will have to be within a range of distances from the coordinating atoms, as 
observed in existing protein metal binding sites (Section 1.4, Table 1-8). 
- 217 - 
6.4.8 Double mutations 
Mutations in this group were directed at a limited set of positions of loop EF-I 
and EF-III: position 5, 9 and 12.  In the variants featuring double mutations, new ion 
selectivity is much higher when both mutations are in EF-I than when one mutation is in 
EF-I and one in EF-III.  All of the double mutants tested exhibit increase of D with lead.  
Asn28Cys/Glu35His favours copper while Asn28Cys/Ser32His favours zinc. 
6.4.9 Software for prediction of mutation effects 
The substitutions will have steric and electrostatic effects, influence the 
hydrogen bond network, the hydrophobic and van den Waals interactions in the local 
environment and where applicable, formation of disulfide bridges.  One possible means 
to predict the effects of mutations would be to use molecular modelling software such 
as ModLoop (Fiser and Sali, 2003).  ModLoop predicts conformation of loops in protein 
structures by satisfaction of spatial restraints.  However, a control simulation of the loop 
of native Ca2+-bound apoaequorin (PDB ID: 1SL8) resulted in an arrangement of the 
loop resembling that of calcium-free aequorin, PDB ID: 1EJ3.  This was an expected 
outcome as the software cannot take into account the presence of bound metals.  The 
coordination of calcium overcomes considerable steric clashes which would not be 
allowed in a local energy minimisation calculation but which are overcome by the 
electrostatic attraction between the oxygen ligands and calcium.  Due to lack of 
predictive power in this case, molecular modelling software were not used to simulate 
mutated, ion bound loops.  The effects of mutations were discussed based on properties 
of the respective amino acids, their position in the protein and previous structural 
knowledge of aequorin and other EF-hand like structures.  
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6.5 Conclusions 
This chapter was divided in two parts:  
(1)  A library of forty-eight mutant variants of the apoaequorin gene was 
successfully created using QuikChange® Site-directed mutagenesis.  Expression of the 
apoaequorin variants and reconstitution of aequorin mutants was carried out in 
microplates.  The choice of mutations is explained in Chapter 5, Section 5.6.3.   
(2)  High-throughput screening of the aequorin mutant library was carried out 
against seven different metal ions (calcium, lanthanum, cadmium, zinc, copper, cobalt, 
lead).  The results were discussed in terms of two assigned metrics: one for yield (C) 
and one for ion selectivity (D).  The main conclusions from the library screening follow.   
In aequorin, EF-I is the gatekeeper for ion selectivity (Section 6.2.3 for definition 
of metrics for retained activity C and ion selectivity D).  EF-IV has significant potential 
as determinant of ion selectivity but was not investigated to the same extent as were EF-
I and EF-III.  It is potentially more important to the binding of zinc, a finding which 
arose from impaired EF-hand mutants (central Gly→Arg).  In Chapter 5, analysis of the 
crystallographic structure of the EF-hands with and without calcium bound revealed that 
among the three calcium-binding EF-hands, EF-IV undergoes the most extensive spatial 
rearrangement in order to bind calcium in the optimal conformation (Section 5.5.2).  
The helices flanking the loops of EF-I and EF-IV contain amino acids that directly and 
indirectly stabilise the hydroperoxy-coelenterazine (Section 5.1.3).  Conformational 
shifts in the loops of EF-I and EF-IV can move their respective helices and destabilise 
the peroxide.  Future work on shifting ion selectivity of aequorin should include 
mutations in EF-IV.   
EF-III does not seem to be endowed with ion selectivity properties in aequorin.  
Every mutant in EF-III exhibited very low values for the metric of selectivity D.  
Results from impaired EF-hand mutants (central Gly→Arg) suggest that flexibility is 
least required in EF-III, which agrees with the structural observation that the loop of 
EF-III is preformed to bind calcium (Section 5.1.3 and 6.4.3).   
Selectivity towards new ions increases (and shifts away from calcium) at the cost 
of activity.  All conserved coordinating positions are very important to calcium binding 
and loss of a single coordinating side chain oxygen resulted in dramatic loss of activity 
in both EF-I and EF-III.   
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As expected, the coordinating and conserved positions 1 and 12 (entry and exit) 
of EF-hand loops are the least tolerant to mutations.  They are also 100% conserved 
amongst the entire EF-hand superfamily, as shown in Table 1–4, Section 1.3.4.  Non-
coordinating (position 11) or coordinating but not conserved (position 7) residues are 
generally more tolerant to mutations and may be used to fine tune ion selectivity.  
Within EF-I, positions 5 and 12 are most important for shifts of ion selectivity.  
Positions 3 and 9 are not prominent in shifting of selectivity (Section 6.4.5) but could be 
important in modulating activity.  The importance of positions 3 and 5 is consistent with 
the extensive structural rearrangement of the N-terminus (positions 1–5) of the EF-hand 
loops upon calcium binding, as seen in the comparison between aequorin structures with 
(1SL8) and without calcium (1EJ3) (Section 5.5.2).  The ion selectivity of the loops and 
the transduction of the signal to the protein core could potentially be modulated through 
a combination of mutations involving coordinating and non-coordinating residues.  This 
agrees with the conclusions by Le Clainche and co-workers (2003 and 2006).  
The effect of mutations is environment-dependent:  location in the protein (e.g. 
EF-hand), position in the binding loop, type of substitution and type of metal tested all 
play a role in the effect of the mutation on selectivity and activity.  Effects of the same 
substitutions are not necessarily the same across different EF-hands of aequorin 
(Section 6.4.5).  Mutation Asp→Asn causes complete loss of calcium affinity in short 
EF-hand like peptides (Le Clainche et al, 2003 and Le Clainche et al, 2006) but in 
aequorin position 3 is conserved Asn.  Oishi and co-workers (1992) working on the 
loops of EF-I, EF-III and EF-IV of aequorin as 22 amino acid fragments found different 
order of calcium binding affinity (EF-III>EF-I>EF-IV) than Tricoire and co-workers 
(2006) in aequorin (EF-III and EF-IV>EF-I), while and Liu and co-workers (2003) 
showed that in crystals of obelin (photoprotein homologous to aequorin) EF-I loop was 
the first to be populated by a calcium ion. 
In this mutant library, selectivity is not shifted toward one new ion independently 
from the rest (Section 6.4.6).  Additional studies would be required in order to achieve 
high affinity for one ion against a background of other metals in a mixture. 
This experimental setup measures activity (light output) only; it does not capture 
structural changes upon ion binding nor does it measure free concentration of metal 
ions, which would then allow direct estimation of binding affinity.  Selectivity (D) is 
inferred by comparing activity for new ions to activity for calcium. 
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6.5.1 Choice of mutant for further study 
A number of mutants stood out as potential candidates for further 
characterisation, based on increased selectivity for new ions over calcium, compared to 
the wild type.  All the mutants carried substitutions in EF-I only.  Amongst the single 
mutants the ones that stood out were Asn28His, Asn28Cys, (at position 5 of the loop), 
Glu35His and Glu35Cys (at position 12 of the loop).  Amongst the double mutants the 
ones that stood out were Asn28His/Glu35Cys, Asn28Cys/Ser32His and 
Asn28Cys/Glu35His.  Asn28Cys/Ser32His exhibited higher selectivity for zinc and 
lead, but not copper;  Asn28His/Glu35Cys exhibited higher selectivity for lead;  
Asn28Cys/Glu35His exhibited higher selectivity for copper and lead.   
A variant with improved lanthanum activity, Ala123Cys was not deemed as a 
priority for further testing.  An aequorin mutant with improved lanthanum activity had 
already been reported by Le Clainche and co-workers (2003), hence focus was drawn to 
mutants that had the potential for improved response to other metals.   
Due to time constraints, only one mutant could be purified and further 
characterised (Chapters 7 and 8).  Asn28Cys/Ser32His was chosen for its high 
selectivity metric D towards zinc, for the fact that two essential side chain oxygens were 
replaced and finally due to high cell growth in 500-mL cultures after transformation into 
high expression E. coli (Lucigen) cells. 
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7 Protein purification 
This chapter describes the production and purification of wild-type aequorin and 
mutant Asn28Cys/Ser32His so that their activity may be further assessed (in Chapter 8).  
Mutant Asn28Cys/Ser32His emerged as an interesting candidate for further study 
amongst other aequorin variants, as explained in Chapter 6.  The size and purity of 
recombinant aequorin obtained was verified by combination of luminescence activity 
measurements, SDS-PAGE protein electrophoresis, spectrometry, Bradford protein 
assay and Mass Spectrometry.  The steps involved in this chapter are summarised in 
Figure 7-15 and further described in the respective subsections.  Commercially available 
pure recombinant aequorin was also purified under the same conditions as wild-type 
and mutant Asn28Cys/Ser32His in order to subject it to the same conditions – exposure 
to the same chemicals, light and duration of process. 
7.1 Introduction  
A range of methods for the purification of apoaequorin and reconstitution of 
fully charged aequorin have been described in literature.  Shimomura and Inouye (1999) 
described a method for preparing 40–60 µg/mL purified recombinant aequorin from 
E. coli cultures.  Apoaequorin was expressed in the periplasmic space of E. coli, 
extracted from the cells and regenerated into aequorin in one step, by incubation with a 
buffer solution containing coelenterazine.  A signal peptide sequence from the 
Escherichia coli outer membrane protein A (ompA) was used to express and translocate 
apoaequorin into the periplasmic space of E. coli cells.  The signal peptide sequence is 
cleaved by proteases as it enters the periplasm.  Apoaequorin is expected to leak from 
the periplasm, driven by a concentration gradient and bind coelenterazine in the 
medium.  Some of the apoaequorin chain may bind to coelenterazine to form a 
holoprotein while still in the periplasm, as coelenterazine readily permeates cell 
membranes from the media.  Shimomura and Shimomura (1981) had previously 
proposed that conversion of apoaequorin into aequorin increases protein stability and 
resistance to proteases and presumed that aequorin’s more rigid conformation facilitates 
its extraction from the periplasm into the medium (Shimomura and Inouye, 1999).  Due 
to the mild in situ extraction conditions, impurities in the extract were minimal.  After 
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obtaining the supernatant, purification was carried out in two chromatographic steps:  
anion exchange (AEX) and hydrophobic interaction chromatography (HIC).   
A fusion of apoaequorin cDNA to ompA peptide sequence was previously used 
by Inouye and co-workers (1989).  When the apoaequorin cDNA was expressed in 
E. coli, a large excess of the recombinant protein was produced and released into the 
culture medium.  Purification of the protein was accomplished by acid precipitation and 
anion exchange (DEAE-cellulose) chromatography to 95% purity (Inouye et al., 1989).  
An alternative method made use of the 6×His-tag sequence fused at the C-
terminus of apoaequorin (Chapter 3).  Glynou and co-workers (2003) reported a one-
step purification and refolding of recombinant photoprotein aequorin by immobilized 
metal-ion affinity chromatography, utilising a hexahistidine tag fused to the N-terminus 
of apoaequorin (Glynou et al., 2003).  The yield of this method was   14–20 µg/mL of 
purified aequorin from an E. coli culture (Glynou et al., 2003).  
In this Chapter, purification of aequorin made use of the periplasmic 
translocation of apoaequorin and one-step extraction and reconstitution with 
coelenterazine into the medium according to Shimomura and Inouye (1999).  Size 
exclusion chromatography was employed post aequorin reconstitution (instead of AEX 
and HIC) in the interest of minimising purification development time. 
7.2 Materials 
Commercial recombinant aequorin (AquaLite®) was purchased from Molecular 
Probes in units of 25 µg as lyophilized powder of a 1 mg/mL solution in 5 mM HEPES, 
0.1 M KCl, 30 mM glucose and 5 µM EDTA, pH 7.1.  Coelenterazine was purchased as 
1 mg powder from Sigma-Aldrich.  It was resuspended in 1 mL of ice cold ethanol to a 
1 mg/mL solution immediately before use. 
All other chemicals were of the highest grade (Sigma Aldrich Ltd.) and the 
theoretical maximum calcium contamination of stock solutions was calculated to be less 
than 2 µM (Section 2.5).  Low retention plastics, RNAse and DNAse-free tips and 
eppendorfs were from Simport and Molecular BioProducts Inc. 
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7.3 Methods 
7.3.1 Culture 
7.3.1.1 Host strain and plasmid 
E. coli host strain E. cloni® BL21(DE3) (Lucigen Corp.) was transformed with 
the expression plasmid pETAQ.  Plasmid pETAQ is a derivative of pET26b plasmid 
(Novagen) containing the apoaequorin cDNA and flanking DNA sequences that fuse a 
pelB signal peptide sequence at the N-terminus and a 6×His-tag at the C-terminus of the 
expressed apoaequorin (Section 3.3.2).  This system is inducible by isopropyl-β-D-
thiogalactopyranoside (IPTG) (Novagen, 2003).  
7.3.1.2 Cell growth 
A single colony was grown overnight in 7 mL of Luria-Bertani (LB) medium 
containing 50 µg/mL kanamycin at 37 °C (seed culture), as described in Sections 
2.2.2−2.2.3.  Two consecutive 5% inoculations were performed into fresh medium in a 
500-mL flask (100 mL culture) and in a 2-L flask (500 mL culture) at 37 °C for 8 hours 
at 200 rpm.  At the end of the 500 mL incubation, the bacterial suspension was divided 
into 50-mL falcon tubes and centrifuged at 4,500 rpm for 30 min.  The supernatant 
contained negligible quantity of total apoaequorin (Shimomura and Inouye, (1999) and 
Section 4.4.2.2) and was decanted;  any remaining supernatant was carefully removed 
from the pellets by pipetting.  The cell paste was stored at −80 °C.   
7.3.2 Regeneration and extraction of aequorin 
7.3.2.1 One-step extraction and charging of active aequorin 
The falcon tubes containing frozen cell paste were removed from −80°C storage 
and left to thaw on ice for approximately 20 min.  To extract apoaequorin from the cells 
and reconstitute active aequorin the following procedure was followed:  the thawed cell 
pellet in each falcon tube was dispersed in 17.5 mL of ice-cold buffer containing 
50 mM Tris-HCl 10 mM EDTA and 2-mercaptoethanol or DTT (Appendix Chapter 7), 
pH 7.5 at 23 °C.  The suspension was transferred into a 50-mL plastic beaker and stirred 
at ~250 rpm on ice using a magnetic stirrer.  700 µL of 1 mg/mL coelenterazine solution 
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(Section 7.2) were added to the stirred suspension in a dropwise manner, resulting in 
92 µM coelenterazine concentration in the final mix.  The beaker was covered with foil 
(coelenterazine is light-sensitive), placed in 4°C storage and left to stir overnight while 
allowing diffusion of oxygen to occur.  Choice of the beaker geometry was such that the 
depth of the suspension was less than 3 cm to facilitate the diffusion of oxygen 
(Shimomura and Inouye, 1999).  Following the overnight incubation the mixture was 
centrifuged at 13,000 rpm for 30 min at 4°C.  A clear supernatant was produced that 
contained fully functional aequorin and the cell pellets were discarded. 
Reconstitution with coelenterazine was initially performed in microwells 
(Section 7.4.1.1) where it was used to screen conditions for shake flask cultures;  culture 
samples collected at different time points were measured for OD and activity post-
reconstitution with coelenterazine.  100 µL of the collected samples were transferred 
into the corresponding wells of a new DSW plate, each containing 950 µL of cold 
coelenterazine solution 4 µM, 50 mM Tris-HCl, 10 mM EDTA and 5 mM 2-
mercaptoethanol, pH 7.5.  The DSW was covered with an inverted shallow 96-well 
plate (Sarstedt Inc), placed on a table top thermomixer (Eppendorf Inc) with intermittent 
stirring at 1,000 rpm and 1 °C;  this was placed overnight in a cold cabinet (4–8 °C).  
The protocol was based on Shimomura and Inouye (1999) who had used a lower protein 
expression strain;  in retrospect it was understood that 4 µM of coelenterazine was not 
sufficient for the apoaequorin produced in shake flasks in this work.  The coelenterazine 
content was consequently increased in the finalised protocol for production of aequorin 
in 500 mL cultures (Figure 7–15).  After the end of the cold incubation with 
coelenterazine solution, 100 µL of each well were transferred into the corresponding 
wells of a Lumitrac™ shallow well plate using automated liquid handling (Tecan).  The 
activity of the regenerated aequorin was then assayed as described in Section 7.3.4. 
7.3.2.2 Periplasmic fraction 
Periplasmic extraction of apoaequorin from E. coli cultures by osmotic shock 
was performed using the protocol by Ausubel (1989) found in the Novagen pET system 
manual (2003).  This preparation did not include coelenterazine for the reconstitution of 
active aequorin, but was an investigatory experiment to determine the localisation of 
apoaequorin in the cell.  Cell pellet from 40 mL of E. coli culture was harvested by 
centrifugation and resuspended thoroughly in 30 mL of 30 mM Tris-HCl pH 8.0, 20% 
sucrose.  EDTA solution (0.5 M pH 8.0) was added to final concentration of 1 mM.  
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PMSF was added to final concentration of 0.2 mM for protection against proteases and 
the mix was stirred slowly at room temperature for 10 min.  The cells were collected by 
centrifugation at 10,000×g at 4°C for 10 min, the supernatant was removed and 
discarded.  The pellet was resuspended in 30 mL of ice-cold 5 mM MgSO4 and the cell 
suspension was stirred slowly for 10 min on ice.  Periplasmic proteins should be 
released into the buffer during this step.  The mix was centrifuged at 4°C for 10 min at 
10,000×g and the shocked cells were separated from the periplasmic proteins 
(supernatant).  One milliliter samples were collected for SDS-PAGE analysis and 
activity assays.  The cell pellet was kept on ice for SDS-PAGE analysis of the soluble 
and insoluble cytoplasmic fractions.  The periplasmic fraction (supernatant) was 
concentrated through spin filtration.  Samples collected for SDS analysis were mixed 
with an equal volume of SDS loading buffer, immediately heated for 3 min at 85 °C to 
denature the proteins and stored at −20 °C. 
7.3.3 Concentration of aequorin 
7.3.3.1 Spin-filtration 
Spin filters were used for the concentration and desalting of aequorin samples 
prior to size exclusion chromatography.  Vivaspin® spin-filters (Vivascience, Germany) 
and Amicon Centriplus® (Milipore, Germany) are centrifugaly operated, disposable 
ultrafiltration devices.  Proteins are separated by size.  They enable concentration of 
samples up to 30-fold and handle sample volumes of 0.5−15 mL (minimum final 
volume 200 µL).  For maximum recovery the molecular weight cut-off (MWCO) should 
be at least 50% smaller than the molecular size of the species of interest (rule of thumb: 
1/5 to 1/3 of the protein size).  Spin filters of 10,000 30,000 and 100,000 kDa nominal 
MWCO were tested for the preparation of aequorin solutions past the coelenterazine 
incubation step.   
Centrifugation was performed in 2−3 repeats at 4,000×g, 4°C for 15 min 
according to manufacturer’s instructions (Vivascience, 2002) until the desired 
concentrate volume was reached.  The spin columns were initially loaded with RO 
water to remove glycerine and sodium azide present in the membranes, followed by 
50 mM Tris-HCl, 10 mM EDTA solution to remove cations which might contaminate 
the protein sample.  At the end of centrifugation a yellow coloured liquid containing 
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concentrated aequorin (yellow indicates coelenterazine) was recovered from the 
concentrate pocket (retentate).  10,000 MWCO spin filters were used for desalting of 
aequorin samples prior to mass spectroscopy analysis or concentration prior to SDS-
PAGE analysis. 
7.3.4 Luminescence assay 
Luminescence assays were performed on the size exclusion chromatography 
fractions in order to determine the active aequorin fractions.  Volumes of 25−75 µL of 
sample were pipetted in microwells of a Lumitrac™ 96-well plate and injected with 
100 µL of 10 mM CaCl2 50 mM Tris-HCl pH 7.5 buffer solution, using the auto-
injector of the BMG platereader at 23 °C.  Platereader gain settings are specified in 
Supplementary Material.  Luminescence assays were also performed in order to 
associate cell growth and activity with bacterial incubation time.  These assays used 
crude bacterial sample (refer to Section 7.3.2.1 for methods and Section 7.4.1.1 for 
results).  One hundred microliters of the regenerated aequorin mixtures were assayed in 
the FluoStar platereader, by measuring the light emission of the sample when an equal 
volume of 100 mM CaCl2 solution in 20 mM Tris-HCl, pH 7.5 was injected. 
7.3.5 Size exclusion chromatography 
A 10mm internal diameter Pharmacia HR column was used, previously packed 
to a bed height of 27.5 cm (total gel volume 21 mL) with resin Pharmacia Superdex 75 
Prep Grade (Amersham Biosciences, Freiburg, Germany).  This resin is suitable for 
optimum molecular weight separation range of 3,000 to 70,000 (globular proteins).  The 
column was operated with an AKTAprime™ purification system and Unicorn™ 
software (GE Healthcare, Uppsala, Sweden). 
The quality of the column packing was checked by performing an acetone pulse 
test:  200 µL of 20 mg/mL acetone solution was pumped into the column through a 
200 µL sample loop at 1.2 mL/min (equivalent to 60 cm/h).  Efficiency and peak 
symmetry were calculated according to the manufacturer’s protocol (GE Healthcare, 
2006).  N=12,612 plates (acceptable values N≥10,000) per meter and Peak symmetry 
Af=1.07 (acceptable range:  0.7 ≤Af ≤1.3) were found to be satisfactory.   
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Due to the temperature-sensitive nature of aequorin, the column and all buffers 
used during the purification process were kept at 0−4°C.  The column was washed with 
50 mM Tris-HCl solutions of decreasing EDTA concentrations (10 mM − 100 µM 
EDTA, 2−3 column volumes per wash) to remove any residual calcium and finally 
equilibrated with 50 mM Tris-HCl, 100 µM EDTA buffer, pH 7.5 (5−10 column 
volumes) until the baseline was stable. 
The flowrate was adjusted in order to keep within the maximum pressure for the 
column (5 bar, 70 psi).  During purification the flowrate was set at 0.2 mL/min 
(manufacturer’s recommended rate: 10−15 cm/h) and for cleaning and equilibration it 
was raised to 0.5 mL/min (GE Healthcare, 2006).  Lower flowrates allow for higher 
resolution of the purified fractions.  Wild type and mutant samples were loaded at 
250 µL (within 0.5−3% of the total gel volume of 21 mL).  Commercial aequorin 
(AquaLite®) was loaded at 15 µg (15 µL of 1 µg/µL stock solution) through a partially 
filled 200 µL loop (remaining volume was equilibration buffer).  
Sanitisation, storage and cleaning-in-place (CIP) were performed according to 
manufacturer’s instructions (GE Healthcare, 2006).  Cleaning-in-place was performed 
in order to remove precipitated proteins and non-specifically bound proteins and 
lipoproteins.  The column was washed at 0.4 mL/min (corresponding to 20 cm/h) and 
reversed flow direction with 0.5 M NaOH solution.  This step was followed by a 
washing step with 70% ethanol at the same flowrate and flow direction.  The column 
was finally washed with two bed volumes of 20% ethanol and stored at 4 °C.  Before 
further use, the column was equilibrated with five bed volumes of buffer. 
 
7.3.5.1 Protein size by mass spectrometry 
Mass Spectrometry analysis was performed on a KRATOS AXIMA CFR V2.3.4 
mass spectrometer by the scientific support services at the Wolfson Institute for 
Biomedical Research, UCL.  KRATOS AXIMA is a matrix-assisted laser desorption - 
ionisation (MALDI) time-of-flight instrument which gives mono-isotopic resolution of 
3,000 up to a mass of 6,000.  It can analyse masses up to approximately 150,000 Da 
both in positive and negative mode, which is very useful for determination of intact 
proteins. 
The analysis was performed on aequorin fractions with luminescent activity 
eluted from the size exclusion chromatography step in order to verify protein.  The 
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purified aequorin samples (recombinant wild type, mutant Asn28Cys/Ser32His and 
AquaLite®) were desalted using spin filtration columns of 10,000 MWCO membrane 
filters (Section 7.2.1.2).  Proteins equine apomyoglobin (16.9 kDa) and rabbit aldolase 
(39.21 kDa) were used as size standards in 5 µL samples of 10 pmol/µL. 
7.3.6 Protein handling considerations 
Calcium is a nearly ubiquitous ion, which even in trace concentrations could 
trigger the bioluminescence reaction of aequorin.  Due to aequorin’s high sensitivity to 
calcium, unprotected aequorin must be handled with extreme care and kept from contact 
with ordinary glass and other substances capable of liberating calcium ions (Blinks et 
al., 2000, Hastings et al., 1969).  Considering native aequorin’s (low) sensitivity and 
mutants’ possible increased sensitivity toward other (than calcium) metal ions, EDTA 
was the cation chelator of choice for all preparatory work; EGTA would be better suited 
for the chelation of calcium but EDTA chelates a wider range of divalent ions more 
effectively.  Glass and metal surfaces were avoided where possible.  The glass syringe 
pump and metal syringe nozzle of the platereader were rinsed with decreasing 
concentrations of EDTA in Tris-HCl buffer (first pass:  10 mM EDTA, final pass:  
10 µM EDTA).  Plasticware were also rinsed with a 50 mM Tris-HCl, 10 mM EDTA 
solution prior to contact with apoaequorin or aequorin.   
Aequorin’s sensitivity to light and temperature is due to its prosthetic group, 
coelenterazine.  Samples containing coelenterazine or active aequorin were kept on ice, 
centrifugation was performed at 4 °C and chromatographic separation was performed at 
4−6 °C (for handling during chromatography refer to Section 7.3.5).  Samples were 
protected from light where possible and tubes were covered with foil. 
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7.4 Results and Discussion 
The purification protocol was based on Shimomura and Inouye (1999) due to the 
simplicity of the process and the use of mild operation conditions.  Two options for 
active protein assays emerge from the published work:  (1) to obtain aequorin in a crude 
bacterial suspension through minimal processing (2) to isolate cell paste and subject it 
to further purification steps.  The first option was deemed acceptable for a crude, initial 
HTS method amenable to automation (Chapter 4 and Chapter 6) but it contains 
impurities and requires high concentrations of a metal chelator (e.g. 10 mM EDTA or 
EGTA) to ensure aequorin is not discharged by calcium or other cations present in the 
mixture.  The second option yields highly purified protein in a buffer of choice with 
minimal chelator concentrations required, all necessary conditions for detailed kinetics 
analysis.  In the HTS protocol (Chapter 4 and Chapter 6), the purity of aequorin was 
78% in a solution containing 20 mM Tris-HCl, 10 mM EDTA, 5 mM 2-
mercaptoethanol, pH 7.7.  In this preparation the desired protein purity would be at least 
95% in a 50 mM Tris-HCl, 100 µM EDTA buffer, pH 7.5.  EDTA concentration would 
be further decreased by dilution for the kinetics experiments of Chapter 8. 
7.4.1 Bacterial cell culture 
7.4.1.1 OD and activity versus incubation time 
In this section the optimum incubation time before harvesting of cells was 
determined.  The activity of the produced aequorin is plotted in association with optical 
density (OD) of the cell culture versus incubation time. 
500 mL cultures were grown in 2-L shake flasks as described in Section 7.3.1.2, 
with the exception of conducting a 10% inoculation from the 100 mL culture into the 
500 mL culture.  The culture was induced at 2 hours (cell culture OD≈1.0) with IPTG at 
a final concentration of 0.6 mM.  One milliliter samples of the culture were collected at 
various time points for OD (immediate measurement) and activity measurement 
(samples kept on ice for further processing and assayed in one microplate).  Samples 
were transferred into a DSW plate containing buffered coelenterazine and incubated at 
1 °C overnight with occasional agitation to fully equilibrate the protein into its holo 
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form.  Luminescence activity of each sample was assayed in the BMG FluoStar 
platereader. 
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Figure 7-1  Luminescence activity and cell density of 500 mL cultures versus time.  
Two replicates per time point (N=2).  Time zero corresponds to 10% inoculation from 
the overnight 100 mL culture.  IPTG was added to a final concentration of 0.6 mM.  
Experimental setup and discussion in Section 7.3.1.2 and 7.4.1.1.   
In Figure 7-1 it is shown that little apoaequorin (hence aequorin) is formed until 
after induction.  The production of apoaequorin rapidly increases between 3−4 hours of 
incubation and approximately 30 min after induction.  Then the total luminescence 
activity measured appears to plateau even though cell density continues to increase 
slightly from 4−10 h.  This would normally suggest that it would have been possible to 
harvest at approximately four hours after induction, had it not been for the limiting 
amount of coelenterazine (4 µM) added in this initial test (Section 7.3.2.1).  Later 
measurements of total protein concentration and aequorin purity in shake flasks led to 
the usage of much higher coelenterazine concentration (92 µM) during the cold 
incubation step.  Figure 7-1 still provides dependable association between OD and 
activity until 5 h of incubation when coelenterazine became limiting.  Harvesting at later 
time points was retained when using the higher coelenterazine concentration as Figure 
7-1 showed no evidence that the aequorin was being significantly degraded.   
IPTG induction 
- 231 - 
7.4.2 Localisation of protein 
7.4.2.1 Localisation of protein in the cell 
In Section 4.4.2.2 it was demonstrated through activity studies that only a small 
quantity of apoaequorin is secreted in the culture medium during incubation.  This 
section now examines the localisation and availability/solubility of apoaequorin in the 
cell pellet of the bacterial culture.  The cells were retrieved by centrifugation and the 
pellet was re-solubilised with Tris-HCl buffer.  The suspension was then sonicated to 
break open the cells and re-centrifuged to separate the soluble proteins in the 
supernatant from the insoluble proteins attached to the cell debris.   
SDS-PAGE results from Figure 7-2 and Figure 7-3 clearly indicate that a 
substantial portion of apoaequorin produced in the cell is in the form of insoluble 
aggregates.  These aggregates will be further discussed in Section 7.4.2.2. 
 
 
Figure 7-2  Localisation of apoaequorin in the cell pellet – (a).  L: Benchmark Protein 
Ladder™ (Invitrogen, Figure 2-2); Lane 1: Bacterial pellet, isolated by centrifugation of 
cell culture; the cells were resuspended in volume of Tris-HCl buffer equal to the 
volume of the cell culture centrifuged.  This lane represents total protein in the cell.  
Lane 2:  The resuspended pellet represented in Lane 1 was sonicated and centrifuged.  
The supernatant of the sonicated mixture represents soluble protein, loaded in Lane 2. 
The precipitated fraction of the sonicated and centrifuged sample represents the 
insoluble protein in the cells, shown in Lane 3.  Lanes 1, 2 and 3 were loaded with 
10 µL total volume, consisting of sample pre-mixed 1:1 with Biorad SDS loading buffer 
and heated to 95 °C for 5 min (Section 2.4.2).  Lane L was loaded with 10 µL of protein 
ladder. 
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Figure 7-3  Localisation of apoaequorin in the cell pellet – (b).  Corresponding to 10 and 
20 cycles of sonication.  Total protein (Lanes 1 and 2) corresponds to Lane 1 of 
Figure 7-2.  Soluble protein (Lanes 3 and 4) corresponds to Lane 2 of Figure 7-2.  
Insoluble protein (Lanes 5 and 6) corresponds to Lane 3 of Figure 7-2.  The samples 
were prepared as described in Figure 7-2. 10 µL loaded per lane. 
7.4.2.2 Localisation of protein after coelenterazine incubation 
This section examines the localisation of apoaequorin post incubation with 
coelenterazine.  Incubation with cold coelenterazine solution was performed as 
described in Section 7.3.2.1.  The suspension (cells in coelenterazine buffer) contains 
two proteins of sizes between 20 kDa and 25 kDa, visualised as two clearly 
distinguishable bands in Figure 7-4.  The smaller size protein is secreted in the 
coelenterazine buffer during the cold incubation (Lane 5).  The bigger band is retained 
in the cell pellet (Lane 4).  The smaller size band is soluble (Lane 2) as it appears in the 
soluble supernatant after sonication and centrifugation of the suspension. 
The two bands between 20 kDa and 25 kDa both contain apoaequorin.  This is 
verified in Section 7.4.2.3 where it is proven that bands of this size and intensity are 
only encoded in pETAQ and not the bacterial strain or pET26b.  Taking into account 
that the size difference between the two bands is ~1 kDa (size of pelB leader peptide), 
that the bigger size band remains as insoluble within the cell and that the lower size 
band is secreted in the medium, it is reasonable to assume that the lower size band is 
apoaequorin that can be reconstituted into aequorin and the bigger band is apoaequorin 
still attached to the pelB leader peptide.  Overall, most of expressed recombinant protein 
remained within the cells.  A reasonable explanation is that the E. cloni® machinery is 
not sufficient to cleave such large quantities of overexpressed protein.   
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Figure 7-4  Localisation of apoaequorin after charging with coelenterazine.  
L:  Benchmark protein ladder (Invitrogen, Figure 2-2).  Lane 1:  O/N suspension after 
cold incubation with coelenterazine (contains total protein).  Lane 2:  supernatant after 
centrifugation of sonicated O/N suspension (contains total soluble protein).  Lane 3:  
Sample of lane 2, diluted 3-fold.  Lane 4:  Resuspended pellet after centrifugation of 
sonicated O/N suspension (contains insoluble protein attached to cells) Lane 5:  
Supernatant after centrifugation of O/N suspension.  Contains soluble protein secreted 
by cells during the O/N incubation with coelenterazine solution.  Apoequorin band 
purity:  72%.  Lane 6:  Sample of lane 5 concentrated by spin centrifugation using 
Vivaspin6 columns (13,000 rpm, 30 min).  Diluted 1:5 with Tris buffer.  Lane 7:  
Sample of lane 5 concentrated by Amicon centriplus centrifugal filter (Milipore) 
(13,000 rpm, 30 min).  Diluted 1:5 with Tris buffer.  All lanes were loaded at 10 µL 
total volume of sample (including Laemli loading buffer) or protein ladder.  
The total protein concentration by Bradford assay of the protein secreted from 
50 mL cell paste into 17.5 mL of coelenterazine solution was 0.275 mg/mL.  This 
corresponds to a yield of 0.096 mg/mL of soluble apoprotein retrievable from the cell 
culture.  Taking into account SDS-PAGE protein gel densitometry, this mixture 
contains 72% apoaequorin chain which if folded and reconstituted correctly can yield a 
maximum of 0.069 mg/mL functional aequorin or 6.9 mg per 100 mL of cell culture.  
The SDS-PAGE of Figure 7–4 was run under reducing conditions which would dissolve 
apoaequorin or aequorin aggregates and display only the linearised polypeptide bands.  
Size exclusion HPLC or a native SDS-PAGE assay would reveal the presence of 
potentially higher order aequorin/apoaequorin structures.  The yield calculations in this 
section assume no loss of protein due to formation of aggregates post secretion from the 
periplasm. 
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7.4.2.3 Periplasmic fraction 
The procedure followed is described in Section 7.3.2.2.  Periplasmic extraction 
from cell pellets producing apoaequorin was performed in order to:  (1) gain more 
insight into the localisation of recombinant apoaequorin the cell culture and (2) explore 
this method’s potential as a purification step.  The protocol was performed on cultures 
of E. cloni® cells carrying vectors pETAQ and pET26b.  The latter was used as control 
for E. coli host proteins and proteins encoded in the pET26b vector without apoaequorin 
expression.  
Comparing the expression profile from cultures carrying each vector, it is clear 
that the high intensity bands between 20 kDa and 25 kDa are indeed related to 
apoaequorin expression and not host cell proteins (Figure 7-5 and Figure 7-6).  The 
periplasmic extraction process leaves a considerable amount of apoaequorin within the 
cells.  Most of the apoaequorin produced does not reach the periplasm and is retained in 
the cytoplasm (Lane 6 of Figure 7-5).  This conclusion agrees well with the findings of 
Section 7.4.2.2. 
Periplasmic extraction can be used as an intermediate stage in the purification of 
apoaequorin from an E. coli culture.  Further dialysis can lead to apoaequorin of high 
purity (Lanes 7,8 of Figure 7-5) although purity and yield were not estimated.  The 
periplasmic extraction method by Ausubel (1980) using sucrose and magnesium 
sulphate was not used going forward in this work.  The final purification protocol used 
the simpler one-step extraction and reconstitution with coelenterazine by Shimomura 
and Inouye (1999). 
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Figure 7-5  Periplasmic extraction SDS gel – (a) of cultures carrying pETAQ and 
pET26b.  L1:  Protein ladder:  PrecisionPlus™ Protein Standards (Invitrogen)  Lane 1:  
E. coli cells expressing pETAQ (referred to as wild type in the text), resuspended in 
sucrose solution.  Lane 2:  E. coli cells expressing pET26b, resuspended in sucrose 
solution.  Lane 3:  Periplasmic fraction of Lane 1 sample.  Lane 4:  Spin-concentrated 
sample of Lane 3.  Lane 5:  Periplasmic fraction of Lane 2 sample, spin-concentrated.  
Lane 6:  pellet of E. coli cells expressing pETAQ, post periplasmic extraction.  Lane 7:  
Dialysed sample from Lane 4.  Lane 8:  Spin-concentrated sample of Lane 7.  L2:  
Protein ladder:  Benchmark™ Protein ladder (Bio-Rad Laboratories).  All lanes were 
loaded at 10 µL total volume of sample (including Laemli loading buffer) or protein 
ladder. 
                      
 
 
Figure 7-6  Periplasmic extraction SDS gel – (b), of cultures carrying pETAQ and 
pET26b. L1:  Protein ladder:  PrecisionPlus™ Protein Standards (Invitrogen)  Lane 1:  
pellet of E coli cells expressing pETAQ (referred to as wild type in the text) after the 
periplasmic extraction procedure.  Same as Lane 6 in Figure 7-5.  Lane 2:  Periplasmic 
fraction of Lane 1, spin-concentrated.  Same as Lane 4 in Figure 7-5.  Lane 3:  wash 1 
of periplasmic extraction from E. coli cells expressing pETAQ.  Lane 4:  elution step of 
periplasmic extraction from E. coli cells expressing pETAQ.  L2:  Protein ladder:  
Benchmark™ Protein ladder (Bio-rad Laboratories).  Lane 5:  pellet of E. coli cells 
expressing pET26b (not containing the apoaequorin gene) post periplasmic extraction.  
Lane 6:  Spin-concentrated periplasmic extraction from E. coli cells expressing pET26b.  
Same as Lane 5 of Figure 7-5.  Lane 7:  wash 1 of periplasmic extraction from E. coli 
cells expressing pET26b.  Lane 8:  elution step of periplasmic extraction from E. coli 
cells expressing pET26b.  All lanes were loaded at 10 µL total volume. 
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7.4.3 Clarification of protein sample 
Centrifugation and filtration were tested as means of clarification of protein 
sample from particulate matter (such as cell debris and lipids) that may clog 
chromatography columns.  This section compares clarification of the aequorin-
coelenterazine suspension by (1) two consecutive centrifugation steps or (2) filtration 
through a low protein-binding 0.2 µM polyvinylidene fluoride (PVDF) filter.  The 
activity of the protein sample was measured pre- and post-clarification (Figure 7-7).  
Using filtration, activity was reduced by approximately 78%;  this may be due to 
aequorin being retained within the filter or activity lost due to cations leaching from the 
filter membrane and discharging aequorin.  Bradford and SDS-PAGE assays would be 
appropriate analytics to further investigate this, but as the aim was to maximise activity 
of the retrieved sample, the filtration step was not used.  
For all further protein sample clarifications, two consecutive runs of 
centrifugation at a maximum speed of 13,000 rpm at 4 °C were used, where the 
supernatant was retrieved at both steps (Figure 7-15).   
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Figure 7-7  Clarification of aequorin suspension after coelenterazine incubation. 
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7.4.4 Enrichment of aequorin prior to chromatography 
7.4.4.1 Spin-filtration 
Limited sample volume can be loaded onto a size exclusion column, in this case 
approximately 250 µL.  Prior to size exclusion chromatography, aequorin was 
concentrated using 30,000 MWCO spin columns (Section 7.3.3.1).  An additional spin-
filtration step was considered in order to test the hypothesis that aequorin could be 
separated from the impurities to >95% purity based on size, by employing spin columns 
of 30,000 and 100,000 MWCO.  The retentate of the 30,000 MWCO centrifugation was 
filtered through a 100,000 MWCO spin column.  Aequorin and a wide range of 
impurities were found both in the retentate, as seen in Figure 7-8.  Aequorin was not 
separated from higher molecular weight impurities successfully using different 
molecular weight cut-off filters;  the MWCO values are nominal, with pore sizes of 
wide distribution and the outcome depends on shape of the proteins, speed, duration and 
temperature of centrifugation. Only the 30,000 MWCO filtration/concentration step was 
incorporated in the final purification protocol (Section 7.4.2.2).  
 
                                       
 
Figure 7-8  Aequorin suspension concentated using Minisart® filters.  The suspension 
contained reconstituted aequorin following incubation with coelenterazine.  
L:  Benchmark™ protein ladder (10 µL).  Lane 1:  Flowthrough of 30,000 MWCO.  
Lane 2:  retentate of 30,000 MWCO (aequorin purity: 78.2%).  Lane 3:  Sample of Lane 
2 filtered through 100,000 MWCO.  This lane is the flowthrough (aequorin purity: 
88.6%, host cell protein ~50 kDa: 7.7%).  Lane 4:  retentate of 100,000 MWCO 
(aequorin purity: 52%).  Spin-centrifugation was for 2×15 min, at 4,000×g, volume 
reduction factor was 17.  Protein standards were loaded at 10 µL per lane and protein 
samples were loaded at 15 µL per lane (including 1:1 mixing with SDS loading dye). 
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7.4.4.2 Mass spectrometry of spin-concentrated sample 
The concentrated protein sample (Section 7.4.4.1) was analysed using mass 
spectrometry (Section 7.3.5.1) to verify protein mass.  The sample of Figure 7-9 
corresponds to Lane 3 of Figure 7-8.  The peak at 23,563 Da is aequorin monomer 
(expected value: 23,535 Da) and the peak at 47,263 Da is possibly a host cell protein, 
also appearing in Lane 3 of Figure 7-8.  According to densitometry results these two 
bands account for ≥95% of the protein content of the sample.  The actual sample put 
through size exclusion chromatography was prepared in the same way as the sample in 
Lane 2 of Figure 7-8;  this features aequorin of lower purity by 10% but was chosen in 
order to keep the processing steps and hence protein loss to a minimum.  
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Figure 7-9  Mass spectrometry of aequorin sample prior to chromatographic 
purification. 
7.4.5 Storage of purified fractions 
Protein fractions were kept on ice thoughout the duration of the wet lab work.  
After the active fractions were identified though activity assays, these were subjected to 
flash-freezing using acetone and dry ice and stored at −80 °C.   
7.4.6 Size exclusion chromatography of aequorin:  wild-type, mutant 
and commercial aequorin 
Size exclusion purification was performed as described in Section 7.3.5.  Figure 
7-10  features the chromatograms of absorbance at 280 nm matched with activity assays 
of the collected fractions (Section 7.3.4) for recombinant wild-type aequorin, mutant 
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Asn28Cys/Ser32His and commercial aequorin (AquaLite®).  The UV traces of 
recombinant wild type and mutant Asn28Cys/Ser32His display three peaks: Peak 1, 
Peak2 and Peak 3 eluting at 8, 10 and 12 mL respectively.  These peaks are not well 
resolved.  All chromatograms and raw data are appended in Supplementary Material.   
Only one peak (Peak 1) at 12 mL is observed in the chromatogram of pure 
AquaLite®.  Peak 1 exhibits the highest activity within each chromatogram and is 
expected to be the higly active monomer of aequorin.  In a normal plot (Figure 7-10) 
both Peak 2 and Peak 3 appear completely inactive but on a logarithmic scale 
(Supplementary Material) it can be seen that there is some little activity in both.  SDS-
PAGE analysis of Peak 2 in both wild type and mutant reveals multiple high molecular 
weight bands (Supplementary Material) and displays the least luminescence activity.  
This minimal activity may be attributed to the activity of the preceding unresolved 
Peak 3 and succeeding Peak 1.   
Interestingly, Peak 3 is proportionally more intense in the plot of mutant 
aequorin and it appears to have increased at the cost of Peak 1, compared to the UV 
trace of the wild type.  It is possible that this particular mutant was expressed at very 
low levels (not analysed in this work).  Mutant Asn28Cys/Ser32His has a solvent-
exposed cysteine in EF-I loop which may encourage the formation of higher order 
aggregates of little or no activity, though disulfide bridges.  It is possible that such 
aggregates of mutant aequorin may have formed after secretion from the cells (due to 
insufficient reducing agent in the solutions), thus decreasing the Asn28Cys/Ser32His 
monomer available for purification.  Formation of aequorin/apoaequorin aggregates 
would explain the decrease of Peak 1 and increase of Peak 3 in the mutant plot and 
partially explain the low luminescence activity of Peak 3.  However, SDS-PAGE 
analysis of the Peak 3 showed no discernible band at the size of aequorin.  The 
difference in UV intensity of Peaks 2 and 3 between wild type and mutant could be 
attributed to variations in protein expression levels in the E. coli cultures.   
Due to the poor resolution of the peaks, only partial fractions of Peak 1 of wild 
type and mutant were used for the kinetics experiments of Chapter 8, in order to avoid 
contamination of the descending Peak 2 and maintain high sample purity.  The samples 
used in kinetics work (Chapter 8) are analysed in Sections 7.4.7 and 7.4.8. 
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Figure 7-10  Elution profiles from size exclusion chromatography matched with activity 
of the eluted fractions.  The midpoints of fraction volumes were used as x-axis for the 
activity plots.  Luminescence activity RLUs (relative luminescence units) are not 
comparable across the three plots as they were performed at different gain settings 
(1,100 900 and 2,000 from top to bottom) to avoid out of range readings. 
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7.4.7 SDS-PAGE of purified samples 
Figure 7-11 presents SDS-PAGE analysis of purified wild type, mutant and 
commercial aequorin from size exclusion chromatography, to be used in the work of 
Chapter 8. 
               
Figure 7-11  SDS-PAGE visualisation of purified aequorin samples.  Lane L:  Standard 
Benchmark™ protein Ladder (Invitrogen). Lane 1:  supernatant of the aequorin 
suspension from high-throughput screening wells, concentrated 35-fold (aequorin 
purity:  78%).  Lane 2:  Total soluble protein of the aequorin suspension from high-
throughput screening wells.  The suspension was sonicated, centrifuged and the 
supernatant was concentrated 26-fold (aequorin purity:  66%).  Lane 3:  purified wild-
type aequorin from size exclusion chromatography, concentrated 3-fold.  Aequorin 
purity: 98%.  Lane 4:  purified mutant Asn28Cys/Ser32His, concentrated 3.5-fold.  
Aequorin purity: 97%.  Lane 5:  AquaLite® (commercially available aequorin from 
Molecular Probes).  Aequorin purity: 100%.  All samples (except Lane 5) were 
concentrated by spin centrifugation using a 10,000 MWCO spin column (Sartorius).  
Total loading volume per lane (including Laemli loading buffer):  Ladder: 10 µL, Lanes 
1-3:  15 µL, Lane 5 (AquaLite®): 10 µL.   
Gel image densitometry was used to obtain a rough estimate of purity.  Lanes 1 
and 2 of Figure 7-11 show the aequorin obtained from the supernatant and total soluble 
protein from high-throughput screening wells, for which the purity of aequorin was 79% 
and 66% respectively. Lanes 3 and 4 show the aequorin obtained size exclusion 
purification for wild type and the Asn28Cys/Ser32His mutant, for which 98% and 97% 
aequorin purity was obtained respectively.   
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7.4.8 Mass spectrometry of purified samples 
The molecular mass of aequorin was estimated through mass spectrometry at 
22,927 Da (Figure 7-12) with potentially a second peak at 23,350 Da.  Considering the 
estimation of the commercial standard (discussed below), these are both reasonably 
close to the estimate of 23,535 Da (including the 6×His tag), calculated theoretically 
using the Compute pI/Mw tool of the ExPASy Proteomics server (Gasteiger et al., 
2005).  The coelenterazine (MW 423 Da) is presumably dissociated from the protein 
during the ionisation process, although the second smaller peak present at 
approximately 23,350 Da indicates a small residual population of the holo-aequorin. 
The Asn28Cys/Ser32His mutant (Figure 7-13) gave a mass of 22,996 Da and a 
second peak of 23,392 Da.  The two mutations were expected to increase the mass by 
41 Da, whereas an increase of 69 Da was measured when compared to the 
experimentally determined wild type mass of 22,927 Da.  This is an acceptable error in 
MALDI mass determination and this change at least qualitatively confirms the 
purification of the mutant.  The second peak, with approximately 400 Da greater mass 
again indicates a population retained the coelenterazine during analysis.   
The commercial AquaLite® sample gave a mass of 21,332 Da.  The expected 
mass is 22,000 Da according to the supplier (Molecular Probes, 2001).   
Given the above reduction of ~600 Da in mass determination for the commercial 
standard, the same apparent losses from the main peaks of wild type and mutant 
compared to their expected values can be attributed to assay-related calibration error (all 
three samples were estimated against the same calibration run).  Any additional, non-
assay related errors would be attributed to truncation at the C- or N-terminus.  The mass 
difference between the first and second peaks in both wild type and mutant are 
consistent with retention of the chromophore during analysis.  Such a peak may also be 
present in the trace of Figure 7-9, however the reduced resolution and peak broadening 
of that trace would potentially mask it. 
From the mass spectrometry it is reasonable to infer that the wild type and 
mutant samples obtained are very pure as few alternative peaks were observed, although 
accurate quantitative measurements cannot be obtained from MALDI data.  
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Figure 7-12  Mass spectrometry analysis of purified wild-type aequorin.  Molecular 
weights are in Dalton.  Protein concentration in the sample was approximately 
157 µg/mL. 
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Figure 7-13  Mass spectrometry analysis of mutant Asn28Cys/Ser32His.  Protein 
concentration in the sample was approximately 107 µg/mL.    
0
10
20
30
40
50
60
70
80
90
100
%Int.
16000 18000 20000 22000 24000 26000 28000 30000 32000 34000 36000
Mass/Charge
0.3 mV[sum= 153 mV]  Profiles 1-580 Smooth Av 250 -Baseline 200
Data: 210607evi30001.J4 21 Jun 2007 12:07 Cal: linear 21 Jun 2007 11:25 
Kratos PC Axima CFR V2.3.4: Mode linear, Power: 150, P.Ext. @ 24000 (bin 248)
21
33
2.
26
19
02
4.
42
18
56
6.
56
19
63
3.
37
20
08
2.
55
20
60
8.
24
24
56
0.
60
24
15
0.
37
25
16
8.
37
 
Figure 7-14  Mass spectrometry analysis of commercial aequorin AquaLite® (Molecular 
Probes) purified using the same size exclusion chromatography protocol as wild type 
(Figure 7-12) and mutant (Figure 7-13).  Protein concentration in the sample was 
approximately 44.17 µg/mL. 
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7.5 Conclusions 
A protocol for the purification of active aequorin and variants in bench scale was 
developed.  The method yields target protein of high purity (Table 7-1) using mild 
extraction conditions and limited number of purification steps.  The finalised procedure 
for the purification of recombinant aequorin and operating parameters are summarised 
in Figure 7-15.   
This approach was sufficient to obtain small amounts of protein for the work 
performed in Chapter 8 and the use of size exclusion chromatography required minimal 
development time compared to separations based on ion exchange, hydrophobic or 
mixed-mode interactions.  The histidine tag fused to apoaequorin that was originally 
envisaged for metal affinity purification (Chapter 3) was not used in this work, although 
an exploratory run with Ni-NTA chromatography was performed (not shown in this 
work). 
A considerable amount (approximately half) of the apoaequorin produced in the 
bacterial culture was not utilised for two reasons:  (1) significant portion of apoaequorin 
remained in the form of insoluble aggregates within the cytoplasm, possibly as the cell 
machinery failed to cleave the pelB leader peptide from the entire population of 
expressed protein (Section 7.4.2.2);  to re-solubilise apoaequorin aggregates would 
require a different path of purification, use of denaturants and omission of the pelB 
leader from the DNA construct  (2) only limited amount of protein can be processed 
through a size exclusion column at one time.  Mass balance of aequorin size band 
between the coelenterazine extraction mix and the purified fractions show minimal to 
zero loss of protein (Supplementary material) during the size exclusion step, which was 
expected.  
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Figure 7-15  Final protocol for the purification of aequorin. 
Table 7-1  Yield and purity of purified aequorin. 
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Wild type 2.60 98% 
Asn28Cys/Ser32His 1.04 97% 
 
2-L 0.5-L 
Thaw 
pellets  
 
0°C 
Resuspend in:  
50 mM Tris-HCl 
10 mM EDTA 
10 mM DTT 
 
–80°C 
  storage 
2×Centrifuge 
Retain supernatant 
  Cold 
incubation 
 
O/N, 0°C 
 Coelenterazine 
    4°C 
 
10,000×g 
    Retain pellets 
Discard supernatant 
           Charging of active protein             Enrichment of protein prior to SEC 
Concentration by 
2–3×centrifugation  
in spin-columns 
  RT 
 
4,000×g 
Activity assay of fractions  Size exclusion chromatography 
  4°C 
 
4,000×g 
0–4°C 
 
  37°C 
 
8–12 h 
200 rpm 
 
  37°C 
 
  O/N 
200 rpm 
 
 37°C 
 
 8 h 
200 rpm 
 
0.2 mL/min 
 
Li
gh
t  
Time 
–80 °C 
 
   Freezing and storage 
                   Fermentation                    Harvest 
- 246 - 
7.5.1 Improvements to the process 
The resolution of size exclusion chromatography separation can be improved by 
increasing the length of the column, reducing the volume of sample loaded to stricter 
specifications of <1% of bed volume and reducing the flowrate to 0.1 mL/min from 
0.2 mL/min used in this study.  Superdex 75 prep grade has a fractionation range 3,000–
70,000 Da but molecular markers would be tested first on the SEC column to ensure the 
desired size separation is achieved before processing the valuable aequorin sample.  
In terms of analytics, GP-HPLC would be used for accurate estimation of protein 
purity instead of SDS-PAGE densitometry employed in this work.  Both native and 
reducing SDS-PAGE would be employed for analysis of the purification fractions to 
identify aequorin aggregates.  Silver staining method would be employed if higher 
detection sensitivity was needed. 
If higher quantities of aequorin were required, available options would be to 
purify the apoaequorin from the periplasmic extract (without coelenterazine) using 
anion exchange chromatography as a capture step – aequorin has a low pI of 4.82 
(Nanolight, 2010) – followed by hydrophobic chromatography if required.  In such a 
case, reconstitution with coelenterazine would be performed on purified apoaequorin, 
and dialysis or buffer exchange step using appropriate chromatographic media (e.g. 
Superdex 30) would also be required. 
The activity assays would all be performed at one common gain setting or more 
material would have to be sacrificed to perform assays at multiple gain settings in order 
to avoid out of range readings.  This would allow specific activity values to be 
calculated and compared across all samples. 
Published literature on aequorin reports activity in RLUs in various 
luminometers of each laboratory and these values are not directly comparable.  
Shimomura and co-workers (1990) calculated that 1 mg of pure aequorin emitted 
4.80×1015 quanta at room temperature by calibration with the Cypridina 
bioluminescence reaction (Shimomura and Johnson, 1970).  A more modern method for 
associating luminescence units to a standardised light source is the use of radioactive 
standards, e.g. Glowell™ luminometric standards by LUX Biotechnology which emit 
stable light and can readily bolt into the wells of a standard 96-well microplate.  This 
would allow comparison of specific activity of aequorin samples across in-house 
experiments and published work alike. 
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8 Response of wild-type aequorin and mutant 
Asn28Cys/Ser32His to seven metal ions 
In this chapter the purified wild-type aequorin and mutant Asn28Cys/Ser32His 
were tested for their response against seven candidate activator ions calcium, 
lanthanum, cadmium, lead, zinc, copper and cobalt.  The work described in the previous 
chapters compiled literature review and theoretical structural study of aequorin 
(Chapters 1 and 5), designed an expression system for production of aequorin in high-
throughput microplate format (Chapters 3 and 4) and created and screened a library of 
mutant aequorin variants against seven metal ions in high-throughput mode (Chapter 6);  
one variant was chosen for further investigation, to be purified (Chapter 7) and studied 
alongside wild-type aequorin (Chapter 8) without the interference of contaminants 
present in the crude screen of Chapter 4. 
The purified wild-type and mutant aequorin were tested against each of the seven 
metal ion solutions at a wide range of metal concentrations.  The light response against 
time was recorded.   
Section 8.1 provides theoretical background on binding and kinetics useful for 
data interpretation.  Section 8.2 compiles experimental methods and data processing 
specific to this chapter.  Luminescence curves (light versus time) of aequorin wild type 
and mutant were plotted for each candidate activator ion in Section 8.3.1.  Response 
curves (light versus metal ion concentration) that were compiled using the luminescence 
curve dataset were plotted in Section 8.3.2.  The shapes of the luminescence curves are 
associated with the speed of reaction and fall under one of two types (sharp or glow-
type).  The shapes of the response curves indicate whether the ions serve as activators or 
inhibitors and allow an estimate of sensitivity of each protein to each ion.   
In Section 8.3.3 a comparison is drawn between the seven ions as activators of 
wild-type and mutant aequorin.  In Section 8.3.5 aequorin was injected with calcium 
and zinc (Double ion experiments) in order to test the premise that the mutated EF-hand 
can be triggered by the new ion (zinc) while the intact EF-hands are still triggered by 
calcium, thus achieving improved mutant aequorin response to zinc compared to wild 
type.   
The kinetics of the sharp curves are discussed in Section 8.3.4.1 and the kinetics 
of glow curves in Section 8.3.4.2.  The shapes of the luminescence, concentration-
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response curves, yield and sensitivity are discussed in relation to ionic size and 
coordination of metal binding in Section 8.3.6.   
8.1 Introduction 
Work on aequorin to date has focused on the effect of calcium as its native 
activator.  Rare earth metals (e.g. lanthanum, strontium) were found to act as calcium 
substitutes in triggering aequorin luminescence, however these ions are less biologically 
relevant.  The novelty of the work described in this chapter lies in testing unusual 
candidates as triggers for aequorin luminescence:  cadmium, zinc, copper, cobalt and 
lead, as well as the known activators calcium and lanthanum.   
Asn28Cys/Ser32His was one of the interesting mutants emerging from the high-
throughput screening of Chapter 6, chosen for its potential to exhibit altered selectivity 
towards new metal ions.  It contains two mutations in the calcium-binding loop of     
EF-hand I which replace two conserved ligands for calcium ions with ligands usually 
found in zinc and copper binding sites; its other EF-hands remain intact.  It is envisaged 
to have decreased affinity for calcium and increased affinity for new metals compared 
to wild type.  A mutant with such features has not been designed and studied before, 
neither has it emerged from screening of randomised aequorin mutant libraries, as its 
low luminescence yield would have excluded it from a selection process based on high 
yields alone.   
In the crude screen of Chapter 4, only one concentration of each metal ion was 
tested on each of the variants of the aequorin library.  The concentration for each ion 
was decided based on optimal activity yielded from wild-type aequorin in cell 
suspension.  Work in this chapter will show that the same metal ion concentration that is 
optimal for wild type can in fact be inhibitory for a mutant variant.  This finding was 
taken into account in the experimental design of this Chapter. 
8.1.1 Binding studies 
Sections 8.1.1 and 8.1.4 discuss the differences between binding and 
concentration-response curves, as these concepts will be useful in data analysis.  To 
study binding reactions quantitatively, the complex must be monitored separately from 
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the free biomolecules.  This can be done via measuring changes in the solution in which 
the reaction occurs (e.g. temperature, absorbance and light emission) or by employing a 
secondary solution assay to probe changes in one of the biomolecules (Goodrich and 
Kugel, 2006).  A number of fluorescence techniques (fluorescence resonance energy 
transfer, fluorescence anisotropy, induced fluorescence and fluorescence quenching) 
allow binding to be studied by monitoring changes in fluorescence due to association 
between a protein and a ligand.  Such assays can monitor changes in a natural 
fluorophore (e.g. a tryptophan) present in a molecule or a label by fluorescent dye.  
Another way is to separate complexes from the free biomolecules based on differences 
in size, charge or conformation (Goodrich and Kugel, 2006). 
8.1.2 Affinity and apparent affinity 
Affinity describes the strength of an interaction between two molecules.  To 
understand affinity constants (dissociation constant Kd and binding constant Kb) it is 
helpful to consider the rate constants governing the association and dissociation of the 
two molecules (Goodrich and Kugel, 2006).  In a bimolecular reaction: 
ABBA
k
k
1
1
→←+
−
      Equation 8.1 
The dissociation constant Kd is equal to the reverse rate constant divided by the 
forward rate constant (Equation 8.2) and is expressed in units of M.   
1
1
k
k
K d
−
=        Equation 8.2 
Binding constant (Kb) is the reciprocal of Kd: 
d
b K
K 1=        Equation 8.3 
An interaction with a low Kd (high affinity) will likely have a large k1 and small 
k
-1 meaning that A and B will associate rapidly and the AB complex will dissociate 
slowly.  Kd can be related to the concentrations of the three components that are present 
at equilibrium (A, B and AB): 
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where: ][A , ][B and ][AB  are the molar concentrations of the reaction 
components at equilibrium. 
At equilibrium, the population of A molecules will consist of free A and A 
bound in AB complexes: 
][][][ ABAATotal +=       Equation 8.5 
][][][ ABBBTotal +=       Equation 8.6 
The forward and reverse rate constants do not need to be known to measure the 
affinity constant; Kd can be measured directly (under equilibrium conditions) as 
follows. 
Equation 8.2 is transformed into: 
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where [AB]/[ATotal] is the fraction of A put into the reaction that is in the AB 
complex at equilibrium.  If the right half of Equation 8.7 is divided by Kd it can be 
transformed into: 
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When [AB]/ [ATotal] is plotted on the y-axis and [B] is plotted on the x-axis, Kd is 
equal to the concentration of free B ([B]) at which the fraction bound ([AB]/[ATotal]) is 
half the maximum value.  Equation 8.7 derives a hyperbola when x-axis is linear and 
one sigmoidal when a logarithmic axis is used (Figure 8-1).  In both cases Kd is the 
concentration of B at which the fraction bound is 0.5, best expressed in Equation 8.8. 
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Figure 8-1 Bimolecular binding curves plotted on a linear x-axis in (A) and a 
logarithmic x-axis (B).  The dissociation consant Kd is 10 nM in both plots.  Figure 
reproduced from Goodrich and Kugel (2006).  This is a non-cooperative system.  In a 
cooperative system both the linear and logarithmic axis plots would be sigmoidal. 
To experimentally measure the Kd using Equation 8.7 or Equation 8.8 a series of 
reactions are performed in which the concentration of A is kept constant and the 
concentration of B is varied, and the concentration of AB complex – and possibly B 
unbound – is determined.   
In principle, any concentration of A can be used.  In practise it is simplest to 
determine a Kd when the concentration of A in the reactions is significantly lower than 
the Kd for the interaction [ATotal]<<Kd  (ideally 100-fold below the Kd).  When 
[ATotal]<< Kd, the amount of B in the AB complex is only a small fraction of total B, 
hence free [B] approximates [BTotal] ([B]≈[BTotal]).  This simplifies performing 
experiments, as free [B] does not have to be measured at equilibrium and [BTotal] (the 
total concentration of B in the reaction mix) can be plotted on the x-axis instead of free 
[B].  The Kd can then be determined using Equation 8.7.  If [ATotal] is not significantly 
lower than Kd, free [B] must be measured at equilibrium in each reaction as [B] does not 
approximate [B]Total under these conditions (Figure 8-2). 
In summary, the simplest way to measure a Kd is to set [ATotal]<<Kd, plot 
[AB]/[ATotal] versus [BTotal] and fit the data with Equation 8.7.  If these conditions 
cannot be met, free [B] must be measured for each [BTotal].  
Experiments to measure affinity constants must be performed under equilibrium 
conditions, where there is no overall change in the concentrations of the free and bound 
species in the reaction over time.  Another experimental consideration is that in most 
assays one biomolecule is labelled (fluorescently or radioactively) to facilitate detecting 
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that molecule and the AB complex.  The Kd is affected by assay conditions such as pH, 
temperature, salt concentration and the presence of divalent ions.   
If one of the biomolecules in a bimolecular reaction is an enzyme, it might be 
possible to use the enzymatic reaction to measure the binding affinity between the 
enzyme and a second biomolecule (e.g. a regulator).  A Kd measured in this way is 
referred to as an apparent Kd because the assay used to make the measurement is 
indirect (i.e. it does not directly monitor binding). 
 
Figure 8-2 Bimolecular binding curves illustrating two experimental extremes: 
[ATotal] << Kd and [ATotal]>> Kd. In all plots, the Kd is 10 nM. [ATotal] is 0.1 nM in (A) 
and 1000 nM in (B).  Figure reproduced from Goodrich and Kugel (2006). 
8.1.3 Allostery and cooperativity 
In allostery a regulatory substance binds to a subunit of a mutli-subunit protein at 
a site other than the protein’s active site.  The binding alters the conformation and 
- 253 - 
functional properties of the molecule (Dorland, 2010).  Cooperative binding is a special 
case of allostery that occurs in macromolecules with more than one binding sites.  
Binding to one site changes the binding affinity of the other subunits by induction of 
conformational changes at the other binding sites.  Cooperative enzymes typically 
display a sigmoidal (S-shaped) plot of reaction rate versus substrate concentration” 
(IUPAC, 1997). 
The Hill equation was formulated in 1910 to describe the sigmoidal O2 binding 
curve of haemoglobin (Hill, 1910).  It is a simple, empirical equation that predicts the 
fraction of the macromolecule saturated by ligand as a function of ligand concentration.   
For the association between enzyme A and x  identical molecules of ligand B the 
equilibrium between A and B can be described: 
xABxBA →←+       Equation 8.9  
The equilibrium between A and B can be described: 
n
d
n
Total
x
AK
A
A
AB
][
][
][
][
+
=       Equation 8.10 
where: n=Hill coefficient and Kd is the dissociation constant. 
In the case of positive cooperativity, the Hill coefficient is the slope of the 
ascending sigmoidal curve in a semi-log plot.  The Hill equation provides useful means 
of assessing cooperativity in systems containing multiple B molecules binding to A, as 
long as its limitations are understood.   
One common misuse of n is to estimate the number of B molecules bound to 
each molecule of A (Weiss, 1997).  Another common misuse is to consider n=1 as 
indicator of completely independent binding (non-cooperative) and n<1 as indicator of 
negative cooperativity; these assumptions are not universally correct.  The Hill equation 
can only provide clear evidence for positive cooperativity when n>1, however it cannot 
be used to determine negative or non-cooperative systems without also taking into 
account the relative affinities of each different site on A for binding B (Goodrich and 
Kugel, 2006).  It cannot provide accurate measurements of the Kd for the interaction of 
B at any site of A or the exact number of B molecules that bind to A.  Coefficient n is 
only a minimum estimate of the number of binding sites involved (Weiss, 1997). 
k1 
k-1 
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8.1.4 Concentration-response curves 
Concentration-response (or dose-response) curves are graphs that help 
characterise the effect of various compounds on enzymes/receptors.  The x-axis plots 
concentration of a substance (e.g. a drug or hormone) and the-y-axis plots response.  
Response could be almost any measurable biological function, such as enzyme activity, 
contraction of a muscle, change in heart rate etc (Motulsky and Christopoulos, 2003).  A 
standard concentration-response curve (Figure 8-3) is defined by four parameters:  the 
baseline response (Bottom), the maximum response (Top), the slope, and the 
concentration that provokes a response halfway between baseline and maximum (half 
maximal effective concentration EC50).   
Some of the standard shapes of many systems concentration-response curves are 
shown in Figure 8-3 to Figure 8-5.  Stimulation is indicated when the curve goes uphill 
from low to high concentration of regulator (Figure 8-3).  The substance may produce a 
full or only a partial response.  Inhibition is indicated by a downward curve (Figure 
8-4).  Some substances may stimulate respone at low concentrations and inhibit 
response at high concentrations, or vice-versa.  This is expressed in bell-shaped 
concentration-response curves (Figure 8-5).  Such a model is used qualitatively as a lot 
of data would be needed to determine all its parameters (Motulsky and Christopoulos, 
2003).  
A hyperbola is descriptive of many binding phenomena.  Although this 
dependence appears sigmoidal in semi-log plots, real cooperative systems exhibit 
sigmoidal behaviour even in linear plots (Section 8.1.1, Figure 8-1) (Bisswanger, 2008).  
Since the linkage between binding and response can be very complex, any shape is 
possible for concentration-response curves.  However, many concentration-response 
curves have shapes “almost identical to hyperbolic/sigmoidal binding curves, even when 
multiple steps intervene between binding and measured response”.  The shape of 
concentration-response curves will often be similar to that of a single-step binding curve 
(Motulsky and Christopoulos, 2003). 
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Figure 8-3  Sigmoidal concentration-response curve – stimulation.  Figure reproduced 
from Motulski and Christopoulos (2003).  
   
Figure 8-4  Concentration-response curve – inhibition.  Figure reproduced from 
Motulski and Christopoulos (2003).  
    
Figure 8-5  Bell-shaped concentration-response curve.  Figure reproduced from 
Motulski and Christopoulos (2003). 
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The EC50 is determined by two properties of the regulator molecule:  (1) its 
affinity (how tightly it binds to the enzyme) and (2) its efficacy (intensity of the 
response once bound).  A single concentration-response experiment will encompass the 
effects of both affinity and efficacy.  If a substance binds with high affinity and low 
efficacy it will produce the same concentration-response curve as one that binds with 
low affinity and high efficacy.   
The EC50 is not a direct measure of drug affinity and usually not necessarily the 
same as the Kd for the binding of a substance to its receptor.  The EC50 is merely the 
concentration of substance required to “provoke a response halfway between the 
baseline and maximum responses” (Motulsky and Christopoulos, 2003).  In the cases 
where the concentration of an inhibitor is varied (concentration-response curve moves 
downhill), IC50 is the concentration that causes 50% inhibition (IUPAC, 2010).  
8.1.5 The aequorin system 
Enzymes are biomolecules that catalyse chemical reactions and are not 
consumed by the reactions they catalyse (Berg et al., 2002).  Aequorin is not a typical 
enzyme, as the catalysed substrate is bound within the protein chain (hydroperoxy-
coelenterazine) and when the reaction is completed the spent substrate remains loosely 
bound to the protein chain (Section 1.3.1).  One molecule of aequorin can only process 
one molecule of coelenterazine.  The spent substrate (coelenteramide) can be separated 
from the protein chain by size exclusion chromatography and calcium (activator ion) 
bound in the EF-hands is removed by chelating agents such as EGTA or EDTA.  In 
order to achieve regeneration of fully active aequorin fresh coelenterazine must be 
added (Section 1.3.8).   
The activators for the bioluminescent reaction are calcium ions which act 
allosterically: in aequorin the activation points are the solvent accessible calcium 
binding EF-hands, whereas the reaction of coelenterazine oxidation occurs in the core of 
the protein (Section 1.3.1).  Two to three calcium ions bind with positive cooperativity, 
i.e. the binding event of the first increases the affinity of aequorin for the consecutive 
calcium ions; it is also known that two calcium ions are required to complete the 
reaction and that even one can trigger the reaction, although with considerably lower 
rate (Section 1.3.7).  Aequorin function does not conform to Michaelis-Menten kinetics 
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but produces a characteristic sigmoidal curve that declares positive cooperativity 
between the calcium binding sites (Section 1.3.1). 
8.1.5.1 Fundamental work on the kinetics of aequorin 
Hastings and co-workers (1969) performed some fundamental experiments to 
explore the mechanism of aequorin luminescence using rapid mixing techniques 
(double-stopped flow apparatus).  The onset of light emission was found to be fairly 
rapid with a pseudo-first order rate constant of about 100 s-1 (half rise time of about 
6 ms) and virtually independent of calcium concentration over the range examined.  The 
decay of light intensity was exponential over at least one order of magnitude with rate 
constants between 1–1.2 s-1.  The rate of decay was found to increase with increasing 
calcium concentrations from a very low value below 10-7 M to a maximum reached 
between 10-5 and 10-4 M.  This rate represented the rate of aequorin utilisation.  Both the 
rate of rise and rate of decay were found to be influenced by temperature, as shown in 
Table 8–1 (Hastings et al., 1969).  The ultimate photon yield was found to be constant 
over a wide range of calcium concentrations tested (Hastings et al., 1969).  
                    Table 8-1  Aequorin kinetic constants in published literature. 
Kinetic constants of aequorin at 5 °C at 25 °C at 50 °C 
Rate constant for rise (s-1) 461 100–3002 6901 
Rate constant for decay (s-1) 0.51 1.0–1.22 71 
                      1: Hastings et al, 1969 
                      2: Loschen and Chance (1971) in Shimomura (2006) 
 
The authors conducted experiments to determine whether the relatively long 
duration of light emission in a great excess of calcium should be attributed to the 
continued presence of free calcium or to the decay of some rapidly formed reaction 
intermediate that could yield light without calcium.  These experiments used mixed 
solutions containing aequorin and calcium in the presence and absence of chelating 
agents.  EDTA was added to bioluminescence reactions already in progress in order to 
deplete free calcium from the solution and calcium already bound to aequorin.  The 
addition of excess of EDTA resulted in continuation of luminescence but with a very 
rapid exponential extinction, indicating that the light emission normally extending over 
a second or more requires the continued presence of free calcium (Hastings et al., 
1969).   
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The authors also concluded that aequorin forms an intermediate in the 
luminescence reaction that, once formed, irreversibly leads to the emission of light 
without the continued presence of free calcium.  The lifetime of this intermediate was 
found to be t1/2≈7 ms at 19 °C.   
A hypothetical reaction scheme (stoichiometry unspecified) that would 
accommodate these results was constructed (Equation 8.11):   
 
A Ca2++
k1
k
-1
ACa
k2 k3 k4X YY* +
  Equation 8.11 
The first step of the proposed mechanism is the very rapid and reversible binding 
of calcium to aequorin.  The authors proposed that – provided maximally effective 
calcium is present – the rate of the overall reaction is limited by the rate of the second 
step (k2 approximately 1 s-1) in which the intermediate X is formed.  X gives rise to an 
excited singlet state Y* (such states typically have lifetimes of nanoseconds) at a rate 
governed by k3, which is in the order of 100 s-1.  Calcium ions initiate the cascade of 
events, but X→Y* does not require the presence of calcium (Hastings et al., 1969).   
In later publications it was proven that the excited singlet state Y* is the excited 
hydroperoxy-coelenterazine (Shimomura and Johnson, 1972, Shimomura and Johnson, 
1975a, Head et al., 2000, Shimomura and Teranishi, 2000).  If one did not assume the 
existence of the intermediate X, the rate of decay of light intensity found on quenching 
with EDTA might be attributed to the rate of dissociation of ACa (governed by k
-1).  In 
this case, however, one would expect the rise-time of the luminescence reaction to be 
dependent on calcium concentration.  Thus  k
-1 was assumed to be considerably greater 
than k3 (Hastings et al., 1969).  
8.1.5.2 A model of double exponential decay 
It was previously known that for wild type aequorin the decay rate of the flash-
type luminescence curve (see Section 1.1.4 for distinction between flash- and glow-type 
luminescence) increases with calcium concentration, while the total light emitted (light 
integral) remains relatively constant (Section 8.1.5.1).  In a recently published study 
Tricoire and co-workers (2006) focused only on the decay of the bioluminescent 
reaction.  This was the first published proposal of a double exponential decay model of 
aequorin luminescence.  The authors deemed that a single exponential component was 
not enough to describe aequorin luminescence decay because the semi-log plot of 
luminescence decay versus time was not linear. 
hν 
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The authors used random mutagenesis and functional screening to isolate 
mutants exhibiting flash-type luminescence with slow decay rate.  They proposed that 
the decay of aequorin’s flash-type luminescence reaction comprises of two exponential 
components: one fast and one slow.  The authors proposed that variations of these two 
components dictate the peak of the luminescence curve.  The decay traces of wild type 
and mutant aequorins were fitted with two exponentials according to Equation 8.12: 
SF t
S
t
F eIeIy
ττ // −− ×+×=       Equation 8.12 
where τF and τS are the time constants of the fast and slow component 
respectively and IF and IS are the initial maximum intensities of the fast and slow 
component.  The light integrals ΣF and ΣS of these components (where total light ΣT is 
ΣT = ΣF + ΣS) were also determined 
SSS I τ×=Σ         Equation 8.13 
FFF I τ×=Σ         Equation 8.14 
Tricoire and co-workers proposed a model of aequorin calcium dependence 
taking into account the variations of decay rate with calcium concentration as a key 
determinant of light intensity.  They suggested that the fast and slow components 
coexist across different aequorin variants and calcium concentrations.  The authors also 
propose that the concept of parallel slow and fast decay agrees with the increase of light 
intensity and decay rate with increasing calcium concentrations, given that the light 
integral is constant at all calcium concentrations.  The kinetics of slow decay mutants 
for a given EF-hand were found to be similar and deemed to result from the disruption 
of a link between an EF-hand domain and coelenterazine binding residues and not from 
the reduction of its calcium affinity (Tricoire et al., 2006).   
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8.2 Materials and methods 
8.2.1 Aequorin and coelenterazine 
Purified fractions of wild-type aequorin and purified mutant Asn28Cys/Ser32His 
were prepared as described in Chapter 7.  Commercially available recombinant aequorin 
AquaLite® was obtained in lyophilised form from Molecular Probes and purified with 
the same chromatographic methods used for wild-type and mutant Asn28Cys/Ser32His 
in Chapter 7.   
8.2.2 Protein concentration 
The concentration of purified aliquots of wild-type and mutant aequorin was 
determined by absorbance at 280 nm on the NanoDrop® ND-1000 (NanoDrop 
Technologies, Rockland, US).   
Shimomura and Shimomura (1981) determined that in order to maintain constant 
specific activity aequorin must be used at concentrations <10 µg/mL.  Appropriate serial 
dilutions of the purified aequorin fractions were made in 50 mM Tris-HCl 10 µM 
EDTA pH 7.5 for a final concentration of 5.1 µg/mL (approximately 0.21 µM).  After 
1:1 mixing with metal ion solutions the final concentration of aequorin was 2.55 µg/mL 
(approximately 0.11 µM).  This concentration of protein in the final mixture is 
sufficiently low compared to previously reported values of aequorin calcium affinity – 
13 µM reported by Kendall and co-workers (1992) – to allow estimation of an apparent 
affinity from the concentration-response curves of the aequorins versus the different 
metals. 
Protein samples were handled as described in Section 7.3.6 in order to avoid 
contact with contaminating calcium in vessels as well as inactivation due to prolonged 
exposure at room temperature.  The 5.1 µg/mL protein solutions were kept on ice in a 
universal tube that had been previously rinsed with 50 mM Tris-HCl, 10 µM EDTA 
buffer so that any metal ions which may be present on the tube surface would be 
chelated and removed.   
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8.2.3 Concentration range of metal ions 
Salts of calcium, lanthanum, cadmium, zinc, copper, cobalt and lead Table 2–9 
were dissolved in 50 mM Tris-HCl buffer, pH 7.5 and their actual metal ion content was 
determined by elemental analysis (Section 2.5.2).  The concentrations of all metal ion 
solutions would include the concentration range from 10-7 M to 10-3  M that is relevant 
for biomedical and environmental studies (Pinton et al., 2007, Shimomura, 1991, 
Shimomura, 2006, Tricoire et al., 2006).  Nominal dilutions were made over a range of 
10-7 M to 10-2 M for all metal ions studied.  The values of the nominal concentrations 
were corrected using total ion determination data (Section 2.5.2).  As EDTA would be 
present in the final bioluminescence mixture of protein and metal ions, only free 
(unchelated by EDTA) metal ions would be available for aequorin binding.   
The WinMAXC32 v2.51 Chelator program (Patton, 2002) was used to calculate 
the free concentration of each metal solution in the final (luminescence measurement) 
mix taking into account the total metal ion concentration, 2.3x10-7 M total 
contaminating calcium (traces of which are present in all chemical preparations) and the 
program in-built affinity constants of EDTA for all metal ions used.  The original range 
of evenly spaced nominal ion concentrations (10-7 to 10-2 M) resulted in a much wider 
range of calculated free (unchelated) metal ion concentrations (10-16 M to 10-2 M) due to 
the chelating effect of EDTA (up to 10 µM) in the final mix.   
According to studies by Shimomura and Shimomura (1984) aequorin’s detection 
limit of calcium ions is 1 nM in low ionic strength buffers and 100 nM in 0.15 KCl 
solutions.  In this work 0.25 nM of free calcium in 50 mM Tris-HCl 5 µM EDTA 
pH 7.5 (negative control buffer) did not trigger luminescence above noise level.  6.4 nM 
of free calcium in 50 mM Tris-HCl 5 µM EDTA pH 7.5 was found to trigger 
measurable luminescence in wild-type aequorin.   
8.2.4 Experimental setup and platereader settings 
Aequorin activity was measured in a BMG FluoStar Optima platereader (Section 
2.7.1) by injecting 50 µL of protein solution (5.1 µg/mL wild-type or mutant aequorin in 
50 µM Tris-HCl 10 µM EDTA) into microwells containing 50 µL of variable metal ion 
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concentrations in 50 mM Tris pH 7.5 (Section 8.2.3).  The measurements were 
performed in Lumitrac™ 96-well plates at 21–23 °C. 
Measurements were performed in triplicate (unless stated otherwise).  Injection 
was set to maximum speed (420 µL/s) for rapid mixing and luminescence was measured 
for a total duration of 15 s.  Recording of luminescence started at time 0 s and the 
injection of protein into the wells started at 0.3 s in order to capture any background 
signal before and during injection.  Data were collected with 0.1 s integration time.  
Where background noise was detected, it was subtracted from light readings before 
further data analysis.   
Due to significant differences in light intensity across different combinations of 
aequorins and metal ions, a uniform gain setting across all experiments would either 
cause over-range readings (e.g. wild type plus calcium) or no detection in others (e.g. 
mutant plus zinc).  The gain settings of the photomultiplier tube were altered in order to 
adjust the sensitivity of the light readings through trial and error.  The gain settings of 
the photomultiplier ranged from gain 2,000 to 4,000.  At low gain settings no 
background signal was detected.  Low levels of noise were captured at gain ≥ 3,500.  
The absolute luminescence output values are not directly comparable across the entire 
dataset, but only within each plate or across plates processed at the same gain settings.   
In order to protect the protein administered through the syringe from traces of 
contaminating calcium, the syringe pump and tubing were rinsed with 50 mM Tris-HCl 
buffer solutions with decreasing concentrations of EDTA (first wash: 10 mM, final 
wash: 10 µM EDTA) for the removal of metal ions and finally primed with 1 mL of 
sacrificial protein sample. 
Addition of high calcium concentrations to protein solutions containing EDTA 
can cause a drop in pH.  It has been reported that aequorin’s stability is maximal within 
the pH range 6.0–8.0 (Shimomura, 2006, Shimomura and Johnson, 1969, Shimomura 
and Johnson, 1970).  Changes in pH were measured for representative samples of each 
set of experiment.   
Solutions containing low and high concentrations of each of the metal ions used 
in this chapter were mixed 1:1 with the buffer aequorin was diluted in (50 mM Tris-HCl 
10 µM EDTA, pH 7.5) in order to assess the effect of EDTA in the final mix on pH.  
The pH of all the solutions remained between 7.1–7.4 post-mixing, with the exception 
of solutions containing lead.  As lead precipitated in Tris-HCl, it was diluted in R.O. 
water instead (Section 2.5.1) and the pH of the solutions was 5.0–5.2 prior to mixing.  
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Post-mixing pH was 7.5 at the lowest and 2.96 at the highest concentration of lead 
tested.  The lack of pH buffering in the lead system is expected to affect the protein’s 
stability and activity.  This will be taken into consideration in discussion of results. 
8.2.5 Method for double ion experiment   
Forty microliters of increasing zinc concentration solutions (1.5 µM to 5.5 mM 
before mixing) were pipetted into microwells.  Forty microliters of 5.1 µg/mL purified 
aequorin (wild-type or mutant) in 50 mM Tris-HCl EDTA 10 µM EDTA pH 7.5, were 
injected into the microwells at time 0.3 s and the reaction was allowed to proceed until 
time 10 s.  At 10 s, 40 µL of 50 mM Tris-HCl 50 µM CaCl2 (shown in Section 8.3.2 to 
be sufficient amount of calcium to complete the luminescence reaction and reach 
plateau in the dose response curves) were injected into the microwells in order to 
provide aequorin with enough calcium to successfully activate the luminescence 
reaction.   
8.2.6 Data processing 
8.2.6.1 Luminescence curves and concentration-response curves 
Light versus time data were originally processed in Microsoft Excel and the peak 
and sum of luminescence counts during measurement time (15 s) were obtained.  The 
term “Peak luminescence” was assigned to the single maximum luminescence 
measurement of each well.  This term is relevant to the flash-type luminescent reactions 
and perhaps less relevant for glow-type reactions (Section 1.1.5, Figure 1.4).   
Concentration-response curves were populated with the peak of the 
luminescence trace curve for every concentration of each ion tested versus ion 
concentration.  As luminescence counts vary across different instruments and across 
different gain settings of the same instrument, the values of luminescence peaks were 
normalised to the maximum peak observed for that particular ion and the y-axes of the 
concentration-response curves were presented as percentage of maximum for the 
particular set of data (aequorin molecule and metal ion).  The concentration-response 
curves were plotted in SigmaPlot software v.11.0 (Systat Software Inc., Chicago, USA) 
and EC50 values (and IC50 where applicable) were determined.   
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8.2.6.2 Exponential model fitting 
Luminescence exponential decays were analysed with SigmaPlot software.  Fast 
and slow components of double exponentials are described by their fast and slow time 
constants (τF and τS respectively), and their light integrals (ΣF and ΣS respectively), 
while the total light integral ΣT=ΣF+ΣS is defined in Section 8.1.5.2. 
The model of double exponential decay published by Tricoire and co-workers 
(2006) (Section 8.1.5.2) is appropriate only to the reactions exhibiting flash 
luminescence.  Based on this work, Equation 8.15 was fitted to the time resolved data 
points past the peak of the luminescence curve using SigmaPlot.  The data points of 
each individual dataset (i.e. corresponding to each ion concentration for wild type or 
mutant) were normalised by the luminescence peak of the dataset.  Equation 8.15 is an 
adaptation of Equation 8.12 to using normalised data points: 
SF tt eceay ττ // −− ×+×=       Equation 8.15 
where τF and τS are the time constants of the fast and slow component 
respectively and a and c are the fractions of the initial maximum intensities of the fast 
and slow component, where a+c=1 (or 100% of total light contribution). 
8.2.6.3 Estimation of glow luminescence kinetics 
In the case of glow luminescence traces, a useful metric of the speed of decay 
would normally be the time required for light to fall to half of the maximum value 
recorded (t1/2).  In this work, measuring t1/2 was not possible because – for most 
experiments – the decay was too slow to extract this parameter within the 15 s window 
of each experiment.  Instead time was fixed at 15 s and the ratios between luminescence 
at 15 s over maximum luminescence of the glow curve were compared.  Thus, by 
quantifying the progress of the decaying curve, an indirect measure of the progression 
of bioluminescence reaction (or reaction rate) was obtained, which was named P15s/Max 
and defined as shown in Equation 8.9.  Specifically, from each glow luminescence 
curve P15s/Max was calculated: 
Max
s
Maxs L
LP 15/15 1−=        Equation 8.16 
where: 
L15s is the luminescence at 15 s and  
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LMax is the maximum value of luminescence  
Subtracting the luminescence ratio from 1 served to produce a metric of the 
progress of the reaction: higher values for P15s/Max correspond to higher reaction 
kinetics.  This metric by its definition can give information of reaction kinetics only and 
cannot be used to describe processes related with yield of light.   
Upon implementation, this proved to be a robust metric in that the variance 
among triplicate experiments was very low.  At very low and very high ion 
concentrations low levels of luminescence and high noise prevented accurate estimation 
of L15s and LMax and such data points were discarded.   
The glow curves are associated with low yield production.  For this reason high 
gain settings were applied in the platereader which in turn resulted in noisy data in 
several cases.  To mitigate this effect, averaging was used both for the estimation of 
both LMax and of L15s.  Specifically, to determine the maximum response observed, the 
raw data was processed using a moving average filter.  A moving average is commonly 
used with time series data to smooth out short-term fluctuations and highlight longer-
term trends or cycles.  For each time point the average of the two preceding points, the 
current point and the two following points was calculated.  To minimise the effect of 
noise on L15s value, this was calculated as the mean of the five last data points (for time 
14.5 to 14.9 s).   
8.2.7 Artefacts from syringe injection 
Artefacts are common occurrences in luminescence and fluorescence readings 
and they are often associated with injection events.  They are different to background 
noise as to their timing and duration:  background noise is present in blank samples or 
samples where a reaction has not been initiated and its values are fairly stable; the 
experimental results can be corrected for noise by means of a simple subtraction.  
Artefacts are different in that they can occur in one or more specific instances during a 
experiment, e.g. more often associated with injection or other events.  Frictional forces 
due to a very rapid injection can excite the probe and produce an injection artefact (Van 
Dyke et al., 2002).  In this work, luminescence artefacts associated with the event of 
injection were identified and removed from the data set.  
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8.2.8 Assay objectives and limitations 
The purpose of the assay was to assess the response of aequorin wild-type and its 
mutant variant Asn28Cys/Ser32His to various metal ions and compare the different ions 
in their ability to induce luminescence in aequorin. 
The experimental setup consists of mixing protein with metal ion solutions and 
recording the light output.  It is important to note the assay’s limitations.  There is no 
direct or indirect measurement of the amount of ions free in solution or bound by the 
protein, hence binding curves are not attainable.  Structural/conformational changes 
occurring in the protein as a result addition of ions were not monitored.  The assay did 
not record any potential spectral changes in light emission but measured all visible light 
as produced by the luminescence reaction.   
With these limitations in mind, the following types of information can be 
elicited: 
• qualitative and quantitative analysis on the effect (activating or inhibitory) of 
ions on luminescence activity of aequorin wild-type and mutant by plotting 
concentration-response curves 
• the rate of luminescence can be quantified into a (set of) kinetic constants or 
characteristic times 
• a measure for sensitivity for each ion can be introduced, by identifying the 
lowest ion concentration at which bioluminescence proceeds or by means of 
estimating EC50. 
These metrics are fairly easy to estimate and are quite relevant in the applications 
of aequorin as a metal biosensor.   
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8.3 Results and discussion 
Seven metal ions – calcium, lanthanum, cadmium, lead, zinc, copper and 
cobalt – were tested as potential activators of wild type and mutant aequorin.  
Luminescence response (activity) versus time was monitored.   
Section 8.3.1 presents one typical shape of the luminescence traces for each 
combination of protein-metal tested.  The shape of the curves will be discussed and 
maximum values from each luminescence curve at every ion concentration will be used 
to compile concentration-response curves in Section 8.3.2.  Concentration-response 
curves show sensitivity of the protein to each metal and the effect of each metal as an 
activator or inhibitor at the ranges of concentrations tested.  In Section 8.3.3 the ions are 
compared to each other for their ability to trigger light production in wild-type and 
mutant aequorin. 
Kinetic parameters for the experimental results were derived using two methods 
of analysis depending on the shape of the luminescence traces in Sections 8.3.4.1and 
8.3.4.2.   
Double ion experiments in Section 8.3.5 show the effect of two ions on aequorin 
(zinc and calcium), with zinc envisaged to bind to and possibly activate the mutated EF-
hand loop and calcium to bind to the non-mutated EF-hands.  
The experimental results regarding shape of luminescence curves, concentration-
response curves, sensitivity and yield are discussed in relation to structural parameters 
derived in Chapter 5. 
8.3.1 Luminescence curves: flash and glow-type 
The light intensity (luminescence) was recorded as described in Section 8.2.4. 
Luminescence was plotted against time for each metal ion concentration.  Both wild 
type and mutant were tested with twelve metal ion concentrations of seven different 
metal ions and each experimental condition was performed in triplicate.  For simplicity 
one representative luminescence trace from each aequorin-metal set was chosen to 
illustrate the shape of the graphs in Figure 8-6 (wild type) and Figure 8-7 (mutant).   
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From the entire dataset of time course experiments with wild-type aequorin and 
all concentrations of calcium (Supplementary Material), it was interesting to notice that 
the rise time was independent of calcium concentration (luminescence peak occurred at 
1 s) but the rate of decay was affected by calcium concentration.  Both observations are 
in agreement with published literature (Hastings et al., 1969).  
Although luminescence traces may vary slightly in sharpness between different 
ion concentrations for each aequorin-metal combination, the curves overall fall under 
two distinct shapes.  Luminescence triggered by calcium, lanthanum and lead is flash-
type, characterised by a sharp onset and sharp decay of light (Figure 8-6) Luminescence 
traces triggered by cobalt and zinc are glow-type, characterised by a slow rise to a fairly 
broad peak followed by a slow decay (Figure 8-7).   
Luminescence curves triggered by copper were classified as glow-type because 
the shapes of the traces varied from a non-sharp peak to a “classic” glow-type shape 
depending on the concentration of copper (Supplementary Material).  Cadmium 
presents a special case in that it triggers luminescence traces of a unique shape that 
seems to be a contribution of a sharp response followed by a glow-type luminescence 
curve with a slow decay.   
The classification of the shape of luminescence curves is the same in wild-type 
aequorin and variant Asn28Cys/Ser32His, but overall the kinetics of decay in the 
mutant are slower compared to wild type.  In wild-type aequorin, luminescence reached 
a sharp peak at 1 to 1.1 s, with the injection occurring between 0.3 and 0.4 s.  Gain 
settings varied across different ions and different proteins (Appendix Chapter 8, Table 
10-14) therefore the output of luminescence units on the y-axes cannot be compared 
across the different plots.  
Table 8-2  Luminescence curve shapes. 
 Wild-type aequorin___ Mutant Asn28Cys/Ser32His 
Calcium Flash-type Flash-type 
Lanthanum Flash-type Flash-type 
Lead Flash-type Flash-type 
Cadmium combination combination 
Cobalt Glow-type* Glow-type* 
Zinc Glow-type Glow-type 
Copper Glow-type Glow-type 
*Borderline flash-type 
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Figure 8-6  Light versus time – Wild-type aequorin.  Tested with Ca2+, La3+, Pb2+, Cd2+, 
Cu2+, Zn2+, Co2+ at the respective ion concentrations that trigger maximal response of 
activity and correspond to the peak of the concentration-response curves in Figure 8-8. 
2.55 µg/mL of protein post mix, pH 7.45 (lead at pH ~5), T=23 °C. 
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Figure 8-7 Light versus time – Mutant Asn28Cys/Ser32His. Tested with Ca2+, La3+, 
Pb2+, Cd2+, Cu2+, Zn2+, Co2+ at the respective ion concentrations that trigger maximal 
response of activity and correspond to the peak of the concentration-response curves in 
Figure 8-9.   2.55 µg/mL of protein post mix, pH 7.45 (lead at pH ~5), T=23 °C.                         
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8.3.2 Concentration-response curves 
Concentration-response (or concentration-response) curves were drawn to study 
the effect of varying concentrations of metal on wild-type and mutant aequorin.  
Triplicates of a range of ion concentrations per aequorin-metal combination were used.  
To simplify comparisons all results were normalised by the highest measured activity of 
each set so that the y-axis of response is the percentile of maximum response achieved 
within each set of aequorin-metal combination (e.g. wild type and calcium, mutant and 
calcium etc). 
A visual inspection of the concentration-response curves reveals that the 
different ions exert different effect on wild-type and mutant aequorin.  The sigmoidal 
curves of wild type triggered by each of calcium, lanthanum and cadmium suggest 
cooperative binding (both linear and semi-logarithmic plots were sigmoidal).  The 
sigmoidal curve of wild type plus calcium agrees well with the sigmoidal curve of 
commercial aequorin AquaLite® (Figure 8-8), which indicates that the preparation of 
aequorin in this work and the presence of His-tag and two additional amino acids at the 
C-terminus (Section 3.3.4, Figure 3-8 and Figure 3-9) did not alter its properties in 
regard to shape of the bioluminescence trace and calcium sensitivity.  Additionally, it 
will be shown in Section 8.3.4.1 that kinetics of wild type and mutant aequorin are very 
similar.   
The profiles of mutant aequorin triggered by each of calcium, cadmium and 
lanthanum resemble a sigmoidal curve but are not as concrete as the profiles of wild 
type with the same ions.  In the case of lanthanum, it hints toward a sigmoidal shape but 
very few non-zero points were available.  For biomedical systems however, 
concentrations of free lanthanum higher than 0.1 M would not be applicable.  It is 
noteworthy that mutant aequorin shows dramatically decreased sensitivity to lanthanum 
compared to wild type.   
The concentration-response curves of lead, cobalt, zinc and copper with wild 
type and mutant are all bell shaped (Section 8.1.4).  This indicates a departure from the 
cooperative binding model.  At low concentrations these ions act as partial activators of 
aequorin until a maximum is reached.  At higher concentrations they have an inhibitory 
effect on aequorin luminescence for both wild type and mutant.  In terms of ion 
sensitivity, wild-type was found to be more sensitive to all other ions than its native 
activator calcium, as expressed by the maximum values (and consequently the EC50) 
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occurring at significantly lower concentrations of metals.  However the activity 
produced with other ions as activators was significantly lower than the wild-type plus 
calcium combination, summarised in Figure 8-10, Section 8.3.3.  Characteristic values 
and qualitative observations of the concentration-response curves are summarised in 
Table 8-3.  Due to lack of some data points in the interesting “ascending range” of some 
of the concentration-response curves, it was not possible to extract exact values but only 
ranges for EC50 and IC50 (where applicable).  
Overall, mutant aequorin exhibited increase of sensitivity to calcium and zinc 
(reduction of EC50 of approximately one order of magnitude) compared to wild type.  
The opposite effect was seen with lanthanum, where mutant aequorin almost lost its 
sensitivity as shown by an estimated increase of EC50 of between four and seven orders 
of magnitude compared to wild type (Table 8-3).  The sensitivity to cadmium remained 
relatively unchanged.  Comparisons of sensitivity to copper, cobalt and lead were not 
possible due to lack of data in the very low ranges where the respective EC50 values 
resided. 
These results can be further discussed in terms of physical processes.  In general, 
increase of sensitivity (decrease of EC50) means either faster or stronger binding, or 
faster light production by the activated intermediate.  
The increase of mutant sensitivity to calcium agrees with findings by Tricoire 
and co-workers (2006) in regard to effect of mutations in EF-I.  The authors reported the 
“seemingly paradoxical” increase of calcium sensitivity in mutants that contained 
altered EF-I but a decrease of sensitivity in mutants that contained altered EF-III or EF-
IV.  As a result they assumed that EF-I must have lower calcium affinity than EF-III 
and EF-IV; the exact increase in sensitivity was not quantified as the ascending range in 
the mutant concentration-response curve was outside the calcium concentration range 
tested by the authors.  The work in this section only included mutated EF-I with 
different type of amino acid sunstitutions from Tricoire’s work (EF-I mutations in this 
work: Asn29Cys/Ser32His and in Tricoire:  Asn26Asp, Glu35Gly and Val44Ala) but 
the agreement in respect to increase of calcium sensitivity is still interesting.   
The dramatic decrease of lanthanum sensitivity in the mutant alludes to EF-I 
being crucial in the binding of lanthanum.  Indeed, in the analysis of the mutant library 
in Chapter 6 the metric of selectivity shift (D) for lanthanum and mutant 
Asn28Cys/Ser32His was very low compared to that for zinc and copper.  
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From the compilation of Table 8-3 an association emerges between the shape of 
the luminescence curves with the shape of the concentration-response curves.  Flash-
type luminescence curves contribute to sigmoidal concentration-response curves 
whereas glow-type luminescence curves contribute to bell-shaped concentration-
response curves.  Some seeming variations from this rule are cadmium, lead and cobalt.  
Cadmium triggers a combination of flash and glow luminescence and its flash-type 
contribution most likely leads to a sigmoidal concentration-response curve.  
Luminescence triggered by cobalt was classified as glow-type, however its 
luminescence versus time traces are sharper than the glow-type traces produced by zinc 
and copper and more blunt than the classical flash-type curves of calcium, lanthanum 
and lead (traces of the entire dataset are provided in Supplementary Material).  The 
relative sharpness of some of the traces by cobalt would contribute to a sigmoidal 
concentration-response curve. 
Lead triggers flash-type luminescence but at higher concentrations an inhibition 
effect is observed that leads to a bell-shaped concentration-response curve.   
On enzyme inhibition due to metal ions 
It is possible for heavy metals, such as lead, silver and mercury, to act as anzyme 
inhibitors by bonding with side groups such as -SH, -COO-, -OH (Hovde, 2011).  
‘Sulfur-seeking’ metals, such as cadmium and copper, would be expected to bind 
mainly to thiols and zinc would be expected to bind mainly to carboxylic acids at 
cytoplasmic pH (Martell and Smith, 1982).   
Binding to the active site can cause competitive reversible or irreversible 
inhibition and binding to a site other than the active site causing non-competitive 
reversible inhibition.  In biological systems, heavy metal toxicity is caused by tight 
binding of a metal such as mercury, lead, aluminum, or iron, to a functional group at the 
active site of an enzyme.  At high concentrations heavy metals are relatively non-
specific for the enzymes they inhibit and inhibit a large number of enzymes.   
In the case of aequorin it is expected that metal ions binding to the EF-hands 
causing partial or no activation, by definition also cause at least partial inactivation of 
aequorin.  It is entirely possible that at higher concentrations they also bind to sites 
other than the ion-binding loops causing additional inhibition with the cumulative 
inhibition effect manifested in the downslope of the bell-shaped curves and reduction at 
the high concentrations of lead’s sigmoidal concentration-response curve.  
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Figure 8-8  Concentration-response curves of wild-type aequorin.  Tested with Ca2+, 
La3+, Pb2+, Cd2+, Cu2+, Zn2+, Co2+. 2.55 µg/mL protein post mixing, pH 7.45 (lead at 
pH ~5.0), T=23 °C. 
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Figure 8-9  Concentration-response curves of mutant Asn28Cys/Ser32His.  Tested with 
Ca2+, La3+, Pb2+, Cd2+, Cu2+, Zn2+, Co2+. 2.55 µg/mL protein post mixing, pH 7.45 (lead 
at pH ~5.0), T=23 °C. 
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Table 8-3  Summary of characteristics of luminescence versus time and concentration-response curves.  When values for EC50 and IC50 could not 
be drawn from the plots due to lack of data points, a range of potential values is provided instead. 
 wild-type aequorin  mutant Asn28Cys/Ser32His 
 EC50 (M)  IC50 (M) luminescence 
curve 
concentration-
response curve 
 EC50 (M)   IC50 (M) luminescence 
curve 
concentration-
response curve 
Ca2+ 1.2×10-5 –1.6×10-5 n.a. flash-type sigmoidal  2×10-6 n.a. flash-type sigmoidal 
Zn2+ 10-13 –10-10 1.3×10-4 glow-type bell-shaped  2×10-14 2×10-5 glow-type bell-shaped 
Cu2+ 3×10-15 –3×10-8 n.d. glow-type bell-shaped  10-14 –10-8 3×10-2 glow-type bell-shaped 
Co2+ 10-12 –2×10-10 5×10-5 glow-type bell-shaped  5×10-13 –2×10-10 10-4 glow-type bell-shaped 
Cd2+ 10-5 n.a. combination sigmoidal  3×10-5 n.a. combination sigmoidal 
Pb2+ 10-14 –10-13 9×10-5 flash-type bell-shaped  2×10-15 –10-12 2×10-4 flash-type bell-shaped 
La3+ 5×10-11 –10-8 n.a. flash-type sigmoidal  9×10-4 n.a. flash-type sigmoidal (?) 
n.d.: not determined 
n.a.: not applicable 
IC50 values are only applicable in bell-shaped concentration-response curves 
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8.3.3 Light yield comparison across all metals with wild-type and 
mutant aequorin 
In biomedical research or environmental monitoring the minimum measurable 
output of a luminescent biosensor would be the peak or sum (cumulative light) of 
emitted light during the duration of the experiment.  In this Section, the peak and sum of 
luminescence for the experiment duration (15 s) are compared between:  
• purified wild-type aequorin with each of the metal ions tested (Figure 8-10) 
• purified mutant Asn28Cys/Ser32His with each of the metal ions tested (Figure 
8-11) 
As discussed in Section 8.1.4, the maximum response occurs with different 
concentrations of different ions and varies between wild-type and mutant aequorin.  For 
simplicity, the comparison was made at each ion’s optimum concentration with wild 
type and mutant respectively.  This decreased the number of experiments required.  The 
metal ion concentrations used in each case are presented in Table 8-4. 
Photomultiplier gain settings were an additional consideration.  In contrast to 
work in Sections 8.3.1 and 8.3.2 the gain settings within wild type experiments were 
kept constant (Gain 2,300) in order to allow direct comparison between luminescence 
outputs.  The respective gain settings used for mutant comparisons were 2,300 and 
4,000.  Gain of 2,300 allowed direct comparison across wild type and mutant aequorin 
with calcium but failed to detect light from some of the mutant-ion sets.  Gain of 4,000 
allowed luminescence from low producers (mutant variant with zinc, cobalt, copper) to 
be detected that would otherwise have been undetectable at the low gain setting of 
2,000.   
As illustrated in Figure 8-10 and Figure 8-11, the order in which metal ions exert 
the highest peak of luminescence in aequorin ranked from highest to lowest is: 
• For wild type: 
Calcium > Lanthanum > Lead > Cobalt > Cadmium > Zinc > Copper 
• For mutant Asn28Cys/Ser32His 
Lanthanum > Cadmium > Calcium > Lead > Zinc > Cobalt > Copper 
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Due to the shape and kinetics of the luminescence curves, the ranking may vary 
slightly where peak or sum of luminescence is taken into account for the entire duration 
of the experiment (15 s).  For example, the peak response of wild type to lead is 
significantly higher than response to cobalt, whereas the sum of light triggered by cobalt 
is slightly higher than that triggered by lead for the experiment duration.  This is 
associated with the different speed at which reactions proceed. 
The peak of light is the most relevant metric for two reasons:  a high intensity 
peak would allow lower limits of detection, hence increased sensitivity of the sensor; a 
sharp peak with a rapidly descending tail would mean it is possible to study rapid 
fluctuations of the analyte of interest.  In this system, high luminescence intensity seems 
to be linked to increased sharpness of peak, hence indirectly suggests fast response 
kinetics.  
Table 8-4  Metal ion concentrations used for overall yield comparisons.  The available 
metal ion concentrations in the final mix (metal ion plus protein solution) that triggered 
the highest activity.   These were used for the overall comparison of wild type and 
mutant performance with all ions.  Free ion concentration post-mixing was calculated as 
described in Section 8.2.3. 
Ion Most effective ion concentration    
for wild type 
Most effective ion concentration 
for mutant 
Calcium 10-2 10-2 
Lanthanum 8.1x10-5 1.8x10-3 
Cadmium 1.9x10-5  2.4x10-4 
Lead 7x10-6 4x10-6 
Zinc 8.4x10-6 1.8x10-12 
Copper 1.2x10-4 3.9x10-6 
Cobalt 1.9x10-5 1.9x10-5 
 
Luminescence activity of mutant plus calcium in comparison with wild-type plus 
calcium at 10-2 M and gain setting 2,300 was 0.032 % ± 0.001 % for Peak and 
0.128 % ± 0.003 % for Sum.   
In theory the total light produced by the luminescence reaction is constant 
(Hastings et al., 1969).  This should apply at all experimental conditions given infinite 
time.  In practice, infinite time is not applicable.  The sum of light readings for the 
duration of each experiment was used as it was a concrete set of results and relevant to 
the kinetics of the reaction (slower kinetics→lower sum of light in a set timeframe). 
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Figure 8-10  Wild type against each metal ion.  2.55 µg/mL aequorin, pH 7–7.5 at 23 °C 
(with the exception of lead that was diluted in R.O. water and post-mix pH was 5.0).  
Error bars are standard error of the mean.  Each metal ion injected was at the optimal 
concentration derived from the concentration-response curves in Section 8.3.2 and 
summarised in Table 8-4. 
 
Figure 8-11  Mutant Asn28Cys/Ser32His against each metal ion.  2.55 µg/mL of 
protein, pH 7–7.5 at 23 °C (with the exception of lead that was diluted in R.O. water 
and post-mix pH was 5.0).  Error bars are standard error of the mean.  Each metal ion 
injected was at the optimal concentration derived from the concentration-response 
curves in Section 8.3.2 and summarised in Table 8-4. 
- 280 - 
8.3.4 Analysis of bioluminescence kinetics 
In Section 8.3.1 it was shown that experimental results fall under two main 
groups in terms of the shape of luminescence curves: flash-type and glow-type.  The 
shape of luminescence curves makes them amenable to different methods of analysis in 
terms of kinetics.   
Flash-type luminescence comprises of the data sets of wild-type and mutant 
aequorin with calcium, lanthanum and lead.  Whereas the ascent from zero to the peak 
value is the same amongst the data set, the luminescence decay differs with aequorin 
type (wild type or mutant), ion type and ion concentration and were fitted to a model of 
exponential decay in Section 8.3.4.1.   
Glow-type data were processed in Section 8.3.4.2 on the basis of progression of 
the bioluminescence reaction within the time course of the experiment.  Due to the 
combination of flash- and glow-type luminescence present in the cadmium-triggered 
curves, neither method was deemed suitable. 
8.3.4.1 Flash-type luminescence:  Model of double exponential decay 
The decay luminescence of wild-type and mutant aequorin with each of calcium, 
lanthanum and lead (flash-type luminescence curves) was fitted with the double 
exponential decay model proposed by Tricoire and co-workers (2006) and introduced in 
Section 8.1.5.2.   
Time constants (τ) express of the duration of a phenomenon whereas kinetic 
constants – the inverse of time constants (k) – express the speed of a phenomenon.  
High values of τ indicate a slow luminescence branch and low values indicate a fast 
luminescence branch.  Salient observations will be discussed in regards to the values of 
the time constants and the contribution of the fast and slow component to total light. 
The slow and fast time constants (τS and τF respectively) as well as contribution 
of the slow and fast component to the integral luminescence (ΣS/ΣT and ΣF/ΣT 
respectively) were derived using SigmaPlot as described in Section 8.2.6.2 and plotted 
against a wide range of ion concentrations (Figure 8-12 and Figure 8-13).  Commercial 
aequorin Aqualite® was also tested with calcium in order to allow comparison with 
wild-type aequorin produced in this work and the results of the exponential model 
fitting are presented in Figure 8-14.   
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Tricoire and co-workers (2006) fitted each trace of luminescence decay to a sum 
of two exponentials and found that it gives better description of the data compared to 
fitting a single exponential component (Section 8.2.6.2).  This is something that was 
also observed in this work.   
Kinetics of commercial versus wild-type aequorin 
In order to verify that the His-tag and additional amino acids (resulting from pET 
cloning of Chapter 3) in aequorin did not alter the bioluminescence kinetics, kinetic 
parameters were derived for both wild-type and commercial aequorin (Aqualite®, 
Section 8.2.1).   
Both proteins exhibited the same trend of τF increasing slightly with increasing 
calcium concentrations and τS decreasing with increasing calcium concentrations until 
they both reached a plateau (Figure 8-12 and Figure 8-14).  The ranges of time constants 
for both proteins were approximately the same: 1.2–14 s (τS) for the slow and 0.2–1.3 s 
(τF) for the fast components.  A similar trend is observed in the contribution of the slow 
and fast branch to integral light (ΣS/ΣT and ΣF/ΣT respectively), with the fast branch 
increasing its contribution at higher calcium concentrations.  Since no significant 
differences were observed, the remaining analysis in this section focused on 
comparisons between wild-type and mutant aequorin. 
Effect of mutation on the fast reaction time constants 
Contrasting wild-type to mutant aequorin, no significant differences in the 
numeric values were observed among the ions causing flash luminescence (calcium, 
lanthanum and lead) (Table 8-5).  Examination of Figure 8-12 and Figure 8-13 shows 
that although some variation exists, there is a general trend.  This trend consists of a 
gradual increase of τF from 0.2 s between low and middle ion concentrations, reaching a 
plateau range around 1.2 s at high concentrations of calcium and lanthanum.  The τF 
values for wild type plus lead fluctuated between 0.1 and 1.2 s without exhibiting a 
clear trend.  The saturation of τF values at mid and high calcium concentrations was 
consistent between this work and Tricoire (2006).   
Effect of mutation on the slow reaction time constants 
In contrast to their fast counterparts, the slow time constants τS differ between 
wild-type and mutant aequorin.  As shown in Table 8-6 τS values can increase up to one 
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order of magnitude for the mutant protein.  This is clearly seen in the cases of calcium 
and lead and might possibly apply to lanthanum.  However, due to low sensitivity of 
mutant aequorin to lanthanum, the data set available for decay fitting was too limited 
(Figure 8-12 and Figure 8-13) and data were fitted at only two lanthanum 
concentrations (~10-3 and 10-2 M).  At these lanthanum concentrations time constants 
for wild type and mutant were comparable. 
The curves depicting τS follow a similar trend across different ions and type of 
protein (wild type or mutant) used.  Specifically, all curves show a slow smooth 
reduction on the value of τS with increasing metal ion concentration, which is consistent 
with the notion that by increasing ion concentrations one should expect to see faster 
kinetics.  This trend is also consistent with previously published work on wild-type 
aequorin and different variants with calcium.  
Wild type: comparison between different ions 
Contrasting the behaviour of wild-type aequorin in the presence of calcium and 
lanthanum where the branches of τS and τF tend to converge, in lead the slow and the 
fast branches move in parallel to each other (Figure 8-12, Table 8-6).  The slow time 
constants of wild type plus lead are lower (faster kinetics) than those triggered by 
calcium and lanthanum, while the fast time constants are in the same range.  However, 
the contribution of the fast branch to the total light (ΣF/ΣT) as well as the actual yields of 
light produced with lead were much less than their calcium and lanthanum counterparts 
during the time course of the experiment, which suggests reduced efficiency in light 
production.  The actual light yield comparisons were derived from the raw data used for 
the luminescence curves (Supplementary Material) and summarised in the bar chart of 
overall yield comparisons (Section 8.3.3).  Such high contibution of the slow reaction 
branch is not a desirable feature for a biosensor envisaged to capture fast metal ion 
fluctuations at real time. 
Mutant aequorin versus different ions 
In this case both the lanthanum and lead systems exhibit faster kinetics (both 
slow and fast branch) than the calcium system (Figure 8-13).  This is useful in that it 
can promote the development of a biosensor which shows a specific fast response for 
these metals.  However it should be noted that high concentrations of lead result in 
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inhibition (refer to concentration-response curves for lead in Figure 8-8, Figure 8-9 and 
Section 8.3.3). 
Fast and slow rate contributions to bioluminescence 
The most important and consistent observation regarding the contibution of the 
fast and slow branches to total light produced is that the contribution of the slow 
reaction is dominant in mutant aequorin, reaching approximately 99% for all three ions 
(Figure 8-12 and Figure 8-13).  One way to read this is that the fast branch is essentially 
blocked by the mutations. 
Extracting the fast and slow components of bioluminescence as well as 
integrating to calculate photon yield for each component is a noisy process.  When the 
time constants tend to converge to values of the same order of magnitude, the pre-
exponential components can vary significantly, as expressed by high error bars in some 
graphs.  Computationally, the slow component is expected to produce more light since 
light production persists for a longer time interval, which is reflected in the results.  The 
calculation of ΣS/ΣT and ΣF/ΣT takes into account both the time constants and the pre-
exponential terms of the fittings (Section 8.2.6.2).  Due to the nature of the calculation 
of ΣS/ΣT and ΣF/ΣT, (ΣS/ΣT + ΣF/ΣT =100%) the branches of these components are mirror 
images of each other on the plots.  In terms of contributions to total light, it is not easy 
to compare with previously published work (Tricoire et al., 2006) since the authors 
plotted ΣS and ΣF normalised by the maximum point in their curves and not by the total 
ΣT for both curves.   
Following the assumptions that the fast branch of the reaction is blocked by the 
mutations (while the slow path remains almost intact), it is reasonable to assume that the 
two branches operate independently.  
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Figure 8-12  Decay kinetics of wild-type aequorin.  Left:  slow and fast decay time 
constants (τS and τF respectively) plotted versus ion concentration (calcium, lanthanum 
and lead).  Right:  Contribution of the slow (ΣS/ΣT) and fast (ΣF/ΣT) light integrals to 
total light versus ion concentration.  Error bars are standard error of the mean. 
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Figure 8-13 Decay kinetics of mutant Asn28Cys/Ser32His aequorin variant.  Left:  slow 
and fast decay time constants (τS and τF respectively) plotted against ion concentration 
(calcium, lanthanum and lead).  Right:  Contribution of the slow (ΣS/ΣT) and fast (ΣF/ΣT) 
light integrals to total light against ion concentration.  Error bars are standard error of 
the mean. 
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Figure 8-14  Decay kinetics of commercial aequorin AquaLite®.  Left:  slow and fast 
decay time constants (τS and τF respectively) plotted against calcium concentration.  
Right:  Contribution of the slow (ΣS/ΣT) and fast (ΣF/ΣT) light integrals to total light 
against calcium concentration. 
Table 8-5  Fast time constant (τF) ranges for flash-type curves 
 AquaLite® Wild-type aequorin mutant aequorin 
Calcium 0.17–1.3  0.4–1.2 s 0.19–1.6 s 
Lanthanum n.a. 0.15–1.13 s 0.3–1.3 s 
Lead n.a. 0.07–0.66 s 0.07–0.78 s 
 
Table 8-6  Slow time constant (τS) ranges for flash-type curves 
 AquaLite® wild-type aequorin mutant aequorin 
Calcium 1.22–14.3 2.09–12 s 14.7–48.7 s 
Lanthanum n.a. 1.5–56.5 s 5.5–5.7 s *  
Lead n.a. 2.9–7.6 s 4.2–31.4 s 
*limited dataset for mutant plus lanthanum (lanthanum concentrations 10-3–10-2 M) 
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8.3.4.2 Glow-type luminescence kinetics 
In the previous section flash-type reactions were dissected in two exponential 
components for the light decay.  The very rapid ascend of the luminescence curves was 
not analysed.  In the case of glow-type luminescence triggered by the metals zinc, 
copper and cobalt, the double exponential decay model was not applicable.  The 
ascending and decay part of luminescence would require a far more intricate model that 
is beyond the scope of this work.   
This section looks at the overall kinetics of the reaction.  A simple metric, 
P15s/Max, was devised as an appropriate measure of the decay rate of the glow curves 
during the experiment duration of 15 s (Section 8.2.6.3).  High values of P15s/Max 
indicate that at 15 s the bioluminescence reaction is almost complete and therefore 
P15s/Max can be used as an indirect measure of the speed of the bioluminescence reaction.  
Values for P15s/Max were plotted for each ion for wild type and mutant in Figure 8-15.  
Table 8-7 summarises the reaction progress metric P15s/Max for all the glow-type 
experiments. 
Out of the three metals examined, zinc was found to trigger the slowest kinetics.  
The mutant plus zinc system was faster than the wild type plus zinc over the range of 
concentrations studied.  The same applies to copper at all concentrations with the 
exception of the highest concentration of 10-2 M where P15s/Max for wild type and mutant 
converged.   
In contrast to zinc and copper, the mutations did not affect the rate of 
bioluminescence for cobalt.  This difference can be attributed to the nature of the 
mutations (substitutions of Asp and Ser by His and Cys respectively) which in theory is 
conducive to enhance binding of zinc and copper (Section 1.4, Section 5.6).   
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Figure 8-15  Metric of reaction progress P15s/Max for glow-type curves.  Reaction 
progress of wild-type and mutant aequorin versus concentration of each of zinc, copper 
and cobalt.   
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Table 8-7  Ranges of P15/Max for glow-type curves.  P15/Max is a dimensionless number. 
Metal Wild-type aequorin Mutant aequorin 
Zinc 0.17–0.28 0.36–0.47 
Copper 0.28–0.82 0.46–0.82 
Cobalt 0.24–0.68 0.26–0.59 
 
8.3.5 Double ion experiments: wild type plus Zn2+ and Ca2+ 
A potentially promising result of increased sensitivity of mutant aequorin 
towards zinc (Section 8.3.2) inspired a new experiment where aequorin was injected 
with a combination of zinc and calcium.   
In the experiments described thus far, each of wild type or mutant was only 
mixed with one type of metal ion.  Mutant Asn28Cys/Ser32His was designed to provide 
a more favourable environment for zinc or copper binding but the mutations were in 
only one out of the three calcium-binding loops.  The remaining (native) EF-hands 
however retain their affinity for calcium and will still require calcium for their 
successful contribution to luminescence.  In this light, no single ion could alone evoke 
the highest possible result, as inevitably one or more EF-hands would be lacking their 
preferred activator ion.  
The premise of this experimental design was that the loop of the mutated EF-
hand (EF-I) can be populated by zinc whist the remaining intact calcium-binding loops 
of EF-III and EF-IV can be populated by their native activator, calcium.  The double ion 
experiment setup is described in Section 8.2.5.  In summary, aequorin was mixed with 
zinc at a range of concentrations.  After a few seconds the mix was enhanced with 
sufficient amount of calcium to complete the luminescence reaction.  This amount was 
determined from the concentration-response curves of wild-type and mutant plus 
calcium in Section 8.3.2. 
The two metal ions were introduced at separate times in order to allow 
monitoring of the zinc effect before addition of calcium that was likely to occupy the 
binding sites (and exclude zinc from binding) from the beginning of the experiment.  An 
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additional reason arose from results of previous experiments that showed that light yield 
produced by zinc binding was very low compared to calcium.  Mixing aequorin and 
zinc first allowed recording of zinc-induced luminescence that would be masked by the 
intensity of calcium-activated luminescence. 
If increased selectivity for zinc has been successfully introduced in EF-I of the 
mutant, then by providing both zinc and calcium EF-I would be primed with zinc and 
EF-III and EF-IV would be primed with calcium.  Zinc and calcium in combination 
should then trigger a higher luminescence yield in the mutant than calcium alone, and 
certainly higher than zinc alone.   
Both assumptions were found to be true.  Figure 8-16 shows that in wild type, 
calcium alone triggers the same luminescence yield as calcium plus low concentrations 
of zinc (~10-14 M).  At increasing concentrations of zinc the light yield decreases, 
possibly following a sigmoidal function with negative slope.  These findings suggest 
that zinc does not contribute in the activation of any EF-hand at low concentrations and 
that in the presence of the abundant activator calcium, zinc cannot compete for the 
binding sites.  As higher concentration of zinc is added, zinc competes with calcium for 
at least one binding site and at ever increasing concentrations it blocks calcium’s access 
to the calcium-binding loops.  Previous work in Section 8.3.2, Figure 8-8, showed that 
the concentration-response curves of zinc are bell-shaped with a maximum at 10-6 M.  A 
generic detrimental effect on aequorin at higher concentrations was assumed.   
In the mutant, the shape of the concentration-response curve of the double ion 
experiment is different (Figure 8-17).  Calcium alone is not performing as highly as 
calcium plus a small addition of zinc.  This observation may suggest that traces of zinc 
incurred a positive effect in the mutant that calcium alone cannot offer.  The reason for 
this change is likely to be the increase of selectivity of EF-I towards zinc and decrease 
towards calcium in mutant Asn28Cys/Ser32His.  These statements make sense 
considering the types of mutations introduced in EF-I and discussed in Chapters 5 and 
6. 
The shape of light versus time plot (Figure 8-16 A and Figure 8-17 A) though 
suggests that despite the positive shift toward zinc selectivity, the mechanism of 
bioluminescence was overall impaired, as the yield was significantly reduced and the 
characteristic sharp peak of flash luminescence of wild type was blunted in the mutant 
experiment when calcium was added.  A possible explanation is that the type of 
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mutation introduced was dispurptive to the propagation of signal between ion binding 
and emission of light. 
In many ways this experiment is more practical and more meaningful that the 
addition of single ions to aequorin, due to the importance of the cooperative function of 
the EF-hands in aequorin.  Future screening for incremental shifts of selectivity toward 
new ions could use a mix of calcium and the new ion, rather than the new ion alone.   
The main finding of this section was that in wild type 100% of maximum 
activity was achieved by using calcium alone whereas in the mutant 100% of maximum 
activity required the addition of a small amount of zinc ions.  The conclusion from this 
section is that the mutations engineered in Asn28Cys/Ser32His resulted in successful 
localised binding of zinc in EF-I with only partial activation of aequorin 
bioluminescence. 
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Figure 8-16  Wild type triggered by zinc and calcium.  40 µL of  zinc were injected into 
40 µL of  purified wild type aequorin solution at 0.3 s at a wide range of concentrations, 
followed by injection of 40 µL of  50 µM calcium at 10 s (16.7 µM final calcium 
concentration in the well).  Top:  Typical trace of luminescence versus time from the 
resulting data set.  The y-axis was set to logarithmic.  In a linear scale the effect of zinc 
would be barely visible due to the very low light yield produced compared to the light 
produced upon addition of calcium in wild-type aequorin.  Bottom:  Concentration-
response curve comprised from the Peak value of all the luminescence curves of the 
data set.  The same trend was observed when plotting the Sum of the light readings for 
the duration of the experiment.  A similar curve was produced when injecting 10 mM 
calcium (fixed) at 10 s (3.33 mM final calcium concentration in the well). 
adding Ca2+ 
adding protein 
10-14 M  Zn2+ + fixed [Ca2+] 
Variable initial [Zn2+] + fixed [Ca2+] 
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Figure 8-17  Mutant Asn28Cys/Ser32His aequorin triggered by zinc and calcium.  
40 µL of zinc were injected into 40 µL of purified wild type aequorin solution at 0.3 s at 
a wide range of concentrations, followed by injection of 40 µL of 50 µM calcium at 10 s 
(16.7 µM final calcium concentration in the well).  Top:  Typical trace of luminescence 
versus time from the resulting data set.  In contrast with Figure 8-16 the y-axis was set 
to linear scale, as the effect of zinc was comparable to that of calcium in mutant 
aequorin.  Bottom:  Concentration-response curve comprised from the Peak value of all 
the luminescence curves of the data set.  The same trend was observed when plotting the 
Sum of the light readings for the duration of the experiment.  A similar curve was 
produced when injecting 10 mM calcium (fixed) at 10 s (3.33 mM final calcium 
concentration in the well).  
adding protein adding Ca2+ 
Variable initial [Zn2+] + fixed [Ca2+] 
3.2×10-15 M  Zn2+ + fixed [Ca2+] 
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8.3.6 Correlation of ion size and shape of luminescence curve 
In this section experimental findings of this chapter - light yield, shape of 
luminescence, shape of concentration-response curves, sensitivity (EC50) - are discussed 
in relation with structural information drawn from Chapters 1 and 5.   
In Figure 8-18 the shape of the luminescence curves of aequorin was plotted 
against the coordination numbers of ions within metal-ligand complexes and its 
potential for interatomic overlap between the metal ion and the coordinating ligands in 
the loop of EF-I of aequorin.  The metric of interatomic overlap (D-r-R) was introduced 
in Section 5.4.2 as the interatomic distance (D) between calcium and each of the oxygen 
ligands in the pentagonal bipyramidal coordination (PDB ID: 1SL8) subtracted by the 
atomic radii of each pair of atoms, where r is the radius of the metal ion and R is the 
radius of the coordinating oxygen atom.  The overlap calculations were obtained by 
“fixing” each ion in the position of calcium in the crystallographic structure of calcium-
bound apoaequorin (PDB ID: 1SL8).  This positioning of the different ions is a 
simplistic assumption in order to study their potential effect within the local 
environment of the EF-I ion binding loop.  With the reasonable assumption that the 
seven-coordinate binding of calcium is optimum for triggering aequorin luminescence, 
ions thay are able to bind in a similar manner should also be effective. 
In Figure 8-18 MIN<0 (green bar) means that there is interatomic overlap 
between at least one metal-ligand (M–L) pair.  MAX<0 (blue bar) indicates that 
interatomic overlap occurs between all of the metal and each of the ligands in the 
crystallographic structure.  SUM (red bar) is the sum of the overlap between the metal 
ion and every coordinating ligand within the loop of EF-I. 
In calcium, lanthanum, cadmium and lead there is overlap in every metal-ligand 
combination, as denoted by both minimum and maximum values being negative.  
Cobalt would appear to be an exception as it produces higher yields than cadmium.  
One would expect all ions with D-r-R>0 to achieve lower yields than ions with D-r-
R<0. However cobalt triggers more light than cadmium and triggers luminescence 
curves that are overall sharper than those of zinc and copper.  Despite its small size, 
cobalt stands out amongst equally small metals and indeed yields higher luminescence 
than the larger cadmium. 
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In Figure 8-19 the metric of sensitivity EC50 of wild type to each metal ion was 
plotted against the sharpness of the luminescence curves, the ionic size and the metric of 
interatomic overlap D-r-R.   
Sharpness of luminescence reflected in the flash-type curves is associated with 
efficiency of the reaction.  However the cobalt-triggered glow-type luminescence was 
the sharpest (and therefore fastest) compared to that of zinc and copper (Section 8.3.1). 
It was not possible to derive specific EC50 values for every combination of 
aequorin type and metal ion and a range was derived instead (Table 8-3).  A causal 
correlation between sensitivity and ionic size was not derived:  native activator calcium 
has a lower sensitivity (higher values of EC50) than its most successful replacement 
lanthanum but similar to that of cadmium which is a lesser performer than lanthanum.  
The range of potential EC50 values for the poorer performers zinc, copper and cobalt 
makes aequorin more sensitive to them than calcium.  For a bioreporter, the sensitivity 
of the molecule should lie within a relevant concentration range, i.e. where fluctuations 
of the measured target molecule (metal ions in this case) occur and are of interest.  If 
studying a new metal ion that is present in very low concentrations (e.g. lower than 
those of calcium), then the envisaged biosensor must be able to detect these 
concentrations and their fluctuations if applicable, hence the EC50 value must be lower 
than that of calcium. 
What differentiates cobalt from zinc and copper is its ability to bind in octahedral 
coordination geometry, as is calcium, whereas zinc is mostly found in tetrahedral 
coordination and copper in square pyramidal and square planar coordinations in 
metalloproteins (Section 1.4, Table 1-7).  In coordination geometries that include a 
higher number of participating atoms, higher radii allow atoms to interact from a 
distance that is still not sterically prohibitive.  In aequorin calcium coordinates with the 
oxygen of a water molecule additionally to the six coordinating atoms of the EF-hand 
loop, thus making its coordination geometry pentagonal bipyramidal.  Geometry of 
binding is of great importance in achieving an efficient bioluminescence reaction.  The 
higher coordination number a new ion can bind in, the easier it will fit the native 
binding sites of aequorin. 
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Figure 8-18  Is radii overlap associated with sharpness of luminescence curves?  For 
some ions, like Zn2+ and Cd2+, more than one possible radius is plotted due to strong 
preference for coordinations with lower coordination number (CN) in metal binding 
sites.  The asterisk at the glow classification for cobalt luminescence denotes the relative 
sharpness of the cobalt curves compared to the other glow-type curves of zinc and 
copper.  Coordination numbers that were considered are shown in parentheses.   
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Figure 8-19  Type of luminescence, metal ion sensitivity and interatomic distance in the 
EF-I loop of wild-type aequorin.  Long blue bars indicate a range of possible logEC50, 
as the actual value could not be estimated from the respective concentration-response 
graphs.  LogEC50 values for wild type plus metal ions were taken from Table 8-3.  As in 
Figure 8-18, more than one possible ionic radius (and hence coordination numbers) was 
considered.  Possible coordination numbers (CN) are shown in parenthesis.   
glow-type luminescence               flash-type luminescence 
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8.4 Conclusion 
This chapter aims to describe the effect of the seven metal ions – calcium, 
lanthanum, cadmium, zinc, copper, cobalt and lead - on aequorin and its mutant variant 
Asn28Cys/Ser32His.  It does not aspire to construct a detailed mechanistic description 
of the processes involved.  Different experiments and data analysis would be required 
for this purpose. 
The experimental setup measured output of luminescence versus time (Section 
8.2.8).  The light response itself is the result of a complex set of events starting from ion 
binding and resulting in subtle conformational changes that lead to the destabilisation of 
the hydroperoxy-coelenterazine in the centre of the protein and concomitant production 
of light (Section 5.1 and 5.6.2).  Interpretation regarding the specific effect of the 
mutations or different metals on the function of the molecule is difficult, especially in 
absence of structural and binding data (Section 8.2.8).  Therefore general conclusions 
were drawn in this work. 
Ions as partial activators 
All ions other than the native activator calcium, act as partial activators for 
aequorin, each to a different extent.  Significant loss of luminescence was observed in 
mutant Asn28Cys/Ser32His with all metal and in the wild type with metals other than 
calcium and lanthanum.  The levels of activation range from <1% to 70% of native 
activity (Section 8.3.3).  Lanthanum was a successful substitute for calcium, with 
relatively high yields of luminescence and concentration-response curves being the 
same shape as that of calcium.  Low yields triggered by other ions suggest that 
cooperativity links are broken and that some of the ions act as inhibitors at higher 
concentrations (Section 8.3.2).   
In this chapter comparisons were made at each ion’s optimal concentration in 
order to assess the extent of activation/inactivation under the conditions tested.  An 
alternative way to conduct comparisons would be to focus at specific ranges of metal 
ion concentrations, as only certain ranges of metal concentration are relevant to 
different biological systems or environmental samples. This type of comparison would 
be essential when considering the suitability of a metal ion biosensor in a relevant 
environment.  
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Size, coordination of metal binding and efficiency of reaction 
The traces of luminescence versus time fell under two major categories (Table 
8-2).  Traces of the first category – which is also the case of the “classic” aequorin 
bioluminescence with native activator calcium – are characterised by a sharp increase in 
luminescence producing a distinct peak followed by a fast decay.  This type of 
luminescence was termed “flash-type” luminescence.  The second major category is 
characterised by a much smoother ascent, substitution of the distinct peak with a wide 
maximum and followed by a slow descent.  This behaviour was termed “glow-type” 
luminescence.   
Flash-type luminescence is associated with higher yields as manifestation of an 
efficient overall process of ion binding and production of light.  Radii overlap is 
necessary for flash-type and higher yields.  Analysis took into account the preferred 
coordination geometries of these ions, as well as their ionic size.  The larger ions 
calcium, lanthanum, cadmium and lead produce flash-type luminescence, whereas the 
smaller ions trigger glow-type luminescence.  This reflects the size selectivity of the 
EF-hand.  Size selectivity would be a major consideration in planning future mutational 
strategies.   
Both the requirement of the protein environment for effective binding and the 
propensity of metals to bind at specific geometries will dictate the performance of 
aequorin variants with new ions.  It will be very challenging to completely redesign the 
EF-hand loop whilst keeping the intrinsic network of interactions within the protein 
intact.  This network is necessary for the appropriate conformational changes to be 
propagated to the centre of the molecule for effective bioluminescence production. 
In terms of the effect of ions on EC50 and yield, it is not possible to uncouple the 
causal effect of binding in the EF-hands or at other sites of the protein causing 
inhibition.   
A mutant with positive response to zinc 
Experimental results showed that EF-I was successfully altered to develop a 
higher affinity towards zinc as well as to contribute to a mutant-specific improvement in 
luminescence production compared to wild type.  In the double ion experiment (Section 
8.3.5) wild-type and mutant aequorin were exposed to a combination of zinc and 
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calcium;  this approach allowed zinc the opportunity to activate the mutated EF-hand 
(EF-I) and calcium to activate the remaining native hands.   
The mutant achieved higher activity with a specific combination of zinc and 
calcium than with either zinc alone or calcium alone.  However it was acknowledged 
that this was still low level activity and that although the mutation caused a successful 
increase of selectivity towards zinc, it also caused impairement of the bioluminescence 
reaction mechanism.  
Sensitivity to metal ions 
In addition to studying the time course of the luminescence reaction, the 
response of aequorin to several concentrations of each metal ion was studied.  This 
process resulted in metrics for the sensitivity of aequorin (wild-type and mutant) to each 
ion.  Concentration-response curves were drawn to study the effect of a wide range of 
concentrations of each ion on the proteins.   
In terms of the shape of concentration-response curves, two main groups emerge: 
sigmoidal and bell-shaped.  From the dataset in this work, an overall association 
emerges between shape of luminescence and shape of concentration-response curves.  
Specifically, the datasets that agree with the flash-type luminescence produce sigmoidal 
concentration-response curves and those that produce glow-type luminescence produce 
bell-shaped concentration-response curves.  At first glance, lead and cobalt appeared to 
be exceptions.  Lead triggers flash-type luminescence but its concentration-response 
behaviour is bell-shaped both for wild-type and mutant aequorin.  However this could 
be due to non-specific enzymatic inhibition (Section 8.3.2), lack of buffering in the lead 
nitrate solutions (Section 8.2.3) and consequent loss of aequorin stability at low pH 
conditions (Section 1.3.3).  Cobalt produced sigmoidal concentration-response curve.  
The luminescence was classified as glow-type but the luminescence curves triggered by 
cobalt were sharper than those triggered by zinc and copper.   
Despite the lack of structural data, a reasonable assumption is that new ions bind 
to the EF-hands but fail to exert the full scale effect of the native activator calcium. 
Kinetics of the reactions 
For wild type, the results for the flash-type luminescence were consistent with 
previous work on the independence of the rate of ascent eluding to first order kinetics 
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and the dependence of descend (decay) of the luminescence curves on calcium 
concentrations (Hastings et al., 1969).   
For the flash luminescence reactions a previously published double exponential 
decay model (Sections 8.1.5.2 and 8.3.4.1) was applied.  The model proposed the 
existence of two branches of luminescence – one fast and one slow.  Time constants and 
estimates of contribution to total light were derived for both the postulated slow and fast 
branch of the reaction.  The results were consistent with published literature in terms of 
the values of the time constants for wild type and calcium.   
The combinations of (1) wild-type with metals other than calcium or lanthanum 
and (2) mutant aequorin with every metal tested, result in the slow branch of the 
reaction becoming even slower (increase of time constant = slower reaction) and in 
increase of the slow branch’s contribution to the total light produced.  Conversely, the 
fast branch of the reaction contributed less than 1% of total light in these cases. 
The glow-type dataset (cobalt, zinc, copper) was analysed using a simple metric 
of reaction progression for the duration of the experiments (Section 8.2.6.3 and 8.3.4.2).  
It was found that the kinetics of zinc and copper were faster in the mutant than the wild 
type, whereas in cobalt no differences were observed.  This suggests that from a kinetics 
point of view, the mutant responded to the presence of zinc and copper more positively 
than wild-type aequorin did.  Cadmium did not conform with the standard models 
(flash-type or glow-type) in that its flash-type curve was followed by a distinct glow-
type shape and as a result its kinetic behaviour was left for future analysis.   
The study of mutant Asn28Cys/Ser32His in comparison to wild-type aequorin 
yielded some step improvements on certain aspects and allowed insight on some basic 
requirements and consequences of redesigning ion selectivity in the EF-hands of 
aequorin.  Additionally, Asn28Cys/Ser32His included mutations in only one EF-hand 
out of the three of aequorin.  Further work would be needed to approach a mutant with 
shifted selectivity toward new ions that will retain high luminescence yields. 
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9 Epilogue 
9.1 Overall summary of this project 
Aequorin is a bioluminescent photoprotein that emits a flash of blue light upon 
binding of calcium ions.  Due to this property, along with its non-invasive nature and its 
response to calcium in a biologically relevant dynamic range, aequorin has been used as 
a real-time intracellular bioreporter for more than forty years.  The active protein 
comprises of a polypeptide chain (apoaequorin) that non-covalently stabilises a 
chromophore (coelenterazine) in an intermediate oxidative state (hydroperoxy-
coelenterazine) within the polypeptide’s hydrophobic core.  Coelenterazine is the source 
of bioluminescence; the decarboxylation of hydroperoxy-coelenterazine leads to release 
of energy.  Aequorin has three highly conserved calcium-binding sites (EF-hand loops) 
that are exposed to the solvent and bind calcium ions with positive cooperativity.  The 
binding of calcium results in local and global conformational changes that ultimately 
lead to the decarboxylation of the hydroperoxy-coelenterazine. 
In the early days of the protein’s discovery it was noted that aequorin is 
potentially responsive to other cations; however, aequorin was highly selective toward 
calcium at biologically relevant concentrations and produced very low light yield in the 
presence of most other ions.  Members of the lanthanide group (e.g. lanthanum, 
terbium) constituted an exception, as they were found to be good substitutes for calcium 
in aequorin bioluminescence.  This potential promiscuity of aequorin towards other 
metal ions was not pursued further; researchers might have been discouraged by the 
significantly low light yields originally reported.   
In this work, the molecule of aequorin was used as a template in a strategy of 
rational mutations with the goal of creating a novel metal ion bioreporter.  The 
envisaged molecule would have high affinity towards new metals and 
reduced/abolished affinity for calcium.  Mutations were engineered with a bias for zinc 
and copper binding, as these metals are particularly interesting in the study of 
neurological diseases.  
The structure and function of the protein was discussed in detail through 
compilation of theoretical analysis and published literature (Chapters 1 and 5).  Previous 
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mutational work on aequorin and other calcium-binding proteins was used as a guide to 
make informed choices on a mutational strategy (Chapter 5).  A library of forty eight 
aequorin mutants was designed in order to be tested against seven metal ions as 
potential activators of bioluminescence: calcium, lanthanum, zinc, copper, cadmium, 
cobalt and lead.  The mutational approach consisted of: 
(1)  replacing the calcium-coordinating residues of aequorin with amino acids 
that are known to bind zinc and copper ions (histidine and cysteine).  These residues are 
exotic to the specific positions in the EF-hands of aequorin, all other photoproteins or 
any other member of the EF-hand superfamily.  Substitutions were made either one by 
one or in pairs of two per aequorin molecule.  Mutations of this type had not been 
reported in any previous work.  
(2)  removing functional groups from the calcium-coordinating positions of the 
EF-hand loops by means of alanine replacements. This would indicate whether the 
performance of mutants is due to the loss of the calcium-coordinating side chain 
oxygens (carboxyl- or hydroxyl-) or due to the introduction of sulfur atoms and 
imidazole nitrogens (from cysteine and histidine substitutions respectively).   
(3)  replacing the highly conserved central glycine of the calcium-binding loops 
with arginine.  The central glycine does not coordinate calcium but is present in all 
calcium-binding EF-hands and in the entire EF-hand superfamily.  It is assumed to act 
as a “hinge”, allowing the coordinating residues to reach for the calcium ion.  Arginine 
was thought to reduce the loop’s flexibility and hence impair binding of calcium and 
cooperative action between the EF-hands. 
Each of the three binding sites carries six coordinating residues.  It was 
impossible to exhaust all possibilities of the desired substitutions and their combinations 
within the duration of this project.  Most of the mutational work was prioritised for the 
loop of EF-I, followed by EF-III, with the least number of mutations designed for the 
loop of EF-IV.  This “ranking” was based on published work on the potential 
importance of the three EF-hands in aequorin activity.  A random or random-rational 
approach was reserved for a later stage, once the study of specific mutations would be 
conducted. 
The gene encoding for apoaequorin was cloned into an expression system 
(Chapter 3) in order to facilitate expression and screening of the mutant library.  The 
expression vector would incorporate the following features:  (1) promoter site and 
ribosome-binding site (RBS) for transcription and translation;  (2) signal peptide 
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sequence for localisation of the expressed apoaequorin in the periplasmic space of the 
cell, e.g. pelB leader sequence;  (3) 6×His-tag encoding sequence for the option of metal 
affinity purification;  (4) unique restriction sites flanking the apoaequorin gene. 
Following the cloning step a microplate based high-throughput screening (HTS) 
process was developed to include the following steps (Chapter 4):  (1) microwell 
cultures (inoculation and induction);  (2) charging of active protein by incubation with 
coelenterazine;  (3) copies of a 96-well microplate library;  (4) high-throughput 
screening luminescence activity assay 
A library of forty eight rational aequorin variants was created using site-directed 
mutagenesis.  The library was screened using the HTS method developed and the results 
were analysed based on two metrics:  (1) metric of the shift of ion selectivity (D) and 
(2) metric of % activity compared to wild type.  The results were analysed in relation to 
the type of mutation, its position in the protein (EF-hand and position within the EF-
hand) and type of metal ion tested. 
A number of mutants stood out for their shift of selectivity towards new ions.  
Due to time constraints only one candidate (Asn28Cys/Ser32His) was selected for 
further study.  This mutant carried two substitutions in the loop of EF-I and in the HTS 
activity assay exhibited high shift of preference toward zinc.   
In order to study the bioluminescence reaction without the contaminants present 
in the crude mix (diluted cell culture) of the HTS library, wild-type apoaequorin and 
Asn28Cys/Ser32His were produced and purified at lab scale (Chapter 7). 
The purified wild type and mutant were tested against a wide range of 
concentrations for each of the seven metal ions (Chapter 8).  The outputs of the analysis 
included:  (1) shape of luminescence versus time traces (flash- or glow-type);  
(2)  determination of ion effect (activation or inhibition) through concentration-response 
curves;  (3) sensitivity of the molecule to each ion (determination of EC50);  (4) kinetics 
of the reactions in both mutant and wild type triggered by the different metals;  
(5)  comparison of all ions on their ability to activate wild-type and mutant aequorin and 
(6)  discussion of the above findings in association with the size of metal ions and 
structural characteristics of the protein. 
Double ion experiments were also performed; in these experiments the protein 
sample was injected with a combination of zinc and calcium ions.  In principle, if 
affinity for zinc increased, this experiment would allow zinc to populate – and 
- 304 - 
potentially “activate” – the mutated EF-hand, whilst calcium ions would populate the 
remaining native EF-hands.   
9.2 Overall conclusions 
9.2.1 Cloning of apoaequorin gene 
Two expression vectors were successfully created: pETAQ is a pET26b 
derivative and TOPAQ is a pCR-Blunt II-TOPO® derivative, both containing the 
apoaequorin cDNA, the pelB signal peptide sequence, unique restriction sites flanking 
the gene and 6xHis-tag fusion downstream of the T7 promoter.  The pET cloning 
approach used predominantly restriction digest and ligation steps whereas for the 
TOPO® route the desired features were added by sequential PCR amplifications.  The 
TOPO® route was pursued as a mitigation strategy to the pET route.  As expected, the 
pET based vector was the higher expresser (verified in Chapter 4) and was used for all 
subsequent work.   
9.2.2 High-throughput screening process 
A practical, automated microplate-based process was successfully developed and 
optimised to cover every stage of the library creation and screening starting from 
colonies of transformants:  (1) cell culture, inoculation and induction;  (2) charging of 
active protein variants in microplates;  (3) replicate copies of the library and (4) 
bioluminescence activity screen.  The method was originally developed using wild-type 
aequorin and can be used with large libraries (using automated colony picking) or 
smaller rational mutation libraries (using manual picking).  The method utilised cell 
culture suspension (not purified protein) which still allowed for high activity signals and 
zero background noise.  It served as an initial “crude” screen of the entire library of 
mutants. 
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9.2.3 Mutant library screening 
In the majority of mutants studied, shift of selectivity towards new ions (and 
away from calcium) increases at the cost of activity (Chapter 6).  The vast majority of 
mutations lead to significant loss of activity (50–100% loss) compared to wild type.  
This observation was common for all ions tested.  In contrast to metric of retained 
activity (metric C) which is fairly uniform across the library, shift of selectivity (metric 
D) is markedly different in the EF-hands studied.  Some EF-I mutations exhibit high 
values of D whereas every mutant in EF-III exhibited very low values of the same 
metric.  Aequorin was able to function with only one intact EF-hand, at low but 
detectable levels of activity.   
EF-I may be the driver of aequorin selectivity.  EF-III does not seem to be 
endowed with ion selectivity properties in aequorin.  Indeed, results from impaired EF-
hand mutants (central Gly→Arg) suggest that loop flexibility is least required in EF-III.  
The same set of results suggests that EF-IV has significant potential as determinant of 
ion selectivity.  These experimental findings agree with previous structural observations 
(Chapter 5) that EF-III is already preformed to bind calcium and the helices attached to 
EF-I and EF-IV are potentially very important in the stability/destabilisation of 
hydroperoxy-coelenterazine through hydrogen bond interactions. 
Loss of even a single conserved calcium-coordinating side chain resulted in 
dramatic loss of activity.  This became evident from the alanine substitutions as well as 
from the histidine and cysteine substitutions.  The amino acids marking the entry and 
exit of the EF-hand loops (100% conserved) were the least tolerant to mutations.  
Within EF-I, the positions most important for modulation of ion selectivity are 5 and 12.  
As expected, non-coordinating or coordinating but non-conserved residues were more 
tolerant to mutations; such residues could be mutated to fine-tune ion selectivity with 
little cost on activity levels.   
The mutants that stood out for further work carried histidine or cysteine 
substitutions in position 5 of the EF-I loop.  Asn28Cys/Ser32His exhibited higher 
selectivity for zinc and lead, but not copper; Asn28His/Glu35Cys exhibited higher 
selectivity for lead; Asn28Cys/Glu35His exhibited higher selectivity for copper and 
lead.  One variant (Ala123Cys) exhibited improved lanthanum activity compared to 
calcium; however an EF-hand-like peptide with improved lanthanum activity had 
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already been reported and was not considered to be a novel outcome to pursue in this 
work. 
9.2.4 Purification of aequorin  
Wild-type apoaequorin and its variant Asn28Cys/Ser32His were purified from 
shake flask E. coli cultures using mild extraction conditions:  one-step periplasmic cell 
extraction and incubation with coelenterazine to form active protein, followed by size 
exclusion chromatography.  This approach yielded 0.61 mg of active wild type and 
0.24 mg of active mutant Asn28Cys/Ser32His, corresponding to purified 2.6 mg of wild 
type and 1.04 mg of mutant aequorin per 100 mL of E. coli culture.  The decreased yield 
of mutant monomer compared to wild type is attributed to its solvent-exposed cysteine, 
which likely caused higher order aggregates via intermolecular disulfide bridges.  The 
size exclusion chromatogram of the mutant indicates a larger elution peak at higher 
molecular weights compared to that of wild type.   
9.2.5 Study of purified wild-type aequorin and mutant 
Asn28Cys/Ser32His 
Significant loss of luminescence was observed in all experimental conditions – 
combinations of wild-type and mutant with all metal ions – compared to the activity of 
wild type aequorin with calcium.  All ions other than calcium act as partial activators for 
wild-type aequorin, each to a different extent.  Despite the lack of structural data, a 
reasonable assumption is that new ions bind to the EF-hands but fail to exert the full 
scale effect of the “native” activator.  Confirming previous reports on the wild type, 
lanthanum was a successful substitute for calcium, producing relatively high yields of 
luminescence (~70% compared to the peak of luminescence triggered by calcium) and a 
sigmoidal concentration-response curve, suggesting cooperativity in ion binding.  The 
levels of activation by the other ions were significantly lower (ranging from <1% up to 
40% of native activity) and in some cases produced bell-shaped concentration response 
curves.  This suggests that cooperativity links are broken and that some of the ions act 
as inhibitors at higher concentrations.   
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The most significant outcome was that EF-I was successfully altered to 
contribute to a mutant-specific improvement:  Asn28Cys/Ser32His was able to utilise 
zinc for its bioluminescence reaction when wild type was not.  A combination of zinc 
and calcium produced more light in the mutant variant than calcium alone did.  This 
was not the case in wild type.  On a theoretical basis it is reasonable to claim that the 
mutations in EF-I increased affinity for zinc and decreased affinity for calcium but the 
experimental results also proved that this affinity shift translates into protein function. 
A clear association emerged between the size of the metal ions and the efficiency 
of the bioluminescence reaction as expressed by the yield, the luminescence curves and 
the concentration-response curves.  The features of bioluminescence produced by wild 
type and calcium were set the as benchmark for the most efficient bioluminescence 
function possible.  The traces of luminescence versus time fell under two major 
categories:  (1)  flash-type luminescence, including the “classic” aequorin 
bioluminescence with native activator calcium and known substitute lanthanum and 
(2)  glow-type luminescence.  
The larger ions can interact electrostatically with protein atoms that are located at 
further positions of the EF-hand loop.  They are able to bind in coordination geometries 
of higher numbers, for example in octahedral geometry, which is the closest to the 
pentagonal bipyramidal binding of calcium in aequorin.  Cobalt – a small ion with 
similar size to zinc and copper – triggers sharper luminescence traces than zinc and 
copper and produces higher yields than those triggered by cadmium – a much bigger 
ion.  In databases of protein-metal and inorganic metal complexes, cobalt is shown to 
have a propensity to bind in octahedral coordination geometries.  These results were in 
line with the notion that successful binding is dictated by both the protein environment 
and the metal ion and that coordination geometry is more important than size of the ion 
alone (although size can inform coordination geometry options). 
Analysis of kinetics was based on the shape of the luminescence traces;  flash-
type traces were fitted to exponential decay curves whilst glow-type traces were 
analysed with an ad hoc metric for reaction progression.  In the flash-type sets (aequorin 
with calcium, lanthanum or lead), the contribution of mutant aequorin or of ions other 
than calcium and lanthanum resulted in slower kinetics.  A previously published 
model/assumption of two independent luminescence decay reactions was applied to the 
decay data.  In the glow-type sets (aequorin with cobalt, zinc or copper), the mutation 
seems to have increased the speed of the reaction for zinc and copper but not for cobalt, 
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suggesting that these mutations were a positive step toward a bioreporter for these 
metals.  Cadmium was not analysed in this work due to the shape of its luminescence 
curve (combination of sharp and glow-type) but would be interesting for further study.   
9.3 Future work 
This work produced an experimental platform for expressing and testing 
aequorin mutants in a high-throughput manner;  rational mutagenesis was used to gain 
insight on the effect of key amino acid substitutions.  It also highlighted the complexity 
of the task at hand.  In an oversimplified view, the successful function of aequorin as a 
bioreporter depends on two events overall:  binding of metal ions and propagation of the 
conformational changes from the three EF-hands to the protein core.  Direction for 
future work would involve the following considerations:  (1) a strategy for simplifying 
the problem;  (2) mutational approach;  (3) an alternative protein scaffold;  
(4)  alternative applications of the envisaged molecule. 
9.3.1 Breaking down the problem 
The problem can be broken into distinct projects: one pertaining to ion binding 
affinity, followed by one pertaining to activity.  Short peptides corresponding to the EF-
hand loop can be mutated and used as models for metal binding studies.  In order for 
such peptides to acquire a native-like fold, some alterations (disulfide bonds) will need 
to be incorporated.  It is also expected that the metal affinities between the peptides and 
metal ions will vary when the same motifs are incorporated in the structure of the entire 
aequorin molecule.  However this strategy will facilitate pure binding studies and 
remove the additional complexity of allostery and cooperativity in aequorin.  This 
approach was employed by other researchers in the past and described in Chapter 5.  
The sequences of the successful peptides can then be introduced in the aequorin 
structure or into protein scaffolds other than aequorin (an option also discussed later in 
this Chapter). 
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9.3.2 Mutational strategy  
Size of the binding cavity 
Size selectivity of the metal binding cavity was found to be decisive in 
aequorin’s effective response to metal ions.  In order for the EF-hand loop to 
accommodate smaller ions, a more drastic mutational strategy may examine decreasing 
the size of the loop by removal of amino acids.  In the past the opposite was done by 
addition of a glycine or substitution for a smaller coordinating residue (Glu→Asp) in 
order to effectively increase the size of the loop.  Placing at least one histidine and one 
cysteine as close as possible to the entry and exit of the binding loop could achieve a 
more prominent conformational response as a result of metal binding. 
Shortening the loop may have serious implications in the transmission of signal 
to the core of the protein.  It may also prove to be ineffective, as despite of reduction of 
the loop size, the distance between the two flanking α-helices which mark the entry and 
exit of the loop may not actually decrease sufficiently;  this distance is dictated by the 
remaining protein structure.  Finally, shortening the loop will alter the current pairing of 
the EF-hand loops (EF-I to EF-II and EF-III to EF-IV) and risk disrupting the 
conformational transduction cascade.   
Rational mutations in the binding sites 
The results of the mutant library screening (Chapter 6) showed that removal of 
any calcium-coordinating side chains is detrimental to aequorin’s response to calcium 
and that introduction of at least one histidine or cysteine can bring about a selectivity 
shift toward zinc, copper or lead.  New rational substitutions in the loop would be 
designed based on these initial findings. 
Random-rational mutations in the first coordination shell 
As next step after implementing and screening rational mutations in a shortened 
loop, a random-rational approach could be applied within and in the close vicinity of the 
binding site (e.g. using cassette mutagenesis or MEGAWHOP).  This approach would 
require screening of large mutant libraries.   
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Random-rational mutations in the extended protein structure 
In this work the mutational strategy was based on precise structural knowledge 
of the EF-hands and of coordination preferences of metal ions in proteins (as shown in 
statistical databases).  Mutations targeted the EF-hand loop, which comprises the first 
coordination shell of metal binding.  In future work, additional rounds of random 
mutagenesis will be required in the entirety of the molecule, exploring long range 
interactions for beneficial results in:  (1) the potential for repair of the aequorin activity 
and (2) additional metal selectivity modulation through distant mutations, which has 
been shown to be possible in metalloproteins. 
9.3.3 Repairing aequorin activity 
After altering the affinity of the metal binding sites, the scope of the next stage 
would be to restore the light yield of aequorin with further rounds of random 
mutagenesis.  In this work, the property that was rewarded was the shift of selectivity 
towards new ions and not the absolute yield.  In a screen aiming for repaired activity the 
selection should be based on absolute yields. 
9.3.4 Alternative scaffold 
In order to avoid the complexities of aequorin function and even the requirement 
for addition of coelenterazine, an alternative scaffold can be proposed for a metal ion 
bioreporter.  The proposed chimeric protein would incorporate at least one EF-hand and 
domains of a fluorescent molecule – e.g. variants of the green fluorescent protein (GFP).  
Conformational changes upon ion binding would translate in altering fluorescence 
emission characteristics of the chimera.  This approach is discussed in Chapter 1 and 
Section 1.2.5).  Omitting coelenterazine would remove light and temperature constraints 
in protein stability, as well as the need for introduction of coelenterazine by diffusion or 
microinjection.  It would allow for a bioreporter that can be utilised repeatedly and not 
depleted after one use. 
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9.3.5 Alternative application 
It would also be useful to consider the landscape of other options for a protein 
molecule that selects for specific metals from its environment.  An alternative goal from 
that of a biosensor would be to use a variant of apoaequorin immobilised on a surface 
(without its cofactor coelenterazine), or use another protein with multiple EF-hands as a 
“sponge” for toxic metals in bioremediation projects. 
9.4 Analytics for future work 
The experimental setup used in this work measures luminescence (activity 
assay).  For future work it would be advisable to complement results from the activity 
assay with analytics that provide additional insight into the binding event 
(conformational response to binding of metals) and the metal uptake by the protein. 
Conformational response 
Conformational responses of polypeptides upon ion binding can potentially be 
tracked by monitoring changes in the fluorescence spectra upon titration with metal 
ions.  This is a microplate based, high-throughput and inexpensive method but it 
requires the presence of aromatic amino acids.  If not already present, aromatic residues 
would need to be introduced in the structure at least for the screening stage.  It should 
be noted that any substitutions can affect the function of the peptide under study and 
may be undesirable in the final construct of the functional protein. 
Other methods that have been used to monitor changes in the structure of 
aequorin (or isolated EF-hand peptides) in response to presence of metal ions are 
nuclear magnetic resonance (NMR) spectroscopy, circular dichroism (CD) spectroscopy 
and electrospray mass spectroscopy.  These are all low-throughput options with 
relatively high sample consumption requirements – higher than the contents of a 
microwell – and NMR in particular is the most expensive, least accessible option.  To 
use such methods, interesting candidates would be cherry-picked based on the results of 
high-throughput bioluminescence (activity) and fluorescence (conformational changes) 
screening, produced in sufficient quantities and submitted for further analysis.  The 
bioluminescence activity assay would be applicable only if working with the entire 
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aequorin molecule, whereas a fluorescence assay that tracks conformational changes 
could be applicable to any polypeptide – provided that its structural changes can be 
translated into fluorescence changes.  Fit for purpose for each method would be verified 
before finalising the analytical strategy.   
Metal uptake 
The amount of metal ion bound by the protein can be deduced from the free 
metal ion remaining in the mixture after the luminescence assay.  Metal-sensitive 
electrodes can be used to measure free metal ions in the test sample.  Another method 
would be to use ultracentrifugation in order to precipitate out the protein with any 
metals bound and use atomic adsorption spectroscopy to measure unbound metals in the 
supernatant. 
These are both low-throughput methods and the sample requirement for metal-
sensitive electrodes exceeds the capacity of microplate formats.  In this case, analysis 
would be performed on mutants selected from an activity screen and later produced in 
the milliliter (instead of microliter) scale. 
Sensitivity and selectivity 
The successful candidate must be fit for its application and environment.  
Selectivity and sensitivity of the molecule to metal ions are both very important.  A tier 
of experiments pertaining to the intended use (e.g. in vivo for real-time intracellular 
imaging) would be required to qualify the envisaged biosensor.  If the bioreporter is not 
suitable for its intended environment, information on selectivity and sensitivity may 
help identify an alternative context where the bioreporter would be of value.   
Sensitivity is related to the bioavailability of the metal ion under study.  The 
bioreporter would be tested with the relevant range of metal ion concentrations.  For 
example, aequorin has been an excellent calcium sensor partly because its EC50 is 
within the biologically relevant range of intracellular calcium concentrations.  Zinc 
would require a far more sensitive sensor to detect changes in the biologically relevant 
range of this metal.  
Selectivity is related to the bioavailability of the metal ion under study versus 
potentially competing ions.  In this mutant library, selectivity is not shifted toward one 
new ion independently from the rest (Section 6.4.6).  Additional work would be 
required in order to achieve high affinity for one ion against a background of other 
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metals in a mixture.  If competing metals are not present in the specific environment 
under study (e.g. cell, cellular compartment), exclusivity of ion binding is not necessary.  
Using aequorin as an example, the lanthanides can be excellent replacements for 
calcium, however they are not present in the biological systems routinely studied. 
9.5 Value and risks of the project 
The search for a functional aequorin mutant with altered metal selectivity was a 
high risk-high gain endeavour.  Further work would be required to increase 
understanding of the structure-function of aequorin with alternative activator ions.  The 
canonical binding site of the EF-hand superfamily evolved to selectively bind calcium 
over a background of other metals.  Cooperativity between the EF-hands and the 
allosteric activation of the protein further complicate the project. 
The three ion binding sites (EF-hands) are spatially distinct from the domain 
where light is produced (hydrophobic core of the protein).  There is no guarantee that 
successful shift of the binding loop affinities for a new metal ion can accommodate the 
necessary conformational changes for production of light.  The risk was reflected in the 
results, whereby improved response of mutant to zinc resulted in significant loss of 
activity compared to aequorin’s full potential. 
Additional risk was in assuming promiscuity of aequorin toward other metal 
ions;  this was originally reported in the 1960s but no follow up work was performed.  
There was a risk that aequorin luminescence with various ions was merely due to non-
specific binding which caused destabilisation and discharge of the protein.  In this work, 
the fact that different ions induce different types of luminescence profiles and 
concentration-response curves suggests that different ions indeed exert different impact 
on the activity of aequorin and that an attempt to study and tweak their binding was 
valid. 
In terms of the rational mutagenesis strategy, the single and double substitutions 
constituted a rather crude initial approach.  The work with forty eight mutants produced 
useful information on the importance of the three EF-hands and of specific positions 
and residues within the EF-hand loops in the response of aequorin to various metals.   
Most mutations in a protein are expected to be deleterious.  The designed 
mutations were not expected to completely transform the ion binding sites in favour of 
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new ions whilst retaining the full activity of the native protein, for the following 
reasons:  (1) canonical EF-hands are fine-tuned to be highly selective for calcium;  (2) 
the mutants of this library contain only single or double mutations out of a total of 
eighteen ion-coordinating positions across the entire molecule and (3) activity is 
dependent on successful binding followed by propagation of each binding event through 
an intricate network of cooperativity and allosteric activation.  It is highly unlikely to 
completely redesign the EF-hand loops whilst keeping the allosteric and cooperative 
functions intact so that the appropriate conformational changes are propagated to the 
centre of the molecule for effective bioluminescence production.   
In continuing to pursue the originally envisaged aequorin mutant, it should be 
noted that the mechanism of calcium binding and cooperativity have co-evolved in 
aequorin, thus the potential for a highly functional molecule with altered ion selectivity 
may not be achieved.  The options discussed in Future work (Section 9.3) can be viable 
alternatives, although they too have limitations to be considered on an individual basis.   
Finally, it is hoped that the present work may contribute to future methodologies 
of screening mutant libraries and identifying promising mutants for new applications.  
This itself is an interesting challenge, especially when there is a trade-off between two 
desired properties (e.g. selectivity and yield).  To reward only high activity mutants 
could lead to missed opportunities.  Disqualifying mutants with low activity in the first 
rounds of screening would exclude valuable candidates where activity could have been 
restored with further rounds of mutagenesis.  Also, certain desired properties cannot be 
directly measured but must be deciphered (e.g. gradual shifts in selectivity) with 
appropriate ad hoc metrics.  
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Appendix  
Appendix Chapter 1 
Table 10-1  Intracellular metal ion sensors 
 
Type of sensor 
 
 
Name 
 
Application 
 
Reference 
bioluminescent protein aequorin  (Czarnik, 1995) 
Fluorescent, synthetic Fura-2 Ca2+, Zn2+, Mn2+, Pb2+, 
Ba2+, Cd2+, Co2+, Sr2+ 
Kwan and Putney, 1990; Hinkle et al, 1992; 
Tomsig and Suszkiw, 1990; Atar et al, 1995;   
Zinpyr-labeled fusion proteins  Zn2+ Tomat et al, 2008 in(Palmer, 2009) 
Derivatives of benzylguanine linked to Indo-1 BG-Indo-1, BG-Indo-
2, BG-Indo-3 
Ca2+ (Keppler et al., 2003) and Gronemeyer et al, 
2006 in Palmer, 2009 
BG-Indo-1 derivatives reacted with SNAP-tag  SNAP-Indo-1 Ca2+ Bannwarth et al, 2009 in Palmer, 2009 
FRET-based, ECFP-calmodulin-M13-cpVenus 
(redesigned calmodulin and M13),  
interaction of domains 
Cameleon D3 Ca2+ Palmer et, 2006 & Wallace et al, 2008 in 
Chudakov et al, 2010 
FRET-based, ECFP-calmodulin-M13-cpVenus, 
interaction of domains 
Yellow Cameleon 3.6 Ca2+ Nagai et al, 2004 in Chudakov et al, 2010 
FRET-based, CFP-2x(COOH-terminal lobe of 
troponin C)-cpYFP, structural rearrangement of 
domain 
TN-XXL Ca2+ Mank et al, 2008 in Chudakov et al, 2010 
Insertion of structurally rearranging calmodulin 
domain into YFP 
Camgaroo-2 Ca2+ Griesbeck et al, 2001in Chudakov et al, 2010 
Single cpFP fused to interacting domains,  
M13-cpGFP-calmodulin 
Case12 Ca2+ Souslova et al, 2007 in Chudakov et al, 2010 
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Type of sensor 
 
 
Name 
 
Application  
 
Reference  
Single cpFP fused to interacting domains,  
M13-cpGFP-calmodulin 
GCaMP3 Ca2+ Tallini et al, 2006 & Tian et al, 2009 in 
Chudakov et al, 2010 
Fluo-3 dye  Ca2+ Czarnik, 1995 
Quin-2  Ca2+ Czarnik, 1995 
Fura-2  Ca2+ Czarnik, 1995 
SBF1  Na+ Czarnik, 1995 
PBF1  K+ Czarnik, 1995 
SPQ  Cl- Czarnik, 1995 
TMAPQ  Cl- Czarnik, 1995 
FURAPTRA (Mag-fura-2)  Mg2+ Czarnik, 1995 
FRET, Intramolecular single domain, apoK1-er, CFP 
YFP 
 Ca2+ Osibow et al, 2006 in Li et al, 2006 
FRET, Intramolecular multiple domain, CaM M13, 
CFP YFP BFP GFP 
 Ca2+ Miyawaki et al, 1997 in Li et al, 2006 
Small fluophore Zinquin Zn2+ Colvin et al, 2006 
Small fluophore ZnAF-1, ZnAF-2, 
ZnAF-3 
Zn2+ Hirano et al, 2000; Hirano et al, 2002; 
Komatsu et al, 2005  
Small fluophore FluoZin-1, FluoZin-
2, FluoZin-3 
Zn2+ Eichelsdoerfer et al, 2010; Domaille et al, 
2008 ; Gee et al, 2002 
Small fluophore FuraZin Zn2+ (Sensi et al., 1999) 
Small fluophore RhodZin-3 Zn2+ (Sensi et al., 2003) 
   (Colvin et al., 2008, Kikuchi et al., 2004) 
Phenanthroline-based Phen Green FL  Cu2+, Cu+, Fe2+, Hg2+, 
Pb2+, Cd2+, Ni2+ 
(Tougu et al., 2008)  
luxCDABE-based  Pb2+, Hg2+, Zn2+ Corbisier et al, 1996; Barkay et al, 1998; Erbe 
et al, 1996  
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Table 10-2  Multiple alignment of calcium-binding proteins a) aequorin, b) mitrocomin, c) obelin, d) clytin, e) human calcmodulin f) bovine 
calmodulin, g) human parvalbumin, h) intestinal Ca2+-binding protein, i) sarcoplasmic Ca2+-binding protein and j) troponin C using ClustalW 
(Thompson, 1994) (DNA and protein sequence IDs in Table 1–6). 
  
                                        EF-I       
a: T P D F D N P K W I G R H K H M F N F L D V N H N G R I S L D E M V Y 
b: T T D F D N P K W I A R H K H M F N F L D I N S N G Q I N L N E M V H 
c: K T D F D N P R W I K R H K H M F D F L D I N G N G K I T L D E I V S 
d: R P N F D N P K W V N R H K F M F N F L D I N G D G K I T L D E I V S 
e: M A D Q L T E E Q I A E F K E A F S L F D K D G D G T I T T K E L G - 
f: - A D Q L T E E Q I A E F K E A F S L F D K D G D G T I T T K E L G - 
g: M T D L L N A E D I K K A V G A F S A T D S - - - - - - - - - - - - - 
h: - - - - K S P E E L K G I F E K Y A A K E G D P N - - - - - - - - - - 
i: L N D F Q K Q K I K F T F D F F L D M N H D G S I Q D N D F E D M M T 
j: - - - - - - - - G V F Y F N M N R V F V Y G - - - - - - - - - - - - - 
Table 10-2 continued 
  
                                                                      
a: K A S D I V I N N L G A T P E Q A K R H K D A V E A F F G G A G M K Y 
b: K A S N I I C K K L G A T E E Q T K R H Q K C V E D F F G G A G L E Y 
c: K A S D D I C A K L E A T P E Q T K R H Q V C V E A F F R G C G M E Y 
d: K A S D D I C A K L G A T P E Q T K R H Q D A V E A F F K K I G M D Y 
e: - - - - T V M R S L G Q N P T E A E L Q D M I N E V D A D D L - - P G 
f: - - - - T V M R S L G Q N P T E A E L Q D M I N E V D A D - - - - - G 
g: - - - - - - - - - - - - - - - - - F D H K K F F Q M V G L K K - - - - 
h: - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
i: R Y K E V N K G S L S D A D Y K S M Q A S L E D E W R D L K G R A D I 
j: - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
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Table 10-2 continued 
  
                                                                      
a: G V E T E W P E Y I E G W K R L A S E E L K R Y S K N Q I T L I R L W 
b: D K D T T W P E Y I E G W K R L A K T E L E R H S K N Q V T L I R L W 
c: G K E I A F P Q F L D G W K Q L A T S E L K K W A R N E P T L I R E W 
d: G K E V E F P A F V D G W K E L A N H D L K L W S Q N K K S L I R D W 
e: N G T I D F P E F L T - - - - - - - - - - M M A R K M K D T D S E E E 
f: N G T I D F P E F L T - - - - - - - - - - M M A R K M K D T D S E E E 
g: - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - K S A D D 
h: - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
i: N K D D V V S W E E Y L A M W E K T I A T C K S V A D L P A W C Q N R 
j: - - - - - - - - - - - - - - - - - - - - - -       - - - - - - - - - - 
 
Table 10-2 continued 
  
  
              
 EF-III                                
a: G D A L F D I I D K D Q N G A I S L D E W K A Y T K S A G - - - I I Q 
b: G D A L F D I I D K D R N G S V S L D E W I Q Y T H C A G - - - I Q Q 
c: G D A V F D I F D K D G S G T I T L D E W K A Y G K I S G - - - I S P 
d: G E A V F D I F D K D G S G S I S L D E W K A Y G R I S G - - - I C S 
e: I R E A F R V F D K D G N G Y I S A A E L R H V M T N L G - - - E K L 
f: I R E A F R V F D K D G N G Y I S A A E L R H V M T N L G - - - E X L 
g: V K K V F H M L D K D K S G F I E E D E L G F I L K G F S P D A R D L 
h: - - - - - - Q L S K E E L K L L L Q T E F P S L L K G G S - - - - - - 
i: I P F L F K G M D V S G D G I V D L E E F Q N Y C K N F Q - - - - - L 
j: - - - - - - - - - T L K R G Q P N H F A L S E V G N E R Y T Y I G - - 
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Table 10-2 continued 
  
                        
 EF-IV                        
a: S S E D C E E T F R V C D I D E S G Q L D V D E M T R Q H L G F W Y T 
b: S R G Q C E A T F A H C D L D G D G K L D V D E M T R Q H L G F W Y S 
c: S Q E D C E A T F R H C D L D D S G D L D V D E M T R Q H L G F W Y T 
d: S D E D A E K T F K H C D L D N S G K L D V D E M T R Q H L G F W Y T 
e: T D E E V D E M I R E A D I D G D G Q V N Y E E F V Q M M T A K - - - 
f: T D E E V D E M I R E A D I D G D G Q V N Y E E F V Q M M T A K - - - 
g: S A K E T K M L M A A G D K D G D G K I G V D E F S T L V A E S - - - 
h: - - - T L D E L F E E L D K N G D G E V S F E E F Q V L V K K I S Q - 
i: Q C A D V P A V Y N V I T D G G K V T F D L N R Y K E L Y Y R L L T S 
j: - - - - - - - N G F T S T K C P L V I A S E H N I P Y L M D K E G N G 
Table 10-2 continued 
  
                                    
a:    M D P A C E K L Y G G A V P - 
b:    V D P T C E G L Y G G A V P Y 
c:    L D P E A D G L Y G N G V P - 
d:    L D P N A D G L Y G N F V P - 
e:    - - - - - - - - - - - - - - - 
f:    - - - - - - - - - - - - - - - 
g:    - - - - - - - - - - - - - - - 
h:    - - - - - - - - - - - - - - - 
i:    P A A D A G N T L M G Q K P - 
j: Y V - - - - - - - - - - - - - - - - 
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Table 10-3  Preferred coordination geometries of metal ions in CSD structures.  Table 
reproduced from Kuppuraj et al, 2009. 
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Table 10-4  Metal-ligand distances in the CSD and PDB.  The numbers of 
observations and mean distances in structures in the PDB determined at near atomic 
resolution and in the CSD with R factor < 0.065.  Sample standard deviations and 
metal-coordination numbers from all coordination geometries are included.  Table 
reproduced from Harding, 2006.   
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Table 10-5  Average metal-ligand distances for metal ions as a function of metal 
charge, coordination number (CN), donor atom’s charge and coordination number of 
ligand (number of atoms connected to the donor atom of the ligand).  Table 
reproduced from Kuppuraj et al, 2009. 
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Appendix Chapter 5 
Table 10-6  Primers for mutants Nr 1-8 
#  Numbering 
according to 
1EJ3 
Numbering 
according to 
1SL8 
position 
in       
EF-I 
position 
in         
EF-III 
position 
in        
EF-IV 
 Primer sequence 5’-3’ 
1 Asp24Ala Asp26Ala 1   For CACAAGCACATGTTTAATTTTCTTGCGGTCAACCACAATGGAAGGATCTCTC 
      Rev GAGAGATCCTTCCATTGTGGTTGACCGCAAGAAAATTAAACATGTGCTTGTG 
2 Asn26Ala Asn28Ala 3   For GCACATGTTTAATTTTCTTGATGTCGCGCACAATGGAAGGATCTCTCTTGACG 
      Rev CGTCAAGAGAGATCCTTCCATTGTGCGCGACATCAAGAAAATTAAACATGTGC 
3 Asn28Ala Asn30Ala 5   For GTTTAATTTTCTTGATGTCAACCACGCGGGAAGGATCTCTCTTGACGAGATGG 
      Rev CCATCTCGTCAAGAGAGATCCTTCCCGCGTGGTTGACATCAAGAAAATTAAAC 
4 Ser32Ala Ser34Ala 9   For CTTGATGTCAACCACAATGGAAGGATCGCGCTTGACGAGATGGTCTACAAGG 
      Rev CCTTGTAGACCATCTCGTCAAGCGCGATCCTTCCATTGTGGTTGACATCAAG 
5 Glu35Ala Glu37Ala 12   For GGAAGGATCTCTCTTGACGCGATGGTCTACAAGGCGTCCGATATTG 
      Rev CAATATCGGACGCCTTGTAGACCATCGCGTCAAGAGAGATCCTTCC 
6 Gly29Arg Gly31Arg 6   For ACCACAATCGTAGGATCTCTC 
      Rev AGATCCTACGATTGTGGTTG 
7 Gly122Arg Gly124Arg  6  For ACCAAAATCGTGCTATTTCAC 
      Rev TGAAATAGCACGATTTTGGTC 
8 Gly158Arg Gly160Arg   6 For ATGAAAGTCGTCAGCTCGATG 
      Rev ATCGAGCTGACGACTTTCATC 
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Table 10-7  Primers for mutants Nr 9-17 
#  Numbering 
according to 1EJ3 
Numbering 
according to 1SL8 
position 
in    
EF-I 
position 
in    
EF-III 
position 
in     
EF-IV 
 Primer sequence 5’-3’ 
9 Gly29Arg/Gly122Arg Gly31Arg/Gly124Arg 6 6  For Template Gly29Arg, primers of #7 
      Rev Template Gly29Arg, primers of #7 
10 Gly29Arg/Gly158Arg Gly31Arg/Gly160Arg 6  6 For Template Gly29Arg, primers of #8 
      Rev Template Gly29Arg, primers of #8 
11 Gly122Arg/Gly158Arg Gly124Arg/Gly160Arg  6 6 For Template Gly122Arg, primers of #8 
      Rev Template Gly122Arg, primers of #8 
12 Asp24His Asp26His 1   For AAGCACATGTTTAATTTTCTTCATGTCAACCACAATGGAAGG 
      Rev TTCCATTGTGGTTGACATGAAGAAAATTAAACATGTGCTTG 
13 Val25His Val27His 2   For CATGTTTAATTTTCTTGATCATAACCACAATGGAAGGATC 
      Rev GATCCTTCCATTGTGGTTATGATCAAGAAAATTAAACATG 
14 Asn26His Asn28His 3   For ATGTTTAATTTTCTTGATGTCCATCACAATGGAAGGATCTC 
      Rev AGATCCTTCCATTGTGATGGACATCAAGAAAATTAAACATG 
15 Asn28His Asn30His 5   For TTCTTGATGTCAACCACCATGGAAGGATCTCTCTTGACG 
      Rev TCGTCAAGAGAGATCCTTCCATGGTGGTTGACATCAAG 
16 Ser32His Ser34His 9   For GTCAACCACAATGGAAGGATCCATCTTGACGAGATGGTCTACAAGG 
      Rev CCTTGTAGACCATCTCGTCAAGATGGATCCTTCCATTGTGGTTGAC 
17 Glu35His Glu37His 12   For ACAATGGAAGGATCTCTCTTGACCATATGGTCTACAAGGCG 
      Rev GCCTTGTAGACCATATGGTCAAGAGAGATCCTTCCATTGTG 
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Table 10-8  Primers for mutants Nr 18-23 
#  Numbering 
according to 1EJ3 
Numbering 
according to 1SL8 
position 
in EF-I 
position 
in EF-III 
position 
in EF-IV 
 Primer sequence 5’-3’ 
18 Asp24Cys Asp26Cys 1   For AGCACATGTTTAATTTTCTTTGCGTCAACCACAATGGAAGG 
      Rev CCTTCCATTGTGGTTGACGCAAAGAAAATTAAACATGTGC 
19 Val25Cys Val27Cys 2   For CATGTTTAATTTTCTTGATCATAACCACAATGGAAGGATC 
      Rev GATCCTTCCATTGTGGTTATGATCAAGAAAATTAAACATG 
20 Asn26Cys Asn28Cys 3   For ATGTTTAATTTTCTTGATGTCTGCCACAATGGAAGGATCTC 
      Rev GAGATCCTTCCATTGTGGCAGACATCAAGAAAATTAAACATG 
21 Asn28Cys Asn30Cys 5   For TTCTTGATGTCAACCACTGCGGAAGGATCTCTCTTGACG 
      Rev CTCGTCAAGAGAGATCCTTCCGCAGTGGTTGACATCAAG 
22 Ser32Cys Ser34Cys 9   For GTCAACCACAATGGAAGGATCTGCCTTGACGAGATGGTCTACAAGG 
      Rev CCTTGTAGACCATCTCGTCAAGGCAGATCCTTCCATTGTGGTTGAC 
23 Glu35Cys Glu37Cys 12   For ACAATGGAAGGATCTCTCTTGACTGCATGGTCTACAAGGCG 
      Rev CTTGTAGACCATGCAGTCAAGAGAGATCCTTCCATTGTG 
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Table 10-9  Primers for mutants Nr 24-32 
#  Numbering 
according to 
1EJ3 
Numbering 
according to 
1SL8 
position 
in      
EF-I 
position 
in       
EF-III 
position 
in      
EF-IV 
 Primer sequence 5’-3’ 
24 Asp117His Asp119His  1  For GGTGATGCATTGTTCGATATCATTCATAAAGACCAAAATGGAGCTATTTCACTGG 
      Rev CCAGTGAAATAGCTCCATTTTGGTCTTTATGAATGATATCGAACAATGCATCACC 
25 Asp119His Asp121His  3  For CATTGTTCGATATCATTGACAAACATCAAAATGGAGCTATTTCACTGG 
      Rev CCAGTGAAATAGCTCCATTTTGATGTTTGTCAATGATATCGAACAATG 
26 Asp121His Asp123His  5  For CGATATCATTGACAAAGACCAACATGGAGCTATTTCACTGGATGAATGG 
      Rev CCATTCATCCAGTGAAATAGCTCCATGTTGGTCTTTGTCAATGATATCG 
27 Ala123His Ala125His  7  For CGATATCATTGACAAAGACCAAAATGGACATATTTCACTGGATGAATGG 
      Rev CCATTCATCCAGTGAAATGCATCCATTTTGGTCTTTGTCAATGATATCG 
28 Thr125His Ser127His  9  For GACAAAGACCAAAATGGAGCTATTCATCTGGATGAATGGAAAGCATACACC 
      Rev GGTGTATGCTTTCCATTCATCCAGATGAATAGCTCCATTTTGGTCTTTGTC 
29 Asp127His Asp129His  11  For CCAAAATGGAGCTATTTCACTGCATGAATGGAAAGCATACACCAAATCTGC 
      Rev GCAGATTTGGTGTATGCTTTCCATTCATGCAGTGAAATAGCTCCATTTTGG 
30 Glu128His Glu130His  12  For CCAAAATGGAGCTATTTCACTGGATCATTGGAAAGCATACACCAAATCTGC 
      Rev GCAGATTTGGTGTATGCTTTCCAATGATCCAGTGAAATAGCTCCATTTTGG 
31 Asp117Cys Asp119Cys  1  For GGTGATGCATTGTTCGATATCATTTGCAAAGACCAAAATGGAGCTATTTCACTGG 
      Rev CCAGTGAAATAGCTCCATTTTGGTCTTTGCAAATGATATCGAACAATGCATCACC 
32 Asp119Cys Asp121Cys  3  For CATTGTTCGATATCATTGACAAATGCCAAAATGGAGCTATTTCACTGG 
      Rev CCAGTGAAATAGCTCCATTTTGGCATTTGTCAATGATATCGAACAATG 
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Table 10-10  Primers for mutants Nr 33-40 
#  Numbering 
according to 1EJ3 
Numbering 
according to 1SL8 
position 
in     
EF-I 
position 
in     
EF-III 
position 
in     
EF-IV 
 Primer sequence 5’-3’ 
33 Asp121Cys Asp123Cys  5  For TTCGATATCATTGACAAAGACCAATGCGGAGCTATTTCACTGGATGAATGG 
      Rev CCATTCATCCAGTGAAATAGCTCCGCATTGGTCTTTGTCAATGATATCGAA 
34 Ala123Cys Ala125Cys  7  For CGATATCATTGACAAAGACCAAAATGGATGCATTTCACTGGATGAATGG 
      Rev CCATTCATCCAGTGAAATGCATCCATTTTGGTCTTTGTCAATGATATCG 
35 Thr125Cys Ser127Cys  9  For GACAAAGACCAAAATGGAGCTATTTGCCTGGATGAATGGAAAGCATACACC 
      Rev GGTGTATGCTTTCCATTCATCCAGGCAAATAGCTCCATTTTGGTCTTTGTC 
36 Asp127Cys Asp129Cys  11  For CCAAAATGGAGCTATTTCACTGTGCGAATGGAAAGCATACACCAAATCTGC 
      Rev GCAGATTTGGTGTATGCTTTCCATTCGCACAGTGAAATAGCTCCATTTTGG 
37 Glu128Cys Glu130Cys  12  For CCAAAATGGAGCTATTTCACTGGATTGCTGGAAAGCATACACCAAATCTGC 
      Rev GCAGATTTGGTGTATGCTTTCCAGCAATCCAGTGAAATAGCTCCATTTTGG 
38 Asn28Cys/Glu35His Asn30Cys/Glu37His 5, 12   For GGAAGGATCTCTCTTGACCATATGGTCTACAAGGCGTC 
      Rev GACGCCTTGTAGACCATATGGTCAAGAGAGATCCTTCC 
39 Asn28His/Glu35Cys Asn30His/Glu37Cys 5, 12   For GAAGGATCTCTCTTGACTGCATGGTCTACAAGG 
      Rev CCTTGTAGACCATGCAGTCAAGAGAGATCCTTC 
40 Asn28Cys/Ser32His Asn30Cys/Ser34His 5, 9   For GTCAACCACTGCGGAAGGATCCATCTTGACGAGATGGTCTACAAG 
      Rev CTTGTAGACCATCTCGTCAAGATGGATCCTTCCGCAGTGGTTGAC 
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Table 10-11  Primers for mutants Nr 41-48 
#  Numbering 
according to 1EJ3 
Numbering 
according to 1SL8 
position 
in EF-I 
position 
in EF-III 
position 
in EF-IV 
 Primers, template 
41 Asn28Cys/Asp119His Asn30Cys/Asp121His 5 3   template Asn28Cys, primers for Asp119His  
42 Asn28Cys/Asp121His Asn30Cys/Asp121His 5 5   template Asn28Cys, primers for Asp121His  
43 Asn28Cys/Ser125His Asn30Cys/Ser127His 5 9   template Asn28Cys, primers for Ser125His 
44 Asn28Cys/Asp127His Asn30Cys/Asp129His 5 11   template Asn28Cys, primers for Asp127His  
45 Asn28Cys/Asp119Cys Asn30Cys/Asp121Cys 5 3   template Asn28Cys, primers for Asn28Cys 
46 Asn28Cys/Asp121Cys Asn30Cys/Asp123Cys 5 5   template Asn28Cys, primers for Asp121Cys 
47 Asn28Cys/Asp127Cys Asn30Cys/Asp129Cys 5 11   template Asn28Cys, primers for Asp127Cys  
48 Asn28Cys/Ser125Cys Asn30Cys/Ser127Cys 5 9   template Asn28Cys, primers for Ser125Cys  
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Table 10-12  Ionic radii of metals according to their coordination and spin state.  
Original data from Shannon, 1976.  
Element Charge Coordination Spin State Ionic Radius 
Copper IV 2 IV       0.57 
Copper IVSQ 2 IVSQ     0.57 
Cobalt IV 2 IV   High spin 0.58 
Zinc IV 2 IV       0.6 
Cobalt VI ls 2 VI Low spin 0.65 
Copper V 2 V     0.65 
Cobalt V 2 V   0.67 
Zinc V 2 V     0.68 
Copper VI 2 VI     0.73 
Zinc VI 2 VI     0.74 
Cobalt VI  2 VI High spin 0.745 
Cadmium IV 2 IV       0.78 
Cadmium V 2 V     0.87 
Cadmium VI 2 VI     0.95 
Lead IVPY 2 IVPY       0.98 
Calcium VI 2 VI       1.00 
Cadmium VII 2 VII     1.03 
Lanthanum VI 3 VI       1.032 
Calcium VII 2 VII     1.06 
Lanthanum VII 3 VII     1.1 
Lead VI 2 VI     1.19 
Lead VII 2 VII     1.23 
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Appendix Chapter 6 
Table 10-13  Library OD(600 nm) for aequorin wild-type and mutants.  OD values were 
converted from platereader into spectrometer units as described in Chapter 4, Section 
4.4.1.  Positions of triplicates are indicated through bold outlines and the wild type 
internal controls of each plate are highlighted.  
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10 20 30 40 50 60
....|....|....|....|....|....|....|....|....|....|....|....|
Aequorin WT ATGACCAGCGAACAATACTCAGTCAAGCTTACACCAGACTTCGACAACCCAAAATGGATT
Asn28Cys ATGACCAGCGAACAATACTCAGTCAAGCTTACACCAGACTTCGACAACCCAAAATGGATT
70 80 90 100 110 120
....|....|....|....|....|....|....|....|....|....|....|....|
Aequorin WT GGACGACACAAGCACATGTTTAATTTTCTTGATGTCAACCACAATGGAAGGATCTCTCTT
Asn28Cys GGACGACACAAGCACATGTTTAATTTTCTTGATGTCAACCACTGCGGAAGGATCTCTCTT
130 140 150 160 170 180
....|....|....|....|....|....|....|....|....|....|....|....|
Aequorin WT GACGAGATGGTCTACAAGGCGTCCGATATTGTTATAAACAATCTTGGAGCAACACCTGAA
Asn28Cys GACGAGATGGTCTACAAGGCGTCCGATATTGTTATAAACAATCTTGGAGCAACACCTGAA
190 200 210 220 230 240
....|....|....|....|....|....|....|....|....|....|....|....|
Aequorin WT CAAGCCAAACGTCACAAAGATGCTGTAGAAGCCTTCTTCGGAGGAGCTGGAATGAAATAT
Asn28Cys CAAGCCAAACGTCACAAAGATGCTGTAGAAGCCTTCTTCGGAGGAGCTGGAATGAAATAT
250 260 270 280 290 300
....|....|....|....|....|....|....|....|....|....|....|....|
Aequorin WT GGTGTAGAAACTGAATGGCCTGAATACATCGAAGGATGGAAAAGACTGGCTTCCGAGGAA
Asn28Cys GGTGTAGAAACTGAATGGCCTGAATACATCGAAGGATGGAAAAGACTGGCTTCCGAGGAA
310 320 330 340 350 360
....|....|....|....|....|....|....|....|....|....|....|....|
Aequorin WT TTGAAAAGGTATTCAAAAAACCAAATCACACTTATTCGTTTATGGGGTGATGCATTGTTC
Asn28Cys TTGAAAAGGTATTCAAAAAACCAAATCACACTTATTCGTTTATGGGGTGATGCATTGTTC
370 380 390 400 410 420
....|....|....|....|....|....|....|....|....|....|....|....|
Aequorin WT GATATCATTGACAAAGACCAAAATGGAGCTATTTCACTGGATGAATGGAAAGCATACACC
Asn28Cys GATATCATTGACAAAGACCAAAATGGAGCTATTTCACTGGATGAATGGAAAGCATACACC
430 440 450 460 470 480
....|....|....|....|....|....|....|....|....|....|....|....|
Aequorin WT AAATCTGCTGGCATCATCCAATCGTCAGAAGATTGCGAGGAAACATTCAGAGTGTGCGAT
Asn28Cys AAATCTGCTGGCATCATCCAATCGTCAGAAGATTGCGAGGAAACATTCAGAGTGTGCGAT
490 500 510 520 530 540
....|....|....|....|....|....|....|....|....|....|....|....|
Aequorin WT ATTGATGAAAGTGGACAGCTCGATGTTGATGAGATGACAAGACAACATTTAGGATTTTGG
Asn28Cys ATTGATGAAAGTGGACAGCTCGATGTTGATGAGATGACAAGACAACATTTAGGATTTTGG
550 560 570 580 590 600
....|....|....|....|....|....|....|....|....|....|....|....|
Aequorin WT TACACCATGGATCCTGCTTGCGAAAAGCTCTACGGTGGAGCTGTCCCCCTCGAGCACCAC
Asn28Cys TACACCATGGATCCTGCTTGCGAAAAGCTCTACGGTGGAGCTGTCCCCCTCGAGCACCAC
610
....|....|....|
Aequorin WT CACCACCACCACTGA
Asn28Cys CACCACCACCACTGA
 
Figure 10-1  Sequencing results for mutant Asn28Cys.  The mutation AAT→TGC, 
corresponding to Asn→Cys at amino acid position 5 of the loop in EF-I is highlighted. 
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Appendix Chapter 7 
Optimisation of cold incubation conditions 
The type and concentration of reducing agents was improved during this 
experiment.  Bacterial pellet containing apoaequorin and harvested from 50 mL culture 
was incubated overnight in two different ice-cold buffers:  (1) 50 mM Tris-HCl, 10 mM 
EDTA, 5 mM 2-mercaptoethanol and (2) 50 mM Tris-HCl, 10 mM EDTA, 10 mM 
DTT.   
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Figure 10-2  Optimisation of reducing agent in charging of aequorin. 
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Appendix Chapter 8 
 
Table 10-14  Gain settings used for luminescence curves. 
 Wild-type aequorin___ Mutant Asn28Cys/Ser32His 
Calcium 2,500 4,000 
Lanthanum 2,500 4,000 
Lead 2,500 4,000 
Cadmium 2,500 4,000 
Cobalt 2,500 4,000 
Zinc 3,900 4,000 
Copper 3,000 4,000 
Zinc+calcium 2,500 4,000 
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